
<html lang="en"     class="pb-page"  data-request-id="d7e2f7e1-85bc-4c83-aee3-b150c804a47c"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2016.59.issue-23;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.6b01373"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Novel and High Affinity 2-[(Diphenylmethyl)sulfinyl]acetamide (Modafinil) Analogues as Atypical Dopamine Transporter Inhibitors" /></meta><meta name="dc.Creator" content="Jianjing  Cao" /></meta><meta name="dc.Creator" content="Rachel D.  Slack" /></meta><meta name="dc.Creator" content="Oluyomi M.  Bakare" /></meta><meta name="dc.Creator" content="Caitlin  Burzynski" /></meta><meta name="dc.Creator" content="Rana  Rais" /></meta><meta name="dc.Creator" content="Barbara S.  Slusher" /></meta><meta name="dc.Creator" content="Theresa  Kopajtic" /></meta><meta name="dc.Creator" content="Alessandro  Bonifazi" /></meta><meta name="dc.Creator" content="Michael P.  Ellenberger" /></meta><meta name="dc.Creator" content="Hideaki  Yano" /></meta><meta name="dc.Creator" content="Yi  He" /></meta><meta name="dc.Creator" content="Guo-Hua  Bi" /></meta><meta name="dc.Creator" content="Zheng-Xiong  Xi" /></meta><meta name="dc.Creator" content="Claus J.  Loland" /></meta><meta name="dc.Creator" content="Amy Hauck  Newman" /></meta><meta name="dc.Description" content="The development of pharmacotherapeutic treatments of psychostimulant abuse has remained a challenge, despite significant efforts made toward relevant mechanistic targets, such as the dopamine trans..." /></meta><meta name="Description" content="The development of pharmacotherapeutic treatments of psychostimulant abuse has remained a challenge, despite significant efforts made toward relevant mechanistic targets, such as the dopamine trans..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 28, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b01373" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01373" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b01373" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01373" /></link>
        
    
    

<title>Novel and High Affinity 2-[(Diphenylmethyl)sulfinyl]acetamide (Modafinil) Analogues as Atypical Dopamine Transporter Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b01373" /></meta><meta property="og:title" content="Novel and High Affinity 2-[(Diphenylmethyl)sulfinyl]acetamide (Modafinil) Analogues as Atypical Dopamine Transporter Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/large/jm-2016-01373u_0011.jpeg" /></meta><meta property="og:description" content="The development of pharmacotherapeutic treatments of psychostimulant abuse has remained a challenge, despite significant efforts made toward relevant mechanistic targets, such as the dopamine transporter (DAT). The atypical DAT inhibitors have received attention due to their promising pharmacological profiles in animal models of cocaine and methamphetamine abuse. Herein, we report a series of modafinil analogues that have an atypical DAT inhibitor profile. We extended SAR by chemically manipulating the oxidation states of the sulfoxide and the amide functional groups, halogenating the phenyl rings, and/or functionalizing the terminal nitrogen with substituted piperazines, resulting in several novel leads such as 11b, which demonstrated high DAT affinity (Ki = 2.5 nM) and selectivity without producing concomitant locomotor stimulation in mice, as compared to cocaine. These results are consistent with an atypical DAT inhibitor profile and suggest that 11b may be a potential lead for development as a psychostimulant abuse medication." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b01373"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b01373">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b01373&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b01373&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b01373&amp;href=/doi/10.1021/acs.jmedchem.6b01373" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 23</span><span class="cit-fg-pageRange">, 10676-10691</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/23" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b01356" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b01389" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Novel and High Affinity 2-[(Diphenylmethyl)sulfinyl]acetamide (Modafinil) Analogues as Atypical Dopamine Transporter Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jianjing++Cao">Jianjing Cao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rachel+D.++Slack">Rachel D. Slack</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Oluyomi+M.++Bakare">Oluyomi M. Bakare</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Caitlin++Burzynski">Caitlin Burzynski</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rana++Rais">Rana Rais</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Barbara+S.++Slusher">Barbara S. Slusher</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Theresa++Kopajtic">Theresa Kopajtic</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alessandro++Bonifazi">Alessandro Bonifazi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+P.++Ellenberger">Michael P. Ellenberger</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hideaki++Yano">Hideaki Yano</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yi++He">Yi He</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Guo-Hua++Bi">Guo-Hua Bi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zheng-Xiong++Xi">Zheng-Xiong Xi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Claus+J.++Loland">Claus J. Loland</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Amy+Hauck++Newman">Amy Hauck Newman</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, 333 Cassell Drive, Baltimore, Maryland 21224, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Neurology, Johns Hopkins Drug Discovery, The Johns Hopkins University School of Medicine, 855 N. Wolfe Street, Baltimore, Maryland 21205, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Psychobiology Section, Molecular Neuropsychiatry Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, 251 Bayview Boulevard, Baltimore, Maryland 21224, United States</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Molecular Neuropharmacology and Genetics Laboratory, Department of Neuroscience and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, DK-2200 Copenhagen, Denmark</span></div><div class="corresp-info"><strong>*</strong>Phone: 443-740-2887. Fax: 443-740-2111. E-mail: <a href="/cdn-cgi/l/email-protection#a6c7c8c3d1cbc7c8e6cfc8d2d4c788c8cfc2c788c8cfce88c1c9d0"><span class="__cf_email__" data-cfemail="bbdad5deccd6dad5fbd2d5cfc9da95d5d2dfda95d5d2d395dcd4cd">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01373&amp;href=/doi/10.1021%2Facs.jmedchem.6b01373" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 23</span><span class="cit-pageRange">, 10676–10691</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 28, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>19 September 2016</li><li><span class="item_label"><b>Published</b> online</span>28 November 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 December 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b01373" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01373</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D10676%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJianjing%2BCao%252C%2BRachel%2BD.%2BSlack%252C%2BOluyomi%2BM.%2BBakare%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D23%26contentID%3Dacs.jmedchem.6b01373%26title%3DNovel%2Band%2BHigh%2BAffinity%2B2-%255B%2528Diphenylmethyl%2529sulfinyl%255Dacetamide%2B%2528Modafinil%2529%2BAnalogues%2Bas%2BAtypical%2BDopamine%2BTransporter%2BInhibitors%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D10691%26publicationDate%3DDecember%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b01373"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1149</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">32</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b01373" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Novel and High Affinity 2-[(Diphenylmethyl)sulfinyl]acetamide (Modafinil) Analogues as Atypical Dopamine Transporter Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Jianjing&quot;,&quot;last_name&quot;:&quot;Cao&quot;},{&quot;first_name&quot;:&quot;Rachel&quot;,&quot;last_name&quot;:&quot;D. Slack&quot;},{&quot;first_name&quot;:&quot;Oluyomi&quot;,&quot;last_name&quot;:&quot;M. Bakare&quot;},{&quot;first_name&quot;:&quot;Caitlin&quot;,&quot;last_name&quot;:&quot;Burzynski&quot;},{&quot;first_name&quot;:&quot;Rana&quot;,&quot;last_name&quot;:&quot;Rais&quot;},{&quot;first_name&quot;:&quot;Barbara&quot;,&quot;last_name&quot;:&quot;S. Slusher&quot;},{&quot;first_name&quot;:&quot;Theresa&quot;,&quot;last_name&quot;:&quot;Kopajtic&quot;},{&quot;first_name&quot;:&quot;Alessandro&quot;,&quot;last_name&quot;:&quot;Bonifazi&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;P. Ellenberger&quot;},{&quot;first_name&quot;:&quot;Hideaki&quot;,&quot;last_name&quot;:&quot;Yano&quot;},{&quot;first_name&quot;:&quot;Yi&quot;,&quot;last_name&quot;:&quot;He&quot;},{&quot;first_name&quot;:&quot;Guo-Hua&quot;,&quot;last_name&quot;:&quot;Bi&quot;},{&quot;first_name&quot;:&quot;Zheng-Xiong&quot;,&quot;last_name&quot;:&quot;Xi&quot;},{&quot;first_name&quot;:&quot;Claus&quot;,&quot;last_name&quot;:&quot;J. Loland&quot;},{&quot;first_name&quot;:&quot;Amy&quot;,&quot;last_name&quot;:&quot;Hauck Newman&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;28&quot;,&quot;issue&quot;:&quot;23&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;10676-10691&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b01373&quot;},&quot;abstract&quot;:&quot;The development of pharmacotherapeutic treatments of psychostimulant abuse has remained a challenge, despite significant efforts made toward relevant mechanistic targets, such as the dopamine transporter (DAT). The atypical DAT inhibitors have received attention due to their promising pharmacological profiles in animal models of cocaine and methamphetamine abuse. Herein, we report a series of modafinil analogues that have an atypical DAT inhibitor profile. We extended SAR by chemically manipulating the oxidation states of the sulfoxide and the amide functional groups, halogenating the phenyl rings, and/or functionalizing the terminal nitrogen with substituted piperazines, resulting in several novel leads such as 11b, which demonstrated high DAT affinity (Ki = 2.5 nM) and selectivity without producing concomitant locomotor stimulation in mice, as compared to cocaine. These results are consistent with an atypical DAT inhibitor profile and suggest that 11b may be a potential lead for development as a psychostimu&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01373&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01373" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01373&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01373" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01373&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01373" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01373&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01373&amp;href=/doi/10.1021/acs.jmedchem.6b01373" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b01373" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b01373" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b01373%26sid%3Dliteratum%253Aachs%26pmid%3D27933960%26genre%3Darticle%26aulast%3DCao%26date%3D2016%26atitle%3DNovel%2Band%2BHigh%2BAffinity%2B2-%255B%2528Diphenylmethyl%2529sulfinyl%255Dacetamide%2B%2528Modafinil%2529%2BAnalogues%2Bas%2BAtypical%2BDopamine%2BTransporter%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D23%26spage%3D10676%26epage%3D10691%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291301" title="Salts">Salts</a>,</li><li><a href="/action/doSearch?ConceptID=291137" title="Lipids">Lipids</a>,</li><li><a href="/action/doSearch?ConceptID=291650" title="Alcohols">Alcohols</a>,</li><li><a href="/action/doSearch?ConceptID=291651" title="Anions">Anions</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/23" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/jmcmar.2016.59.issue-23/20161208/jmcmar.2016.59.issue-23.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/medium/jm-2016-01373u_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/large/jm-2016-01373u_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01373&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The development of pharmacotherapeutic treatments of psychostimulant abuse has remained a challenge, despite significant efforts made toward relevant mechanistic targets, such as the dopamine transporter (DAT). The atypical DAT inhibitors have received attention due to their promising pharmacological profiles in animal models of cocaine and methamphetamine abuse. Herein, we report a series of modafinil analogues that have an atypical DAT inhibitor profile. We extended SAR by chemically manipulating the oxidation states of the sulfoxide and the amide functional groups, halogenating the phenyl rings, and/or functionalizing the terminal nitrogen with substituted piperazines, resulting in several novel leads such as <b>11b</b>, which demonstrated high DAT affinity (<i>K</i><sub>i</sub> = 2.5 nM) and selectivity without producing concomitant locomotor stimulation in mice, as compared to cocaine. These results are consistent with an atypical DAT inhibitor profile and suggest that <b>11b</b> may be a potential lead for development as a psychostimulant abuse medication.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40875" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40875" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">With millions of people worldwide suffering from substance use disorders, the development of pharmacotherapeutics for the treatment of addiction is imperative. While medications exist for treating alcohol and opiate addiction, there remains no FDA-approved medication to treat psychostimulant use disorder.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> Psychostimulant drugs of abuse, such as cocaine and methamphetamine, bind to the dopamine transporter (DAT), inhibiting the reuptake of dopamine (DA) into the presynaptic neuron, increasing extracellular dopamine levels, and resulting in the behavioral activation and euphoria that can lead to addiction.<a onclick="showRef(event, 'ref3 ref4 ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5 ref6 ref7">(3-7)</a> Although tremendous efforts have been made to develop dopamine uptake inhibitors to block the effects of cocaine and methamphetamine, most of these compounds share the psychostimulant effects and addictive liability of cocaine and have not been developed beyond preclinical studies.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> One DAT inhibitor, GBR 12909 [<b>1</b>, 1-(2-(bis(4-fluorophenyl)methoxy)ethyl)-4-(3-phenylpropyl)piperazine, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>] was taken on into a Phase 1 clinical trial but failed before being tested for efficacy in the cocaine-abusing population.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> These results dampened interest in the DAT as a potential therapeutic target for psychostimulant abuse and, indeed, negatively impacted the development of any drugs toward this target, despite the great success of methylphenidate, for example, a DAT inhibitor that has been used for decades to treat Attention Deficit Hyperactivity Disorder (ADHD).<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/medium/jm-2016-01373u_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/large/jm-2016-01373u_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of known DAT inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/large/jm-2016-01373u_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01373&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Another DAT inhibitor, (±)-modafinil (<b>2</b>, 2-[(diphenylmethyl)sulfinyl]acetamide, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) and its (<i>R</i>)-enantiomer (armodafinil) are FDA-approved to treat narcolepsy and other sleep disorders; however, they are also used off-label as cognitive enhancers, with little evidence of abuse liability in humans.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Though modafinil primarily targets the DAT, it does not share the same psychostimulant and abuse liability profile of cocaine.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Parallels to its atypical behavior in both humans<a onclick="showRef(event, 'ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16">(14-16)</a> and psychostimulant abuse animal models,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> along with its unique DAT binding profile have piqued interest for further drug development. In addition, as sleep and cognitive disorders have been linked to chronic drug abuse and the inability to remain abstinent,<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a> modafinil has additional therapeutic attributes that may be useful in preventing relapse. Nevertheless, in clinical trials, modafinil has demonstrated limited effectiveness in treating cocaine abuse,<a onclick="showRef(event, 'ref14 ref15 ref16 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16 ref20 ref21">(14-16, 20, 21)</a> although a recent clinical study showed promising results in nonalcohol-dependent cocaine abusers.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div><div class="NLM_p">(±)-Modafinil and its (<i>R</i>)-enantiomer display unique pharmacological profiles, suggesting they may bind to a conformation of the DAT dissimilar to the cocaine-bound conformation and more similar to a class of “atypical” DAT inhibitors, based on benztropine (e.g., JHW 007, <b>3</b>, (3-(bis(4-fluorophenyl)methoxy)-8-butyl-8-azabicyclo[3.2.1]octane,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a><a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> An independent study on modafinil<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> supported these findings and led us to further investigate (<i>R</i>)-modafinil in rodent models of nicotine abuse.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> These studies and previous investigations of several benztropine analogues suggested that atypical DAT inhibitors might attenuate the psychostimulant effects of cocaine and methamphetamine but may not have abuse liability, thereby leading us to further explore (<i>R</i>)-modafinil for the treatment of psychostimulant abuse.</div><div class="NLM_p">Modafinil is essentially insoluble in water and has relatively low affinity for DAT (<i>K</i><sub>i</sub> = 2 μM), which in some ways makes it an excellent therapeutic, as it cannot be illicitly diverted into an injectable and/or abused drug; however, clinical studies in cocaine addicts who also abuse other substances suggest that modafinil is not an ideal medication for this patient population, especially for those who also abuse alcohol.<a onclick="showRef(event, 'ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22">(20-22)</a> One possibility for its lack of effectiveness in reducing cocaine-taking in this patient population might be due to modafinil’s low affinity for the DAT relative to cocaine, precluding it from efficiently blocking cocaine’s rapid inhibition of dopamine uptake. Moreover, its low DAT affinity and poor water solubility make modafinil a challenging compound to study preclinically, and thus, our previous efforts<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26, 27)</a> were aimed at improving its pharmacological profile via a structure–activity relationship (SAR) analyses at the DAT, norepinephrine transporter (NET), and serotonin transporter (SERT). Several compounds from those libraries showed improved water solubility and higher affinity for DAT (<i>K</i><sub>i</sub> < 1 μM) relative to modafinil; one lead compound arose and is currently being evaluated in behavioral models of cocaine and methamphetamine abuse (<b>4</b>, JJC8-016, <i>N</i>-(2-((bis(4-fluorophenyl)methyl)thio)ethyl)-3-phenylpropan-1-amine, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><div class="NLM_p last">In order to further improve DAT binding affinity and selectivity, we designed a series of compounds that extended SAR by chemically manipulating the oxidation states of the sulfoxide and the amide functional groups, halogenating the phenyl rings, and/or functionalizing the terminal nitrogen, borrowing the piperazine ring from <b>1</b>, as part of the scaffold.<a onclick="showRef(event, 'ref28 ref29 ref30 ref31 ref32 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref28 ref29 ref30 ref31 ref32 ref33 ref34">(28-34)</a> All final compounds were evaluated for DAT, NET, and SERT binding in rat brains, and a subset was tested for binding to the σ1 receptor, as it has been previously posited that a dual DAT/σ1 profile may have therapeutic advantages over a highly DAT selective compound.<a onclick="showRef(event, 'ref35 ref36 ref37 ref38 ref39 ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref35 ref36 ref37 ref38 ref39 ref40 ref41">(35-41)</a> This subset was also tested for binding affinities at the dopamine D<sub>2</sub>, D<sub>3</sub>, and D<sub>4</sub> receptor subtypes and for efficacy in a D<sub>2</sub> Gi<sub>1</sub> Bioluminescence Resonance Energy Transfer (BRET) assay. In addition, we tested this subset of analogues for inhibition of [<sup>3</sup>H]DA uptake and in a binding assay previously shown to determine if a compound possesses a classical or an atypical DAT binding profile, as reported for (±)-modafinil and its (<i>R</i>)-enantiomer.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> These data suggest that the analogues do indeed appear to bind the DAT in this desired atypical fashion like modafinil and the benztropines, but unlike cocaine. This subset of compounds was also evaluated for metabolic stability in mouse liver microsomes, and the compound with highest DAT affinity and selectivity in this series, <b>11b</b>, was tested for its effects on locomotor activity in mice.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11278" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11278" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Syntheses of novel sulfenylethanamine (<b>8a</b>–<b>8k</b>, <b>10a</b>,<b>b</b>) and sulfinylethanamine analogues (<b>9a</b>–<b>9i</b>, <b>11a</b>,<b>b</b>) were achieved as depicted in <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a> and <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Dehydration of commercially available benzhydrols <b>5a</b>–<b>c</b> with 2-mercaptoethan-1-ol in the presence of trifluoroacetic acid followed by treatment with K<sub>2</sub>CO<sub>3</sub> in H<sub>2</sub>O/acetone provided sulfide alcohols <b>6a</b>–<b>6c</b> in 61–95% yield. Appel reaction on <b>6a</b>–<b>6c</b> with triphenylphosphine and tetrabromomethane gave bromides <b>7a</b>–<b>7c</b> in 61–82% yield. Next, alkylation with the appropriate piperazine provided the sulfenylethanamine analogues <b>8a</b>–<b>8k</b> in 50–87% yield. Epoxide ring opening of 2-benzyloxirane using unsubstituted piperazine analogues <b>8e</b> and <b>8f</b> gave alcohols <b>10a</b> and <b>10b</b>, respectively (84% and 86% yield, respectively). Lastly, oxidation of the appropriate sulfenylethanamine was achieved using hydrogen peroxide in an acetic acid/methanol solution to give sulfinylethanamine (<b>9a</b>–<b>9i</b>, <b>11a</b>,<b>b</b>) in 43–78% yield.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/medium/jm-2016-01373u_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/large/jm-2016-01373u_0007.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>8a</b>–<b>8k</b> and <b>9a</b>–<b>9i</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/large/jm-2016-01373u_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01373&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) TFA, CH<sub>2</sub>Cl<sub>2</sub>, r.t. overnight; (ii) K<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O/acetone, overnight; (b) PPh<sub>3</sub>, CBr<sub>4</sub>, CH<sub>3</sub>CN, r.t. overnight; (c) appropriate piperazine, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux, overnight; (d) H<sub>2</sub>O<sub>2</sub>, AcOH/MeOH, 40 °C, overnight.</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/medium/jm-2016-01373u_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/large/jm-2016-01373u_0008.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>10a</b>,<b>b</b> and <b>11a</b>,<b>b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/large/jm-2016-01373u_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01373&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2-benzyloxirane, isopropanol, reflux, overnight; (b) H<sub>2</sub>O<sub>2</sub>, AcOH/MeOH, 40 °C, overnight.</p></p></figure><div class="NLM_p">Piperazine-substituted sulfenylacetamides <b>13a</b>–<b>13g</b> were generated via either synthetic routes a or b, outlined in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. Compounds <b>13a</b>–<b>13c</b> and <b>13g</b> were synthesized through route a by amidation of carboxylic acids <b>12a</b>–<b>12c</b> using 1,1′-carbonyldiimidazole (CDI) and the appropriate amines in 71–90% yield. Synthetic route b utilized thionyl chloride to form the acid chloride intermediate of carboxylic acids <b>12a</b>,<b>b</b>, followed by coupling with the respective amine to afford <b>13d</b>–<b>13f</b> in 54–67% yield. Oxidation of the sulfenyl moiety gave the desired sulfinylacetamide <b>14a</b>–<b>14g</b> in 11–72% yield. All final compounds were purified and characterized in their free base form and then converted to the oxalate salts for testing. Note that all final compounds with sulfoxide groups and/or hydroxylated linking chains are the racemic and/or diastereomeric mixtures.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/medium/jm-2016-01373u_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/large/jm-2016-01373u_0009.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compounds <b>13a</b>–<b>g</b> and <b>14 a</b>–<b>g</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/large/jm-2016-01373u_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01373&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) THF, CDI, r.t. 2 h; (ii) substituted piperazine analogue, THF, r.t. overnight; (b) (i) SOCl<sub>2</sub>, reflux, 2 h; (ii) appropriate piperazine; (c) H<sub>2</sub>O<sub>2</sub>, AcOH/MeOH, 40 °C, overnight.</p></p></figure></div><div id="secB" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Biological Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34812" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34812" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> SAR at DAT, SERT, and NET</h3><div class="NLM_p">All final compounds (<b>8</b>, <b>9</b>, <b>11</b>, <b>13</b>, and <b>14</b>) were evaluated for binding at the monoamine transporters (DAT, SERT, and NET) in rat brain membranes and compared to known DAT inhibitors <b>1</b>–<b>4</b> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). Changes in DAT binding affinity and selectivity as a result of modifications to the modafinil structure were evaluated; SAR analyses explored the effects of (1) the sulfur oxidation state, (2) reducing the terminal amide to a secondary amine, (3) halogenating the benzhydrol, and (4) varying the amide/amine substituent. The binding affinities (<i>K</i><sub>i</sub> values) are presented in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>, where, in general, these novel analogues displayed low nanomolar DAT affinities and showed >100-fold selectivity for DAT over NET and/or SERT.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Binding Data for Sulfenyl- and Sulfinylacetamide, Sulfenyl-, and Sulfinylethanamine Analogues<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/medium/jm-2016-01373u_0010.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" colspan="6" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center"><i>K</i><sub>i</sub> (nM) ± SEM</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">Y</th><th class="colsep0 rowsep0" align="center">Z</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">clogP</th><th class="colsep0 rowsep0" align="center">DAT</th><th class="colsep0 rowsep0" align="center">NET</th><th class="colsep0 rowsep0" align="center">SERT</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GBR12909, <b>1</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1.77 ± 0.181<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">497 ± 17.0<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">104 ± 11.4<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">modafinil, <b>2</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2520 ± 204<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">IA<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">IA<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">10.5 ± 0.748</td><td class="colsep0 rowsep0" align="left">1670 ± 232</td><td class="colsep0 rowsep0" align="left">IA<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">6.43</td><td class="colsep0 rowsep0" align="left">116 ± 16.3</td><td class="colsep0 rowsep0" align="left">3,848 ± 21.7</td><td class="colsep0 rowsep0" align="left">360 ± 48.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8a</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">3-phenylpropyl</td><td class="colsep0 rowsep0" align="left">5.87</td><td class="colsep0 rowsep0" align="left">3.58 ± 0.157</td><td class="colsep0 rowsep0" align="left">988 ± 22.8</td><td class="colsep0 rowsep0" align="left">1,050 ± 152</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8b</b></td><td class="colsep0 rowsep0" align="left">4,4′-diF</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">3-phenylpropyl</td><td class="colsep0 rowsep0" align="left">6.12</td><td class="colsep0 rowsep0" align="left">4.50 ± 0.344</td><td class="colsep0 rowsep0" align="left">1,890 ± 116</td><td class="colsep0 rowsep0" align="left">285 ± 35.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8c</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">2-OH-propyl</td><td class="colsep0 rowsep0" align="left">3.13</td><td class="colsep0 rowsep0" align="left">49.6 ± 4.31</td><td class="colsep0 rowsep0" align="left">44,500 ± 2400</td><td class="colsep0 rowsep0" align="left">26,700 ± 2,630</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8d</b></td><td class="colsep0 rowsep0" align="left">4,4′-diF</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">2-OH-propyl</td><td class="colsep0 rowsep0" align="left">3.42</td><td class="colsep0 rowsep0" align="left">16.7 ± 1.22</td><td class="colsep0 rowsep0" align="left">17,800 ± 885</td><td class="colsep0 rowsep0" align="left">1,770 ± 234</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8g</b></td><td class="colsep0 rowsep0" align="left">4,4′-diF</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">benzyl</td><td class="colsep0 rowsep0" align="left">6.86</td><td class="colsep0 rowsep0" align="left">7.40 ± 1.04</td><td class="colsep0 rowsep0" align="left">8,240 ± 1,240</td><td class="colsep0 rowsep0" align="left">949 ± 122</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8h</b></td><td class="colsep0 rowsep0" align="left">4,4′-diF</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">4-F-benzyl</td><td class="colsep0 rowsep0" align="left">6.92</td><td class="colsep0 rowsep0" align="left">4.98 ± 0.716</td><td class="colsep0 rowsep0" align="left">6,850 ± 633</td><td class="colsep0 rowsep0" align="left">463 ± 69.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8i</b></td><td class="colsep0 rowsep0" align="left">4,4′-diF</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">4-CF<sub>3</sub>-benzyl</td><td class="colsep0 rowsep0" align="left">7.74</td><td class="colsep0 rowsep0" align="left">26.6 ± 2.09</td><td class="colsep0 rowsep0" align="left">15,400 ± 1,950</td><td class="colsep0 rowsep0" align="left">2,020 ± 266</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8j</b></td><td class="colsep0 rowsep0" align="left">4,4′-diF</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">4-Cl-benzyl</td><td class="colsep0 rowsep0" align="left">7.57</td><td class="colsep0 rowsep0" align="left">19.3 ± 1.91</td><td class="colsep0 rowsep0" align="left">7,410 ± 102</td><td class="colsep0 rowsep0" align="left">905 ± 121</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8k</b></td><td class="colsep0 rowsep0" align="left">3,3′-diCl</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">2-OH-propyl</td><td class="colsep0 rowsep0" align="left">4.56</td><td class="colsep0 rowsep0" align="left">143 ± 19.2</td><td class="colsep0 rowsep0" align="left">31,300 ± 2,980</td><td class="colsep0 rowsep0" align="left">10,800 ± 1,030</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9a</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">S═O</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">3-phenylpropyl</td><td class="colsep0 rowsep0" align="left">3.91</td><td class="colsep0 rowsep0" align="left">3.17 ± 0.112</td><td class="colsep0 rowsep0" align="left">5,540 ± 808</td><td class="colsep0 rowsep0" align="left">7,360 ± 881</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9b</b></td><td class="colsep0 rowsep0" align="left">4,4′-diF</td><td class="colsep0 rowsep0" align="left">S═O</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">3-phenylpropyl</td><td class="colsep0 rowsep0" align="left">4.20</td><td class="colsep0 rowsep0" align="left">2.92 ± 0.383</td><td class="colsep0 rowsep0" align="left">4281 ± 343</td><td class="colsep0 rowsep0" align="left">678 ± 66.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9c</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">S═O</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">2-OH-propyl</td><td class="colsep0 rowsep0" align="left">1.21</td><td class="colsep0 rowsep0" align="left">636 ± 14.7</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9d</b></td><td class="colsep0 rowsep0" align="left">4,4′-diF</td><td class="colsep0 rowsep0" align="left">S═O</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">2-OH-propyl</td><td class="colsep0 rowsep0" align="left">1.49</td><td class="colsep0 rowsep0" align="left">289 ± 43.0</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">50,300 ± 5,760</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9e</b></td><td class="colsep0 rowsep0" align="left">4,4′-diF</td><td class="colsep0 rowsep0" align="left">S═O</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">benzyl</td><td class="colsep0 rowsep0" align="left">4.93</td><td class="colsep0 rowsep0" align="left">27.2 ± 1.29</td><td class="colsep0 rowsep0" align="left">45,700 ± 8,480</td><td class="colsep0 rowsep0" align="left">11,200 ± 195</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9f</b></td><td class="colsep0 rowsep0" align="left">4,4′-diF</td><td class="colsep0 rowsep0" align="left">S═O</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">4-F-benzyl</td><td class="colsep0 rowsep0" align="left">5.00</td><td class="colsep0 rowsep0" align="left">9.67 ± 1.37</td><td class="colsep0 rowsep0" align="left">>50 μM</td><td class="colsep0 rowsep0" align="left">8,520 ± 349</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9g</b></td><td class="colsep0 rowsep0" align="left">4,4′-diF</td><td class="colsep0 rowsep0" align="left">S═O</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">4-CF<sub>3</sub>-benzyl</td><td class="colsep0 rowsep0" align="left">5.81</td><td class="colsep0 rowsep0" align="left">39.4 ± 1.45</td><td class="colsep0 rowsep0" align="left">>50 μM</td><td class="colsep0 rowsep0" align="left">6,800 ± 468</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9h</b></td><td class="colsep0 rowsep0" align="left">4,4′-diF</td><td class="colsep0 rowsep0" align="left">S═O</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">4-Cl-benzyl</td><td class="colsep0 rowsep0" align="left">5.64</td><td class="colsep0 rowsep0" align="left">7.62 ± 0.900</td><td class="colsep0 rowsep0" align="left">>50 μM</td><td class="colsep0 rowsep0" align="left">4,940 ± 665</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9i</b></td><td class="colsep0 rowsep0" align="left">3,3′-diCl</td><td class="colsep0 rowsep0" align="left">S═O</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">2-OH-propyl</td><td class="colsep0 rowsep0" align="left">2.63</td><td class="colsep0 rowsep0" align="left">403 ± 23.8</td><td class="colsep0 rowsep0" align="left">>50 μM</td><td class="colsep0 rowsep0" align="left">58,900 ± 7,310</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10a</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">2-OH-3-phenylpropyl</td><td class="colsep0 rowsep0" align="left">4.70</td><td class="colsep0 rowsep0" align="left">2.54 ± 0.233</td><td class="colsep0 rowsep0" align="left">1,430 ± 118</td><td class="colsep0 rowsep0" align="left">1,630 ± 169</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10b</b></td><td class="colsep0 rowsep0" align="left">4,4′-diF</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">2-OH-3-phenylpropyl</td><td class="colsep0 rowsep0" align="left">5.00</td><td class="colsep0 rowsep0" align="left">6.72 ± 0.977</td><td class="colsep0 rowsep0" align="left">1,950 ± 227</td><td class="colsep0 rowsep0" align="left">213 ± 13.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11a</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">S═O</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">2-OH-3-phenylpropyl</td><td class="colsep0 rowsep0" align="left">2.78</td><td class="colsep0 rowsep0" align="left">3.43 ± 0.499</td><td class="colsep0 rowsep0" align="left">25,300 ± 2,040</td><td class="colsep0 rowsep0" align="left">21,700 ± 2,020</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11b</b></td><td class="colsep0 rowsep0" align="left">4,4′-diF</td><td class="colsep0 rowsep0" align="left">S═O</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">2-OH-3-phenylpropyl</td><td class="colsep0 rowsep0" align="left">3.06</td><td class="colsep0 rowsep0" align="left">2.53 ± 0.250</td><td class="colsep0 rowsep0" align="left">15,000 ± 575</td><td class="colsep0 rowsep0" align="left">4,610 ± 562</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13a</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">C═O</td><td class="colsep0 rowsep0" align="left">3-phenylpropyl</td><td class="colsep0 rowsep0" align="left">6.37</td><td class="colsep0 rowsep0" align="left">47.2 ± 5.56</td><td class="colsep0 rowsep0" align="left">22,600 ± 3,010</td><td class="colsep0 rowsep0" align="left">9,320 ± 932</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13b</b></td><td class="colsep0 rowsep0" align="left">4,4′-diF</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">C═O</td><td class="colsep0 rowsep0" align="left">3-phenylpropyl</td><td class="colsep0 rowsep0" align="left">6.66</td><td class="colsep0 rowsep0" align="left">28.6 ± 1.52</td><td class="colsep0 rowsep0" align="left">20,200 ± 1,410</td><td class="colsep0 rowsep0" align="left">3,170 ± 275</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13c</b></td><td class="colsep0 rowsep0" align="left">4,4′-diF</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">C═O</td><td class="colsep0 rowsep0" align="left">2-OH-propyl</td><td class="colsep0 rowsep0" align="left">4.03</td><td class="colsep0 rowsep0" align="left">214 ± 20.7</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">11,400 ± 902</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13d</b></td><td class="colsep0 rowsep0" align="left">4,4′-diF</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">C═O</td><td class="colsep0 rowsep0" align="left">propyl</td><td class="colsep0 rowsep0" align="left">5.36</td><td class="colsep0 rowsep0" align="left">277 ± 12.5</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">5,970 ± 497</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13e</b></td><td class="colsep0 rowsep0" align="left">4,4′-diF</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">C═O</td><td class="colsep0 rowsep0" align="left">4-F-benzyl</td><td class="colsep0 rowsep0" align="left">6.16</td><td class="colsep0 rowsep0" align="left">53.7 ± 1.89</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">6,210 ± 579</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13f</b></td><td class="colsep0 rowsep0" align="left">4,4′-diF</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">C═O</td><td class="colsep0 rowsep0" align="left">4-Cl-benzyl</td><td class="colsep0 rowsep0" align="left">6.74</td><td class="colsep0 rowsep0" align="left">58.7 ± 5.05</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">2,200 ± 177</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13g</b></td><td class="colsep0 rowsep0" align="left">3,3′-diCl</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">C═O</td><td class="colsep0 rowsep0" align="left">2-OH-propyl</td><td class="colsep0 rowsep0" align="left">5.17</td><td class="colsep0 rowsep0" align="left">915 ± 84.5</td><td class="colsep0 rowsep0" align="left">>50 μM</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14a</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">S═O</td><td class="colsep0 rowsep0" align="left">C═O</td><td class="colsep0 rowsep0" align="left">3-phenylpropyl</td><td class="colsep0 rowsep0" align="left">4.67</td><td class="colsep0 rowsep0" align="left">33.0 ± 2.83</td><td class="colsep0 rowsep0" align="left">54,300 ± 3,210</td><td class="colsep0 rowsep0" align="left">15,200 ± 1,100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14b</b></td><td class="colsep0 rowsep0" align="left">4,4′-diF</td><td class="colsep0 rowsep0" align="left">S═O</td><td class="colsep0 rowsep0" align="left">C═O</td><td class="colsep0 rowsep0" align="left">3-phenylpropyl</td><td class="colsep0 rowsep0" align="left">5.00</td><td class="colsep0 rowsep0" align="left">37.6 ± 1.86</td><td class="colsep0 rowsep0" align="left">12,000 ± 1,430</td><td class="colsep0 rowsep0" align="left">1,320 ± 152</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14c</b></td><td class="colsep0 rowsep0" align="left">4,4′-diF</td><td class="colsep0 rowsep0" align="left">S═O</td><td class="colsep0 rowsep0" align="left">C═O</td><td class="colsep0 rowsep0" align="left">2-OH-propyl</td><td class="colsep0 rowsep0" align="left">2.33</td><td class="colsep0 rowsep0" align="left">752 ± 87.4</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">32,800 ± 4,430</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14d</b></td><td class="colsep0 rowsep0" align="left">4,4′-diF</td><td class="colsep0 rowsep0" align="left">S═O</td><td class="colsep0 rowsep0" align="left">C═O</td><td class="colsep0 rowsep0" align="left">propyl</td><td class="colsep0 rowsep0" align="left">3.66</td><td class="colsep0 rowsep0" align="left">279 ± 23.4</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">14,500 ± 1,430</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14e</b></td><td class="colsep0 rowsep0" align="left">4,4′-diF</td><td class="colsep0 rowsep0" align="left">S═O</td><td class="colsep0 rowsep0" align="left">C═O</td><td class="colsep0 rowsep0" align="left">4-F-benzyl</td><td class="colsep0 rowsep0" align="left">4.47</td><td class="colsep0 rowsep0" align="left">74.3 ± 9.64</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">23,600 ± 1,030</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14f</b></td><td class="colsep0 rowsep0" align="left">4,4′-diF</td><td class="colsep0 rowsep0" align="left">S═O</td><td class="colsep0 rowsep0" align="left">C═O</td><td class="colsep0 rowsep0" align="left">4-Cl-benzyl</td><td class="colsep0 rowsep0" align="left">5.04</td><td class="colsep0 rowsep0" align="left">56.3 ± 6.60</td><td class="colsep0 rowsep0" align="left">63,500 ± 5,290</td><td class="colsep0 rowsep0" align="left">9,460 ± 386</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14g</b></td><td class="colsep0 rowsep0" align="left">3,3′-diCl</td><td class="colsep0 rowsep0" align="left">S═O</td><td class="colsep0 rowsep0" align="left">C═O</td><td class="colsep0 rowsep0" align="left">2-OH-propyl</td><td class="colsep0 rowsep0" align="left">3.47</td><td class="colsep0 rowsep0" align="left">1,380 ± 191</td><td class="colsep0 rowsep0" align="left">>50 μM</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Each <i>K</i><sub>i</sub> value represents data from at least three independent experiments, each performed in triplicate. <i>K</i><sub>i</sub> values were analyzed by PRISM. Binding assays are described in detail in <a class="ref internalNav" href="#sec4" aria-label="Experimental Procedures">Experimental Procedures</a>.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Previously reported in Cao et al.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">Previously reported in Cao et al.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></p></div><div class="footnote" id="t1fn4"><sup>d</sup><p class="last">IA; less than 50% inhibition at 100 μM.</p></div><div class="footnote" id="t1fn5"><sup>e</sup><p class="last">ND; not determined.</p></div></div></div><div class="NLM_p">In general, the sulfoxides had similar affinities at DAT relative to their sulfide counterparts; however, affinities at SERT and NET generally decreased, resulting in more DAT-selective sulfoxides. The largest sulfide to sulfoxide improvement in DAT selectivities was seen for the <i>N</i>-bearing 2-hydroxypropyl and 2-hydroxyphenylpropyl derivatives (compared to their deshydroxy counterparts). In particular, oxidation of hydroxyl-containing sulfide <b>10b</b> to its sulfoxide <b>11b</b> gave nominal improvement in DAT affinity (<i>K</i><sub>i</sub> = 6.72 to 2.53 nM, respectively), but a 7- and 20-fold decrease in SERT and NET affinities, respectively, was observed for sulfoxide <b>11b</b>, improving DAT selectivity. In contrast, the deshydroxy counterparts sulfide <b>8b</b> and sulfoxide <b>9b</b> showed no significant difference in DAT <i>K</i><sub>i</sub> values, while SERT/NET selectivities decreased only ∼2-fold for the oxidized compound.</div><div class="NLM_p">To prevent potential metabolism on the benzhydrol moiety, 4,4′-difluorination was probed, resulting in varying effects on the monoamine transporter binding affinities. When the unsubstituted <b>8a</b>, <b>9a</b>, <b>10a</b>, and <b>11a</b> were 4,4′-difluoro-substituted to give <b>8b</b>, <b>9b</b>, <b>10b</b>, and <b>11b</b>, respectively, no appreciable change was observed in DAT and SERT <i>K</i><sub>i</sub> values, although NET affinity improved between 5- and 10-fold. DAT affinity (<i>K</i>i = 143–1380 nM) was lost when the benzhydrol was 3,3′-dichloro-substituted in <b>8k</b>, <b>9i</b>, <b>13g</b>, and <b>14g</b>.</div><div class="NLM_p">The phenylpropyls (<b>8a</b>, <b>8b</b>, <b>9a</b>, <b>9b</b>, <b>13a</b>, <b>13b</b>, <b>14a</b>, and <b>14b</b>) and 2-hydroxyphenylpropyls (<b>10a</b>, <b>10b</b>, <b>11a</b>, and <b>11b</b>) generally demonstrated high binding affinities for DAT, with DAT <i>K</i><sub>i</sub> = 2.5–47 nM. The removal of the phenyl group resulted in a loss of affinity at DAT, implying that an <i>N</i>-arylalkyl substituent may be optimal. For example, when the phenyl group is removed from <b>10a</b> and <b>11a</b> (<i>K</i><sub>i</sub> = 2.5 and 3.4, respectively) to give <b>8c</b> and <b>9c</b>, respectively, DAT affinity decreases by 25- and 187-fold. In general, the <i>N</i>-benzyl analogues (e.g., <b>8g</b>–<b>8j</b> and <b>9e</b>–<b>9h</b>) also demonstrated high DAT affinities, but metabolic instability was problematic in this subset (see below).</div><div class="NLM_p last">The 2-hydroxy analogues were prepared based on previous SAR<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> to give compounds with lower cLogP values (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). While 2-hydroxylation of the propyl and phenylpropyl substitutions did not appreciably change <i>K</i><sub>i</sub> values at DAT, the 2-hydroxy sulfoxides <b>9d</b>, <b>11a</b>, <b>11b</b>, and <b>14c</b> resulted in a significant decrease in NET and SERT affinities. In contrast, 2-hydroxylation of the linker in sulfides <b>10a</b> and <b>10b</b> gave only nominal loss in NET or SERT <i>K</i><sub>i</sub> values. Of note, cLogP values were typically in the >5-range for 4,4′-difluoro substituted-analogues without the sulfoxide function or hydroxylated terminal <i>N</i>-substituents.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Off-Target Binding Profiles: Dopamine D<sub>2</sub>, D<sub>3</sub>, D<sub>4</sub>, and σ1 Receptors</h3><div class="NLM_p">On the basis of the DAT, SERT, and NET binding results and cLogP values, a subset of analogues (<b>8d</b>, <b>9d</b>, and <b>11b</b>) was then evaluated for binding affinities at dopamine D<sub>2</sub>, D<sub>3</sub>, and D<sub>4</sub> receptors in HEK 293 cells, as well as σ1 receptors in rat brains and compared to known compounds (<i>R</i>)-modafinil [<b>(</b><i><b>R</b></i><b>)-2</b>], <b>3</b>, and <b>4</b>. As can be seen in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>, (<i>R</i>)-modafinil is highly selective for DAT compared to these off-target receptors but has relatively low affinity for the DAT. In contrast, the atypical DAT inhibitor in the benztropine class, <b>3</b>, has relatively high affinities for dopamine D<sub>2</sub> and D<sub>3</sub> receptors and has higher affinity for σ1 than for DAT (σ1/DAT = 0.2). Likewise, our previous lead compound <b>4</b><a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> had low affinity for D<sub>2</sub> receptors but moderate affinities for D<sub>3</sub> and D<sub>4</sub> and had comparable affinities at σ1 and DAT (σ1/DAT = 1.4). Compound <b>8d</b> was selective for DAT over the D<sub>2</sub>-like receptors but had the highest affinity for σ1 in the series (<i>K</i><sub>i</sub> = 4 nM) resulting in a σ1/DAT ratio similar to <b>3</b>. Compound <b>9d</b> had the lowest affinity for DAT in the group (although ∼10-fold higher than (<b><i>R</i></b>)-<b>2</b>), and its selectivity across the off-target sites was relatively low. Nevertheless, compared to that of the classic D<sub>2</sub> antagonist, eticlopride, the D<sub>2</sub>-like receptor affinities are very low. Indeed, in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>, it can be seen that although all of these compounds were inhibitors of quinpirole-stimulated D<sub>2</sub> receptor activation of Gi<sub>1</sub>, all of them had very low potency. Hence, we conclude that they are very weak antagonists at D<sub>2</sub> receptors and that this off-target activity would likely not affect their behavioral profiles. Finally, in this series, compound <b>11b</b> emerged as the highest affinity and most selective DAT inhibitor (<a class="ref internalNav" href="#tbl2" aria-label="Tables 2">Tables 2</a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Off Target Binding Affinities for a Selected Subset of Analogues<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="6" align="center"><i>K</i><sub>i</sub>  ± SEM (nM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">DAT</th><th class="colsep0 rowsep0" align="center">D<sub>2</sub>R<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">D<sub>3</sub>R<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">D<sub>4</sub>R<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">σ<sub>1</sub></th><th class="colsep0 rowsep0" align="center">σ<sub>1</sub>/DAT</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>(</b><i><b>R</b></i><b>)-2</b></td><td class="colsep0 rowsep0" align="left">3050 ± 258</td><td class="colsep0 rowsep0" align="left">>100,000</td><td class="colsep0 rowsep0" align="left">39,000 ± 1050</td><td class="colsep0 rowsep0" align="left">>100,000</td><td class="colsep0 rowsep0" align="left">>100,000</td><td class="colsep0 rowsep0" align="left">>300</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">10.5 ± 0.748</td><td class="colsep0 rowsep0" align="left">68.1 ± 7.81</td><td class="colsep0 rowsep0" align="left">34.4 ± 6.47</td><td class="colsep0 rowsep0" align="left">583 ± 128</td><td class="colsep0 rowsep0" align="left">2.4</td><td class="colsep0 rowsep0" align="left">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">116 ± 16.3</td><td class="colsep0 rowsep0" align="left">228 ± 27.6</td><td class="colsep0 rowsep0" align="left">65.9 ± 12.1</td><td class="colsep0 rowsep0" align="left">28.1 ± 5.22</td><td class="colsep0 rowsep0" align="left">159 ± 22.7</td><td class="colsep0 rowsep0" align="left">1.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8d</b></td><td class="colsep0 rowsep0" align="left">16.7 ± 1.22</td><td class="colsep0 rowsep0" align="left">693 ± 159</td><td class="colsep0 rowsep0" align="left">424 ± 117</td><td class="colsep0 rowsep0" align="left">6300 ± 1460</td><td class="colsep0 rowsep0" align="left">4.03 ± 0.22</td><td class="colsep0 rowsep0" align="left">0.24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9d</b></td><td class="colsep0 rowsep0" align="left">289 ± 43.0</td><td class="colsep0 rowsep0" align="left">298 ± 61.1</td><td class="colsep0 rowsep0" align="left">480 ± 184</td><td class="colsep0 rowsep0" align="left">3820 ± 876</td><td class="colsep0 rowsep0" align="left">1010 ± 134</td><td class="colsep0 rowsep0" align="left">3.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11b</b></td><td class="colsep0 rowsep0" align="left">2.53 ± 0.25</td><td class="colsep0 rowsep0" align="left">78.6 ± 16.6</td><td class="colsep0 rowsep0" align="left">652 ± 105</td><td class="colsep0 rowsep0" align="left">1750 ± 593</td><td class="colsep0 rowsep0" align="left">336 ± 42.2</td><td class="colsep0 rowsep0" align="left">133</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">eticlopride</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">0.26 ± 0.06</td><td class="colsep0 rowsep0" align="left">0.11 ± 0.03</td><td class="colsep0 rowsep0" align="left">70.4 ± 2.33</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Each <i>K</i><sub>i</sub> value represents data from at least three independent experiments, each performed in duplicate. <i>K</i><sub>i</sub> values were analyzed by PRISM. Binding assays are described in detail in <a class="ref internalNav" href="#sec4" aria-label="Experimental Procedures">Experimental Procedures</a>.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">ND; not determined.</p></div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Inhibition of Dopamine D<sub>2</sub> Receptor Gi<sub>1</sub> Activation Using 1 μM Quinpirole<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>(</b><i><b>R</b></i><b>)-2</b></td><td class="colsep0 rowsep0" align="left">>10,000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">2000 ± 730</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">>10,000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8d</b></td><td class="colsep0 rowsep0" align="left">>10,000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9d</b></td><td class="colsep0 rowsep0" align="left">>10,000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11b</b></td><td class="colsep0 rowsep0" align="left">>10,000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">eticlopride</td><td class="colsep0 rowsep0" align="left">2.1 ± 0.8 nM</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Results were obtained from G protein activation-BRET experiments in HEK-293T cells transiently transfected with Gαi1-RLuc8 and γ2-GFP10 in cells expressing D<sub>2</sub>R. Data were fit by nonlinear regression to a sigmoidal dose–response relationship against the ligand concentration (prestimulated with 1 μM quinpirole). The IC<sub>50</sub> values are the mean ± SEM of 5 experiments performed in triplicate.</p></div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Molecular Pharmacology and Mutagenesis Studies</h3><div class="NLM_p">To assess the effect on DAT function, this subset of analogues (<b>4</b>, <b>8d</b>, <b>9d</b>, and <b>11b</b>) was tested for inhibition of [<sup>3</sup>H]DA uptake. Accordingly, COS7 cells transiently expressing DAT were employed. The analogues were added in increasing concentrations followed by a fixed concentration of [<sup>3</sup>H]DA to allow transport. The reaction was stopped after 5 min, and the amount of [<sup>3</sup>H]DA taken up by the COS7 cells was determined by scintillation counting and plotted as a function of the concentration of added analogue (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). All analogues from this subset possessed higher inhibition potency than (±)-modafinil. In line with the binding data from rat brain membranes, compound <b>11b</b> emerged as the DA uptake inhibitor with the highest potency (<i>K</i><sub>i</sub> = 12 [10;14] nM, mean [SEM interval], <i>n</i> = 3). Compound <b>8d</b> had an inhibitory potency similar to that of cocaine (<i>K</i><sub>i</sub> = 200 [140;290] nM and 200 [110;350] nM, respectively, mean [SEM interval], <i>n</i> = 3–4), whereas both compounds <b>4</b> and <b>9d</b> had significantly lower <i>K</i><sub>i</sub> values than cocaine (890 [810;980] nM and 1730 [1370;2170] nM, respectively, mean [SEM interval], <i>n</i> = 6–8). Although all DAT inhibitors by definition block DA uptake, cocaine’s binding preference to an outward facing conformation of DAT has been described experimentally, computationally,<a onclick="showRef(event, 'ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref43 ref44">(43, 44)</a> and more recently demonstrated in the X-ray crystal structure of the drosophila DAT.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> It has been proposed that the stabilization of the outward facing DAT conformation by cocaine is, at least in part, mediated by its interference with a H-bond that forms between the OH-group of Tyr156 in TM3 and Asp79 in TM1. This has been substantiated experimentally by showing that the binding mode of cocaine is independent of the OH-group in Tyr156;<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> however, when the DAT moves to a more outward occluded and ultimately closed conformation, a critical H-bond forms between Y156 and D79, closing the outer “gate.” This conformation seems to be preferred by substrates, such as dopamine, amphetamine, and MDMA and also the atypical DAT inhibitors, such as the benztropines<a onclick="showRef(event, 'ref44 ref46'); return false;" href="javascript:void(0);" class="ref ref44 ref46">(44, 46)</a> [e.g., <b>3</b>]. Accordingly, in contrast to cocaine, the binding of modafinil and other atypical DAT inhibitors does depend on the presence of the OH-group since the Y156F mutation affects their binding affinity.<a onclick="showRef(event, 'ref13 ref43'); return false;" href="javascript:void(0);" class="ref ref13 ref43">(13, 43)</a> To assess whether or not compounds <b>4</b>, <b>8d</b>, <b>9d</b>, and/or <b>11b</b> demonstrated an atypical DAT inhibitor binding mode, their binding affinities were evaluated in wild type (WT) DAT and the Y156F mutant (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a> and <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). The results were compared to the effects of (±)-modafinil (<b>2</b>), <b>3</b>, and cocaine (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a> and <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). Inhibition of [<sup>3</sup>H]WIN35,428 binding on COS7 cells transiently expressing WT DAT or Y156F was determined. In contrast to cocaine, (±)-modafinil (<b>2</b>) and all the tested analogues showed a significant decrease in binding affinity for Y156F relative to WT DAT. Remarkably, <b>11b</b> was particularly affected with a Y156F/WT ratio of ∼15, similar to that found for [<b>(</b><i><b>R</b></i><b>)-2</b>] (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a> and <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). Also, <b>9d</b> shows a marked change (7.6-fold, <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>), whereas <b>4</b> and <b>8d</b> were affected to a lesser degree (2.8 and 2.6-fold, respectively, <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a> and <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). Interestingly, the sulfoxide function was present in the three compounds [<b>(</b><i><b>R</b></i><b>)-2</b>, <b>9d</b> and <b>11b</b>)] that were most impacted by the Y156F mutation. For comparison, the classical atypical DAT inhibitor, <b>3</b>, had a Y156F/WT ratio of 5.5.</div><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/medium/jm-2016-01373u_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/large/jm-2016-01373u_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Inhibition potency of [<sup>3</sup>H]DA uptake by modafinil analogues and cocaine. COS7 cells transiently expressing DAT wild type were incubated with [<sup>3</sup>H]DA at the indicated concentrations of <b>4</b> (green), <b>8d</b> (brown), <b>9d</b> (magenta), <b>11b</b> (black), and cocaine (cyan). The inhibition potency of <b>2</b> as assessed previously<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> is inserted for comparison (dotted line). Data are the means ± SEM of 3–10 experiments performed in triplicate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/large/jm-2016-01373u_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01373&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/medium/jm-2016-01373u_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/large/jm-2016-01373u_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Assessment of DAT binding profiles by modafinil analogues. As demonstrated previously,<a onclick="showRef(event, 'ref13 ref43'); return false;" href="javascript:void(0);" class="ref ref13 ref43">(13, 43)</a> a characteristic feature for atypical DAT inhibitors is that, in contrast to cocaine, their binding depends on the presence of the OH-group on Tyr156. Inhibition of [<sup>3</sup>H]WIN35,428 binding to DAT WT (black) or the Y156F (green) mutant by (A) cocaine, (B) <b>2</b>, (C) <b>4</b>, and (D) <b>11b</b>. The fold change in IC<sub>50</sub> values between WT and Y156F is 1.4, 10, 2.8, and 14.9 for cocaine, <b>2</b>, <b>4</b>, and <b>11b</b>, respectively. Binding assays are performed as triplicates on COS7 cells transiently expressing DAT WT or Y156F (<i>n</i> = 3–6). Data are shown as the means ± SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/large/jm-2016-01373u_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01373&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Assessment of Atypical Binding Properties for Selected Analogues<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" align="center">WT</th><th class="rowsep1 colsep0" align="center">Y156F</th><th class="rowsep1 colsep0" align="center">Y156F/WT</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub> (nM)</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub> (nM)</th><th class="colsep0 rowsep0" align="center">affinity ratio</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">927 [834; 1030]</td><td class="colsep0 rowsep0" align="left">9250 [7350; 11700]</td><td class="colsep0 rowsep0" align="left">10.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>(</b><i><b>R</b></i><b>)-2</b></td><td class="colsep0 rowsep0" align="left">647 [593;704]</td><td class="colsep0 rowsep0" align="left">8920 [6930;11500]</td><td class="colsep0 rowsep0" align="left">13.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>(</b><i><b>S</b></i><b>)-2</b></td><td class="colsep0 rowsep0" align="left">1960 [1700;2270]</td><td class="colsep0 rowsep0" align="left">5910 [4640; 7520]</td><td class="colsep0 rowsep0" align="left">3.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">47 [33;66]</td><td class="colsep0 rowsep0" align="left">260 [229;296]</td><td class="colsep0 rowsep0" align="left">5.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">720 [661;784]</td><td class="colsep0 rowsep0" align="left">2050 [1840;2280]</td><td class="colsep0 rowsep0" align="left">2.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8d</b></td><td class="colsep0 rowsep0" align="left">101 [82;125]</td><td class="colsep0 rowsep0" align="left">267 [227; 314]</td><td class="colsep0 rowsep0" align="left">2.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9d</b></td><td class="colsep0 rowsep0" align="left">1200 [824;1760]</td><td class="colsep0 rowsep0" align="left">9170 [7680; 10900]</td><td class="colsep0 rowsep0" align="left">7.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11b</b></td><td class="colsep0 rowsep0" align="left">6.5 [5.1;8.3]</td><td class="colsep0 rowsep0" align="left">97 [67;140]</td><td class="colsep0 rowsep0" align="left">14.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cocaine</td><td class="colsep0 rowsep0" align="left">223 [160;309]</td><td class="colsep0 rowsep0" align="left">321 [235; 438]</td><td class="colsep0 rowsep0" align="left">1.4</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Inhibition of [<sup>3</sup>H] WIN35,428 binding to DAT WT or the Y156F mutant. COS7 cells transiently expressing DAT WT or Y156F were assessed for affinity (<i>K</i><sub>i</sub>) for the indicated compounds. Data were analyzed by nonlinear regression analysis using Prism 6.0 (GraphPad). The IC<sub>50</sub> values were calculated from means of pIC<sub>50</sub> values and the SEM interval from pIC<sub>50</sub> ± SEM. The <i>K</i><sub>i</sub> values were calculated from the IC<sub>50</sub>-values using the equation <i>K</i><sub>i</sub> = IC<sub>50</sub>/(1 + (<i>L</i> +<i>K</i><sub>d</sub>), where <i>K</i><sub>d</sub> is the affinity for WIN35,428, and L is the concentration of added [<sup>3</sup>H]WIN35,428). All data are performed in triplicate, <i>n</i> = 3–6.</p></div></div></div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/medium/jm-2016-01373u_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/large/jm-2016-01373u_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Phase I metabolic stability of selected analogues in mouse liver microsomes. Compounds <b>8d</b>, <b>9d</b>, and <b>11b</b> were tested in mouse liver microsomes fortified with NADPH. Compounds <b>8d</b> and <b>9d</b> both showed slow metabolism with a half-life of approximately 60 min suggesting the compounds to be stable. Compound <b>11b</b>, on the contrary, had a much shorter half-life of 13 min suggesting rapid metabolism. Note: control experiments without cofactors were conducted in parallel, and in all cases, >95% compound remained at 60 min suggesting that the compounds were undergoing Cyp dependent metabolism. Testosterone was used as a positive control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/large/jm-2016-01373u_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01373&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Metabolic Stability in Mouse Microsomes</h3><div class="NLM_p last">On the basis of their in vitro profiles, compounds <b>8d</b>, <b>9d</b>, and <b>11b</b> were tested for phase I metabolism following procedures previously described<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> to predict the susceptibility to metabolism following in vivo administration. As depicted in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>, compounds <b>8d</b> and <b>9d</b> exhibited good stability with approximately 50% of both compounds remaining in mouse microsomes fortified with NADPH. Corresponding in vitro half-lives for <b>8d</b> and <b>9d</b> were calculated to be ∼60 min confirming compounds stable to CYP dependent phase I metabolism. In contrast, compound <b>11b</b> undergoes substantial phase I metabolism with only ∼4% remaining in microsomes fortified with NADPH at 1 h, suggesting CYP dependent metabolism of the compound and a relatively short in vitro half-life of 13 min. Of note, compounds <b>9f</b>, <b>9g</b>, <b>9h</b>, <b>11a</b>, <b>13c</b>, <b>14b</b>, and <b>14e</b> were all metabolized in <30 min in the mouse liver microsomes.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Locomotor Activity in Mice Compared to Cocaine</h3><div class="NLM_p"><a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a> shows the effects of (<i>R</i>)-modafinil and its analogues <b>4</b> and <b>11b</b> on locomotor activity compared to cocaine. Systemic administration (i.p.) of cocaine (3, 10 mg/kg) produced a robust dose-dependent increase in locomotion (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A, cocaine treatment main effect, F<sub>2,21</sub> = 10,82, <i>p</i> < 0.001, two-way ANOVA), while (<i>R</i>)-modafinil and compounds <b>4</b> and <b>11b</b>, at the same dose (10 mg/kg), produced no significant or a very mild locomotor response. When the dose was increased to 30 mg/kg, (<i>R</i>)-modafinil and <b>11b</b> produced a significant dose-dependent increase, while <b>4</b> did not. Two-way ANOVA for repeated measures over time revealed a statistically significant treatment main effect for (<i>R</i>)-modafinil (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>B, F<sub>2,21</sub> = 10.01, <i>p</i> < 0.001) and for compound <b>11b</b> (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>D, F<sub>2,21</sub> = 4.35, <i>p</i> < 0.005) but not for compound <b>4</b> (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>C, F<sub>2,21</sub> = 0.65, <i>p</i> = ns). Although the assay did not show a significant treatment main effect for compound <b>4</b>, it revealed a significant time main effect (F<sub>11,231</sub> = 5.11, <i>p</i> < 0.001) and treatment × time interactions (F<sub>21,231</sub> = 1.73, <i>p</i> < 0.05). Therefore, posthoc individual group comparisons revealed statistically significant differences between the different dose groups at certain time points (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>C).</div><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/medium/jm-2016-01373u_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/large/jm-2016-01373u_0006.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Locomotor effects of (<i>R</i>)-modafinil [<b>(</b><i><b>R</b></i><b>)-2</b>] and its analogues <b>4</b> and <b>11b</b> compared to cocaine in mice. Systemic administration of cocaine (3, 10 mg/kg, i.p.) produced a robust dose-dependent increase in locomotion (A). However, <b>(</b><i><b>R</b></i><b>)-2</b> and its analogues <b>4</b> and <b>11b</b>, at the same dose of 10 mg/kg, did not (C,D) or produced a very mild increase (B) in locomotion. When the dose was increased to 30 mg/kg, <b>(</b><i><b>R</b></i><b>)-2</b> and <b>11b</b> produced a significant dose-dependent increase in locomotion, while its analogue <b>4</b> did not. *<i>p</i> < 0.05, **<i>p</i> < 0.01, and ***<i>p</i> < 0.001, compared to the vehicle control group at each time point marked.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/large/jm-2016-01373u_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01373&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Most typical DAT inhibitors increase locomotor activity in mice; indeed, this is one behavioral hallmark of this class of agents. In contrast, we and others have reported “atypical” DAT inhibitors that, despite binding with high affinity and selectivity to the DAT and inhibiting DA uptake, are not efficacious locomotor stimulants and do not exhibit other cocaine-like behaviors. (±)-Modafinil and its (<i>R</i>)-enantiomer display unique pharmacological profiles<a onclick="showRef(event, 'ref12 ref13 ref24 ref48'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref24 ref48">(12, 13, 24, 48)</a> that suggest they may be atypical. Herein, compound <b>11b</b> displayed the highest DAT affinity in the series with good selectivity over other off-targets (<a class="ref internalNav" href="#tbl2" aria-label="Tables 2">Tables 2</a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). As seen in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>, compound <b>11d</b>, does increase locomotor activity in mice, but it is far less efficacious than cocaine suggesting that this modafinil analogue is an atypical DAT inhibitor. In addition, <b>11b</b> demonstrated the highest Y156F/WT ratio in the mutagenesis study (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>, <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>) suggesting that it binds the DAT in a more occluded conformation, unlike cocaine.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17683" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17683" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, we have designed and synthesized a series of modafinil analogues that have higher DAT affinity than the parent molecule and have extended SAR at the DAT by manipulating the oxidation states of the sulfoxide and the amide, halogenating the phenyl rings, and/or functionalizing the terminal nitrogen with <i>N</i>-substituted piperazines. Compounds <b>8d</b>, <b>9d</b>, and <b>11b</b> were selected as lead compounds from this series and were tested for binding to σ1, as well as dopamine D<sub>2</sub>, D<sub>3</sub>, and D<sub>4</sub> receptor subtypes, and for efficacy in a D<sub>2</sub> Gi<sub>1</sub> BRET assay. In addition, we tested this subset of analogues in cell-based [<sup>3</sup>H]DA uptake and binding assays for affinities at both the WT and the Y156F DAT mutant, in order to determine if they demonstrated an atypical binding profile, as previously reported for (±)-modafinil and its (<i>R</i>)-enantiomer.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> These data suggest that all three lead compounds did indeed bind the DAT in a conformation that was more like the atypical benztropines and unlike cocaine, with <b>11b</b> having the highest DAT affinity and selectivity in this series. We discovered, that similar to previously reported atypical DAT inhibitors,<a onclick="showRef(event, 'ref49 ref50 ref51 ref52 ref53'); return false;" href="javascript:void(0);" class="ref ref49 ref50 ref51 ref52 ref53">(49-53)</a> compound <b>11b</b> produced only moderate locomotor stimulation in mice and was substantially less efficacious than cocaine. These results are consistent with an atypical DAT inhibitor profile and suggest that <b>11b</b> may be a potential lead for development as a psychostimulant abuse therapeutic. Further investigations of this compound in rodent models of cocaine and methamphetamine abuse, along with compounds <b>4</b>, <b>8d</b>, and <b>9d</b>, are underway to extend testing of the atypical DAT inhibitor hypothesis, as well as to further investigate the role of σ1 receptors in the behavioral profile of these agents. Finally, although <b>11b</b> showed significant metabolism in mouse microsomes, preliminary data show a rapid and high brain to plasma ratio, suggesting that <b>11b</b> can penetrate the blood–brain barrier sufficiently to block DA uptake via the DAT. Nevertheless, efforts to modify this structural template in order to improve metabolic stability are also ongoing and will be reported in due course.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Procedures</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53235" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53235" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Synthesis</h3><div class="NLM_p"><sup>1</sup>H and <sup>13</sup>C NMR spectra were acquired using a Varian Mercury Plus 400 spectrometer at 400 and 100 MHz, respectively. Chemical shifts are reported in parts-per-million (ppm) and referenced according to deuterated solvent for <sup>1</sup>H NMR spectra (CDCl<sub>3</sub>, 7.26 or DMSO-<i>d</i><sub>6</sub>, 2.50) and <sup>13</sup>C NMR spectra (CDCl<sub>3</sub>, 77.2 or DMSO-<i>d</i><sub>6</sub>, 39.5). Gas chromatography–mass spectrometry (GC/MS) data were acquired (where obtainable) using an Agilent Technologies (Santa Clara, CA) 6890N GC equipped with an HP-5MS column (cross-linked 5% PH ME siloxane, 30 m × 0.25 mm i.d. × 0.25 μm film thickness) and a 5973 mass-selective ion detector in electron-impact mode. Ultrapure grade helium was used as the carrier gas at a flow rate of 1.2 mL/min. The injection port and transfer line temperatures were 250 and 280 °C, respectively. Combustion analysis was performed by Atlantic Microlab, Inc. (Norcross, GA), and the results agree within ±0.5% of calculated values. Melting point determination was conducted using a Thomas-Hoover melting point apparatus and is uncorrected. On the basis of NMR and combustion data, all final compounds are >95% pure.</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> 2-(Benzhydrylthio)ethan-1-ol (<b>6a</b>)</h4><div class="NLM_p last">2-Mercaptoethan-1-ol (7.8 g, 100 mmol) was added to commercially available diphenylmethanol (3.7 g, 20 mmol) in TFA (40 mL) and CH<sub>2</sub>Cl<sub>2</sub> (40 mL) at 0 °C. The solution was warmed to room temperature and stirred overnight. The solvent was removed, K<sub>2</sub>CO<sub>3</sub> (11 g, 80 mmol), H<sub>2</sub>O (7 mL) and acetone (25 mL) were added to the reaction residue, and the mixture stirred at room temperature overnight. The solvent was removed, H<sub>2</sub>O (100 mL) was added to the residue obtained, and the aqueous mixture was extracted with ethyl acetate (3 × 100 mL). The organic layer was dried over MgSO<sub>4</sub>, and the solvent was removed <i>in vacuo</i>. The crude product was purified by flash column chromatography (hexane/ethyl acetate = 6:4) to give <b>6a</b> (3.0 g, 61% yield) as a clear oil. GC/MS (EI) <i>m</i>/<i>z</i> 244 (M<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.43–7.45 (m, 4H), 7.30–7.34 (m, 4H), 7.21–7.26 (m, 2H), 5.21 (s, 1H), 3.64–3.69 (m, 2H), 2.62–2.65 (m, 2H).</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> 2-((Bis(4-fluorophenyl)methyl)thio)ethan-1-ol (<b>6b</b>)</h4><div class="NLM_p last">Compound <b>6b</b> was prepared as described for <b>6a</b> using bis(4-fluorophenyl)methanol (6.6 g, 30 mmol) to give the product (6.9 g, 82% yield) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.35–7.39 (m, 4H), 6.99–7.03 (m, 4H), 5.20 (s, 1H), 3.68–3.70 (m, 2H), 2.59–2.62 (m, 2H).</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> 2-((Bis(3-chlorophenyl)methyl)thio)ethan-1-ol (<b>6c</b>)</h4><div class="NLM_p last">Compound <b>6c</b> was synthesized as described for compound <b>6a</b> using bis(3-chlorophenyl)methanol (2.84 g, 11.2 mmol) to give the product (3.34 g, 95% yield) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.40 (s, 2H), 7.31–7.22 (m, 6H), 5.14 (s, 1H), 3.71 (t, <i>J</i> = 5.8 Hz, 2H), 2.63 (t, <i>J</i> = 6.0 Hz, 2H), 1.93 (br s, 1H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 142.5, 134.6, 130.0, 128.3, 127.9, 126.4, 60.6, 52.8, 35.3.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> Benzhydryl(2-bromoethyl)sulfane (<b>7a</b>)</h4><div class="NLM_p last">Triphenylphosphine (1.4 g, 5.3 mmol) was added to a solution of <b>6a</b> (890 mg, 3.64 mmol) in CH<sub>3</sub>CN (12 mL), followed by the addition of carbon tetrabromide (1.77 g, 5.34 mmol). The reaction was stirred at room temperature overnight. The solvent was removed, and the crude product was purified by flash column chromatography (hexane/ethyl acetate = 5:1) to give <b>6a</b> (850 mg, 76% yield) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.23–7.45 (m, 10H), 5.23 (s, 1H), 3.33–3.39 (m, 2H), 2.80–2.90 (m, 2H); GC/MS (EI) <i>m</i>/<i>z</i> 307 (M<sup>+</sup>).</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> (Bis(4-fluorophenyl)methyl)(2-bromoethyl)sulfane (<b>7b</b>)</h4><div class="NLM_p last">Compound <b>7b</b> was prepared as described for <b>7a</b> using <b>6b</b> (6.9 g, 25 mmol) to give the product (7.0 g, 83% yield) as a light yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.34–7.37 (m, 4H), 6.00–7.04 (m, 4H), 5.21 (s, 1H), 3.36–3.40 (m, 2H), 2.81–2.85 (m, 2H); GC/MS (EI) <i>m</i>/<i>z</i> 343 (M<sup>+</sup>).</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> (Bis(3-chlorophenyl)methyl)(2-bromoethyl)sulfane (<b>7c</b>)</h4><div class="NLM_p last"><b>7c</b> was prepared as described for <b>7a</b> using <b>6c</b> (3.23 g, 10.3 mmol) to give product as colorless oil (3.03 g, 78% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.38 (s, 2H), 7.28–7.22 (m, 6H), 5.14 (s, 1H), 3.39 (t, <i>J</i> = 8.0 Hz, 2H), 2.86 (t, <i>J</i> = 8.0 Hz, 2H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 142.3, 134.9, 130.2, 128.5, 128.2, 126.5, 53.6, 34.5, 30.2.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 1-(2-(Benzhydrylthio)ethyl)-4-(3-phenylpropyl)piperazine (<b>8a</b>)</h4><div class="NLM_p last">A mixture of <b>7a</b> (850 mg, 2.76 mmol), commercially available 1-(3-phenylpropyl)piperazine (564 mg, 2.76 mmol), K<sub>2</sub>CO<sub>3</sub> (1.52 g, 11.0 mmol), and KI (catalytic) in acetone (30 mL) was refluxed overnight. The solvent was removed, H<sub>2</sub>O (50 mL) was added to the residue, and the aqueous mixture was extracted with ethyl acetate (3 × 50 mL). The organic layer was dried over MgSO<sub>4</sub>, the solvent was removed <i>in vacuo</i>, and the crude product was purified by flash column chromatography [ethyl acetate/triethylamine = 95:5] to give <b>8a</b> (810 mg, 61% yield) as a yellow oil. The free base was converted to the oxalate salt and recrystallized from methanol to give a white solid. Mp 210 °C (dec.); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.16–7.43 (m, 15H), 5.22 (s, 1H), 2.33–2.64 (m, 16H), 1.78–1.82 (m, 2H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 142.1, 141.4, 128.5, 128.4, 128.3, 127.2, 125.7, 58.0, 54.5, 54.4, 53.1, 53.0, 33.7, 29.3, 28.6; Anal. (C<sub>28</sub>H<sub>34</sub>N<sub>2</sub>S·2C<sub>2</sub>H<sub>2</sub>O<sub>4</sub>·0.25H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 1-(2-((Bis(4-fluorophenyl)methyl)thio)ethyl)-4-(3-phenylpropyl)piperazine (<b>8b</b>)</h4><div class="NLM_p last">Compound <b>8b</b> was prepared as described for <b>8a</b> using <b>7b</b> (950 mg, 2.76 mmol) to give the product (940 mg, 73% yield) as a yellow oil. The free base was converted to the oxalate salt and recrystallized from methanol to give a white solid. Mp 216–217 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.34–7.37(m, 4H), 7.24–7.29(m, 2H), 7.15–7.19(m, 3H), 6.97–7.01(m, 4H), 5.20 (s, 1H), 2.33–2.64 (m, 16H), 1.67–1.82 (m, 2H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 163.1, 160.7, 142.1, 137.0, 129.8, 129.7, 128.4, 128.3, 125.7, 115.6, 115.3, 58.0, 53.1, 52.9, 52.8, 33.7, 29.4, 28.6; Anal. (C<sub>28</sub>H<sub>32</sub>F<sub>2</sub>N<sub>2</sub>S·2C<sub>2</sub>H<sub>2</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 1-(4-(2-(Benzhydrylthio)ethyl)piperazin-1-yl)propan-2-ol (<b>8c</b>)</h4><div class="NLM_p last">Compound <b>8c</b> was prepared as described for (<b>8a)</b> using <b>7a</b> (848 mg, 2.76 mmol) and 1-(piperazin-1-yl)propan-2-ol (398 mg, 2.76 mmol) to give the product (850 mg, 83% yield) as a yellow oil. The free base was converted to the oxalate salt and recrystallized from methanol to give a white solid. Mp 209–210 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.41–7.43 (m, 4H), 7.19–7.32 (m, 6H), 5.21 (s, 1H), 3.77–3.82 (m, 1H), 3.41 (br, 1H), 2.17–2.67 (m, 14H), 1.11–1.14 (m, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 141.4, 128.6, 128.5, 128.3, 127.2, 65.6, 62.2, 57.9, 54.5, 54.4, 53.1, 29.3, 20.0; Anal. (C<sub>22</sub>H<sub>30</sub>N<sub>2</sub>OS·2C<sub>2</sub>H<sub>2</sub>O<sub>4</sub>·0.25H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 1-(4-(2-((Bis(4-fluorophenyl)methyl)thio)ethyl)piperazin-1-yl)propan-2-ol (<b>8d</b>; JJC 8-089)</h4><div class="NLM_p last">Compound <b>8d</b> was prepared as described for <b>8a</b> using <b>7b</b> (950 mg, 2.76 mmol) and 1-(piperazin-1-yl)propan-2-ol (398 mg, 2.76 mmol) to give the product (880 mg, 79% yield) as a yellow oil. The free base was converted to the oxalate salt and recrystallized from methanol to give a white solid. Mp 205–206 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.33–7.37 (m, 4H), 6.96–7.02 (m, 4H), 5.19 (s, 1H), 3.77–3.82 (m, 1H), 3.41 (br,1H), 2.18–2.69 (m, 14H), 1.11–1.13 (m, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 163.1, 160.7, 137.0, 129.8, 129.7, 115.7, 115.6, 115.5, 115.4, 65.5, 62.2, 57.8, 53.1, 52.9, 29.4, 20.0; Anal. (C<sub>22</sub>H<sub>28</sub>F<sub>2</sub>N<sub>2</sub>OS·2C<sub>2</sub>H<sub>2</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 1-(2-(Benzhydrylthio)ethyl)piperazine (<b>8e</b>)</h4><div class="NLM_p last">A mixture of <b>7a</b> (1.4 g, 4.6 mmol), piperazine (2.35 g, 27.3 mmol), and K<sub>2</sub>CO<sub>3</sub> (1.05 g, 9.12 mmol) in acetonitrile (25 mL) was refluxed overnight. The solvent was removed, H<sub>2</sub>O (100 mL) was added to the residue, and the aqueous mixture was extracted with ethyl acetate (3 × 100 mL). The organic layer was dried over MgSO<sub>4</sub>, and solvent was removed <i>in vacuo</i>. The crude product was purified by flash column chromatography (CHCl<sub>3</sub>/MeOH/NH<sub>4</sub>OH = 90/10/0.5) to give <b>8e</b> (710 mg, 50% yield) as a yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.41–7.43 (m, 4H), 7.19–7.32 (m, 6H), 5.22 (s, 1H), 2.83–2.85 (m, 4H), 2.52–2.54 (m, 4H), 2.34–2.37 (m, 4H).</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 1-(2-((Bis(4-fluorophenyl)methyl)thio)ethyl)piperazine (<b>8f</b>)</h4><div class="NLM_p last">Compound <b>8f</b> was prepared as described for <b>8e</b> using <b>7b</b> (1.03 g, 3.00 mmol) to give the product (910 mg, 87% yield) as a yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.34–7.37 (m, 4H), 6.97–7.26 (m, 4H), 5.20 (s, 1H), 2.84–2.86 (m, 4H), 2.50–2.52 (m, 4H), 2.35–2.37 (m, 4H).</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 1-Benzyl-4-(2-((bis(4-fluorophenyl)methyl)thio)ethyl)piperazine (<b>8g</b>)</h4><div class="NLM_p last">Compound <b>8g</b> was prepared as described as <b>8a</b> using <b>7b</b> (687 mg, 2.00 mmol) and 1-benzylpiperazine (353 mg, 2.00 mmol) to give the product as a yellow oil (530 mg, 60%). The free base was converted to the oxalate salt and recrystallized from methanol to give a white solid. Mp 224–226 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.22–7.38 (m, 9H), 6.96–7.02 (m, 4H), 5.20 (s, 1H), 3.45–3.51 (m, 2H), 2.43–2.68 (m, 12H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 163.1, 160.4, 138.0, 137.0, 129.8, 129.7, 129.2, 128.2, 127.0, 115.7, 115.6, 115.5, 115.4, 63.0, 57.9, 53.1, 53.0, 52.9, 29.4. Anal. Calc.: C, 58.24, H, 5.21, N, 4.53. Found: C, 57.98, H, 5.16, N, 4.63. Anal. (C<sub>26</sub>H<sub>28</sub>F<sub>2</sub>N<sub>2</sub>S·2C<sub>2</sub>H<sub>2</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec4_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 1-(2-((Bis(4-fluorophenyl)methyl)thio)ethyl)-4-(4-fluorobenzyl)piperazine (<b>8h</b>)</h4><div class="NLM_p last">Compound <b>8h</b> was prepared as described as <b>8a</b> using <b>7b</b> (515 mg, 1.50 mmol) and 1-(4-fluorobenzyl)piperazine (194 mg, 1.50 mmol) to give the product as a yellow oil (450 mg, 65.7%). The free base was converted to the oxalate salt and recrystallized from methanol to give a white solid Mp 221–223 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.33–7.37 (m, 4H), 7.23–7.27 (m, 2H), 6.95–7.00 (m, 6H), 5.18 (s, 1H), 3.44–3.46 (m, 2H), 2.41–2.56 (m, 12H); <sup>13</sup>C NMR (100 MHz, CDCl3) δ 163.1, 160.4, 137.0, 133.8,130.6, 130.5, 129.8, 115.6, 115.4, 115.1, 114.9, 62.2, 57.9, 53.0, 52.9, 29.4; GC/MS (EI) <i>m</i>/<i>z</i> 456 (M<sup>+</sup>). Anal. Calc.: C, 56.6, H, 4.91, N, 4.40. Found: C, 56.35, H, 4.91, N, 4.38. Anal. (C<sub>26</sub>H<sub>27</sub>F<sub>3</sub>N<sub>2</sub>S·2C<sub>2</sub>H<sub>2</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec4_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 1-(2-((Bis(4-fluorophenyl)methyl)thio)ethyl)-4-(4-(trifluoromethyl)benzyl)piperazine (<b>8i</b>)</h4><div class="NLM_p last">Compound <b>8i</b> was prepared as described as <b>8a</b> using <b>7b</b> (515 mg, 1.50 mmol) and commercially available 1-(4-(trifluoromethyl)benzyl)piperazine (367 mg, 1.50 mmol) to give the product as yellow oil (500 mg, 66%). The free base was converted to the oxalate salt and recrystallized from methanol to give a white solid Mp 223–224 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.55–7.57 (m, 2H), 7.41–7.43 (m, 2H), 7.33–7.37 (m, 4H), 6.97–7.01 (m, 4H), 5.19 (s, 1H), 3.53–3.54 (m, 2H), 2.43–2.55 (m, 12H); <sup>13</sup>C NMR (100 MHz, CDCl3) δ 163.1, 160.7, 142.4, 137.0, 129.8, 129.7, 129.2, 125.2, 125.1, 115.6, 115.4, 62.4, 57.8, 53.0, 52.9, 29.4; GC/MS (EI) <i>m</i>/<i>z</i> 506 (M<sup>+</sup>). Anal. Calc.: C, 53.87, H, 4.59, N, 4.05. Found: C, 53.78, H, 4.69, N, 4.05. Anal. (C<sub>27</sub>H<sub>27</sub>F<sub>5</sub>N<sub>2</sub>S·2C<sub>2</sub>H<sub>2</sub>O<sub>4</sub>·0.25H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 1-(2-((Bis(4-fluorophenyl)methyl)thio)ethyl)-4-(4-chlorobenzyl)piperazine (<b>8j</b>)</h4><div class="NLM_p last">Compound <b>8j</b> was prepared as described as <b>8a</b> using <b>7b</b> (515 mg, 1.50 mmol) and commercially available1-(4-chlorobenzyl)piperazine (316 mg, 1.50 mmol) to give the product as a yellow oil (500 mg, 67.7%). The free base was converted to the oxalate salt and recrystallized from methanol to give a white solid Mp 224–225 °C; GC/MS (EI) <i>m</i>/<i>z</i> 473 (M<sup>+</sup>); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.33–7.37 (m, 4H), 7.22–7.28 (m, 4H), 6.97–7.01 (m, 4H), 5.19 (s, 1H), 3.44–3.45 (m, 2H), 2.41–2.54 (m, 12H); <sup>13</sup>C NMR (100 MHz, CDCl3) δ 163.1, 160.6, 137.0, 136.6, 132.8, 130.4, 129.8, 129.7, 128.3, 115.7, 115.6, 115.5, 115.4, 62.2, 57.8, 52.9, 29.4. Anal. Calc.: C, 54.80, H, 4.83, N, 4.26. Found: C, 54.61, H, 4.80, N, 4.28. Anal. (C<sub>26</sub>H<sub>27</sub>ClF<sub>2</sub>N<sub>2</sub>S·2C<sub>2</sub>H<sub>2</sub>O<sub>4</sub>·0.25H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 1-(4-(2-((Bis(3-chlorophenyl)methyl)thio)ethyl)piperazin-1-yl)propan-2-ol (<b>8k</b>)</h4><div class="NLM_p last">Compound <b>8k</b> was prepared as described for <b>8a</b> using <b>7c</b> (866 mg, 2.30 mmol) and commercially available 1-(piperazin-1-yl)propan-2-ol (335 mg, 2.32 mmol) to give the product as a yellow oil (650 mg, 64% yield). The free base was converted to the oxalate salt in a 2-propanol/acetone solvent mixture and recovered as a white solid. Mp 119–121 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.39 (s, 2H), 7.29–7.18 (m, 6H), 5.15 (s, 1H), 3.85–3.76 (m, 1H), 2.72–2.62 (br m, 2H), 2.59–2.18 (m, 13H), 1.13 (d, <i>J</i> = 6.4 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 142.8, 134.5, 129.96, 128.4, 127.7, 126.4, 65.5, 62.2, 60.4, 57.8, 53.5, 53.1, 29.5, 19.9; Anal. (C<sub>22</sub>H<sub>28</sub>Cl<sub>2</sub>N<sub>2</sub>OS·2C<sub>2</sub>H<sub>2</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec4_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 1-(2-(Benzhydrylsulfinyl)ethyl)-4-(3-phenylpropyl)piperazine (<b>9a</b>)</h4><div class="NLM_p last">Compound <b>9a</b> was prepared as previously described<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> using <b>8a</b> (431 mg, 1.00 mmol) to give the product (250 mg, 56% yield) as a yellow oil. The free base was converted to the hydrochloride salt and recrystallized from methanol to give a white solid. Mp 210 °C (dec.); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.15–7.50 (m, 15H), 4.96 (s, 1H), 2.33–2.82 (m, 16H), 1.76–1.84 (m, 2H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 142.1, 136.0, 135.2, 129.3, 129.2, 128.7, 128.4, 128.3, 128.2, 125.8, 72.1, 57.9, 53.4, 53.0, 51.0, 48.2, 33.7, 28.6; Anal. (C<sub>28</sub>H<sub>34</sub>N<sub>2</sub>OS·2HCl·0.5H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 1-(2-((Bis(4-fluorophenyl)methyl)sulfinyl)ethyl)-4-(3-phenylpropyl)piperazine (<b>9b</b>)</h4><div class="NLM_p last">Compound <b>9b</b> was prepared as described for <b>9a</b> using <b>8b</b> (466 mg, 1.00 mmol) to give the product (290 mg, 60% yield) as a yellow oil. The free base was converted to the oxalate salt and recrystallized from methanol to give a white solid. Mp 204 °C (dec.); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.37–7.40(m, 4H), 7.24–7.28(m, 2H), 7.16–7.19(m, 3H), 7.05–7.11(m, 4H), 4.95 (s, 1H), 2.34–2.79 (m, 16H), 1.76–2.04 (m, 2H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 164.0, 163.8, 161.6, 142.1, 131.0, 130.6, 130.3, 128.4, 128.3, 125.8, 116.4, 116.2, 115.9, 115.6, 68.8, 68.2, 65.8, 57.9, 53.0, 50.9, 48.1, 33.7, 28.5; Anal. (C<sub>28</sub>H<sub>32</sub>F<sub>2</sub>N<sub>2</sub>OS·2C<sub>2</sub>H<sub>2</sub>O<sub>4</sub>·H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 1-(4-(2-(Benzhydrylsulfinyl)ethyl)piperazin-1-yl)propan-2-ol (<b>9c</b>)</h4><div class="NLM_p last">Compound <b>9c</b> was prepared as described for <b>9a</b> using <b>8c</b> (556 mg, 1.50 mmol) to give the product (450 mg, 78% yield) as a white solid. The free base was converted to the oxalate salt and recrystallized from methanol to give a white solid. Mp 195–197 °C (dec.); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.30–7.49 (m, 10H), 4.95 (s, 1H), 3.78–3.82 (m, 1H), 3.39 (br s, 1H), 2.18–2.83 (m, 14H), 1.11–1.12 (m, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 136.0, 135.1, 129.3, 129.2, 128.7, 128.6, 128.3, 72.2, 65.5, 62.2, 53.1, 50.9, 48.3, 20.0; Anal. (C<sub>22</sub>H<sub>30</sub>N<sub>2</sub>O<sub>2</sub>S·2C<sub>2</sub>H<sub>2</sub>O<sub>4</sub>·0.25H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 1-(4-(2-((Bis(4-fluorophenyl)methyl)sulfinyl)ethyl)piperazin-1-yl)propan-2-ol (<b>9d</b>; JJC8-091)</h4><div class="NLM_p last">Compound <b>9d</b> was prepared as described for <b>9a</b> using <b>8d</b> (610 mg, 1.50 mmol) to give the product (340 mg, 54% yield) as a yellow oil. The free base was converted to the oxalate salt and recrystallized from methanol to give a white solid. Mp 190–191 °C (dec.); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.36–7.43 (m, 4H), 7.04–7.12 (m, 4H), 4.92 (s, 1H), 3.77–3.83 (m, 1H), 2.22–2.84 (m, 14H), 1.11–1.12 (m, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 164.0, 163.8, 161.6, 161.3, 131.7, 131.0, 130.6, 130.5, 130.4, 130.3, 116.4, 116.2, 115.9, 115.6, 69.9, 69.8, 65.5, 62.3, 53.1, 50.8, 48.3, 20.0; Anal. (C<sub>22</sub>H<sub>28</sub>F<sub>2</sub>N<sub>2</sub>O<sub>2</sub>S·2C<sub>2</sub>H<sub>2</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec4_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 1-Benzyl-4-(2-((bis(4-fluorophenyl)methyl)sulfinyl)ethyl)piperazine (<b>9e</b>)</h4><div class="NLM_p last">Compound <b>5e</b> was prepared as described for <b>9a</b> using <b>8g</b> (307 mg, 0.700 mmol) to give the product (150 mg, 47.1% yield) as a yellow oil. The free base was converted to the oxalate salt and recrystallized from methanol to give a white solid. Mp 219–220 °C (dec.); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.37–7.44 (m, 4H), 7.24–7.33 (m, 5H), 7.05–7.11 (m, 4H), 5.30 (s, 1H), 3.50 (s, 2H), 2.45–2.80 (m, 12H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 165.9, 163.7, 161.5, 159.3, 138.0, 131.8, 129.2, 127.1, 115.6, 69.7, 63.0, 52.9, 50.9, 48.1; Anal. (C<sub>26</sub>H<sub>28</sub>F<sub>2</sub>N<sub>2</sub>OS·2C<sub>2</sub>H<sub>2</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec4_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 1-(2-((Bis(4-fluorophenyl)methyl)sulfinyl)ethyl)-4-(4-fluorobenzyl)piperazine (<b>9f</b>)</h4><div class="NLM_p last">Compound <b>9f</b> was prepared as described for <b>9a</b> using <b>8h</b> (251 mg, 0.549 mmol) to give the product (100 mg, 38.5% yield) as a yellow oil. The free base was converted to the oxalate salt and recrystallized from methanol to give a white solid. Mp 216–218 °C (dec.); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.37–7.43 (m, 4H), 7.24–7.27 (m, 2H), 6.96–7.11 (m, 6H), 4.94 (s, 1H), 3,46 (s, 2H), 2.44–2.78 (m, 12H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 164.0, 163.7, 163.2, 161.5, 161.3, 160.8, 133.5, 131.8, 131.7, 131.0, 130.7, 130.6, 130.5, 130.4, 130.3, 116.4, 116.2, 115.9, 115.6, 115.1, 114.9, 69.7, 62.1, 53.0, 52.7, 50.8, 48.1; Anal. (C<sub>26</sub>H<sub>27</sub>F<sub>3</sub>N<sub>2</sub>OS·2C<sub>2</sub>H<sub>2</sub>O<sub>4</sub>·0.5H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 1-(2-((Bis(4-fluorophenyl)methyl)sulfinyl)ethyl)-4-(4-(trifluoromethyl)benzyl)piperazine (<b>9g</b>)</h4><div class="NLM_p last">Compound <b>9g</b> was prepared as described for <b>9a</b> using <b>8i</b> (304 mg, 0.601 mmol) to give the product (100 mg, 47.8% yield) as a yellow oil. The free base was converted to the oxalate salt and recrystallized from methanol to give a white solid. Mp 216–218 °C (dec.); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.55–7.57 (m, 2H), 7.37–7.43 (m, 6H), 7.04–7.11 (m, 4H), 4.94 (s, 1H), 3.54 (s, 2H), 2.45–2.83 (m, 12H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 164.0, 163.8, 161.6, 161.3, 142.3, 131.8, 131.0, 130.5, 130.4, 130.3, 129.5, 129.2, 128.6, 125.6, 125.2, 125.1, 122.9, 116.4, 116.2, 115.9, 115.669.8, 62.3, 53.0, 52.9, 50.8, 48.2; Anal. (C<sub>27</sub>H<sub>27</sub>F<sub>5</sub>N<sub>2</sub>OS·2C<sub>2</sub>H<sub>2</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec4_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 1-(2-((Bis(4-fluorophenyl)methyl)sulfinyl)ethyl)-4-(4-chlorobenzyl)piperazine (<b>9h</b>)</h4><div class="NLM_p last">Compound <b>9h</b> was prepared as described for <b>9a</b> using <b>8j</b> (360 mg, 0.761 mmol) to give the product (160 mg, 43.0% yield) as a yellow oil. The free base was converted to the oxalate salt and recrystallized from methanol to give a white solid. Mp 217–219 °C (dec.); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.37–7.43 (m, 4H), 7.22–7.26 (m, 4H), 7.04–7.10 (m, 4H), 4.94 (s, 1H), 3.45 (s, 2H), 2.44–2.80 (m, 12H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub> δ 164.4, 164.0, 163.8, 161.5, 161.3, 136.4, 132.8, 131.7, 131.7, 131.0, 130.5, 130.4, 130.3, 128.4, 116.4, 116.2, 115.9, 115.6, 69.8, 62.1, 52.9, 52.8, 50.8, 48.1; Anal. (C<sub>26</sub>H<sub>27</sub>ClF<sub>2</sub>N<sub>2</sub>OS·2C<sub>2</sub>H<sub>2</sub>O<sub>4</sub>·0.25H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 1-(4-(2-((Bis(3-chlorophenyl)methyl)sulfinyl)ethyl)piperazin-1-yl)propan-2-ol (<b>9i</b>)</h4><div class="NLM_p last">Compound <b>9i</b> was prepared as described for <b>9a</b> using <b>8k</b> (400 mg, 1.00 mmol) The free base (190 mg, 46% yield) was obtained as a yellow oil, which was converted to the oxalate salt in a 2-propanol/acetone solvent mixture and recovered as a cream-colored solid. Mp 192–194 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.42–7.31 (m, 8H), 4.91 (s, 1H), 3.85–3.80 (m, 1H), 2.84–2.21 (m, 15H), 1.12 (d, <i>J</i> = 6.4 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 137.5, 136.4, 135.3, 134.7, 130.6, 130.1, 129.3, 128.80, 128.77, 127.5, 126.7, 70.4, 65.5, 62.3, 53.2, 50.7, 48.3, 19.9; Anal. (C<sub>22</sub>H<sub>28</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>2</sub>S·2C<sub>2</sub>H<sub>2</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec4_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 1-(4-(2-(Benzhydrylthio)ethyl)piperazin-1-yl)-3-phenylpropan-2-ol (<b>10a</b>)</h4><div class="NLM_p last">A solution of compound <b>8e</b> (710 mg, 2.27 mmol) and 2-benzyloxirane (304.6 mg, 2.27 mmol) in isopropanol (24 mL) was refluxed overnight. Solvent was removed, and the reaction residue was purified by flash column chromatography (hexane/ethyl acetate/triethylamine = 49:49:2) to give <b>10a</b> (850 mg, 84% yield) as a yellow oil. The free base was converted to the oxalate salt and recrystallized from hot isopropanol to give a white solid. Mp 210–211 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.40–7.43 (m, 4H), 7.20–7.32 (m, 11H), 5.22 (s, 1H), 3.88–3.93 (m, 1H), 3.45 (br s, 1H), 2.27–2.83 (m, 16H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 141.4, 138.3, 129.3, 128.6, 128.5, 128.3, 127.3, 127.2, 126.3, 67.2, 63.4, 57.9, 54.4, 53.1, 41.3, 29.3; Anal. (C<sub>28</sub>H<sub>34</sub>N<sub>2</sub>OS·2C<sub>2</sub>H<sub>2</sub>O<sub>4</sub>·0.5H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 1-(4-(2-((Bis(4-fluorophenyl)methyl)thio)ethyl)piperazin-1-yl)-3-phenylpropan-2-ol (<b>10b</b>)</h4><div class="NLM_p last">Compound <b>10b</b> was prepared as described for <b>10a</b> using <b>8f</b> (455 mg, 1.31 mmol) to give the product (540 mg, 86% yield) as a yellow oil. The free base was converted to the oxalate salt and recrystallized from hot acetone to give a white solid. Mp 206–207 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.19–7.37 (m, 9H), 6.96–7.02 (m, 4H), 5.18 (s, 1H), 3.88–3.93 (m, 1H), 3.45 (br s, 1H), 2.31–2.81 (m, 16H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 163.1, 160.7, 138.2, 137.0, 129.8, 129.7, 129.3, 128.3, 126.3, 115.6, 115.4, 67.2, 63.4, 57.8, 53.1, 52.9, 41.3, 29.4; Anal. (C<sub>28</sub>H<sub>32</sub>F<sub>2</sub>N<sub>2</sub>OS·2C<sub>2</sub>H<sub>2</sub>O<sub>4</sub>·0.25H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 1-(4-(2-(Benzhydrylsulfinyl)ethyl)piperazin-1-yl)-3-phenylpropan-2-ol (<b>11a</b>)</h4><div class="NLM_p last">Compound <b>11a</b> was prepared as described for <b>9a</b> using <b>10a</b> (534 mg, 1.20 mmol) to give the product (340 mg, 61% yield) as a yellow oil. The free base was converted to the oxalate salt and recrystallized from hot methanol to give a white solid. Mp 198–200 °C (dec.); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.20–7.49 (m, 15H), 4.95 (s, 1H), 3.88–3.92 (m, 1H), 2.31–2.83 (m, 16H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 138.2, 136.0, 135.2, 129.3, 129.2, 128.9, 128.7, 128.6, 128.4, 128.3, 126.3, 72.1, 67.3, 63.4, 53.0, 50.8, 48.2, 41.3; Anal. (C<sub>28</sub>H<sub>34</sub>N<sub>2</sub>O<sub>2</sub>S·2C<sub>2</sub>H<sub>2</sub>O<sub>4</sub>·0.25H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 1-(4-(2-((Bis(4-fluorophenyl)methyl)sulfinyl)ethyl)piperazin-1-yl)-3-phenylpropan-2-ol (<b>11b</b>; JJC 8-088)</h4><div class="NLM_p last">Compound <b>11b</b> was prepared as described for <b>11a</b> using <b>10b</b> (400 mg, 0.83 mmol) to give the product (280 mg, 68% yield) as a yellow oil. The free base was converted to the oxalate salt and recrystallized from hot methanol to give a white solid. Mp 198–200 °C (dec.); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.20–7.43 (m, 9H), 7.05–7.11 (m, 4H), 4.93 (s, 1H), 3.88–3.92 (m, 1H), 2.29–2.84 (m, 16H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 161.6, 161.3, 138.2, 131.8, 131.0, 130.9, 130.5, 130.3, 129.3, 128.4, 126.3, 116.4, 116.2, 115.9, 115.6, 69.4, 67.3, 63.4, 53.1, 50.8, 48.2, 41.3, Anal. (C<sub>28</sub>H<sub>32</sub>F<sub>2</sub>N<sub>2</sub>O<sub>2</sub>S·2C<sub>2</sub>H<sub>2</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec4_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 2-(Benzhydrylthio)-1-(4-(3-phenylpropyl)piperazin-1-yl)ethan-1-one (<b>13a</b>)</h4><div class="NLM_p last">A mixture of CDI (583 mg, 3.60 mmol) and <b>12a</b><a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> (775 mg, 3.00 mmol) in THF (24 mL) was stirred at room temperature under argon. After 2 h of reaction time, 1-(3-phenylpropyl)piperazine (613 mg, 3.00 mmol) in THF (15 mL) was added, and the reaction mixture was stirred overnight. Solvent was removed, and the reaction residue was purified by flash column chromatography (ethyl acetate/triethylamine 95:5) to give <b>13a</b> (1.2 g, 90% yield) as a yellow oil. The free base was converted to the oxalate salt and recrystallized from hot isopropanol to give a white solid. Mp 92–95 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.42–7.45 (m, 4H), 7.17–7.33(m, 11H), 5.34 (s, 1H), 3.57–3.60 (t, 2H, <i>J</i> = 5.0 Hz), 3.37–3.40 (t, 2H, <i>J</i> = 5.2 Hz), 3.18 (s, 2H), 2.62–2.66 (m, 2H), 2.34–2.39 (m, 6H), 1.78–1.84 (m, 2H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 167.2, 141.9, 140.7, 128.6, 128.5, 128.4, 128.3, 127.3, 125.8, 57.7, 54.1, 53.2, 52.7, 46.3, 41.9, 33.5, 28.4; Anal. (C<sub>28</sub>H<sub>32</sub>N<sub>2</sub>OS·C<sub>2</sub>H<sub>2</sub>O<sub>4</sub>·0.5H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 2-((Bis(4-fluorophenyl)methyl)thio)-1-(4-(3-phenylpropyl)piperazin-1-yl)ethan-1-one (<b>13b</b>)</h4><div class="NLM_p last">Compound <b>13b</b> was prepared as described for <b>13a</b> using <b>12b</b><a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> (588 mg, 2.00 mmol) and 1-(3-phenylpropyl)piperazine (408 mg, 2.00 mmol) to give the product (650 mg, 71% yield) as a yellow oil. The free base was converted to the oxalate salt and recrystallized from hot methanol to give a white solid. Mp 123–125 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.36–7.39 (m, 4H), 7.26–7.30 (m, 2H), 7.17–7.20 (m, 3H), 6.98–7.02 (m, 4H), 5.34 (s, 1H), 3.58–3.60 (t, 2H, <i>J = 5.0 Hz</i>), 3.39–3.42 (t, 2H, <i>J</i> = 4.8 Hz), 3.15 (s, 2H), 2.62–2.66 (m, 2H), 2.34–2.41 (m, 6H), 1.79–1.83 (m, 2H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 167.1, 163.2, 160.7, 141.9, 136.3, 130.0, 128.4, 125.9, 115.6, 115.4, 57.7, 53.1, 52.7, 52.4, 46.4, 41.9, 33.5, 33.3, 28.4; Anal. (C<sub>28</sub>H<sub>30</sub>F<sub>2</sub>N<sub>2</sub>OS·C<sub>2</sub>H<sub>2</sub>O<sub>4</sub>·0.25H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 2-((Bis(4-fluorophenyl)methyl)thio)-1-(4-(2-hydroxypropyl)piperazin-1-yl)ethan-1-one (<b>13c</b>)</h4><div class="NLM_p last">Compound <b>13c</b> was prepared as described for <b>13a</b> using <b>12b</b> (588 mg, 2.00 mmol) and 1-(piperazin-1-yl)propan-2-ol (288 mg, 2.00 mmol) to give the product (630 mg, 75% yield) as a yellow oil. The free base was converted to the oxalate salt and recrystallized from hot methanol to give a white solid. Mp 163–165 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.36–7.37 (m, 4H), 6.99–7.03 (m, 4H), 5.33 (s, 1H), 3.82–3.87 (m, 1H), 3.57–3.61 (m, 2H), 3.40–3.43 (m, 2H), 3.22 (s, 1H), 3.16 (s, 2H), 2.59–2.60 (m, 2H), 2.23–2.38 (m, 4H), 1.13–1.27 (m, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 167.2, 163.2, 160.7, 136.2, 130.0, 115.6, 115.4, 65.5, 62.4, 53.2, 52.7, 52.4, 46.4, 41.9, 33.2, 21.1; Anal. (C<sub>22</sub>H<sub>26</sub>F<sub>2</sub>N<sub>2</sub>O<sub>2</sub>S·C<sub>2</sub>H<sub>2</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec4_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 2-((Bis(4-fluorophenyl)methyl)thio)-1-(4-propylpiperazin-1-yl)ethan-1-one (<b>13d</b>)</h4><div class="NLM_p last">Compound <b>12b</b> (294 mg, 1.00 mmol) was refluxed in SOCl<sub>2</sub> (3 mL) for 2 h. The solvent was removed. The reaction mixture was added to 1-propylpiperazine (128 mg, 1 mmol), NaHCO<sub>3</sub> (500 mg, 6.00 mmol) in amylene-stabilized CHCl<sub>3</sub> (10 mL) and H<sub>2</sub>O (5 mL) at 0 °C and stirred at room temperature for 2 h. H<sub>2</sub>O (5 mL) was added to the reaction mixture, and the aqueous mixture was extracted with chloroform (3 × 10 mL). The organic layer was dried over MgSO<sub>4</sub>, and the solvent was removed <i>in vacuo</i>. The crude product was purified by flash column chromatography (ethyl acetate/triethylamine = 95:5) to give <b>13d</b> (220 mg, 54% yield) as a yellow oil. The free base was converted to the oxalate salt and recrystallized from methanol and acetone to give a white solid. Mp 167–168 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.36–7.40 (m, 4H), 6.98–7.03 (m, 4H), 5.34 (s, 1H), 3.58–3.60 (m, 2H), 3.40–3.42 (m, 2H), 3.16 (s, 2H), 2.37–2.41 (m, 4H), 2.28–2.31 (m, 2H), 1.47–1.52 (m, 2H), 1.13–1.27 (m, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 167.1, 163.2, 160.7, 136.3, 130.0, 115.6, 115.4, 60.4, 53.2, 52.7, 52.4, 46.3, 41.9, 33.3, 19.9, 11.9; Anal. (C<sub>22</sub>H<sub>26</sub>F<sub>2</sub>N<sub>2</sub>OS·C<sub>2</sub>H<sub>2</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec4_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 2-((Bis(4-fluorophenyl)methyl)thio)-1-(4-(4-fluorobenzyl)piperazin-1-yl)ethan-1-one (<b>13e</b>)</h4><div class="NLM_p last">Compound <b>13e</b> was prepared as described for <b>13d</b> using <b>12b</b> (589 mg, 2.00 mmol) and 1-(4-fluorobenzyl)piperazine (389 mg, 2.00 mmol) to give the product (600 mg, 64% yield) as a yellow oil. The free base was converted to the oxalate salt and recrystallized from acetone to give a white solid. Mp 168–170 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.35–7.39 (m, 4H), 7.25–7.28 (m, 2H), 6.98–7.03 (m, 6H), 5.34 (s, 1H), 3.57–3.60 (m, 2H), 3.46 (s, 2H), 3.38–3.41 (m, 2H), 3.15 (s, 2H), 2.37–2.40 (m, 4H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 167.1, 163.3, 163.2, 160.9, 160.7, 136.3, 133.3, 133.2, 130.6, 130.5, 130.0, 115.6, 115.4, 115.3, 115.1, 62.0, 52.8, 52.5, 52.4, 46.3, 41.9, 33.3; Anal. (C<sub>26</sub>H<sub>25</sub>F<sub>3</sub>N<sub>2</sub>OS·C<sub>2</sub>H<sub>2</sub>O<sub>4</sub>·1.25H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 2-((Bis(4-fluorophenyl)methyl)thio)-1-(4-(4-chlorobenzyl)piperazin-1-yl)ethan-1-one (<b>13f</b>)</h4><div class="NLM_p last">Compound <b>13f</b> was prepared as described for <b>13d</b> using <b>12b</b> (589 mg, 2.00 mmol) and 1-(4-chlorobenzyl)piperazine (411 mg, 2.00 mmol) to give the product (650 mg, 67% yield) as a yellow oil. The free base was converted to the oxalate salt and recrystallized from acetone/ethyl ether to give a white solid. Mp 165–167 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.36–7.40 (m, 4H), 7.25–7.28 (m, 4H), 6.98–7.02 (m, 4H), 5.33 (s, 1H), 3.58–3.59 (m, 2H), 3.38–3.46 (m, 4H), 3.15 (s, 2H), 2.37–2.40 (m, 4H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 167.1, 163.2, 160.7, 136.3, 136.1, 133.0, 130.3, 130.0, 128.5, 115.6, 115.4, 62.0, 52.9, 52.6, 52.4, 46.3, 41.8, 33.3; Anal. (C<sub>26</sub>H<sub>25</sub>ClF<sub>2</sub>N<sub>2</sub>OS·C<sub>2</sub>H<sub>2</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec4_1_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 2-((Bis(3-chlorophenyl)methyl)thio)-1-(4-(2-hydroxypropyl)piperazin-1-yl)ethan-1-one (<b>13g</b>)</h4><div class="NLM_p last">Compound <b>13g</b> was prepared as described for <b>13a</b> using <b>12c</b><a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> (654 mg, 2.00 mmol) and 1-(piperazin-1-yl)propan-2-ol (288 mg, 2.00 mmol) to give the product (770 mg, 75% yield) as a yellow oil. The free base was converted to the oxalate salt and recrystallized from hot methanol to give a white solid. Mp 160–161 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.28–7.41 (m, 2H), 7.22–7.24 (m, 6H), 5.30 (s, 1H), 3.82–3.87 (m, 1H), 3.56–3.62 (m, 2H), 3.40–3.43 (m, 2H), 3.20–3.22 (m, 3H), 2.59–2.65 (m, 2H), 2.23–2.40 (m, 4H), 1.13–1.15 (m, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 166.9, 142.1, 134.6, 130.0, 128.4, 127.9, 126.7, 65.5, 62.3, 53.1, 52.9, 52.7, 46.4, 41.9, 33.2, 19.9; Anal. (C<sub>22</sub>H<sub>26</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>2</sub>S·C<sub>2</sub>H<sub>2</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec4_1_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 2-(Benzhydrylsulfinyl)-1-(4-(3-phenylpropyl)piperazin-1-yl)ethan-1-one (<b>14a</b>)</h4><div class="NLM_p last">Compound <b>14a</b> was prepared as described for <b>9a</b> using <b>13a</b> (667 mg, 1.50 mmol) to give the product (500 mg, 72%) as a yellow oil. The free base was converted to the oxalate salt and recrystallized from hot acetone to give a white solid. Mp 180–182 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.49–7.55 (m, 4H), 7.16–7.43 (m, 11H), 5.30 (s, 1H), 3.27–3.70 (m, 6H), 2.61–2.65 (m, 2H), 2.33–2.47 (m, 6H), 1.75–1.83 (m, 2H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 163.1, 141.9, 136.0, 133.6, 130.0, 129.1, 129.0, 128.7, 128.5, 128.4, 128.3, 128.2, 125.8, 70.1, 70.0, 57.5, 53.1, 52.6, 46.4, 42.0, 33.5, 28.4; Anal. (C<sub>28</sub>H<sub>32</sub>N<sub>2</sub>O<sub>2</sub>S·C<sub>2</sub>H<sub>2</sub>O<sub>4</sub>·0.25H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_1_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 2-((Bis(4-fluorophenyl)methyl)sulfinyl)-1-(4-(3-phenylpropyl)piperazin-1-yl)ethan-1-one (<b>14b</b>)</h4><div class="NLM_p last">Compound <b>14b</b> was prepared as described for <b>9a</b> using <b>13b</b> (480 mg, 1.00 mmol) to give the product (200 mg, 40%) as a yellow oil. The free base was converted to the oxalate salt and recrystallized from hot acetone to give a white solid. Mp 135–136 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.45–7.52 (m, 4H), 7.06–7.30 (m, 9H), 5.36 (s, 1H), 3.54–3.69 (m, 3H), 3.27–3.45 (m, 3H), 2.61–2.65 (m 2H), 2.35–2.45 (m, 6H), 1.76–1.84 (m, 2H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 164.2, 163.8, 162.8, 162.7, 161.7, 161.3, 160.2, 141.8, 131.8, 131.7, 130.7, 130.6, 129.0, 128.4, 125.9, 116.2, 116.0, 115.9, 115.7, 67.7, 57.5, 53.1, 52.7, 52.6, 46.4, 42.0, 33.5, 28.3; Anal. (C<sub>28</sub>H<sub>30</sub>F<sub>2</sub>N<sub>2</sub>O<sub>2</sub>S·2C<sub>2</sub>H<sub>2</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec4_1_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 2-((Bis(4-fluorophenyl)methyl)sulfinyl)-1-(4-(2-hydroxypropyl)piperazin-1-yl)ethan-1-one (<b>14c</b>)</h4><div class="NLM_p last">Compound <b>14c</b> was prepared as described for <b>9a</b> using <b>13c</b> (600 mg, 1.43 mmol) to give the product (70 mg, 16%) as a yellow oil. The free base was converted to the oxalate salt and recrystallized from hot acetone to give a white solid. Mp 162–164 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.44–7.51 (m, 4H), 7.06–7.13 (m, 4H), 5.36 (s, 1H), 3.83–3.88 (m, 1H), 3.24–3.67 (m, 7H), 2.60–2.67 (m, 2H), 2.26–2.42 (m, 4H), 1.13–1.14 (m, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 164.2, 163.8, 162.9, 161.7, 161.3, 131.7, 131.6, 131.5, 130.7, 129.1, 116.3, 116.1, 116.0, 65.4, 62.4, 53.3, 53.2, 52.7, 52.6, 52.4, 52.3, 46.4, 42.0, 20.0; Anal. (C<sub>22</sub>H<sub>26</sub>F<sub>2</sub>N<sub>2</sub>O<sub>3</sub>S·C<sub>2</sub>H<sub>2</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec4_1_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 2-((Bis(4-fluorophenyl)methyl)sulfinyl)-1-(4-propylpiperazin-1-yl)ethan-1-one (<b>14d</b>)</h4><div class="NLM_p last">Compound <b>14d</b> was prepared as described for <b>9a</b> using <b>13d</b> (120 mg, 0.297 mmol) to give the product (40 mg, 32%) as a yellow oil. The free base was converted to the oxalate salt and recrystallized from hot acetone and methanol to give a white solid. Mp 170–171 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.45–7.52 (m, 4H), 7.06–7.13 (m, 4H), 5.36 (s, 1H), 3.36–3.67 (m, 6H), 2.30–2.45 (m, 6H), 1.47–1.53 (m, 2H), 0.90–0.92 (m, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 164.2, 163.8, 162.8, 161.7, 161.3, 131.8, 131.7, 130.7, 130.6, 129.0, 116.2, 116.0, 115.9, 115.7, 67.7, 60.2, 53.1, 52.6, 46.3, 41.9, 19.8, 11.8; Anal. (C<sub>22</sub>H<sub>26</sub>F<sub>2</sub>N<sub>2</sub>O<sub>2</sub>S·C<sub>2</sub>H<sub>2</sub>O<sub>4</sub>) C, H, N.</div></div><div id="sec4_1_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 2-((Bis(4-fluorophenyl)methyl)sulfinyl)-1-(4-(4-fluorobenzyl)piperazin-1-yl)ethan-1-one (<b>14e</b>)</h4><div class="NLM_p last">Compound <b>14e</b> was prepared as described for <b>9a</b> using <b>10e</b> (510 mg, 1.09 mmol) to give the product (120 mg, 23%) as a yellow oil. The free base was converted to the oxalate salt and recrystallized from hot acetone and methanol to give a white solid. Mp 158–159 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.44–7.48 (m, 4H), 7.24–7.26 (m, 2H), 6.98–7.13 (m, 6H), 5.36 (s, 1H), 3.27–3.68 (m, 8H), 2.34–2.45 (m, 4H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 166.2, 164.2, 163.8, 162.8, 161.7, 161.3, 160.9, 133.1, 131.7, 130.7, 130.6, 130.5, 129.0, 116.2, 116.0, 115.9, 115.7, 115.3, 115.1, 67.7, 61.8, 52.9, 52.7, 52.4, 46.4, 42.0; Anal. (C<sub>26</sub>H<sub>25</sub>F<sub>3</sub>N<sub>2</sub>O<sub>2</sub>S·C<sub>2</sub>H<sub>2</sub>O<sub>4</sub>·1.5H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_1_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 2-((Bis(4-fluorophenyl)methyl)sulfinyl)-1-(4-(4-chlorobenzyl)piperazin-1-yl)ethan-1-one (<b>14f</b>)</h4><div class="NLM_p last">Compound <b>14f</b> was prepared as described for <b>9a</b> using <b>13f</b> (487 mg, 1.00 mmol) to give the product (200 mg, 40%) as a yellow oil. The free base was converted to the oxalate salt and recrystallized from hot acetone and methanol to give a white solid. Mp 157–158 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.44–7.52 (m, 4H), 7.22–7.30 (m, 4H), 7.06–7.13 (m, 4H), 5.36 (s, 1H), 3.30–3.65 (m, 8H), 2.37–2.43 (m, 4H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 164.2, 163.8, 162.8, 161.7, 161.3, 136.0, 133.1, 131.7, 130.7, 130.3, 129.1, 129.0, 128.5, 116.2, 116.0, 115.9, 115.7, 67.7, 61.9, 52.9, 52.7, 52.4, 46.4, 42.0; Anal. (C<sub>26</sub>H<sub>25</sub>ClF<sub>2</sub>N<sub>2</sub>O<sub>2</sub>S·C<sub>2</sub>H<sub>2</sub>O<sub>4</sub>·1.5H<sub>2</sub>O) C, H, N.</div></div><div id="sec4_1_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 2-((Bis(3-chlorophenyl)methyl)sulfinyl)-1-(4-(2-hydroxypropyl)piperazin-1-yl)ethan-1-one (<b>14g</b>)</h4><div class="NLM_p last">Compound <b>14g</b> was prepared as described for <b>9a</b> using <b>13g</b> (590 mg, 1.15 mmol) to give the product (70 mg, 11%) as a yellow oil. The free base was converted to the oxalate salt and recrystallized from hot acetone and methanol to give a white solid. Mp 169–170 °C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.31–7.43 (m, 8H), 5.33 (s, 1H), 3.82–3.84 (m, 1H), 3.59–3.67 (m, 3H), 3.33–3.47 (m, 3H), 3.16–3.19 (m, 1H), 2.61–2.66 (m, 2H), 2.24–2.42 (m, 4H), 1.13–1.14 (m, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 162.7, 137.4, 135.1, 134.8, 134.7, 130.4, 130.1, 130.0, 129.1, 129.0, 128.7, 128.1, 127.1, 68.1, 65.4, 62.4, 53.2, 53.1, 52.8, 52.7, 52.6, 46.4, 46.2, 42.0, 19.9; Anal. (C<sub>22</sub>H<sub>26</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>3</sub>S·C<sub>2</sub>H<sub>2</sub>O<sub>4</sub>) C, H, N.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> Radioligand Binding Assays</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> DAT Binding Assay</h4><div class="NLM_p last">Striata were dissected from male Sprague–Dawley rat brains (supplied on ice from Bioreclamation (Hicksville, NY) and prepared by homogenizing tissues in 20 volumes (w/v) of ice cold modified sucrose phosphate buffer (0.32 M sucrose, 7.74 mM Na<sub>2</sub>HPO<sub>4</sub>, and 2.26 mM NaH<sub>2</sub>PO<sub>4</sub>, pH adjusted to 7.4) using a Brinkman Polytron (Setting 6 for 20 s) and centrifuged at 20,000 rpm for 10 min at 4 °C. The resulting pellet was resuspended in buffer, recentrifuged, and suspended in buffer again to a concentration of 10 mg/mL, original wet weight (OWW). Experiments were conducted in assay tubes containing 0.5 mL of sucrose phosphate buffer, 0.5 nM [<sup>3</sup>H]WIN 35,428<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> (<i>K</i><sub>d</sub> value = 5.53, specific activity = 84 ci/mmol; PerkinElmer Life Sciences, Waltham, MA), 1.0 mg of tissue OWW, and various concentrations of the inhibitor. The reaction was started with the addition of tissue, and tubes were incubated for 120 min on ice. Nonspecific binding was determined using 100 μM cocaine HCl.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> SERT Binding Assay</h4><div class="NLM_p last">Membranes from frozen brain stems dissected from male Sprague–Dawley rat brains (supplied on ice from Bioreclamation, Hicksville, NY) were homogenized in 20 volumes (w/v) of 50 mM Tris buffer (120 mM NaCl and 5 mM KCl, adjusted to pH 7.4) at 25 °C using a Brinkman Polytron (at setting 6 for 20 s). The tissue was centrifuged at 20,000 rpm for 10 min at 4 °C. The resulting pellet was suspended in buffer and centrifuged again. The final pellet was resuspended in cold buffer to a concentration of 15 mg/mL OWW. Experiments were conducted in assay tubes containing 0.5 mL of buffer, 1.4 nM [<sup>3</sup>H]citalopram (<i>K</i><sub>d</sub> value = 1.94 nM, specific activity = 83 ci/mmol; PerkinElmer Life Sciences, Waltham, MA), 1.5 mg of brain stem tissue, and various concentrations of the inhibitor. The reaction was started with the addition of the tissue, and the tubes were incubated for 60 min at room temperature. Nonspecific binding was determined using 10 μM fluoxetine.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> NET Binding Assay</h4><div class="NLM_p">Membranes from frozen frontal cortex dissected from male Sprague–Dawley rat brains (supplied on ice from Bioreclamation, Hicksville, NY) were homogenized in 20 volumes (w/v) of 50 mM Tris buffer (120 mM NaCl and 5 mM KCl, adjusted to pH 7.4) at 25 °C using a Brinkman Polytron (at setting 6 for 20 s). The tissue was centrifuged at 20,000 rpm for 10 min at 4 °C. The resulting pellet was suspended in buffer and centrifuged again. The final pellet was resuspended in cold buffer to a concentration of 80 mg/mL OWW. Experiments were conducted in assay tubes containing 0.5 mL of buffer, 0.5 nM [<sup>3</sup>H]nisoxetine (<i>K</i><sub>d</sub> value = 1.0 nM, specific activity = 82 ci/mmol; PerkinElmer Life Sciences, Waltham, MA), 8 mg of frontal cortex tissue, and various concentrations of the inhibitor. The reaction was started with the addition of the tissue, and the tubes were incubated for 180 min at 0–4 °C. Nonspecific binding was determined using 1 μM desipramine.</div><div class="NLM_p last">The solvent used to dissolve the various analogues of modafinil was typically methanol and was present at a final concentration of 5%. Extensive studies previously in this and other laboratories determined that methanol has no effect on binding at the DAT and SERT. However, there is an effect of methanol on binding at the NET, and therefore, methanol concentration was controlled in all tubes in that assay. When compounds were not soluble in methanol, we used either ethanol or DMSO at final concentrations of no greater than 5 or 6%, respectively. Previous studies found no effect of either of these solvents at these concentrations on binding at any of the sites. For all three MAT binding assays, incubations were terminated by rapid filtration through Whatman GF/B filters, presoaked in 0.3% (SERT) or 0.05% (DAT, NET) polyethylenimine, using a Brandel R48 filtering manifold (Brandel Instruments Gaithersburg, Maryland). The filters were washed twice with 5 mL of cold buffer and transferred to scintillation vials. Cytoscint (MP Biomedicals, OH) (3.0 mL) was added, and the vials were counted the next day using a Beckman 6000 liquid scintillation counter (Beckman Coulter Instruments, Fullerton, California) or a Tri-Carb 2910-B liquid scintillation counter (PerkinElmer Life Sciences, MA). The <i>K</i><sub>i</sub> values for the modafinil derivatives were obtained using nonlinear least-squares regression (using GraphPad Prism Software, San Diego, CA) of the displacement data giving IC<sub>50</sub> values, from which affinities (<i>K</i><sub>i</sub> values) were calculated using the Cheng–Prusoff equation.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a></div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> σ<sub>1</sub> Receptor Binding Assay</h4><div class="NLM_p">σ<sub>1</sub> receptor binding was performed as previously reported.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Briefly, frozen whole-guinea pig brains (minus cerebellum) were thawed on ice, weighed, and homogenized (with a glass and Teflon homogenizer) in 10 mM Tris-HCl with 0.32 M sucrose at pH 7.4 (10 mL/g tissue). The homogenate was centrifuged at 1000<i>g</i> for 10 min at 4 °C. The supernatant was collected into a clean centrifuge tube, and the remaining pellet was resuspended by vortex in 10 mL of buffer (tissue) and centrifuged again at 50,000<i>g</i> for 15 min at 4 °C. The resulting pellet was resuspended in experimental buffer to 80 mg/mL original wet weight (OWW).</div><div class="NLM_p">Ligand binding experiments were conducted in polypropylene assay tubes containing 0.5 mL of 50 mM Tris-HCl buffer at pH 8.0. Each tube contained 3 nM [<sup>3</sup>H](+)-pentazocine (PerkinElmer Life and Analytical Sciences, Waltham, MA) and 8.0 mg of tissue OWW. Nonspecific binding was determined using 10 mM haloperidol. The reaction was started with the addition of tissue, and the tubes were incubated for 120 min at room temperature.</div><div class="NLM_p">Incubations for all binding assays were terminated by rapid filtration through Whatman GF/B filters, presoaked in polyethylenimine, using a Brandel R48 filtering manifold (Brandel Instruments, Gaithersburg, MD). The filters were washed twice with 5 mL of ice-cold buffer and transferred to scintillation vials. Beckman Ready Safe (3.0 mL) was added, and the vials were counted the next day using a Beckman 6000 liquid scintillation counter (Beckman Coulter Instruments, Fullerton, CA) at 50% efficiency. Assays were typically conducted in at least three independent experiments, each performed in triplicate.</div><div class="NLM_p last">For the displacement of radioligand binding, IC<sub>50</sub> values were computed using a nonlinear, least-squares regression analysis (Prism; GraphPad Software Inc., San Diego, CA). Affinities (<i>K</i><sub>i</sub> values) were calculated using the concentration of radioligand used in the assay.</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> D<sub>2</sub>-Like Binding Assay</h4><div class="NLM_p last">Binding at dopamine D<sub>2</sub>-like receptors was determined using previously described methods.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> Membranes were prepared from HEK293 cells stably expressing human D<sub>2</sub>R, D<sub>3</sub>R, or D<sub>4</sub>R, grown in a 50:50 mix of DMEM and Ham’s F12 culture media, supplemented with 20 mM HEPES, 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine, 0.1 mM nonessential amino acids, 1× antibiotic/antimycotic, 10% heat-inactivated fetal bovine serum, and 200 μg/mL hygromycin (Life Technologies, Grand Island, NY) and kept in an incubator at 37 °C and 5% CO<sub>2</sub>. Upon reaching 80–90% confluence, cells were harvested using premixed Earle’s Balanced Salt Solution (EBSS) with 5 mM EDTA (Life Technologies) and centrifuged at 3000 rpm for 10 min at 21 °C. The supernatant was removed, and the pellet was resuspended in 10 mL of hypotonic lysis buffer (5 mM MgCl<sub>2</sub>·6 H<sub>2</sub>O, 5 mM Tris, pH 7.4 at 4 °C) and centrifuged at 20,000 rpm for 30 min at 4 °C. The pellet was then resuspended in fresh EBSS buffer made from 8.7 g/L Earle’s Balanced Salts without phenol red (US Biological, Salem, MA) and 2.2 g/L sodium bicarbonate, pH to 7.4. A Bradford protein assay (Bio-Rad, Hercules, CA) was used to determine the protein concentration, and membranes were diluted to 500 μg/mL and stored in a −80 °C freezer for later use. Radioligand competition binding experiments were conducted using thawed membranes. Test compounds were freshly dissolved in 30% DMSO and 70% H<sub>2</sub>O to a stock concentration of 1 mM or 100 μM. To assist the solubilization of free-base compounds, 10 μL of glacial acetic acid was added along with the DMSO. Each test compound was then diluted into 11 half-log serial dilutions using 30% DMSO vehicle; final test concentrations ranged from 100 μM to 100 pM or from 10 μM to 10 pM. Previously frozen membranes were diluted in fresh EBSS to a 200 μg/mL (for hD<sub>2</sub>R or hD<sub>3</sub>R) or 300 μg/mL (hD<sub>4</sub>R) stock for binding. Radioligand competition experiments were conducted in 96-well plates containing 300 μL of fresh EBSS buffer with 0.2 mM sodium metabisulfite, 50 μL of diluted test compound, 100 μL of membranes (20 μg total protein for hD<sub>2</sub>R or hD<sub>3</sub>R, 30 μg of total protein for hD<sub>4</sub>R), and 50 μL of [<sup>3</sup>H]<i>N</i>-methylspiperone (0.4 nM final concentration; PerkinElmer). Nonspecific binding was determined using 10 μM butaclamol (Sigma-Aldrich, St. Louis, MO), and total binding was determined with 30% DMSO vehicle. The reaction was incubated for 1 h at room temperature and then terminated by filtration through PerkinElmer UniFilter-96 GF/B filters, presoaked for 1 h in 0.5% polyethylenimine, using a Brandel 96-Well Plates Harvester Manifold (Brandel Instruments, Gaithersburg, MD). The filters were washed 3 times with 3 mL (3 × 1 mL/well) of ice cold EBSS buffer. 65 μL of PerkinElmer MicroScint 20 Scintillation Cocktail was added to each well, and filters were counted using a PerkinElmer MicroBeta Microplate Counter. IC<sub>50</sub> values for each compound were determined from dose–response curves, and <i>K</i><sub>i</sub> values were calculated using the Cheng–Prusoff equation.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> These analyses were performed using GraphPad Prism version 6.00 for Macintosh (GraphPad Software, San Diego, CA). Reported <i>K</i><sub>i</sub> values were determined from at least three independent experiments, each with duplicate determinations.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> Bioluminescence Resonance Energy Transfer (BRET) Assay</h3><div class="NLM_p last">The Gα–γ protein activation assay uses the RLuc8-fused Gα protein subunit and GFP10-fused Gγ protein for a resonance energy transfer pair. Flag-tagged receptor and untagged Gβ constructs were cotransfected. The BRET assays were performed as described previously.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Briefly, human embryonic kidney cells (HEK-293T) were transfected, using a constant amount of plasmid DNA but various ratios of plasmids encoding the fusion protein partners. Expression of GFP10 fusion proteins was estimated by measuring fluorescence at 515 nm following excitation at 405 nm. Expression of RLuc8 fusion proteins was estimated by measuring the luminescence of the cells after incubation with 5 μM coelenterazine 400a. In parallel, BRET was measured as the fluorescence of the cells at 535 nm at the same time points using a Mithras LB940 reader (Berthold). In order to measure the antagonist activity, 10 min of preincubation of 1 μM quinpirole precedes the 10 min of incubation of tested compounds before the sample reading.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> Molecular Pharmacology</h3><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> Site-Directed Mutagenesis</h4><div class="NLM_p last">Synthetic cDNA encoding the human DAT (synDAT) was subcloned into pcDNA3 (Invitrogen, Carlsbad, CA). The Y156F mutation was introduced using QuickChange (adapted from Stratagene, La Jolla, CA) and confirmed by restriction enzyme mapping and DNA sequencing. DAT WT and Y156F cDNA containing plasmids were amplified by transformation into XL1 blue competent cells (Stratagene) and grown in LB media overnight at 37 °C in an orbital incubator (Infors) at 200 rpm. Plasmids were harvested using the maxi prep kit (Qiagen) according to the manufacturer’s manual.</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> Cell Culture and Transfection</h4><div class="NLM_p last">COS7 cells were grown in Dulbecco’s modified Eagle’s medium 041 01885 supplemented with 10% fetal calf serum, 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine, and 0.01 mg/mL gentamicin at 37 °C in 10% CO<sub>2</sub>. DAT WT and Y156F were transiently transfected into COS7 cells with Lipo2000 (Invitrogen) according to the manufacturer’s manual using a cDNA/Lipo2000 ratio of 3:6.</div></div><div id="sec4_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> [<sup>3</sup>H]DA Uptake Experiments</h4><div class="NLM_p last">Uptake assays were performed on intact COS7 cells essentially as described<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> using 3,4-[Ring-2,5,6-<sup>3</sup><i>H</i>]-dihydroxyphenylethylamine ([<sup>3</sup>H]DA) (30–60 Ci/mmol) (PerkinElmer). Briefly, transfected COS7 cells were plated in 24-well dishes (10<sup>5</sup> cells/well) coated with poly ornithine (Sigma) to achieve an uptake level of no more than 10% of total added [<sup>3</sup>H]DA. The uptake assays were carried out 2 days after transfection in uptake buffer (UB) (25 mM HEPES, 130 mM NaCl, 5.4 mM KCl, 1.2 mM CaCl<sub>2</sub>, 1.2 mM MgSO<sub>4</sub>, 1 mM <span class="smallcaps smallerCapital">l</span>-ascorbic acid, 5 mM <span class="smallcaps smallerCapital">d</span>-glucose, and 1 μM of the catechol-<i>O</i>-methyltransferase inhibitor Ro 41-0960 (Sigma), pH 7.4). Prior to the experiment, the cells were washed once in 500 μL of UB, and the nonlabeled compound was added to the cells in the indicated concentrations in a total volume of 500 μL. The assay was initiated by the addition of 6–10 nM [<sup>3</sup>H]DA. Nonspecific uptake was determined with 1 μM nomifensine (Sigma-Aldrich). After 5 min of incubation at room temperature, the cells were washed twice with 500 μL of ice cold UB, lysed in 250 μL (24 well) of 1% SDS and left for >30 min at 37 °C on gentle shaking. All samples were transferred to 24-well counting plates (PerkinElmer, Waltham, MA), 500 μL (24 well) of Opti-phase Hi Safe 3 scintillation fluid (PerkinElmer) was added followed by counting of the plates in a Wallac Tri-Lux β-scintillation counter (PerkinElmer). All experiments were carried out with 12 determinations of DA or inhibitor concentrations ranging from 1 nM to 1 mM performed in triplicate.</div></div><div id="sec4_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> [<sup>3</sup>H]WIN35,428 Binding Experiments</h4><div class="NLM_p last">Binding assays were carried out essentially as described for the uptake experiments on whole cells only using [<sup>3</sup>H]2β-carbomethoxy-3β-(4-fluorophenyl)tropane ([<sup>3</sup>H]WIN35,428) (76–87 Ci/mmol) (PerkinElmer). Previous to the binding experiment, cells were washed once in ice cold UB, and after the addition of unlabeled compound in the indicated concentrations and [<sup>3</sup>H]WIN35,428, the reactions were incubated at 5 °C until equilibrium were obtained (>90 min). All experiments were carried out with 12 determinations with inhibitor concentration range from 1 nM to 1 mM, performed in triplicate.</div></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> Mouse Microsomal Stability Assay</h3><div class="NLM_p">The phase I metabolic stability assay was conducted in mouse liver microsomes as described previously<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> with minor modifications. Briefly, the reaction was carried out using potassium phosphate buffer (100 mM, pH 7.4), in the presence of an NADPH regenerating system, (compound final concentration was 10 μM; and 0.5 mg/mL microsomes). Testosterone was used as a positive control. Compound disappearance was monitored over time using a liquid chromatography and tandem mass spectrometry (LC/MS/MS) method.</div><div class="NLM_p last">Chromatographic analysis was performed using an Accela ultra high-performance system consisting of an analytical pump and an autosampler coupled with a TSQ Vantage mass spectrometer (Thermo Fisher Scientific Inc., Waltham, MA). Separation of analyte was achieved at ambient temperature using Agilent Eclipse Plus column (100 × 2.1 mm i.d.) packed with a 1.8 μm C18 stationary phase. The mobile phase used was composed of 0.1% formic acid in acetonitrile and 0.1% formic acid in H<sub>2</sub>O with gradient elution, starting with 10% (organic) linearly increasing to 99% up to 2 min, maintaining at 99% (2–2.5 min) and reequlibrating to 10%. The total run time was 4.5 min. The mass transitions used for compounds for LC/MS/MS analysis are given in Table S1 (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01373/suppl_file/jm6b01373_si_001.pdf" class="ext-link">Supporting Information</a>).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> Locomotor Activity Studies in Mice</h3><div class="NLM_p">Thirty-two male mice with a C57BL/6J genetic background and body weight of 22–25 g were purchased from the Charles River Laboratories (Raleigh, NC). After arrival, they were group housed (4 per cage) in the animal facility under a reversed 12 h light-dark cycle (light on at 7:00 PM) with free access to food and water, and allowed to acclimate to the new environment for 7 days prior to initiating the experiment. All procedures were in accordance with the “Principles of Laboratory Animal Care” outlined by National Institutes of Health (NIH publication 86–23, 1996).</div><div class="NLM_p">Locomotor activity tests were conducted in open-field chambers (43 × 43 × 30 cm<sup>3</sup>) (Accuscan Instruments, Inc., Columbus, OH, USA). Before testing, the mice were habituated to the locomotor chamber (2 h/day for 3 consecutive days) and then were randomly divided into 4 groups (<i>n</i> = 8 per group) to examine the effects of cocaine, (<i>R</i>)-modafinil [<b>(</b><i><b>R</b></i><b>)-2</b>], and compounds <b>4</b> and <b>11b</b> on locomotor activity, respectively. On habituation days, the animals were moved to the test room, acclimated there for about 30 min, and then placed in their assigned locomotor chambers. On test day 1, each group of mice was first placed in the locomotor chambers for 1 h of habituation, and then they received either vehicle (25% of 2-hydroxypropyl-β-cyclodextrin) or one dose of the corresponding test compound. The animals were then immediately placed into the test chambers. Their locomotor activities were recorded every 10 min for 2 h. Each animal was tested 3 times with 3 different doses, with the intertest interval of 3–5 days. The order of the drug doses was counterbalanced.</div><div class="NLM_p last">The locomotor behavioral data are expressed as means (±SEM). The traveled distance (cm) every 10 min (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>) was used to evaluate the locomotor effects of each test compound in mice. Two-way ANOVA with repeated measures over time was used to evaluate the statistical significance of the changes in locomotor activity after each drug administration. Posthoc Fisher’s least significant difference was used for multiple comparisons. <i>p</i> < 0.05 was considered statistically significant.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i77"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01373">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07232" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07232" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b01373" class="ext-link">10.1021/acs.jmedchem.6b01373</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Elemental analysis results (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01373/suppl_file/jm6b01373_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">SMILES data (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01373/suppl_file/jm6b01373_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01373/suppl_file/jm6b01373_si_001.pdf">jm6b01373_si_001.pdf (131.67 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01373/suppl_file/jm6b01373_si_002.csv">jm6b01373_si_002.csv (3.55 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b01373" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72428" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72428" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Amy Hauck Newman</span> - <span class="hlFld-Affiliation affiliation">Molecular
Targets and Medications Discovery Branch, National Institute on Drug
Abuse, Intramural Research Program, National
Institutes of Health, 333 Cassell Drive, Baltimore, Maryland 21224, United
States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7918171c0e1418173910170d0b185717101d1857171011571e160f"><span class="__cf_email__" data-cfemail="71101f14061c101f31181f0503105f1f1815105f1f18195f161e07">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jianjing Cao</span> - <span class="hlFld-Affiliation affiliation">Molecular
Targets and Medications Discovery Branch, National Institute on Drug
Abuse, Intramural Research Program, National
Institutes of Health, 333 Cassell Drive, Baltimore, Maryland 21224, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rachel D. Slack</span> - <span class="hlFld-Affiliation affiliation">Molecular
Targets and Medications Discovery Branch, National Institute on Drug
Abuse, Intramural Research Program, National
Institutes of Health, 333 Cassell Drive, Baltimore, Maryland 21224, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Oluyomi M. Bakare</span> - <span class="hlFld-Affiliation affiliation">Molecular
Targets and Medications Discovery Branch, National Institute on Drug
Abuse, Intramural Research Program, National
Institutes of Health, 333 Cassell Drive, Baltimore, Maryland 21224, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Caitlin Burzynski</span> - <span class="hlFld-Affiliation affiliation">Molecular
Targets and Medications Discovery Branch, National Institute on Drug
Abuse, Intramural Research Program, National
Institutes of Health, 333 Cassell Drive, Baltimore, Maryland 21224, United
States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Neurology, Johns Hopkins Drug Discovery, The Johns Hopkins University School of Medicine, 855 N. Wolfe Street, Baltimore, Maryland 21205, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rana Rais</span> - <span class="hlFld-Affiliation affiliation">Department
of Neurology, Johns Hopkins Drug Discovery, The Johns Hopkins University School of Medicine, 855 N. Wolfe Street, Baltimore, Maryland 21205, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Barbara S. Slusher</span> - <span class="hlFld-Affiliation affiliation">Department
of Neurology, Johns Hopkins Drug Discovery, The Johns Hopkins University School of Medicine, 855 N. Wolfe Street, Baltimore, Maryland 21205, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Theresa Kopajtic</span> - <span class="hlFld-Affiliation affiliation">Psychobiology
Section, Molecular Neuropsychiatry Branch, National Institute on Drug
Abuse, Intramural Research Program, National
Institutes of Health, 251 Bayview Boulevard, Baltimore, Maryland 21224, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alessandro Bonifazi</span> - <span class="hlFld-Affiliation affiliation">Molecular
Targets and Medications Discovery Branch, National Institute on Drug
Abuse, Intramural Research Program, National
Institutes of Health, 333 Cassell Drive, Baltimore, Maryland 21224, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael P. Ellenberger</span> - <span class="hlFld-Affiliation affiliation">Molecular
Targets and Medications Discovery Branch, National Institute on Drug
Abuse, Intramural Research Program, National
Institutes of Health, 333 Cassell Drive, Baltimore, Maryland 21224, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hideaki Yano</span> - <span class="hlFld-Affiliation affiliation">Molecular
Targets and Medications Discovery Branch, National Institute on Drug
Abuse, Intramural Research Program, National
Institutes of Health, 333 Cassell Drive, Baltimore, Maryland 21224, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yi He</span> - <span class="hlFld-Affiliation affiliation">Molecular
Targets and Medications Discovery Branch, National Institute on Drug
Abuse, Intramural Research Program, National
Institutes of Health, 333 Cassell Drive, Baltimore, Maryland 21224, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guo-Hua Bi</span> - <span class="hlFld-Affiliation affiliation">Molecular
Targets and Medications Discovery Branch, National Institute on Drug
Abuse, Intramural Research Program, National
Institutes of Health, 333 Cassell Drive, Baltimore, Maryland 21224, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zheng-Xiong Xi</span> - <span class="hlFld-Affiliation affiliation">Molecular
Targets and Medications Discovery Branch, National Institute on Drug
Abuse, Intramural Research Program, National
Institutes of Health, 333 Cassell Drive, Baltimore, Maryland 21224, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Claus J. Loland</span> - <span class="hlFld-Affiliation affiliation">Molecular
Neuropharmacology and Genetics Laboratory, Department of Neuroscience
and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, DK-2200 Copenhagen, Denmark</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d89e6548-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i78">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67145" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67145" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Support for this research was provided to A.H.N., J.C., R.D.S., O.M.B., C.B., T.K., A.B., M.P.E., H.Y., Y.H., G.-H.B., and Z.-X.X. by the National Institute on Drug Abuse, Intramural Research Program. C.J.L. is supported by the Lundbeck Foundation and the Danish Council for Independent Research Sapere Aude programme.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i79" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i79"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i80" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i80"> Abbreviations Used</h2><tr><td class="NLM_term">DA</td><td class="NLM_def"><p class="first last">dopamine</p></td></tr><tr><td class="NLM_term">DAT</td><td class="NLM_def"><p class="first last">dopamine transporter</p></td></tr><tr><td class="NLM_term">SERT</td><td class="NLM_def"><p class="first last">serotonin transporter</p></td></tr><tr><td class="NLM_term">NET</td><td class="NLM_def"><p class="first last">norepinephrine transporter</p></td></tr><tr><td class="NLM_term">CDI</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>′-carbonyldiimidazole</p></td></tr><tr><td class="NLM_term">IA</td><td class="NLM_def"><p class="first last">inactive</p></td></tr><tr><td class="NLM_term">ND</td><td class="NLM_def"><p class="first last">not determined</p></td></tr><tr><td class="NLM_term">NADPH</td><td class="NLM_def"><p class="first last">nicotinamide adenine dinucleotide phosphate</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i81">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62303" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62303" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 59 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Keck, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">John, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czoty, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nader, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span> </span><span class="NLM_article-title">Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">5361</span><span class="NLM_x">–</span> <span class="NLM_lpage">5380</span><span class="refDoi"> DOI: 10.1021/jm501512b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501512b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsFGgu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=5361-5380&author=T.+M.+Keckauthor=W.+S.+Johnauthor=P.+W.+Czotyauthor=M.+A.+Naderauthor=A.+H.+Newman&title=Identifying+Medication+Targets+for+Psychostimulant+Addiction%3A+Unraveling+the+Dopamine+D3+Receptor+Hypothesis&doi=10.1021%2Fjm501512b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis</span></div><div class="casAuthors">Keck, Thomas M.; John, William S.; Czoty, Paul W.; Nader, Michael A.; Newman, Amy Hauck</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5361-5380</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The dopamine D3 receptor (D3R) is a target for developing medications to treat substance use disorders.  D3R-selective compds. with high affinity and varying efficacies have been discovered, providing crit. research tools for cell-based studies that have been translated to in vivo models of drug abuse.  D3R antagonists and partial agonists have shown esp. promising results in rodent models of relapse-like behavior, including stress-, drug-, and cue-induced reinstatement of drug seeking.  However, to date, translation to human studies has been limited.  Herein, we present an overview and illustrate some of the pitfalls and challenges of developing novel D3R-selective compds. toward clin. utility, esp. for treatment of cocaine abuse.  Future research and development of D3R-selective antagonists and partial agonists for substance abuse remains critically important but will also require further evaluation and development of translational animal models to det. the best time in the addiction cycle to target D3Rs for optimal therapeutic efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKVPGvcTvN87Vg90H21EOLACvtfcHk0lijuVSFfA2uGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsFGgu74%253D&md5=99f531d840ad7f94d0eeadeb6fd48100</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Fjm501512b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501512b%26sid%3Dliteratum%253Aachs%26aulast%3DKeck%26aufirst%3DT.%2BM.%26aulast%3DJohn%26aufirst%3DW.%2BS.%26aulast%3DCzoty%26aufirst%3DP.%2BW.%26aulast%3DNader%26aufirst%3DM.%2BA.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DIdentifying%2520Medication%2520Targets%2520for%2520Psychostimulant%2520Addiction%253A%2520Unraveling%2520the%2520Dopamine%2520D3%2520Receptor%2520Hypothesis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D5361%26epage%3D5380%26doi%3D10.1021%2Fjm501512b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Czoty, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoops, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rush, C. R.</span><span> </span><span class="NLM_article-title">Evaluation of the “Pipeline” for Development of Medications for Cocaine Use Disorder: A Review of Translational Preclinical, Human Laboratory, and Clinical Trial Research</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">533</span><span class="NLM_x">–</span> <span class="NLM_lpage">562</span><span class="refDoi"> DOI: 10.1124/pr.115.011668</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1124%2Fpr.115.011668" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2016&pages=533-562&author=P.+W.+Czotyauthor=W.+W.+Stoopsauthor=C.+R.+Rush&title=Evaluation+of+the+%E2%80%9CPipeline%E2%80%9D+for+Development+of+Medications+for+Cocaine+Use+Disorder%3A+A+Review+of+Translational+Preclinical%2C+Human+Laboratory%2C+and+Clinical+Trial+Research&doi=10.1124%2Fpr.115.011668"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1124%2Fpr.115.011668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.115.011668%26sid%3Dliteratum%253Aachs%26aulast%3DCzoty%26aufirst%3DP.%2BW.%26aulast%3DStoops%26aufirst%3DW.%2BW.%26aulast%3DRush%26aufirst%3DC.%2BR.%26atitle%3DEvaluation%2520of%2520the%2520%25E2%2580%259CPipeline%25E2%2580%259D%2520for%2520Development%2520of%2520Medications%2520for%2520Cocaine%2520Use%2520Disorder%253A%2520A%2520Review%2520of%2520Translational%2520Preclinical%252C%2520Human%2520Laboratory%252C%2520and%2520Clinical%2520Trial%2520Research%26jtitle%3DPharmacol.%2520Rev.%26date%3D2016%26volume%3D68%26spage%3D533%26epage%3D562%26doi%3D10.1124%2Fpr.115.011668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Schuster, C. R.; Kuhar, M. J.; Balster, R. L.</span>, Eds.  <span class="citation_source-book">Pharmacological Aspects of Drug Dependence: Toward an Integrated Neurobehavioral Approach</span>; <span> </span><span class="NLM_article-title">Handbook of Experimental Pharmacology</span>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1996</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">118</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1007%2F978-3-642-60963-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1996&author=C.+R.+Schuster&author=M.+J.+Kuhar&author=R.+L.+Balster&title=Pharmacological+Aspects+of+Drug+Dependence%3A+Toward+an+Integrated+Neurobehavioral+Approach"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-60963-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-642-60963-3%26sid%3Dliteratum%253Aachs%26aulast%3DSchuster%26aufirst%3DC.%2BR.%26btitle%3DPharmacological%2520Aspects%2520of%2520Drug%2520Dependence%253A%2520Toward%2520an%2520Integrated%2520Neurobehavioral%2520Approach%26atitle%3DHandbook%2520of%2520Experimental%2520Pharmacology%26pub%3DSpringer%26date%3D1996%26volume%3D118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Schmitt, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E. A.</span><span> </span><span class="NLM_article-title">Regulation of the Dopamine Transporter</span> <span class="citation_source-journal">Ann. N. Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1187</span><span class="NLM_x">, </span> <span class="NLM_fpage">316</span><span class="NLM_x">–</span> <span class="NLM_lpage">340</span><span class="refDoi"> DOI: 10.1111/j.1749-6632.2009.05148.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1111%2Fj.1749-6632.2009.05148.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1187&publication_year=2010&pages=316-340&author=K.+C.+Schmittauthor=M.+E.+A.+Reith&title=Regulation+of+the+Dopamine+Transporter&doi=10.1111%2Fj.1749-6632.2009.05148.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Fj.1749-6632.2009.05148.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1749-6632.2009.05148.x%26sid%3Dliteratum%253Aachs%26aulast%3DSchmitt%26aufirst%3DK.%2BC.%26aulast%3DReith%26aufirst%3DM.%2BE.%2BA.%26atitle%3DRegulation%2520of%2520the%2520Dopamine%2520Transporter%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2010%26volume%3D1187%26spage%3D316%26epage%3D340%26doi%3D10.1111%2Fj.1749-6632.2009.05148.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Fleckenstein, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volz, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddle, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibb, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, G. R.</span><span> </span><span class="NLM_article-title">New Insights into the Mechanism of Action of Amphetamines</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">681</span><span class="NLM_x">–</span> <span class="NLM_lpage">698</span><span class="refDoi"> DOI: 10.1146/annurev.pharmtox.47.120505.105140</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1146%2Fannurev.pharmtox.47.120505.105140" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=17209801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BD2sXit1alurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2007&pages=681-698&author=A.+E.+Fleckensteinauthor=T.+J.+Volzauthor=E.+L.+Riddleauthor=J.+W.+Gibbauthor=G.+R.+Hanson&title=New+Insights+into+the+Mechanism+of+Action+of+Amphetamines&doi=10.1146%2Fannurev.pharmtox.47.120505.105140"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">New insights into the mechanism of action of amphetamines</span></div><div class="casAuthors">Fleckenstein, Annette E.; Volz, Trent J.; Riddle, Evan L.; Gibb, James W.; Hanson, Glen R.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">681-698</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Amphetamine is a psychostimulant commonly used to treat several disorders, including attention deficit, narcolepsy, and obesity.  Plasmalemmal and vesicular monoamine transporters, such as the neuronal dopamine transporter and the vesicular monoamine transporter-2, are two of its principal targets.  This review focuses on new insights, obtained from both in vivo and in vitro studies, into the mol. mechanisms whereby amphetamine, and the closely related compds. methamphetamine and methylenedioxymethamphetamine, cause monoamine, and particularly dopamine, release.  These mechanisms include amphetamine-induced exchange diffusion, reverse transport, and channel-like transport phenomena as well as the weak base properties of amphetamine.  Addnl., amphetamine analogs may affect monoamine transporters through phosphorylation, transporter trafficking, and the prodn. of reactive oxygen and nitrogen species.  All of these mechanisms have potential implications for both amphetamine- and methamphetamine-induced neurotoxicity, as well as dopaminergic neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraPle7JPAeKrVg90H21EOLACvtfcHk0li5dyJE_CM-1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXit1alurs%253D&md5=ead84eb20c530d952c181a79122a1971</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pharmtox.47.120505.105140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pharmtox.47.120505.105140%26sid%3Dliteratum%253Aachs%26aulast%3DFleckenstein%26aufirst%3DA.%2BE.%26aulast%3DVolz%26aufirst%3DT.%2BJ.%26aulast%3DRiddle%26aufirst%3DE.%2BL.%26aulast%3DGibb%26aufirst%3DJ.%2BW.%26aulast%3DHanson%26aufirst%3DG.%2BR.%26atitle%3DNew%2520Insights%2520into%2520the%2520Mechanism%2520of%2520Action%2520of%2520Amphetamines%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2007%26volume%3D47%26spage%3D681%26epage%3D698%26doi%3D10.1146%2Fannurev.pharmtox.47.120505.105140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Wood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sage, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anagnostaras, S. G.</span><span> </span><span class="NLM_article-title">Psychostimulants and Cognition: A Continuum of Behavioral and Cognitive Activation</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">221</span><span class="refDoi"> DOI: 10.1124/pr.112.007054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1124%2Fpr.112.007054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=24344115" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVGnu73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2014&pages=193-221&author=S.+Woodauthor=J.+R.+Sageauthor=T.+Shumanauthor=S.+G.+Anagnostaras&title=Psychostimulants+and+Cognition%3A+A+Continuum+of+Behavioral+and+Cognitive+Activation&doi=10.1124%2Fpr.112.007054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Psychostimulants and cognition: a continuum of behavioral and cognitive activation</span></div><div class="casAuthors">Wood, Suzanne; Sage, Jennifer R.; Shuman, Tristan; Anagnostaras, Stephan G.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">193-221, 29 pp.</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">1521-0081</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Psychostimulants such as cocaine have been used as performance enhancers throughout recorded history.  Although psychostimulants are commonly prescribed to improve attention and cognition, a great deal of literature has described their ability to induce cognitive deficits, as well as addiction.  How can a single drug class be known to produce both cognitive enhancement and impairment.  Properties of the particular stimulant drug itself and individual differences between users have both been suggested to dictate the outcome of stimulant use.  A more parsimonious alternative, which we endorse, is that dose is the crit. detg. factor in cognitive effects of stimulant drugs.  Herein, we review several popular stimulants (cocaine, amphetamine, methylphenidate, modafinil, and caffeine), outlining their history of use, mechanism of action, and use and abuse today.  One common graphic depiction of the cognitive effects of psychostimulants is an inverted U-shaped dose-effect curve.  Moderate arousal is beneficial to cognition, whereas too much activation leads to cognitive impairment.  In parallel to this schematic, we propose a continuum of psychostimulant activation that covers the transition from one drug effect to another as stimulant intake is increased.  Low doses of stimulants effect increased arousal, attention, and cognitive enhancement; moderate doses can lead to feelings of euphoria and power, as well as addiction and cognitive impairment; and very high doses lead to psychosis and circulatory collapse.  This continuum helps account for the seemingly disparate effects of stimulant drugs, with the same drug being assocd. with cognitive enhancement and impairment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKUCx_-Q7V6rVg90H21EOLACvtfcHk0li5dyJE_CM-1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVGnu73E&md5=ec43a4e0babb213d36455c2a070ba16e</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1124%2Fpr.112.007054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.112.007054%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DS.%26aulast%3DSage%26aufirst%3DJ.%2BR.%26aulast%3DShuman%26aufirst%3DT.%26aulast%3DAnagnostaras%26aufirst%3DS.%2BG.%26atitle%3DPsychostimulants%2520and%2520Cognition%253A%2520A%2520Continuum%2520of%2520Behavioral%2520and%2520Cognitive%2520Activation%26jtitle%3DPharmacol.%2520Rev.%26date%3D2014%26volume%3D66%26spage%3D193%26epage%3D221%26doi%3D10.1124%2Fpr.112.007054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Trifilieff, P.; Martinez, D.</span><span> </span><span class="NLM_article-title">Chapter Five. Cocaine: Mechanism and Effects in the Human Brain</span>. In  <span class="citation_source-book">The Effects of Drug Abuse on the Human Nervous System</span>; <span class="NLM_contrib-group">Madras, B.; Kuhar, K.</span>, Eds.; <span class="NLM_publisher-name">Elsevier Inc.</span>: <span class="NLM_publisher-loc">Oxford, United Kingdom</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">133</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1016%2FB978-0-12-418679-8.00005-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&pages=103-133&author=P.+Trifilieff&author=D.+Martinezauthor=B.+Madras&author=K.+Kuhar&title=The+Effects+of+Drug+Abuse+on+the+Human+Nervous+System"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-418679-8.00005-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-418679-8.00005-8%26sid%3Dliteratum%253Aachs%26aulast%3DTrifilieff%26aufirst%3DP.%26atitle%3DChapter%2520Five.%2520Cocaine%253A%2520Mechanism%2520and%2520Effects%2520in%2520the%2520Human%2520Brain%26btitle%3DThe%2520Effects%2520of%2520Drug%2520Abuse%2520on%2520the%2520Human%2520Nervous%2520System%26aulast%3DMadras%26aufirst%3DB.%26pub%3DElsevier%2520Inc%26date%3D2014%26spage%3D103%26epage%3D133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Stoops, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rush, C. R.</span><span> </span><span class="NLM_article-title">Agonist Replacement for Stimulant Dependence: A Review of Clinical Research</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">7026</span><span class="NLM_x">–</span> <span class="NLM_lpage">7035</span><span class="refDoi"> DOI: 10.2174/138161281940131209142843</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.2174%2F138161281940131209142843" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFelu7vK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=7026-7035&author=W.+W.+Stoopsauthor=C.+R.+Rush&title=Agonist+Replacement+for+Stimulant+Dependence%3A+A+Review+of+Clinical+Research&doi=10.2174%2F138161281940131209142843"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Agonist Replacement for Stimulant Dependence: A Review of Clinical Research</span></div><div class="casAuthors">Stoops, William W.; Rush, Craig R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">7026-7035</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Stimulant use disorders are an unrelenting public health concern worldwide.  Agonist replacement therapy is among the most effective strategies for managing substance use disorders including nicotine and opioid dependence.  The present paper reviewed clin. data from human lab. self-administration studies and clin. trials to det. whether agonist replacement therapy is a viable strategy for managing cocaine and/or amphetamine use disorders.  The extant literature suggests that agonist replacement therapy may be effective for managing stimulant use disorders, however, the clin. selection of an agonist replacement medication likely needs to be based on the pharmacol. mechanism of the medication and the stimulant abused by patients.  Specifically, dopamine releasers appear most effective for reducing cocaine use whereas dopamine reuptake inhibitors appear most effective for reducing amphetamine use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRmnvr2wpDebVg90H21EOLACvtfcHk0lgfxkwnezxoCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFelu7vK&md5=358bce5530e1cb2e8698172565b366a8</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2174%2F138161281940131209142843&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161281940131209142843%26sid%3Dliteratum%253Aachs%26aulast%3DStoops%26aufirst%3DW.%2BW.%26aulast%3DRush%26aufirst%3DC.%2BR.%26atitle%3DAgonist%2520Replacement%2520for%2520Stimulant%2520Dependence%253A%2520A%2520Review%2520of%2520Clinical%2520Research%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2013%26volume%3D19%26spage%3D7026%26epage%3D7035%26doi%3D10.2174%2F138161281940131209142843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Preti, A.</span><span> </span><span class="NLM_article-title">Review: New Developments in the Pharmacotherapy of Cocaine Abuse</span> <span class="citation_source-journal">Addict. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span><span class="refDoi"> DOI: 10.1111/j.1369-1600.2007.00061.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1111%2Fj.1369-1600.2007.00061.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=17508985" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVOqur3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=133-151&author=A.+Preti&title=Review%3A+New+Developments+in+the+Pharmacotherapy+of+Cocaine+Abuse&doi=10.1111%2Fj.1369-1600.2007.00061.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">New developments in the pharmacotherapy of cocaine abuse</span></div><div class="casAuthors">Preti, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Addiction Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">133-151</span>CODEN:
                <span class="NLM_cas:coden">ADBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1355-6215</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Despite huge advances in the neuroscience of substance abuse and dependence in the past 20 years, no approved pharmacol. treatment exists for cocaine abuse.  The available drugs for the treatment of cocaine abuse are poorly effective, hence the need for new compds. to be screened and tested for efficacy: targeting symptoms might improve the effectiveness of the treatment of cocaine abuse and dependence.  On the basis of the known neurochem. of cocaine, some target compds. have been studied: among others.  BP-897, a D3 partial agonist: vanoxerine, a highly selective inhibitor of dopamine uptake: aripiprazole, a partial mixed-action agonist approved for the treatment of schizophrenia.  Recently modafinil, approved for the treatment of narcolepsy, proved effective in favoring cocaine abstinence in cocaine-abusing people.  Some placebo-controlled studies also reported the effectiveness of topiramate, a licensed antiepileptic drug, and of tiagabine, a gamma-aminobutyric acid (GABA) re-uptake inhibitor also approved as an anticonvulsant: both compds. increased cocaine abstinence with no serious adverse events.  Promising results came from two more compds. acting on the GABA circuits, baclofen and valproic acid.  Finally disulfiram, prescribed with active psychosocial therapy, was found to favor higher retention rates and longer abstinence periods from both alc. and cocaine in polydrug-abusing patients.  An alternative approach rests on the use of vaccines, to date in the exptl. stage still.  Psychosocial treatments are a useful companion in the pharmacotherapy of cocaine abuse, with group therapy and contingency management therapies improving motivation and social functioning, particularly in patients abusing alc. as well.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBg9wU-hybkLVg90H21EOLACvtfcHk0lgfxkwnezxoCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVOqur3N&md5=93b4725efc304ddaee04534fa1ecfa8c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1111%2Fj.1369-1600.2007.00061.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1369-1600.2007.00061.x%26sid%3Dliteratum%253Aachs%26aulast%3DPreti%26aufirst%3DA.%26atitle%3DReview%253A%2520New%2520Developments%2520in%2520the%2520Pharmacotherapy%2520of%2520Cocaine%2520Abuse%26jtitle%3DAddict.%2520Biol.%26date%3D2007%26volume%3D12%26spage%3D133%26epage%3D151%26doi%3D10.1111%2Fj.1369-1600.2007.00061.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Gowrishankar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blakely, R. D.</span><span> </span><span class="NLM_article-title">Good Riddance to Dopamine: Roles for the Dopamine Transporter in Synaptic Function and Dopamine-Associated Brain Disorders</span> <span class="citation_source-journal">Neurochem. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">42</span><span class="NLM_x">–</span> <span class="NLM_lpage">48</span><span class="refDoi"> DOI: 10.1016/j.neuint.2013.10.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1016%2Fj.neuint.2013.10.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpvVSgsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2014&pages=42-48&author=R.+Gowrishankarauthor=M.+K.+Hahnauthor=R.+D.+Blakely&title=Good+Riddance+to+Dopamine%3A+Roles+for+the+Dopamine+Transporter+in+Synaptic+Function+and+Dopamine-Associated+Brain+Disorders&doi=10.1016%2Fj.neuint.2013.10.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Good riddance to dopamine: Roles for the dopamine transporter in synaptic function and dopamine-associated brain disorders</span></div><div class="casAuthors">Gowrishankar, Raajaram; Hahn, Maureen K.; Blakely, Randy D.</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">42-48</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The neurotransmitter dopamine (DA) plays a crit. role in CNS circuits that provide for attention, executive function, reward responses, motivation and movement.  DA is inactivated by the cocaine- and amphetamine-sensitive DA transporter (DAT), a protein that also provides a pathway for non-vesicular DA release.  After a brief review of DAT function and psychostimulant actions, we consider the importance DAT in relation to the distinct firing patterns of DA neurons that permit awareness of novelty and reward.  Finally, we review recent efforts to gather direct support for DAT-linked disorders, with a specific focus on DAT mutations recently identified in subjects with ADHD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3ijhHU6X1e7Vg90H21EOLACvtfcHk0lgfxkwnezxoCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpvVSgsbg%253D&md5=328ac7c14194158f305afabd63f0637a</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2013.10.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2013.10.016%26sid%3Dliteratum%253Aachs%26aulast%3DGowrishankar%26aufirst%3DR.%26aulast%3DHahn%26aufirst%3DM.%2BK.%26aulast%3DBlakely%26aufirst%3DR.%2BD.%26atitle%3DGood%2520Riddance%2520to%2520Dopamine%253A%2520Roles%2520for%2520the%2520Dopamine%2520Transporter%2520in%2520Synaptic%2520Function%2520and%2520Dopamine-Associated%2520Brain%2520Disorders%26jtitle%3DNeurochem.%2520Int.%26date%3D2014%26volume%3D73%26spage%3D42%26epage%3D48%26doi%3D10.1016%2Fj.neuint.2013.10.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Heal, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheetham, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. L.</span><span> </span><span class="NLM_article-title">The Neuropharmacology of ADHD Drugs In Vivo: Insights on Efficacy and Safety</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">608</span><span class="NLM_x">–</span> <span class="NLM_lpage">618</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2009.08.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1016%2Fj.neuropharm.2009.08.020" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2009&pages=608-618&author=D.+J.+Healauthor=S.+C.+Cheethamauthor=S.+L.+Smith&title=The+Neuropharmacology+of+ADHD+Drugs+In+Vivo%3A+Insights+on+Efficacy+and+Safety&doi=10.1016%2Fj.neuropharm.2009.08.020"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2009.08.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2009.08.020%26sid%3Dliteratum%253Aachs%26aulast%3DHeal%26aufirst%3DD.%2BJ.%26aulast%3DCheetham%26aufirst%3DS.%2BC.%26aulast%3DSmith%26aufirst%3DS.%2BL.%26atitle%3DThe%2520Neuropharmacology%2520of%2520ADHD%2520Drugs%2520In%2520Vivo%253A%2520Insights%2520on%2520Efficacy%2520and%2520Safety%26jtitle%3DNeuropharmacology%26date%3D2009%26volume%3D57%26spage%3D608%26epage%3D618%26doi%3D10.1016%2Fj.neuropharm.2009.08.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Mereu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanda, G.</span><span> </span><span class="NLM_article-title">The Neurobiology of Modafinil as an Enhancer of Cognitive Performance and a Potential Treatment for Substance Use Disorders</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">229</span><span class="NLM_x">, </span> <span class="NLM_fpage">415</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span><span class="refDoi"> DOI: 10.1007/s00213-013-3232-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1007%2Fs00213-013-3232-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=23934211" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1CrsLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=229&publication_year=2013&pages=415-434&author=M.+Mereuauthor=A.+Bonciauthor=A.+H.+Newmanauthor=G.+Tanda&title=The+Neurobiology+of+Modafinil+as+an+Enhancer+of+Cognitive+Performance+and+a+Potential+Treatment+for+Substance+Use+Disorders&doi=10.1007%2Fs00213-013-3232-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders</span></div><div class="casAuthors">Mereu, Maddalena; Bonci, Antonello; Newman, Amy Hauck; Tanda, Gianluigi</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">229</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">415-434</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Rationale and objectives: Modafinil (MOD) and its R-enantiomer (R-MOD) are approved medications for narcolepsy and other sleep disorders.  They have also been used, off-label, as cognitive enhancers in populations of patients with mental disorders, including substance abusers that demonstrate impaired cognitive function.  A debated nonmedical use of MOD in healthy individuals to improve intellectual performance is raising questions about its potential abuse liability in this population.  Results and conclusions: MOD has low micromolar affinity for the dopamine transporter (DAT).  Inhibition of dopamine (DA) reuptake via the DAT explains the enhancement of DA levels in several brain areas, an effect shared with psychostimulants like cocaine, methylphenidate, and the amphetamines.  However, its neurochem. effects and anatomical pattern of brain area activation differ from typical psychostimulants and are consistent with its beneficial effects on cognitive performance processes such as attention, learning, and memory.  At variance with typical psychostimulants, MOD shows very low, if any, abuse liability, in spite of its use as a cognitive enhancer by otherwise healthy individuals.  Finally, recent clin. studies have focused on the potential use of MOD as a medication for treatment of drug abuse, but have not shown consistent outcomes.  However, pos. trends in several result measures suggest that medications that improve cognitive function, like MOD or R-MOD, may be beneficial for the treatment of substance use disorders in certain patient populations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpk7rhhVPs1w7Vg90H21EOLACvtfcHk0liN3Hqh57eX8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1CrsLvN&md5=65a22f87cf0588b5050f1a8993392990</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1007%2Fs00213-013-3232-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-013-3232-4%26sid%3Dliteratum%253Aachs%26aulast%3DMereu%26aufirst%3DM.%26aulast%3DBonci%26aufirst%3DA.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DTanda%26aufirst%3DG.%26atitle%3DThe%2520Neurobiology%2520of%2520Modafinil%2520as%2520an%2520Enhancer%2520of%2520Cognitive%2520Performance%2520and%2520a%2520Potential%2520Treatment%2520for%2520Substance%2520Use%2520Disorders%26jtitle%3DPsychopharmacology%26date%3D2013%26volume%3D229%26spage%3D415%26epage%3D434%26doi%3D10.1007%2Fs00213-013-3232-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Loland, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mereu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okunola, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prisinzano, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopajtic, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanda, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span> </span><span class="NLM_article-title">R-Modafinil (Armodafinil): A Unique Dopamine Uptake Inhibitor and Potential Medication for Psychostimulant Abuse</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">405</span><span class="NLM_x">–</span> <span class="NLM_lpage">413</span><span class="refDoi"> DOI: 10.1016/j.biopsych.2012.03.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1016%2Fj.biopsych.2012.03.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=22537794" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtFelt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=405-413&author=C.+J.+Lolandauthor=M.+Mereuauthor=O.+M.+Okunolaauthor=J.+Caoauthor=T.+E.+Prisinzanoauthor=S.+Mazierauthor=T.+Kopajticauthor=L.+Shiauthor=J.+L.+Katzauthor=G.+Tandaauthor=A.+H.+Newman&title=R-Modafinil+%28Armodafinil%29%3A+A+Unique+Dopamine+Uptake+Inhibitor+and+Potential+Medication+for+Psychostimulant+Abuse&doi=10.1016%2Fj.biopsych.2012.03.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">R-Modafinil (Armodafinil): A Unique Dopamine Uptake Inhibitor and Potential Medication for Psychostimulant Abuse</span></div><div class="casAuthors">Loland, Claus J.; Mereu, Maddalena; Okunola, Oluyomi M.; Cao, Jianjing; Prisinzano, Thomas E.; Mazier, Sonia; Kopajtic, Theresa; Shi, Lei; Katz, Jonathan L.; Tanda, Gianluigi; Newman, Amy Hauck</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">405-413</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">(±)-Modafinil has piqued interest as a treatment for attention-deficit/hyperactivity disorder and stimulant dependence.  The R-enantiomer of modafinil might have unique pharmacol. properties that should be further investigated.  (±)-Modafinil and its R-(-)- and S-(+)-enantiomers were synthesized and tested for inhibition of [3H] dopamine (DA) uptake and [3H]WIN 35428 binding in human dopamine transporter (DAT) wild-type and mutants with altered conformational equil.  Data were compared with cocaine and the atypical DA uptake inhibitor, JHW 007.  R- and S-modafinil were also evaluated in microdialysis studies in the mouse nucleus accumbens shell and in a cocaine discrimination procedure.  (±)-, R-, and S-modafinil bind to the DAT and inhibit DA uptake less potently than cocaine, with R-modafinil having approx. threefold higher affinity than its S-enantiomer.  Mol. docking studies revealed subtle differences in binding modes for the enantiomers.  R-modafinil was significantly less potent in the DAT Y156F mutant compared with wild-type DAT, whereas S-modafinil was affected less.  Studies with the Y335A DAT mutant showed that the R- and S-enantiomers tolerated the inward-facing conformation better than cocaine, which was further supported by [2-(trimethylammonium)ethyl]-methanethiosulfonate reactivity on the DAT E2C I159C.  Microdialysis studies demonstrated that both R- and S-modafinil produced increases in extracellular DA concns. in the nucleus accumbens shell less efficaciously than cocaine and with a longer duration of action.  Both enantiomers fully substituted in mice trained to discriminate cocaine from saline.R-modafinil displays an in vitro profile different from cocaine.  Future trials with R-modafinil as a substitute therapy with the potential benefit of cognitive enhancement for psychostimulant addiction are warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjL4KiRs4PUbVg90H21EOLACvtfcHk0liN3Hqh57eX8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtFelt74%253D&md5=78808210fc68d2fbcdd97190f03b63d0</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2012.03.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2012.03.022%26sid%3Dliteratum%253Aachs%26aulast%3DLoland%26aufirst%3DC.%2BJ.%26aulast%3DMereu%26aufirst%3DM.%26aulast%3DOkunola%26aufirst%3DO.%2BM.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DPrisinzano%26aufirst%3DT.%2BE.%26aulast%3DMazier%26aufirst%3DS.%26aulast%3DKopajtic%26aufirst%3DT.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26aulast%3DTanda%26aufirst%3DG.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DR-Modafinil%2520%2528Armodafinil%2529%253A%2520A%2520Unique%2520Dopamine%2520Uptake%2520Inhibitor%2520and%2520Potential%2520Medication%2520for%2520Psychostimulant%2520Abuse%26jtitle%3DBiol.%2520Psychiatry%26date%3D2012%26volume%3D72%26spage%3D405%26epage%3D413%26doi%3D10.1016%2Fj.biopsych.2012.03.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Dackis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samaha, F. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kampman, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornish, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poole, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, C. P.</span><span> </span><span class="NLM_article-title">Modafinil and Cocaine: A Double-Blind, Placebo-Controlled Drug Interaction Study</span> <span class="citation_source-journal">Drug Alcohol Depend.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">37</span><span class="refDoi"> DOI: 10.1016/S0376-8716(02)00335-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1016%2FS0376-8716%2802%2900335-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BD3sXis12rtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2003&pages=29-37&author=C.+A.+Dackisauthor=K.+G.+Lynchauthor=E.+Yuauthor=F.+F.+Samahaauthor=K.+M.+Kampmanauthor=J.+W.+Cornishauthor=A.+Rowanauthor=S.+Pooleauthor=L.+Whiteauthor=C.+P.+O%E2%80%99Brien&title=Modafinil+and+Cocaine%3A+A+Double-Blind%2C+Placebo-Controlled+Drug+Interaction+Study&doi=10.1016%2FS0376-8716%2802%2900335-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study</span></div><div class="casAuthors">Dackis, Charles A.; Lynch, Kevin G.; Yu, Elmer; Samaha, Frederick F.; Kampman, Kyle M.; Cornish, James W.; Rowan, Amy; Poole, Sabrina; White, Lenae; O'Brien, Charles P.</div><div class="citationInfo"><span class="NLM_cas:title">Drug and Alcohol Dependence</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-37</span>CODEN:
                <span class="NLM_cas:coden">DADEDV</span>;
        ISSN:<span class="NLM_cas:issn">0376-8716</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">Modafinil is a novel compd. that is approved for the treatment of narcolepsy.  It is now being studied as a potential treatment for cocaine dependence.  Cocaine withdrawal symptoms are assocd. with poor clin. outcome and are likely to be reversed by modafinil.  In addn., the neurotransmitter actions of modafinil are opposite to cocaine-induced neuroadaptations affecting dopamine and glutamate reward circuits.  Since cocaine-dependent subjects might use cocaine during a clin. trial with modafinil, this study tested the safety of i.v. cocaine (30 mg) in combination with modafinil.  Each of seven subjects received a baseline (open-label) cocaine infusion.  Three subsequent cocaine infusions were administered after subjects received 4 days of low dose modafinil (200 mg/day), high dose modafinil (400 mg/day), or placebo in randomized double-blind sequences.  One subject received placebo prior to all infusions.  Our results indicate that co-administering modafinil and a single dose of i.v. cocaine is not assocd. with medical risk in terms of blood pressure, pulse, temp., or ECG measures.  Furthermore, pretreatment with modafinil did not intensify cocaine euphoria or cocaine-induced craving.  In fact, cocaine euphoria was significantly blunted in one of our subjective measures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3OAw9c_66srVg90H21EOLACvtfcHk0lijcXv2CCNYLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXis12rtrY%253D&md5=603e451bce498d1622e63999509fbb8e</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2FS0376-8716%2802%2900335-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0376-8716%252802%252900335-6%26sid%3Dliteratum%253Aachs%26aulast%3DDackis%26aufirst%3DC.%2BA.%26aulast%3DLynch%26aufirst%3DK.%2BG.%26aulast%3DYu%26aufirst%3DE.%26aulast%3DSamaha%26aufirst%3DF.%2BF.%26aulast%3DKampman%26aufirst%3DK.%2BM.%26aulast%3DCornish%26aufirst%3DJ.%2BW.%26aulast%3DRowan%26aufirst%3DA.%26aulast%3DPoole%26aufirst%3DS.%26aulast%3DWhite%26aufirst%3DL.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DC.%2BP.%26atitle%3DModafinil%2520and%2520Cocaine%253A%2520A%2520Double-Blind%252C%2520Placebo-Controlled%2520Drug%2520Interaction%2520Study%26jtitle%3DDrug%2520Alcohol%2520Depend.%26date%3D2003%26volume%3D70%26spage%3D29%26epage%3D37%26doi%3D10.1016%2FS0376-8716%2802%2900335-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Malcolm, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swayngim, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donovan, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeVane, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elkashef, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mojsiak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myrick, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedden, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cochran, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolson, R. F.</span><span> </span><span class="NLM_article-title">Modafinil and Cocaine Interactions</span> <span class="citation_source-journal">Am. J. Drug Alcohol Abuse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">577</span><span class="NLM_x">–</span> <span class="NLM_lpage">587</span><span class="refDoi"> DOI: 10.1080/00952990600920425</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1080%2F00952990600920425" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A280%3ADC%252BD28noslanuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2006&pages=577-587&author=R.+Malcolmauthor=K.+Swayngimauthor=J.+L.+Donovanauthor=C.+L.+DeVaneauthor=A.+Elkashefauthor=N.+Chiangauthor=R.+Khanauthor=J.+Mojsiakauthor=D.+L.+Myrickauthor=S.+Heddenauthor=K.+Cochranauthor=R.+F.+Woolson&title=Modafinil+and+Cocaine+Interactions&doi=10.1080%2F00952990600920425"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Modafinil and cocaine interactions</span></div><div class="casAuthors">Malcolm Robert; Swayngim Karla; Donovan Jennifer L; DeVane C Lindsay; Elkashef Ahmed; Chiang Nora; Khan Roberta; Mojsiak Jurij; Myrick Donald L; Hedden Sarra; Cochran Kristi; Woolson Robert F</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of drug and alcohol abuse</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">577-87</span>
        ISSN:<span class="NLM_cas:issn">0095-2990</span>.
    </div><div class="casAbstract">This Phase I trial evaluated the interaction between modafinil steady-state and cocaine.  Twelve non-treatment seeking, cocaine dependent volunteers received four sets of randomized blinded infusions of saline, 20 mg IV cocaine, and 40 mg IV cocaine.  Modafinil was given open label at 0 mg, 400 mg, or 800 mg.  Modafinil combined with IV cocaine did not result in any significant hemodynamic interactions.  Modafinil significantly dampened scores on Visual Analog Scale measures as compared to baseline cocaine conditions.  No significant alterations in labs occurred.  Further outpatient trials of modafinil appear to be warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSP_heaDwdoPJ6KlWarZTAzfW6udTcc2ebZhhFCK2jfOrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28noslanuw%253D%253D&md5=6da6cf5481414f3693e6078f20f23178</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1080%2F00952990600920425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00952990600920425%26sid%3Dliteratum%253Aachs%26aulast%3DMalcolm%26aufirst%3DR.%26aulast%3DSwayngim%26aufirst%3DK.%26aulast%3DDonovan%26aufirst%3DJ.%2BL.%26aulast%3DDeVane%26aufirst%3DC.%2BL.%26aulast%3DElkashef%26aufirst%3DA.%26aulast%3DChiang%26aufirst%3DN.%26aulast%3DKhan%26aufirst%3DR.%26aulast%3DMojsiak%26aufirst%3DJ.%26aulast%3DMyrick%26aufirst%3DD.%2BL.%26aulast%3DHedden%26aufirst%3DS.%26aulast%3DCochran%26aufirst%3DK.%26aulast%3DWoolson%26aufirst%3DR.%2BF.%26atitle%3DModafinil%2520and%2520Cocaine%2520Interactions%26jtitle%3DAm.%2520J.%2520Drug%2520Alcohol%2520Abuse%26date%3D2006%26volume%3D32%26spage%3D577%26epage%3D587%26doi%3D10.1080%2F00952990600920425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Hart, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haney, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vosburg, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foltin, R. W.</span><span> </span><span class="NLM_article-title">Smoked Cocaine Self-Administration is Decreased by Modafinil</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">761</span><span class="NLM_x">–</span> <span class="NLM_lpage">768</span><span class="refDoi"> DOI: 10.1038/sj.npp.1301472</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1038%2Fsj.npp.1301472" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=17568397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhvVykt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2008&pages=761-768&author=C.+L.+Hartauthor=M.+Haneyauthor=S.+K.+Vosburgauthor=E.+Rubinauthor=R.+W.+Foltin&title=Smoked+Cocaine+Self-Administration+is+Decreased+by+Modafinil&doi=10.1038%2Fsj.npp.1301472"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Smoked cocaine self-administration is decreased by modafinil</span></div><div class="casAuthors">Hart, Carl L.; Haney, Margaret; Vosburg, Suzanne K.; Rubin, Eric; Foltin, Richard W.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">761-768</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Modafinil has been reported to reduce cocaine use in a clin. sample of infrequent users (2 days/wk), but the effects of modafinil on cocaine self-administration in the lab. have not been studied.  The present study investigated the effects of modafinil maintenance on cocaine self-administration by frequent users (4 days/wk) under controlled lab. conditions.  During this 48-day double-blind, crossover design study, the effects of modafinil maintenance (0, 200, and 400 mg/day) on response to smoked cocaine (0, 12, 25, and 50 mg) were examd. in nontreatment-seeking cocaine-dependent individuals (n = 8).  Cocaine significantly increased self-administration, subjective-effect ratings, and cardiovascular measures; modafinil at both doses (200 and 400 mg/day) markedly attenuated these effects.  These findings agree with data from previous human lab. and clin. investigations of modafinil as a potential cocaine abuse treatment medication.  Thus, our data support the potential of modafinil as a pharmacotherapy for cocaine dependence.  Neuropsychopharmacol. (2008) 33, 761-768; doi:10.1038/sj.npp.1301472; published online 13 June 2007.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrL8E5sCPheKLVg90H21EOLACvtfcHk0lgur4McZpp2Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhvVykt7o%253D&md5=e399fbba32fc9718ac7a8a642bff717a</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fsj.npp.1301472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.npp.1301472%26sid%3Dliteratum%253Aachs%26aulast%3DHart%26aufirst%3DC.%2BL.%26aulast%3DHaney%26aufirst%3DM.%26aulast%3DVosburg%26aufirst%3DS.%2BK.%26aulast%3DRubin%26aufirst%3DE.%26aulast%3DFoltin%26aufirst%3DR.%2BW.%26atitle%3DSmoked%2520Cocaine%2520Self-Administration%2520is%2520Decreased%2520by%2520Modafinil%26jtitle%3DNeuropsychopharmacology%26date%3D2008%26volume%3D33%26spage%3D761%26epage%3D768%26doi%3D10.1038%2Fsj.npp.1301472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Newman, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Negus, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prisinzano, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mello, N. K.</span><span> </span><span class="NLM_article-title">Behavioral Evaluation of Modafinil and the Abuse-Related Effects of Cocaine in Rhesus Monkeys</span> <span class="citation_source-journal">Exp. Clin. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">395</span><span class="NLM_x">–</span> <span class="NLM_lpage">408</span><span class="refDoi"> DOI: 10.1037/a0021042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1037%2Fa0021042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVagsb3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=395-408&author=J.+L.+Newmanauthor=S.+S.+Negusauthor=A.+Lozamaauthor=T.+E.+Prisinzanoauthor=N.+K.+Mello&title=Behavioral+Evaluation+of+Modafinil+and+the+Abuse-Related+Effects+of+Cocaine+in+Rhesus+Monkeys&doi=10.1037%2Fa0021042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Behavioral evaluation of modafinil and the abuse-related effects of cocaine in rhesus monkeys</span></div><div class="casAuthors">Newman, Jennifer L.; Lozama, Anthony; Prisinzano, Thomas E.; Negus, S. Stevens; Mello, Nancy K.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental and Clinical Psychopharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">395-408</span>CODEN:
                <span class="NLM_cas:coden">ECLPES</span>;
        ISSN:<span class="NLM_cas:issn">1064-1297</span>.
    
            (<span class="NLM_cas:orgname">American Psychological Association</span>)
        </div><div class="casAbstract">Modafinil is a central nervous system stimulant used to promote wakefulness, and it is being evaluated clin. as an agonist medication for treating stimulant abuse.  This is the first report of the effects of modafinil on the abuse-related effects of cocaine in nonhuman primates.  The behavioral effects of modafinil were examd. in three studies.  First, the discriminative stimulus effects of modafinil (3.2-32 mg/kg) were evaluated in rhesus monkeys (Macaca mulatta) trained to discriminate either low (0.18 mg/kg, IM) or high (0.4 mg/kg, IM) doses of cocaine from saline.  Modafinil dose-dependently substituted for cocaine in 6 of 7 monkeys.  In the second study, the effects of chronically administered modafinil (32-56 mg/kg/day, IV) on food- and cocaine-maintained (0.001-0.1 mg/kg/inj) operant responding were examd.  Modafinil was administered 3 times/h for 23 h/day to ensure stable drug levels.  Chronic treatment with 32 mg/kg/day modafinil selectively reduced responding maintained by intermediate and peak reinforcing doses of cocaine, but responding maintained by higher doses of cocaine was unaffected.  Food-maintained behavior did not change during chronic modafinil treatment.  In a third study, modafinil (32 and 56 mg/kg/day, IV) was examd. in a reinstatement model.  Modafinil transiently increased responding during extinction.  These findings indicate that modafinil shares discriminative stimulus effects with cocaine and selectively reduces responding maintained by reinforcing doses of cocaine.  In addn., modafinil reinstated cocaine-seeking behavior, which may reflect its cocaine-like discriminative stimulus effects.  These data support clin. findings and indicate that these preclin. models may be useful for predicting the effectiveness of agonist medications for drug abuse treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrO36RqqltDtrVg90H21EOLACvtfcHk0lgur4McZpp2Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVagsb3J&md5=a8c26d78f40e16a6fafa722d001e91d5</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1037%2Fa0021042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1037%252Fa0021042%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DJ.%2BL.%26aulast%3DNegus%26aufirst%3DS.%2BS.%26aulast%3DLozama%26aufirst%3DA.%26aulast%3DPrisinzano%26aufirst%3DT.%2BE.%26aulast%3DMello%26aufirst%3DN.%2BK.%26atitle%3DBehavioral%2520Evaluation%2520of%2520Modafinil%2520and%2520the%2520Abuse-Related%2520Effects%2520of%2520Cocaine%2520in%2520Rhesus%2520Monkeys%26jtitle%3DExp.%2520Clin.%2520Psychopharmacol.%26date%3D2010%26volume%3D18%26spage%3D395%26epage%3D408%26doi%3D10.1037%2Fa0021042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Irwin, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjurstrom, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olmstead, R.</span><span> </span><span class="NLM_article-title">Polysomnographic Measures of Sleep in Cocaine Dependence and Alcohol Dependence: Implications for Age-Related Loss of Slow Wave, Stage 3 Sleep</span> <span class="citation_source-journal">Addiction</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">1084</span><span class="NLM_x">–</span> <span class="NLM_lpage">1092</span><span class="refDoi"> DOI: 10.1111/add.13300</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1111%2Fadd.13300" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2016&pages=1084-1092&author=M.+R.+Irwinauthor=M.+F.+Bjurstromauthor=R.+Olmstead&title=Polysomnographic+Measures+of+Sleep+in+Cocaine+Dependence+and+Alcohol+Dependence%3A+Implications+for+Age-Related+Loss+of+Slow+Wave%2C+Stage+3+Sleep&doi=10.1111%2Fadd.13300"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1111%2Fadd.13300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fadd.13300%26sid%3Dliteratum%253Aachs%26aulast%3DIrwin%26aufirst%3DM.%2BR.%26aulast%3DBjurstrom%26aufirst%3DM.%2BF.%26aulast%3DOlmstead%26aufirst%3DR.%26atitle%3DPolysomnographic%2520Measures%2520of%2520Sleep%2520in%2520Cocaine%2520Dependence%2520and%2520Alcohol%2520Dependence%253A%2520Implications%2520for%2520Age-Related%2520Loss%2520of%2520Slow%2520Wave%252C%2520Stage%25203%2520Sleep%26jtitle%3DAddiction%26date%3D2016%26volume%3D111%26spage%3D1084%26epage%3D1092%26doi%3D10.1111%2Fadd.13300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Irwin, M. R.; Opp, M. R.</span><span> </span><span class="NLM_article-title">Sleep-Health: Reciprocal Regulation of Sleep and Innate Immunity</span>.  <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span>[Online Early Access] DOI: <span class="refDoi"> DOI: 10.1038/npp.2016.148</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1038%2Fnpp.2016.148" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=M.+R.+Irwin&author=M.+R.+Opp&title=Sleep-Health%3A+Reciprocal+Regulation+of+Sleep+and+Innate+Immunity&doi=10.1038%2Fnpp.2016.148"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2016.148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2016.148%26sid%3Dliteratum%253Aachs%26aulast%3DIrwin%26aufirst%3DM.%2BR.%26atitle%3DSleep-Health%253A%2520Reciprocal%2520Regulation%2520of%2520Sleep%2520and%2520Innate%2520Immunity%26jtitle%3DNeuropsychopharmacology%26date%3D2016%26doi%3D10.1038%2Fnpp.2016.148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Martinez-Raga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cepeda, C.</span><span> </span><span class="NLM_article-title">K. and S. Modafinil: A Useful Medication for Cocaine Addiction? Review of the Evidence from Neuropharmacological, Experimental and Clinical Studies</span> <span class="citation_source-journal">Curr. Drug Abuse Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">221</span><span class="refDoi"> DOI: 10.2174/1874473710801020213</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.2174%2F1874473710801020213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=19630720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BD1cXntFCrsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2008&pages=213-221&author=J.+Martinez-Ragaauthor=C.+Cepeda&title=K.+and+S.+Modafinil%3A+A+Useful+Medication+for+Cocaine+Addiction%3F+Review+of+the+Evidence+from+Neuropharmacological%2C+Experimental+and+Clinical+Studies&doi=10.2174%2F1874473710801020213"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Modafinil: a useful medication for cocaine addiction? review of the evidence from neuropharmacological, experimental and clinical studies</span></div><div class="casAuthors">Martinez-Raga, Jose; Knecht, Carlos; Cepeda, Sonsoles</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Abuse Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-221</span>CODEN:
                <span class="NLM_cas:coden">CDARDV</span>;
        ISSN:<span class="NLM_cas:issn">1874-4737</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Cocaine addiction is a chronic relapsing disorder assocd. with severe medical and psychosocial complications.  However, there are no approved medications for cocaine dependent individuals.  Modafinil, a medication that differs chem. and pharmacol. from other central nervous system stimulants, has been suggested to be potentially useful for this complex disorder.  The present paper aims to critically review the published evidence from lab. and clin. studies on modafinil for cocaine addiction, including discussion of its pharmacol. characteristics and how it may relate with cocaine neurobiol.  While its exact mechanism of action remains to be elucidated, different neurotransmitter systems have been implicated, including modulation on dopamine, glutamate/GABA, noradrenaline and the hypocretin/orexin system, but it is possible that modafinil acts by a synergistic combination of mechanisms.  With a favorable pharmacokinetic profile, it appears to have a low abuse potential.  Lab. and clin. studies provide consistent, albeit preliminary, evidence of the potential usefulness of modafinil for cocaine dependent patients.  Not only there is no evidence of pharmacokinetic interactions between modafinil and cocaine, but in addn. cocaine induced euphoria and cardiovascular effects appear to be attenuated by modafinil.  Furthermore, modafinil has been shown to decrease cocaine self-administration.  In addn., modafinil treated patient are more likely to achieve protracted abstinence than placebo treated patients.  However, further research is needed to confirm these findings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphUk-JjG420rVg90H21EOLACvtfcHk0lie5OoQrzLjHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXntFCrsLw%253D&md5=231bfe95f2ba7bcfada19c0b3e731732</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.2174%2F1874473710801020213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1874473710801020213%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez-Raga%26aufirst%3DJ.%26aulast%3DCepeda%26aufirst%3DC.%26atitle%3DK.%2520and%2520S.%2520Modafinil%253A%2520A%2520Useful%2520Medication%2520for%2520Cocaine%2520Addiction%253F%2520Review%2520of%2520the%2520Evidence%2520from%2520Neuropharmacological%252C%2520Experimental%2520and%2520Clinical%2520Studies%26jtitle%3DCurr.%2520Drug%2520Abuse%2520Rev.%26date%3D2008%26volume%3D1%26spage%3D213%26epage%3D221%26doi%3D10.2174%2F1874473710801020213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Anderson, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shemanski, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vocci, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciraulo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dackis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roache, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salloum, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somoza, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urschel, H. C.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elkashef, A. M.</span><span> </span><span class="NLM_article-title">Modafinil for the Treatment of Cocaine Dependence</span> <span class="citation_source-journal">Drug Alcohol Depend.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="NLM_x">–</span> <span class="NLM_lpage">139</span><span class="refDoi"> DOI: 10.1016/j.drugalcdep.2009.04.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1016%2Fj.drugalcdep.2009.04.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=19560290" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosleiu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2009&pages=133-139&author=A.+L.+Andersonauthor=M.+S.+Reidauthor=S.-H.+Liauthor=T.+Holmesauthor=L.+Shemanskiauthor=A.+Sleeauthor=E.+V.+Smithauthor=R.+Kahnauthor=N.+Chiangauthor=F.+Vocciauthor=D.+Cirauloauthor=C.+Dackisauthor=J.+D.+Roacheauthor=I.+M.+Salloumauthor=E.+Somozaauthor=H.+C.+Urschelauthor=A.+M.+Elkashef&title=Modafinil+for+the+Treatment+of+Cocaine+Dependence&doi=10.1016%2Fj.drugalcdep.2009.04.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Modafinil for the treatment of cocaine dependence</span></div><div class="casAuthors">Anderson, Ann L.; Reid, Malcolm S.; Li, Shou-Hua; Holmes, Tyson; Shemanski, Lynn; Slee, April; Smith, Edwina V.; Kahn, Roberta; Chiang, Nora; Vocci, Frank; Ciraulo, Domenic; Dackis, Charles; Roache, John D.; Salloum, Ihsan M.; Somoza, Eugene; Urschel, Harold C., III; Elkashef, Ahmed M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug and Alcohol Dependence</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">133-139</span>CODEN:
                <span class="NLM_cas:coden">DADEDV</span>;
        ISSN:<span class="NLM_cas:issn">0376-8716</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Modafinil was tested for efficacy in facilitating abstinence in cocaine-dependent patients, compared to placebo.  This was a double-blind placebo-controlled study, with 12 wk of treatment and a 4-wk follow-up.  Six outpatient substance abuse treatment clinics participated in the study.  There were 210 treatment-seekers randomized, having a diagnosis of cocaine dependence; 72 participants were randomized to placebo, 69 to modafinil 200 mg, and 69 to modafinil 400 mg, taken once daily on awakening.  Participants came to the clinic three times per wk for assessments and urine drug screens, and had one hour of individual psychotherapy weekly.  The primary outcome measure was the weekly percentage of cocaine non-use days.  The GEE regression anal. showed that for the total sample, there was no significant difference between either modafinil group and placebo in the change in av. weekly percent of cocaine non-use days over the 12-wk treatment period (p > 0.79).  However, two secondary outcomes showed significant effects by modafinil 200 mg: the max. no. of consecutive non-use days for cocaine (p = 0.02), and a redn. in craving (p = 0.04).  Also, a post hoc anal. showed a significant effect of modafinil that increased the weekly percentage of non-use days in the subgroup of those cocaine patients who did not have a history of alc. dependence (p < 0.02).  These data suggest that modafinil, in combination with individual behavioral therapy, was effective for increasing cocaine non-use days in participants without co-morbid alc. dependence, and in reducing cocaine craving.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9pQ-oRIN93bVg90H21EOLACvtfcHk0lie5OoQrzLjHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosleiu7g%253D&md5=ff0d575a8b8e77162121c855de376554</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.drugalcdep.2009.04.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drugalcdep.2009.04.015%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DA.%2BL.%26aulast%3DReid%26aufirst%3DM.%2BS.%26aulast%3DLi%26aufirst%3DS.-H.%26aulast%3DHolmes%26aufirst%3DT.%26aulast%3DShemanski%26aufirst%3DL.%26aulast%3DSlee%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DE.%2BV.%26aulast%3DKahn%26aufirst%3DR.%26aulast%3DChiang%26aufirst%3DN.%26aulast%3DVocci%26aufirst%3DF.%26aulast%3DCiraulo%26aufirst%3DD.%26aulast%3DDackis%26aufirst%3DC.%26aulast%3DRoache%26aufirst%3DJ.%2BD.%26aulast%3DSalloum%26aufirst%3DI.%2BM.%26aulast%3DSomoza%26aufirst%3DE.%26aulast%3DUrschel%26aufirst%3DH.%2BC.%26aulast%3DElkashef%26aufirst%3DA.%2BM.%26atitle%3DModafinil%2520for%2520the%2520Treatment%2520of%2520Cocaine%2520Dependence%26jtitle%3DDrug%2520Alcohol%2520Depend.%26date%3D2009%26volume%3D104%26spage%3D133%26epage%3D139%26doi%3D10.1016%2Fj.drugalcdep.2009.04.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Kampman, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettinati, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spratt, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wierzbicki, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dackis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, C. P.</span><span> </span><span class="NLM_article-title">A Double Blind, Placebo Controlled Trial of Modafinil for the Treatment of Cocaine Dependence without Co-Morbid Alcohol Dependence</span> <span class="citation_source-journal">Drug Alcohol Depend.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">155</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span><span class="refDoi"> DOI: 10.1016/j.drugalcdep.2015.08.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1016%2Fj.drugalcdep.2015.08.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlGku7vM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=2015&pages=105-110&author=K.+M.+Kampmanauthor=K.+G.+Lynchauthor=H.+M.+Pettinatiauthor=K.+Sprattauthor=M.+R.+Wierzbickiauthor=C.+Dackisauthor=C.+P.+O%E2%80%99Brien&title=A+Double+Blind%2C+Placebo+Controlled+Trial+of+Modafinil+for+the+Treatment+of+Cocaine+Dependence+without+Co-Morbid+Alcohol+Dependence&doi=10.1016%2Fj.drugalcdep.2015.08.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">A double blind, placebo controlled trial of modafinil for the treatment of cocaine dependence without co-morbid alcohol dependence</span></div><div class="casAuthors">Kampman, Kyle M.; Lynch, Kevin G.; Pettinati, Helen M.; Spratt, Kelly; Wierzbicki, Michael R.; Dackis, Charles; O'Brien, Charles P.</div><div class="citationInfo"><span class="NLM_cas:title">Drug and Alcohol Dependence</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">155</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">105-110</span>CODEN:
                <span class="NLM_cas:coden">DADEDV</span>;
        ISSN:<span class="NLM_cas:issn">0376-8716</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Modafinil is a medication approved for narcolepsy and shift work sleep disorder.  It has both dopaminergic and glutamatergic activity that could be useful for the treatment of cocaine dependence.  Modafinil has reduced cocaine subjective effects and cocaine self-administration in human lab. trials and has reduced cocaine use in cocaine dependent patients in some clin. trials.  This was an 8-wk, double blind, placebo controlled clin. trial involving 94 cocaine dependent subjects.  Subjects received 300 mg of modafinil or identical placebo daily along with weekly individual therapy.  The primary outcome measure was cocaine use measured by self-report, and confirmed by twice weekly urine benzoylecgonine tests (UBT).  Addnl. outcome measures included cocaine craving measured by the Brief Substance Craving Scale and global improvement measured by the Clin. Global Impression Scale (CGI).  The odds ratio (OR) in favor of abstinence for modafinil vs. placebo was 2.54 (p = . 03) and modafinil-treated subjects were significantly more likely than placebo-treated subjects to be abstinent from cocaine during the last 3 wk of the trial, 23% vs. 9%, χ2 = 3.9, p < .05.  Modafinil treated subjects were more likely to report very low levels of cocaine craving intensity and duration on the Brief Substance Craving Scale (OR = 2.04, p = .03 and OR 1.06, p = .03 resp.).  Modafinil-treated subjects were also more likely than placebo-treated subjects to rate themselves as "very much improved" on the CGI (OR = 2.69, p = .03).  Modafinil may be an efficacious treatment for cocaine dependence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKlp1r4LCr97Vg90H21EOLACvtfcHk0lhNZAwgzsjdtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlGku7vM&md5=284894c7d171d8d9e8bde18538d90bef</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.drugalcdep.2015.08.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drugalcdep.2015.08.005%26sid%3Dliteratum%253Aachs%26aulast%3DKampman%26aufirst%3DK.%2BM.%26aulast%3DLynch%26aufirst%3DK.%2BG.%26aulast%3DPettinati%26aufirst%3DH.%2BM.%26aulast%3DSpratt%26aufirst%3DK.%26aulast%3DWierzbicki%26aufirst%3DM.%2BR.%26aulast%3DDackis%26aufirst%3DC.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DC.%2BP.%26atitle%3DA%2520Double%2520Blind%252C%2520Placebo%2520Controlled%2520Trial%2520of%2520Modafinil%2520for%2520the%2520Treatment%2520of%2520Cocaine%2520Dependence%2520without%2520Co-Morbid%2520Alcohol%2520Dependence%26jtitle%3DDrug%2520Alcohol%2520Depend.%26date%3D2015%26volume%3D155%26spage%3D105%26epage%3D110%26doi%3D10.1016%2Fj.drugalcdep.2015.08.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Agoston, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izenwasser, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kline, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span> </span><span class="NLM_article-title">Novel <i>N</i>-Substituted 3α-[Bis(4′-fluorophenyl)methoxy]tropane Analogues: Selective Ligands for the Dopamine Transporter</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">4329</span><span class="NLM_x">–</span> <span class="NLM_lpage">4339</span><span class="refDoi"> DOI: 10.1021/jm970525a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm970525a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=4329-4339&author=G.+E.+Agostonauthor=J.+H.+Wuauthor=S.+Izenwasserauthor=C.+Georgeauthor=J.+Katzauthor=R.+H.+Klineauthor=A.+H.+Newman&title=Novel+N-Substituted+3%CE%B1-%5BBis%284%E2%80%B2-fluorophenyl%29methoxy%5Dtropane+Analogues%3A+Selective+Ligands+for+the+Dopamine+Transporter&doi=10.1021%2Fjm970525a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm970525a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970525a%26sid%3Dliteratum%253Aachs%26aulast%3DAgoston%26aufirst%3DG.%2BE.%26aulast%3DWu%26aufirst%3DJ.%2BH.%26aulast%3DIzenwasser%26aufirst%3DS.%26aulast%3DGeorge%26aufirst%3DC.%26aulast%3DKatz%26aufirst%3DJ.%26aulast%3DKline%26aufirst%3DR.%2BH.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DNovel%2520N-Substituted%25203%25CE%25B1-%255BBis%25284%25E2%2580%25B2-fluorophenyl%2529methoxy%255Dtropane%2520Analogues%253A%2520Selective%2520Ligands%2520for%2520the%2520Dopamine%2520Transporter%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D4329%26epage%3D4339%26doi%3D10.1021%2Fjm970525a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Schmitt, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E. A.</span><span> </span><span class="NLM_article-title">The Atypical Stimulant and Nootropic Modafinil Interacts with the Dopamine Transporter in a Different Manner than Classical Cocaine-Like Inhibitors</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e25790</span><span class="refDoi"> DOI: 10.1371/journal.pone.0025790</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1371%2Fjournal.pone.0025790" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=22043293" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVCku73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e25790&author=K.+C.+Schmittauthor=M.+E.+A.+Reith&title=The+Atypical+Stimulant+and+Nootropic+Modafinil+Interacts+with+the+Dopamine+Transporter+in+a+Different+Manner+than+Classical+Cocaine-Like+Inhibitors&doi=10.1371%2Fjournal.pone.0025790"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The atypical stimulant and nootropic modafinil interacts with the dopamine transporter in a different manner than classical cocaine-like inhibitors</span></div><div class="casAuthors">Schmitt, Kyle C.; Reith, Maarten E. A.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e25790</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Modafinil is a mild psychostimulant with pro-cognitive and antidepressant effects.  Unlike many conventional stimulants, modafinil has little appreciable potential for abuse, making it a promising therapeutic agent for cocaine addiction.  The chief mol. target of modafinil is the dopamine transporter (DAT); however, the mechanistic details underlying modafinil's unique effects remain unknown.  Recent studies suggest that the conformational effects of a given DAT ligand influence the magnitude of the ligand's reinforcing properties.  For example, the atypical DAT inhibitors benztropine and GBR12909 do not share cocaine's notorious addictive liability, despite having greater binding affinity.  Here, we show that the binding mechanism of modafinil is different than cocaine and similar to other atypical inhibitors.  We previously established two mutations (W84L and D313N) that increase the likelihood that the DAT will adopt an outward-facing conformational state - these mutations increase the affinity of cocaine-like inhibitors considerably, but have little or opposite effect on atypical inhibitor binding.  Thus, a compd.'s WT/mutant affinity ratio can indicate whether the compd. preferentially interacts with a more outward- or inward-facing conformational state.  Modafinil displayed affinity ratios similar to those of benztropine, GBR12909 and bupropion (which lack cocaine-like effects in humans), but far different than those of cocaine, β-CFT or methylphenidate.  Whereas treatment with zinc (known to stabilize an outward-facing transporter state) increased the affinity of cocaine and methylphenidate two-fold, it had little or no effect on the binding of modafinil, benztropine, bupropion or GBR12909.  Addnl., computational modeling of inhibitor binding indicated that while β-CFT and methylphenidate stabilize an "open-to-out" conformation, binding of either modafinil or bupropion gives rise to a more closed conformation.  Our findings highlight a mechanistic difference between modafinil and cocaine-like stimulants and further demonstrate that the conformational effects of a given DAT inhibitor influence its phenomenol. effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk_0tcjHjbqbVg90H21EOLACvtfcHk0lhNZAwgzsjdtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVCku73L&md5=6599e43f3f518b78bf834fb6c6d72010</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0025790&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0025790%26sid%3Dliteratum%253Aachs%26aulast%3DSchmitt%26aufirst%3DK.%2BC.%26aulast%3DReith%26aufirst%3DM.%2BE.%2BA.%26atitle%3DThe%2520Atypical%2520Stimulant%2520and%2520Nootropic%2520Modafinil%2520Interacts%2520with%2520the%2520Dopamine%2520Transporter%2520in%2520a%2520Different%2520Manner%2520than%2520Classical%2520Cocaine-Like%2520Inhibitors%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De25790%26doi%3D10.1371%2Fjournal.pone.0025790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Wang, X.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bi, G.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, J.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okunola-Bakare, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slack, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xi, Z.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span> </span><span class="NLM_article-title">R-Modafinil Attenuates Nicotine-Taking and Nicotine-Seeking Behavior in Alcohol-Preferring Rats</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">1762</span><span class="NLM_x">–</span> <span class="NLM_lpage">1771</span><span class="refDoi"> DOI: 10.1038/npp.2015.24</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1038%2Fnpp.2015.24" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2015&pages=1762-1771&author=X.-F.+Wangauthor=G.-H.+Biauthor=Y.+Heauthor=H.-J.+Yangauthor=J.-T.+Gaoauthor=O.+M.+Okunola-Bakareauthor=R.+D.+Slackauthor=E.+L.+Gardnerauthor=Z.-X.+Xiauthor=A.+H.+Newman&title=R-Modafinil+Attenuates+Nicotine-Taking+and+Nicotine-Seeking+Behavior+in+Alcohol-Preferring+Rats&doi=10.1038%2Fnpp.2015.24"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2015.24&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2015.24%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.-F.%26aulast%3DBi%26aufirst%3DG.-H.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DH.-J.%26aulast%3DGao%26aufirst%3DJ.-T.%26aulast%3DOkunola-Bakare%26aufirst%3DO.%2BM.%26aulast%3DSlack%26aufirst%3DR.%2BD.%26aulast%3DGardner%26aufirst%3DE.%2BL.%26aulast%3DXi%26aufirst%3DZ.-X.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DR-Modafinil%2520Attenuates%2520Nicotine-Taking%2520and%2520Nicotine-Seeking%2520Behavior%2520in%2520Alcohol-Preferring%2520Rats%26jtitle%3DNeuropsychopharmacology%26date%3D2015%26volume%3D40%26spage%3D1762%26epage%3D1771%26doi%3D10.1038%2Fnpp.2015.24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prisinzano, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okunola, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopajtic, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shook, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span> </span><span class="NLM_article-title">SARs at the Monoamine Transporters for a Novel Series of Modafinil Analogues</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">48</span><span class="NLM_x">–</span> <span class="NLM_lpage">52</span><span class="refDoi"> DOI: 10.1021/ml1002025</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml1002025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht12lt7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=48-52&author=J.+Caoauthor=T.+E.+Prisinzanoauthor=O.+M.+Okunolaauthor=T.+Kopajticauthor=M.+Shookauthor=J.+L.+Katzauthor=A.+H.+Newman&title=SARs+at+the+Monoamine+Transporters+for+a+Novel+Series+of+Modafinil+Analogues&doi=10.1021%2Fml1002025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">SARs at the Monoamine Transporters for a Novel Series of Modafinil Analogues</span></div><div class="casAuthors">Cao, Jianjing; Prisinzano, Thomas E.; Okunola, Oluyomi M.; Kopajtic, Theresa; Shook, Matthew; Katz, Jonathan L.; Hauck Newman, Amy</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">48-52</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of modafinil (1) analogs were synthesized wherein (1) para-halo-substitutents were added to the aryl rings, (2) the sulfoxide function was removed, and (3) the primary amide group was replaced with secondary and tertiary amides and amines to investigate the effects of these chem. modifications on dopamine transporter, serotonin transporter, and norepinephrine transporter binding.  In addn., the locomotor-stimulant effects in mice of (±)-modafinil (1) (I), its R- and S-enantiomers, and its para-chloro sulfinylacetamide analog (5c) (II) were compared to those of cocaine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDr9ac-J7nqbVg90H21EOLACvtfcHk0lil5CkBh63RPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht12lt7bN&md5=660e546e8524b2e5e8b448ee5bf0e567</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fml1002025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml1002025%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DPrisinzano%26aufirst%3DT.%2BE.%26aulast%3DOkunola%26aufirst%3DO.%2BM.%26aulast%3DKopajtic%26aufirst%3DT.%26aulast%3DShook%26aufirst%3DM.%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DSARs%2520at%2520the%2520Monoamine%2520Transporters%2520for%2520a%2520Novel%2520Series%2520of%2520Modafinil%2520Analogues%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D48%26epage%3D52%26doi%3D10.1021%2Fml1002025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Okunola-Bakare, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopajtic, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loland, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span> </span><span class="NLM_article-title">Elucidation of Structural Elements for Selectivity across Monoamine Transporters: Novel 2-[(Diphenylmethyl)sulfinyl]acetamide (Modafinil) Analogues</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">1000</span><span class="NLM_x">–</span> <span class="NLM_lpage">1013</span><span class="refDoi"> DOI: 10.1021/jm401754x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401754x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslyhtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1000-1013&author=O.+M.+Okunola-Bakareauthor=J.+Caoauthor=T.+Kopajticauthor=J.+L.+Katzauthor=C.+J.+Lolandauthor=L.+Shiauthor=A.+H.+Newman&title=Elucidation+of+Structural+Elements+for+Selectivity+across+Monoamine+Transporters%3A+Novel+2-%5B%28Diphenylmethyl%29sulfinyl%5Dacetamide+%28Modafinil%29+Analogues&doi=10.1021%2Fjm401754x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Elucidation of Structural Elements for Selectivity across Monoamine Transporters: Novel 2-[(Diphenylmethyl)sulfinyl]acetamide (Modafinil) Analogues</span></div><div class="casAuthors">Okunola-Bakare, Oluyomi M.; Cao, Jianjing; Kopajtic, Theresa; Katz, Jonathan L.; Loland, Claus J.; Shi, Lei; Newman, Amy Hauck</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1000-1013</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">2-[(Diphenylmethyl)sulfinyl]acetamide (modafinil, (±)-1) is a unique dopamine uptake inhibitor that binds the dopamine transporter (DAT) differently than cocaine and may have potential for the treatment of psychostimulant abuse.  To further investigate structural requirements for this divergent binding mode, novel thio- and sulfinylacetamide and ethanamine analogs of (±)-1 were synthesized wherein (1) the di-Ph rings were substituted with Me, trifluoromethyl, and halogen substituents and (2) substituents were added to the terminal amide/amine nitrogen.  Halogen substitution of the di-Ph rings of (±)-1 gave several amide analogs with improved binding affinity for DAT and robust selectivity over the serotonin transporter (SERT), whereas affinity improved at SERT over DAT for the p-halo-substituted amine analogs.  Mol. docking studies, using a subset of analogs with DAT and SERT homol. models, and functional data obtained with DAT (A480T) and SERT (T497A) mutants defined a role for TM10 in the substrate/inhibitor S1 binding sites of DAT and SERT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjxRhiOBM-ErVg90H21EOLACvtfcHk0lil5CkBh63RPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslyhtrY%253D&md5=8c9679d83c0101e335bd59867b0c2863</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm401754x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401754x%26sid%3Dliteratum%253Aachs%26aulast%3DOkunola-Bakare%26aufirst%3DO.%2BM.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DKopajtic%26aufirst%3DT.%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26aulast%3DLoland%26aufirst%3DC.%2BJ.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DElucidation%2520of%2520Structural%2520Elements%2520for%2520Selectivity%2520across%2520Monoamine%2520Transporters%253A%2520Novel%25202-%255B%2528Diphenylmethyl%2529sulfinyl%255Dacetamide%2520%2528Modafinil%2529%2520Analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D1000%26epage%3D1013%26doi%3D10.1021%2Fjm401754x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Lewis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prisinzano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dersch, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, K. C.</span><span> </span><span class="NLM_article-title">Further Exploration of 1-{2-[Bis-(4-fluorophenyl)methoxy]ethyl}piperazine (GBR 12909): role of <i>N</i>-Aromatic, <i>N</i>-Heteroaromatic, and 3-Oxygenated <i>N</i>-Phenylpropyl Substituents on Affinity for the Dopamine and Serotonin Transporter</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1385</span><span class="NLM_x">–</span> <span class="NLM_lpage">1389</span><span class="refDoi"> DOI: 10.1016/S0960-894X(03)00108-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1016%2FS0960-894X%2803%2900108-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1385-1389&author=D.+Lewisauthor=Y.+Zhangauthor=T.+Prisinzanoauthor=C.+M.+Derschauthor=R.+B.+Rothmanauthor=A.+E.+Jacobsonauthor=K.+C.+Rice&title=Further+Exploration+of+1-%7B2-%5BBis-%284-fluorophenyl%29methoxy%5Dethyl%7Dpiperazine+%28GBR+12909%29%3A+role+of+N-Aromatic%2C+N-Heteroaromatic%2C+and+3-Oxygenated+N-Phenylpropyl+Substituents+on+Affinity+for+the+Dopamine+and+Serotonin+Transporter&doi=10.1016%2FS0960-894X%2803%2900108-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2803%2900108-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252803%252900108-2%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DPrisinzano%26aufirst%3DT.%26aulast%3DDersch%26aufirst%3DC.%2BM.%26aulast%3DRothman%26aufirst%3DR.%2BB.%26aulast%3DJacobson%26aufirst%3DA.%2BE.%26aulast%3DRice%26aufirst%3DK.%2BC.%26atitle%3DFurther%2520Exploration%2520of%25201-%257B2-%255BBis-%25284-fluorophenyl%2529methoxy%255Dethyl%257Dpiperazine%2520%2528GBR%252012909%2529%253A%2520role%2520of%2520N-Aromatic%252C%2520N-Heteroaromatic%252C%2520and%25203-Oxygenated%2520N-Phenylpropyl%2520Substituents%2520on%2520Affinity%2520for%2520the%2520Dopamine%2520and%2520Serotonin%2520Transporter%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D1385%26epage%3D1389%26doi%3D10.1016%2FS0960-894X%2803%2900108-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Hsin, L.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dersch, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stafford, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glowa, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, K. C.</span><span> </span><span class="NLM_article-title">Development of Long-Acting Dopamine Transporter Ligands as Potential Cocaine-Abuse Therapeutic Agents: Chiral Hydroxyl-Containing Derivatives of 1-[2-[Bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine and 1-[2-(Diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1321</span><span class="NLM_x">–</span> <span class="NLM_lpage">1329</span><span class="refDoi"> DOI: 10.1021/jm010430f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm010430f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtVWlu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=1321-1329&author=L.-W.+Hsinauthor=C.+M.+Derschauthor=M.+H.+Baumannauthor=D.+Staffordauthor=J.+R.+Glowaauthor=R.+B.+Rothmanauthor=A.+E.+Jacobsonauthor=K.+C.+Rice&title=Development+of+Long-Acting+Dopamine+Transporter+Ligands+as+Potential+Cocaine-Abuse+Therapeutic+Agents%3A+Chiral+Hydroxyl-Containing+Derivatives+of+1-%5B2-%5BBis%284-fluorophenyl%29methoxy%5Dethyl%5D-4-%283-phenylpropyl%29piperazine+and+1-%5B2-%28Diphenylmethoxy%29ethyl%5D-4-%283-phenylpropyl%29piperazine&doi=10.1021%2Fjm010430f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Long-Acting Dopamine Transporter Ligands as Potential Cocaine-Abuse Therapeutic Agents: Chiral Hydroxyl-Containing Derivatives of 1-[2-[Bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine and 1-[2-(Diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine</span></div><div class="casAuthors">Hsin, Ling-Wei; Dersch, Christina M.; Baumann, Michael H.; Stafford, David; Glowa, John R.; Rothman, Richard B.; Jacobson, Arthur E.; Rice, Kenner C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1321-1329</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In the search for long-acting agents for the treatment of cocaine abuse, a series of optically pure hydroxylated derivs. of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR 12909) and 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine (GBR 12935) were synthesized and evaluated in vitro and in vivo.  The enantiomers of the 2-hydroxylated analogs displayed substantial enantioselectivity.  The S enantiomers displayed higher dopamine transporter (DAT) affinity and the R enantiomers were found to interact at the serotonin transporter (SERT) with higher affinity.  The two-carbon spacer between the hydroxyl group and the piperazine ring was essential for enantioselectivity, and the length of the alkyl chain between the Ph group and the piperazine ring influenced binding affinity and selectivity for the DAT and SERT.  Phenylethyl analogs had a higher binding affinity for the SERT and a weaker affinity and selectivity for the DAT than the corresponding phenylpropyl analogs.  Thus, (S)-(+)-1-[4-[2-[bis(4-fluorophenyl)methoxy]ethyl]piperazinyl]-3-phenylpropan-2-ol (I) displayed the highest affinity to the DAT, and (S)-(+)-1-[4-[2-(diphenylmethoxy)ethyl]piperazinyl]-3-phenylpropan-2-ol (II) had the highest selectivity.  II is one of the most DAT selective ligands known.  In accord with the in vitro data, I showed greater potency than its (R)-isomer in elevating extracellular dopamine levels in a microdialysis assay and in inhibiting cocaine-maintained responding in rhesus monkeys.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_q2bi-qjXXrVg90H21EOLACvtfcHk0lgWdmh_UPQStA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtVWlu7Y%253D&md5=6e1a7400e69f4183bd83ef377c5d2944</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm010430f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010430f%26sid%3Dliteratum%253Aachs%26aulast%3DHsin%26aufirst%3DL.-W.%26aulast%3DDersch%26aufirst%3DC.%2BM.%26aulast%3DBaumann%26aufirst%3DM.%2BH.%26aulast%3DStafford%26aufirst%3DD.%26aulast%3DGlowa%26aufirst%3DJ.%2BR.%26aulast%3DRothman%26aufirst%3DR.%2BB.%26aulast%3DJacobson%26aufirst%3DA.%2BE.%26aulast%3DRice%26aufirst%3DK.%2BC.%26atitle%3DDevelopment%2520of%2520Long-Acting%2520Dopamine%2520Transporter%2520Ligands%2520as%2520Potential%2520Cocaine-Abuse%2520Therapeutic%2520Agents%253A%2520Chiral%2520Hydroxyl-Containing%2520Derivatives%2520of%25201-%255B2-%255BBis%25284-fluorophenyl%2529methoxy%255Dethyl%255D-4-%25283-phenylpropyl%2529piperazine%2520and%25201-%255B2-%2528Diphenylmethoxy%2529ethyl%255D-4-%25283-phenylpropyl%2529piperazine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D1321%26epage%3D1329%26doi%3D10.1021%2Fjm010430f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Matecka, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dersch, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wojnicki, F. H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glowa, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeVries, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pert, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, K. C.</span><span> </span><span class="NLM_article-title">Heteroaromatic Analogs of 1-[2-(Diphenylmethoxy)ethyl]- and 1-[2-[Bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909) as High-Affinity Dopamine Reuptake Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">705</span><span class="NLM_x">–</span> <span class="NLM_lpage">716</span><span class="refDoi"> DOI: 10.1021/jm9606599</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9606599" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=705-716&author=D.+Mateckaauthor=D.+Lewisauthor=R.+B.+Rothmanauthor=C.+M.+Derschauthor=F.+H.+E.+Wojnickiauthor=J.+R.+Glowaauthor=A.+C.+DeVriesauthor=A.+Pertauthor=K.+C.+Rice&title=Heteroaromatic+Analogs+of+1-%5B2-%28Diphenylmethoxy%29ethyl%5D-+and+1-%5B2-%5BBis%284-fluorophenyl%29methoxy%5Dethyl%5D-4-%283-phenylpropyl%29piperazines+%28GBR+12935+and+GBR+12909%29+as+High-Affinity+Dopamine+Reuptake+Inhibitors&doi=10.1021%2Fjm9606599"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm9606599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9606599%26sid%3Dliteratum%253Aachs%26aulast%3DMatecka%26aufirst%3DD.%26aulast%3DLewis%26aufirst%3DD.%26aulast%3DRothman%26aufirst%3DR.%2BB.%26aulast%3DDersch%26aufirst%3DC.%2BM.%26aulast%3DWojnicki%26aufirst%3DF.%2BH.%2BE.%26aulast%3DGlowa%26aufirst%3DJ.%2BR.%26aulast%3DDeVries%26aufirst%3DA.%2BC.%26aulast%3DPert%26aufirst%3DA.%26aulast%3DRice%26aufirst%3DK.%2BC.%26atitle%3DHeteroaromatic%2520Analogs%2520of%25201-%255B2-%2528Diphenylmethoxy%2529ethyl%255D-%2520and%25201-%255B2-%255BBis%25284-fluorophenyl%2529methoxy%255Dethyl%255D-4-%25283-phenylpropyl%2529piperazines%2520%2528GBR%252012935%2520and%2520GBR%252012909%2529%2520as%2520High-Affinity%2520Dopamine%2520Reuptake%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D705%26epage%3D716%26doi%3D10.1021%2Fjm9606599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Matecka, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radesca, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Costa, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dersch, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Partilla, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pert, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glowa, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wojnicki, F. H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, K. C.</span><span> </span><span class="NLM_article-title">Development of Novel, Potent, and Selective Dopamine Reuptake Inhibitors through Alteration of the Piperazine Ring of 1-[2-(Diphenylmethoxy)ethyl]- and 1-[2-[Bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">4704</span><span class="NLM_x">–</span> <span class="NLM_lpage">4716</span><span class="refDoi"> DOI: 10.1021/jm960305h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm960305h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=4704-4716&author=D.+Mateckaauthor=R.+B.+Rothmanauthor=L.+Radescaauthor=B.+R.+de+Costaauthor=C.+M.+Derschauthor=J.+S.+Partillaauthor=A.+Pertauthor=J.+R.+Glowaauthor=F.+H.+E.+Wojnickiauthor=K.+C.+Rice&title=Development+of+Novel%2C+Potent%2C+and+Selective+Dopamine+Reuptake+Inhibitors+through+Alteration+of+the+Piperazine+Ring+of+1-%5B2-%28Diphenylmethoxy%29ethyl%5D-+and+1-%5B2-%5BBis%284-fluorophenyl%29methoxy%5Dethyl%5D-4-%283-phenylpropyl%29piperazines+%28GBR+12935+and+GBR+12909%29&doi=10.1021%2Fjm960305h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm960305h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm960305h%26sid%3Dliteratum%253Aachs%26aulast%3DMatecka%26aufirst%3DD.%26aulast%3DRothman%26aufirst%3DR.%2BB.%26aulast%3DRadesca%26aufirst%3DL.%26aulast%3Dde%2BCosta%26aufirst%3DB.%2BR.%26aulast%3DDersch%26aufirst%3DC.%2BM.%26aulast%3DPartilla%26aufirst%3DJ.%2BS.%26aulast%3DPert%26aufirst%3DA.%26aulast%3DGlowa%26aufirst%3DJ.%2BR.%26aulast%3DWojnicki%26aufirst%3DF.%2BH.%2BE.%26aulast%3DRice%26aufirst%3DK.%2BC.%26atitle%3DDevelopment%2520of%2520Novel%252C%2520Potent%252C%2520and%2520Selective%2520Dopamine%2520Reuptake%2520Inhibitors%2520through%2520Alteration%2520of%2520the%2520Piperazine%2520Ring%2520of%25201-%255B2-%2528Diphenylmethoxy%2529ethyl%255D-%2520and%25201-%255B2-%255BBis%25284-fluorophenyl%2529methoxy%255Dethyl%255D-4-%25283-phenylpropyl%2529piperazines%2520%2528GBR%252012935%2520and%2520GBR%252012909%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D4704%26epage%3D4716%26doi%3D10.1021%2Fjm960305h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Lewis, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matecka, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span> </span><span class="NLM_article-title">Oxygenated Analogues of 1-[2-(Diphenylmethoxy)ethyl]- and 1-[2-[Bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909) as Potential Extended-Action Cocaine-Abuse Therapeutic Agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">5029</span><span class="NLM_x">–</span> <span class="NLM_lpage">5042</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm990291q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=5029-5042&author=D.+B.+Lewisauthor=D.+Mateckaauthor=Y.+Zhang&title=Oxygenated+Analogues+of+1-%5B2-%28Diphenylmethoxy%29ethyl%5D-+and+1-%5B2-%5BBis%284-fluorophenyl%29methoxy%5Dethyl%5D-4-%283-phenylpropyl%29piperazines+%28GBR+12935+and+GBR+12909%29+as+Potential+Extended-Action+Cocaine-Abuse+Therapeutic+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm990291q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990291q%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DD.%2BB.%26aulast%3DMatecka%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DOxygenated%2520Analogues%2520of%25201-%255B2-%2528Diphenylmethoxy%2529ethyl%255D-%2520and%25201-%255B2-%255BBis%25284-fluorophenyl%2529methoxy%255Dethyl%255D-4-%25283-phenylpropyl%2529piperazines%2520%2528GBR%252012935%2520and%2520GBR%252012909%2529%2520as%2520Potential%2520Extended-Action%2520Cocaine-Abuse%2520Therapeutic%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D5029%26epage%3D5042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Lewis, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matecka, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsin, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dersch, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stafford, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glowa, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, K. C.</span><span> </span><span class="NLM_article-title">Oxygenated Analogues of 1-[2-(Diphenylmethoxy)ethyl]- and 1-[2-[Bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909) as Potential Extended-Action Cocaine-Abuse Therapeutic Agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">5029</span><span class="NLM_x">–</span> <span class="NLM_lpage">5042</span><span class="refDoi"> DOI: 10.1021/jm990291q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990291q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=5029-5042&author=D.+B.+Lewisauthor=D.+Mateckaauthor=Y.+Zhangauthor=L.+W.+Hsinauthor=C.+M.+Derschauthor=D.+Staffordauthor=J.+R.+Glowaauthor=R.+B.+Rothmanauthor=K.+C.+Rice&title=Oxygenated+Analogues+of+1-%5B2-%28Diphenylmethoxy%29ethyl%5D-+and+1-%5B2-%5BBis%284-fluorophenyl%29methoxy%5Dethyl%5D-4-%283-phenylpropyl%29piperazines+%28GBR+12935+and+GBR+12909%29+as+Potential+Extended-Action+Cocaine-Abuse+Therapeutic+Agents&doi=10.1021%2Fjm990291q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm990291q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990291q%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DD.%2BB.%26aulast%3DMatecka%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DHsin%26aufirst%3DL.%2BW.%26aulast%3DDersch%26aufirst%3DC.%2BM.%26aulast%3DStafford%26aufirst%3DD.%26aulast%3DGlowa%26aufirst%3DJ.%2BR.%26aulast%3DRothman%26aufirst%3DR.%2BB.%26aulast%3DRice%26aufirst%3DK.%2BC.%26atitle%3DOxygenated%2520Analogues%2520of%25201-%255B2-%2528Diphenylmethoxy%2529ethyl%255D-%2520and%25201-%255B2-%255BBis%25284-fluorophenyl%2529methoxy%255Dethyl%255D-4-%25283-phenylpropyl%2529piperazines%2520%2528GBR%252012935%2520and%2520GBR%252012909%2529%2520as%2520Potential%2520Extended-Action%2520Cocaine-Abuse%2520Therapeutic%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D5029%26epage%3D5042%26doi%3D10.1021%2Fjm990291q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Rothman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mele, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akunne, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greig, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thurkauf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Costa, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pert, A.</span><span> </span><span class="NLM_article-title">GBR12909 Antagonizes the Ability of Cocaine to Elevate Extracellular Levels of Dopamine</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">397</span><span class="refDoi"> DOI: 10.1016/0091-3057(91)90570-R</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1016%2F0091-3057%2891%2990570-R" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1839568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADyaK38XhsFOgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1991&pages=387-397&author=R.+B.+Rothmanauthor=A.+Meleauthor=A.+A.+Reidauthor=H.+C.+Akunneauthor=N.+Greigauthor=A.+Thurkaufauthor=B.+R.+de+Costaauthor=K.+C.+Riceauthor=A.+Pert&title=GBR12909+Antagonizes+the+Ability+of+Cocaine+to+Elevate+Extracellular+Levels+of+Dopamine&doi=10.1016%2F0091-3057%2891%2990570-R"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">GBR12909 antagonizes the ability of cocaine to elevate extracellular levels of dopamine</span></div><div class="casAuthors">Rothman, Richard B.; Mele, Andrea; Reid, Audrey A.; Akunne, Hyacinth C.; Greig, Nigel; Thurkauf, Andrew; De Costa, Brian R.; Rice, Kenner C.; Pert, Agu</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology, Biochemistry and Behavior</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">387-97</span>CODEN:
                <span class="NLM_cas:coden">PBBHAU</span>;
        ISSN:<span class="NLM_cas:issn">0091-3057</span>.
    </div><div class="casAbstract">Rats were administered various i.p. doses of the high-affinity dopamine (DA) reuptake inhibitor GBR12909.  The brain caudate nuclei were removed 60 min after drug administration and striatal membranes were prepd.  GBR12909 produced a dose-dependent decrease in the binding of [3H]GBR12935 to the DA transporter (ED50∼ 10 mg/kg).  Satn. binding studies with [3H]GBR12935 showed that this was due to increased residual drug, and decreased Bmax.  At 25 mg/kg i.p., GBR12909 produced a 50% decrease in Bmax and a 3.4-fold increase in Kd.  In microdialysis studies, GBR12909 (25 mg/kg i.p.) produced a modest, long-lasting, and stable elevation of extracellular DA.  Administration of cocaine through the microdialysis probe to rats pretreated with saline or GBR12909 (25 mg/kg i.p.) produced a dose-dependent increase in extracellular DA in both groups.  GBR12909 inhibited the cocaine-induced increases in extracellular DA by ∼ 50% at all doses.  At a dose sufficient to decrease by 50% the Bmax of [3H]GBR12935 binding sites, GBR12909 antagonizes the ability of cocaine to elevate extracellular DA by 50%.  GBR12909 may have a use in the medical treatment of cocaine addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdR8WIxCGwGbVg90H21EOLACvtfcHk0ljrpQ-oe5OLuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XhsFOgtQ%253D%253D&md5=d79867ab017e0a9837f8f074318636e7</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2F0091-3057%2891%2990570-R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0091-3057%252891%252990570-R%26sid%3Dliteratum%253Aachs%26aulast%3DRothman%26aufirst%3DR.%2BB.%26aulast%3DMele%26aufirst%3DA.%26aulast%3DReid%26aufirst%3DA.%2BA.%26aulast%3DAkunne%26aufirst%3DH.%2BC.%26aulast%3DGreig%26aufirst%3DN.%26aulast%3DThurkauf%26aufirst%3DA.%26aulast%3Dde%2BCosta%26aufirst%3DB.%2BR.%26aulast%3DRice%26aufirst%3DK.%2BC.%26aulast%3DPert%26aufirst%3DA.%26atitle%3DGBR12909%2520Antagonizes%2520the%2520Ability%2520of%2520Cocaine%2520to%2520Elevate%2520Extracellular%2520Levels%2520of%2520Dopamine%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1991%26volume%3D40%26spage%3D387%26epage%3D397%26doi%3D10.1016%2F0091-3057%2891%2990570-R" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopajtic, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span> </span><span class="NLM_article-title">Dual DAT/σ1 Receptor Ligands Based on 3-(4-(3-(Bis(4-fluorophenyl)amino)propyl)piperazin-1-yl)-1-phenylpropan-1-ol</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5238</span><span class="NLM_x">–</span> <span class="NLM_lpage">5241</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2008.08.065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1016%2Fj.bmcl.2008.08.065" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5238-5241&author=J.+Caoauthor=T.+Kopajticauthor=J.+L.+Katzauthor=A.+H.+Newman&title=Dual+DAT%2F%CF%831+Receptor+Ligands+Based+on+3-%284-%283-%28Bis%284-fluorophenyl%29amino%29propyl%29piperazin-1-yl%29-1-phenylpropan-1-ol&doi=10.1016%2Fj.bmcl.2008.08.065"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.08.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.08.065%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DKopajtic%26aufirst%3DT.%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DDual%2520DAT%252F%25CF%25831%2520Receptor%2520Ligands%2520Based%2520on%25203-%25284-%25283-%2528Bis%25284-fluorophenyl%2529amino%2529propyl%2529piperazin-1-yl%2529-1-phenylpropan-1-ol%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5238%26epage%3D5241%26doi%3D10.1016%2Fj.bmcl.2008.08.065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulkarni, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Husbands, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowen, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopajtic, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span> </span><span class="NLM_article-title">Dual Probes for the Dopamine Transporter and σ1 Receptors: Novel Piperazinyl Alkyl-bis(4′-fluorophenyl)amine Analogues as Potential Cocaine-Abuse Therapeutic Agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2589</span><span class="NLM_x">–</span> <span class="NLM_lpage">2598</span><span class="refDoi"> DOI: 10.1021/jm030008u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030008u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=2589-2598&author=J.+Caoauthor=S.+S.+Kulkarniauthor=S.+M.+Husbandsauthor=W.+D.+Bowenauthor=W.+Williamsauthor=T.+Kopajticauthor=J.+L.+Katzauthor=C.+Georgeauthor=A.+H.+Newman&title=Dual+Probes+for+the+Dopamine+Transporter+and+%CF%831+Receptors%3A+Novel+Piperazinyl+Alkyl-bis%284%E2%80%B2-fluorophenyl%29amine+Analogues+as+Potential+Cocaine-Abuse+Therapeutic+Agents&doi=10.1021%2Fjm030008u"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm030008u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030008u%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DKulkarni%26aufirst%3DS.%2BS.%26aulast%3DHusbands%26aufirst%3DS.%2BM.%26aulast%3DBowen%26aufirst%3DW.%2BD.%26aulast%3DWilliams%26aufirst%3DW.%26aulast%3DKopajtic%26aufirst%3DT.%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26aulast%3DGeorge%26aufirst%3DC.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DDual%2520Probes%2520for%2520the%2520Dopamine%2520Transporter%2520and%2520%25CF%25831%2520Receptors%253A%2520Novel%2520Piperazinyl%2520Alkyl-bis%25284%25E2%2580%25B2-fluorophenyl%2529amine%2520Analogues%2520as%2520Potential%2520Cocaine-Abuse%2520Therapeutic%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D2589%26epage%3D2598%26doi%3D10.1021%2Fjm030008u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Husbands, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izenwasser, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopajtic, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowen, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilner, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span> </span><span class="NLM_article-title">Structure–Activity Relationships at the Monoamine Transporters and σ Receptors for a Novel Series of 9-[3-(<i>cis</i>-3,5-Dimethyl-1-piperazinyl)-propyl]carbazole (Rimcazole) Analogues</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">4446</span><span class="NLM_x">–</span> <span class="NLM_lpage">4455</span><span class="refDoi"> DOI: 10.1021/jm9902943</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9902943" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=4446-4455&author=S.+M.+Husbandsauthor=S.+Izenwasserauthor=T.+Kopajticauthor=W.+D.+Bowenauthor=B.+J.+Vilnerauthor=J.+L.+Katzauthor=A.+H.+Newman&title=Structure%E2%80%93Activity+Relationships+at+the+Monoamine+Transporters+and+%CF%83+Receptors+for+a+Novel+Series+of+9-%5B3-%28cis-3%2C5-Dimethyl-1-piperazinyl%29-propyl%5Dcarbazole+%28Rimcazole%29+Analogues&doi=10.1021%2Fjm9902943"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm9902943&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9902943%26sid%3Dliteratum%253Aachs%26aulast%3DHusbands%26aufirst%3DS.%2BM.%26aulast%3DIzenwasser%26aufirst%3DS.%26aulast%3DKopajtic%26aufirst%3DT.%26aulast%3DBowen%26aufirst%3DW.%2BD.%26aulast%3DVilner%26aufirst%3DB.%2BJ.%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DStructure%25E2%2580%2593Activity%2520Relationships%2520at%2520the%2520Monoamine%2520Transporters%2520and%2520%25CF%2583%2520Receptors%2520for%2520a%2520Novel%2520Series%2520of%25209-%255B3-%2528cis-3%252C5-Dimethyl-1-piperazinyl%2529-propyl%255Dcarbazole%2520%2528Rimcazole%2529%2520Analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D4446%26epage%3D4455%26doi%3D10.1021%2Fjm9902943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Husbands, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izenwasser, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loeloff, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowen, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilner, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span> </span><span class="NLM_article-title">Isothiocyanate Derivatives of 9-[3-(<i>cis</i>-3,5-Dimethyl-1-piperazinyl)propyl]-carbazole (Rimcazole): Irreversible Ligands for the Dopamine Transporter</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">4340</span><span class="NLM_x">–</span> <span class="NLM_lpage">4346</span><span class="refDoi"> DOI: 10.1021/jm9705519</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9705519" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADyaK1cXjtFKlug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=4340-4346&author=S.+M.+Husbandsauthor=S.+Izenwasserauthor=R.+J.+Loeloffauthor=J.+L.+Katzauthor=W.+D.+Bowenauthor=B.+J.+Vilnerauthor=A.+H.+Newman&title=Isothiocyanate+Derivatives+of+9-%5B3-%28cis-3%2C5-Dimethyl-1-piperazinyl%29propyl%5D-carbazole+%28Rimcazole%29%3A+Irreversible+Ligands+for+the+Dopamine+Transporter&doi=10.1021%2Fjm9705519"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Isothiocyanate derivatives of 9-[3-(cis-3,5-dimethyl-1-piperazinyl)propyl]carbazole (Rimcazole): irreversible ligands for the dopamine transporter</span></div><div class="casAuthors">Husbands, Stephen M.; Izenwasser, Sari; Loeloff, Richard J.; Katz, Jonathan L.; Bowen, Wayne D.; Vilner, Bertold J.; Newman, Amy Hauck</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">4340-4346</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cocaine has been reported to bind to the dopamine transporter in a biphasic fashion, and the low-affinity component may play a modulatory role in cocaine's psychomotor stimulant effects.  To study this further, the authors have prepd. a series of irreversible ligands based on rimcazole [I; 9-[3-(cis-3,5-dimethyl-1-piperazinyl)propyl]carbazole], a compd. that has been postulated to bind only to the low-affinity site.  The alkylating moiety, isothiocyanate, is attached to the distal nitrogen of the piperazine ring via alkyl chains of varying lengths or directly attached to one of the arom. groups.  It was found that substitution on the piperazine nitrogen caused an initial decrease in affinity that was recovered as the alkyl chain length increased.  Isothiocyanate deriv. II of rimcazole, with the highest affinity for the dopamine transporter (DAT), binds in a monophasic and irreversible manner, as evidenced by the greatly diminished binding of [3H]WIN 35,428 in tissue that had been preincubated with the ligand and then thoroughly washed using centrifugation.  The dose-dependent redn. in Bmax was accompanied by a concn.-related decrease in KD values.  This shift in KD to a lower value suggests that the preincubation with isothiocyanate II produced a preferential irreversible binding to the low-affinity [3H]WIN 35,428 site on the dopamine transporter.  These ligands may prove to be important tools with which to study the significance of the low-affinity site on the DAT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJm0uovk7Z7LVg90H21EOLACvtfcHk0lgLUCs13bdwlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjtFKlug%253D%253D&md5=b3d7f07a10569ea9be26b9bd324c4b31</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm9705519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9705519%26sid%3Dliteratum%253Aachs%26aulast%3DHusbands%26aufirst%3DS.%2BM.%26aulast%3DIzenwasser%26aufirst%3DS.%26aulast%3DLoeloff%26aufirst%3DR.%2BJ.%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26aulast%3DBowen%26aufirst%3DW.%2BD.%26aulast%3DVilner%26aufirst%3DB.%2BJ.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DIsothiocyanate%2520Derivatives%2520of%25209-%255B3-%2528cis-3%252C5-Dimethyl-1-piperazinyl%2529propyl%255D-carbazole%2520%2528Rimcazole%2529%253A%2520Irreversible%2520Ligands%2520for%2520the%2520Dopamine%2520Transporter%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D4340%26epage%3D4346%26doi%3D10.1021%2Fjm9705519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Hiranita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohut, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopajtic, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanda, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, J. L.</span><span> </span><span class="NLM_article-title">Decreases in Cocaine Self-Administration with Dual Inhibition of the Dopamine Transporter and σ Receptors</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">339</span><span class="NLM_x">, </span> <span class="NLM_fpage">662</span><span class="NLM_x">–</span> <span class="NLM_lpage">677</span><span class="refDoi"> DOI: 10.1124/jpet.111.185025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1124%2Fjpet.111.185025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFehtbvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=2011&pages=662-677&author=T.+Hiranitaauthor=P.+L.+Sotoauthor=S.+J.+Kohutauthor=T.+Kopajticauthor=J.+Caoauthor=A.+H.+Newmanauthor=G.+Tandaauthor=J.+L.+Katz&title=Decreases+in+Cocaine+Self-Administration+with+Dual+Inhibition+of+the+Dopamine+Transporter+and+%CF%83+Receptors&doi=10.1124%2Fjpet.111.185025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Decreases in cocaine self-administration with dual inhibition of the dopamine transporter and σ receptors</span></div><div class="casAuthors">Hiranita, Takato; Soto, Paul L.; Kohut, Stephen J.; Kopajtic, Theresa; Cao, Jianjing; Newman, Amy H.; Tanda, Gianluigi; Katz, Jonathan L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">339</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">662-677</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Sigma receptor (σR) antagonists attenuate many behavioral effects of cocaine but typically not its reinforcing effects in self-administration procedures.  However, the σR antagonist rimcazole and its N-propylphenyl analogs, [3-(cis-3,5-dimethyl-4-[3-phenylpropyl]-1-piperazinyl)-propyl]diphenylamine hydrochloride (SH 3-24) and 9-[3-(cis-3,5-dimethyl-4-[3-phenylpropyl]-1-piperazinyl)-propyl]carbazole hydrobromide (SH 3-28), dose-dependently decreased the maximal rates of cocaine self-administration without affecting comparable responding maintained by food reinforcement.  In contrast, a variety of σR antagonists [N-phenethylpiperidine oxalate (AC927), N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1-pyrrolidinyl)ethylamine dihydrobromide (BD 1008), N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(dimethylamino) ethylamine dihydrobromide (BD 1047), N-[2-(3,4-dichlorophenyl) ethyl]-4-methylpiperazine dihydrochloride (BD 1063), and N,N-dipropyl-2-[4-methoxy-3-(2-phenylethoxy)phenyl]-ethylamine monohydrochloride (NE-100)] had no effect on cocaine self-administration across the range of doses that decreased rates of food-maintained responding.  Rimcazole analogs differed from selective σR antagonists in their dual affinities for σRs and the dopamine transporter (DAT) assessed with radioligand binding.  Selective DAT inhibitors and σR antagonists were studied alone and in combination on cocaine self-administration to det. whether actions at both σRs and the DAT were sufficient to reproduce the effects of rimcazole analogs.  Typical DAT inhibitors [2β-carbomethoxy-3β-(4-fluorophenyl)tropane (WIN 35,428), methylphenidate, and nomifensine] dose-dependently shifted the cocaine dose-effect curve leftward.  Combinations of DAT inhibitor and σR antagonist doses that were behaviorally inactive alone decreased cocaine self-administration without effects on food-maintained responding.  In addn., whereas the DAT inhibitors were self-administered at rates similar to those of cocaine, neither rimcazole analogs nor typical σR antagonists (NE-100 and AC927) maintained responding above control levels across a wide range of doses.  These findings suggest that the unique effects of rimcazole analogs are due to dual actions at the DAT and σRs and that a combined target approach may have utility in development of medical treatments for cocaine abuse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs0gcxwJwV_LVg90H21EOLACvtfcHk0lgLUCs13bdwlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFehtbvJ&md5=7be9d75e9be58be204e9f89e672f4a5a</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1124%2Fjpet.111.185025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.111.185025%26sid%3Dliteratum%253Aachs%26aulast%3DHiranita%26aufirst%3DT.%26aulast%3DSoto%26aufirst%3DP.%2BL.%26aulast%3DKohut%26aufirst%3DS.%2BJ.%26aulast%3DKopajtic%26aufirst%3DT.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DTanda%26aufirst%3DG.%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26atitle%3DDecreases%2520in%2520Cocaine%2520Self-Administration%2520with%2520Dual%2520Inhibition%2520of%2520the%2520Dopamine%2520Transporter%2520and%2520%25CF%2583%2520Receptors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D339%26spage%3D662%26epage%3D677%26doi%3D10.1124%2Fjpet.111.185025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Katz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiranita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopajtic, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesangeau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayanan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdelazeem, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCurdy, C. R.</span><span> </span><span class="NLM_article-title">Blockade of Cocaine or σ Receptor Agonist Self Administration by Subtype-Selective σ Receptor Antagonists</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">358</span><span class="NLM_x">, </span> <span class="NLM_fpage">109</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span><span class="refDoi"> DOI: 10.1124/jpet.116.232728</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1124%2Fjpet.116.232728" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=27189970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFOhsLnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=2016&pages=109-124&author=J.+L.+Katzauthor=T.+Hiranitaauthor=T.+A.+Kopajticauthor=K.+C.+Riceauthor=C.+Mesangeauauthor=S.+Narayananauthor=A.+H.+Abdelazeemauthor=C.+R.+McCurdy&title=Blockade+of+Cocaine+or+%CF%83+Receptor+Agonist+Self+Administration+by+Subtype-Selective+%CF%83+Receptor+Antagonists&doi=10.1124%2Fjpet.116.232728"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Blockade of cocaine or σ receptor agonist self administration by subtype-selective σ receptor antagonists</span></div><div class="casAuthors">Katz, Jonathan L.; Hiranita, Takato; Kopajtic, Theresa A.; Rice, Kenner C.; Mesangeau, Christophe; Narayanan, Sanju; Abdelazeem, Ahmed H.; McCurdy, Christopher R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">358</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">109-124</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The identification of sigma receptor (σR) subtypes has been based on radioligand binding and, despite progress with σ1R cellular function, less is known about σR subtype functions in vivo.  Recent findings that cocaine self administration experience will trigger σR agonist self administration was used in this study to assess the in vivo receptor subtype specificity of the agonists (1)-pentazocine, PRE-084 [2-(4-morpholinethyl) 1-phenylcyclohexanecarboxylate hydrochloride], and 1,3-di-o-tolylguanidine (DTG) and several novel putative σR antagonists.  Radioligand binding studies detd. in vitro σR selectivity of the novel compds., which were subsequently studied for self administration and antagonism of cocaine, (1)-pentazocine, PRE-084, or DTG self administration.  Across the dose ranges studied, none of the novel compds. were self administered, nor did they alter cocaine self administration.  All compds. blocked DTG self administration, with a subset also blocking (1)-pentazocine and PRE-084 self administration.  The most selective of the compds. in binding σ1Rs blocked cocaine self administration when combined with a dopamine transport inhibitor, either methylphenidate or nomifensine.  These drug combinations did not decrease rates of responding maintained by food reinforcement.  In contrast, the most selective of the compds. in binding σ2Rs had no effect on cocaine self administration in combination with either dopamine transport inhibitor.  Thus, these results identify subtype-specific in vivo antagonists, and the utility of σR agonist substitution for cocaine self administration as an assay capable of distinguishing σR subtype selectivity in vivo.  These results further suggest that effectiveness of dual σR antagonism and dopamine transport inhibition in blocking cocaine self administration is specific for σ1Rs and further support this dual targeting approach to development of cocaine antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqz4jCUfp7CsLVg90H21EOLACvtfcHk0ljFG8DV5rQFeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFOhsLnK&md5=721dfe4db5a272382b8c6a50b1dda748</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1124%2Fjpet.116.232728&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.116.232728%26sid%3Dliteratum%253Aachs%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26aulast%3DHiranita%26aufirst%3DT.%26aulast%3DKopajtic%26aufirst%3DT.%2BA.%26aulast%3DRice%26aufirst%3DK.%2BC.%26aulast%3DMesangeau%26aufirst%3DC.%26aulast%3DNarayanan%26aufirst%3DS.%26aulast%3DAbdelazeem%26aufirst%3DA.%2BH.%26aulast%3DMcCurdy%26aufirst%3DC.%2BR.%26atitle%3DBlockade%2520of%2520Cocaine%2520or%2520%25CF%2583%2520Receptor%2520Agonist%2520Self%2520Administration%2520by%2520Subtype-Selective%2520%25CF%2583%2520Receptor%2520Antagonists%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2016%26volume%3D358%26spage%3D109%26epage%3D124%26doi%3D10.1124%2Fjpet.116.232728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Katz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiranita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, T.-P.</span><span> </span><span class="NLM_article-title">A Role for Sigma Receptors in Stimulant Self-Administration and Addiction</span> <span class="citation_source-journal">Behav. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">100</span><span class="NLM_x">–</span> <span class="NLM_lpage">115</span><span class="refDoi"> DOI: 10.1097/FBP.0000000000000209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1097%2FFBP.0000000000000209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=26650253" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BC28XktVOht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2016&pages=100-115&author=J.+L.+Katzauthor=W.+C.+Hongauthor=T.+Hiranitaauthor=T.-P.+Su&title=A+Role+for+Sigma+Receptors+in+Stimulant+Self-Administration+and+Addiction&doi=10.1097%2FFBP.0000000000000209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">A role for sigma receptors in stimulant self-administration and addiction</span></div><div class="casAuthors">Katz, Jonathan L.; Hong, Weimin C.; Hiranita, Takato; Su, Tsung-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Behavioural Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2 and 3</span>),
    <span class="NLM_cas:pages">100-115</span>CODEN:
                <span class="NLM_cas:coden">BPHAEL</span>;
        ISSN:<span class="NLM_cas:issn">0955-8810</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  Sigma-1 receptors (σ1Rs) are structurally unique intracellular proteins that function as chaperones. σ1Rs translocate from the mitochondria-assocd. membrane to other subcellular compartments, and can influence a host of targets, including ion channels, G-protein-coupled receptors, lipids, and other signaling proteins.  Drugs binding to σRs can induce or block the actions of σRs.  Studies indicate that stimulant self-administration induces the reinforcing effects of σR agonists, because of dopamine transporter actions.  Once established, the reinforcing effects of σR agonists are independent of dopaminergic mechanisms traditionally thought to be crit. to the reinforcing effects of stimulants.  Self-administered doses of σR agonists do not increase dopamine concns. in the nucleus accumbens shell, a transmitter and brain region considered important for the reinforcing effects of abused drugs.  However, self-administration of σR agonists is blocked by σR antagonists.  Several effects of stimulants have been blocked by σR antagonists, including the reinforcing effects, assessed by a place-conditioning procedure.  However, the self-administration of stimulants is largely unaffected by σR antagonists, indicating fundamental differences in the mechanisms underlying these two procedures used to assess the reinforcing effects.  When σR antagonists are administered in combination with dopamine uptake inhibitors, an effective and specific blockade of stimulant self-administration is obtained.  Actions of stimulant drugs related to their abuse induce unique changes in σR activity and the changes induced potentially create redundant and, once established, independent reinforcement pathways.  Concomitant targeting of both dopaminergic pathways and σR proteins produces a selective antagonism of stimulant self-administration, suggesting new avenues for combination chemotherapies to specifically combat stimulant abuse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozieYVfrbwdLVg90H21EOLACvtfcHk0ljFG8DV5rQFeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktVOht7o%253D&md5=262279d7e148fade608c21d7c6f87704</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1097%2FFBP.0000000000000209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FFBP.0000000000000209%26sid%3Dliteratum%253Aachs%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26aulast%3DHong%26aufirst%3DW.%2BC.%26aulast%3DHiranita%26aufirst%3DT.%26aulast%3DSu%26aufirst%3DT.-P.%26atitle%3DA%2520Role%2520for%2520Sigma%2520Receptors%2520in%2520Stimulant%2520Self-Administration%2520and%2520Addiction%26jtitle%3DBehav.%2520Pharmacol.%26date%3D2016%26volume%3D27%26spage%3D100%26epage%3D115%26doi%3D10.1097%2FFBP.0000000000000209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Rothman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prisinzano, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span> </span><span class="NLM_article-title">Dopamine Transport Inhibitors Based on GBR12909 and Benztropine as Potential Medications to Treat Cocaine Addiction</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span><span class="refDoi"> DOI: 10.1016/j.bcp.2007.08.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1016%2Fj.bcp.2007.08.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=17897630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVCksLjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2008&pages=2-16&author=R.+B.+Rothmanauthor=M.+H.+Baumannauthor=T.+E.+Prisinzanoauthor=A.+H.+Newman&title=Dopamine+Transport+Inhibitors+Based+on+GBR12909+and+Benztropine+as+Potential+Medications+to+Treat+Cocaine+Addiction&doi=10.1016%2Fj.bcp.2007.08.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine transport inhibitors based on GBR12909 and benztropine as potential medications to treat cocaine addiction</span></div><div class="casAuthors">Rothman, Richard B.; Baumann, Michael H.; Prisinzano, Thomas E.; Newman, Amy Hauck</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2-16</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The discovery and development of medications to treat addiction and notably, cocaine addiction, have been frustrated by both the complexity of the disorder and the lack of target validation in human subjects.  The dopamine transporter has historically been a primary target for cocaine abuse medication development, but addictive liability and other confounds of such inhibitors of dopamine uptake have limited clin. evaluation and validation.  Herein we describe efforts to develop analogs of the dopamine uptake inhibitors GBR 12909 and benztropine that show promising profiles in animal models of cocaine abuse that contrast to that of cocaine.  Their unique pharmacol. profiles have provided important insights into the reinforcing actions of cocaine and we propose that clin. investigation of novel dopamine uptake inhibitors will facilitate the discovery of cocaine-abuse medications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyk01dVAiBsLVg90H21EOLACvtfcHk0lh77rR8tR3K-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVCksLjK&md5=98fbd67bb986dc0557788d219a760a80</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2007.08.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2007.08.007%26sid%3Dliteratum%253Aachs%26aulast%3DRothman%26aufirst%3DR.%2BB.%26aulast%3DBaumann%26aufirst%3DM.%2BH.%26aulast%3DPrisinzano%26aufirst%3DT.%2BE.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DDopamine%2520Transport%2520Inhibitors%2520Based%2520on%2520GBR12909%2520and%2520Benztropine%2520as%2520Potential%2520Medications%2520to%2520Treat%2520Cocaine%2520Addiction%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2008%26volume%3D75%26spage%3D2%26epage%3D16%26doi%3D10.1016%2Fj.bcp.2007.08.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Loland, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, M.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerstbrein, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sitte, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gether, U.</span><span> </span><span class="NLM_article-title">Relationship between Conformational Changes in the Dopamine Transporter and Cocaine-Like Subjective Effects of Uptake Inhibitors</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">813</span><span class="NLM_x">–</span> <span class="NLM_lpage">823</span><span class="refDoi"> DOI: 10.1124/mol.107.039800</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1124%2Fmol.107.039800" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=17978168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjt1egs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=813-823&author=C.+J.+Lolandauthor=R.+I.+Desaiauthor=M.-F.+Zouauthor=J.+Caoauthor=P.+Grundtauthor=K.+Gerstbreinauthor=H.+H.+Sitteauthor=A.+H.+Newmanauthor=J.+L.+Katzauthor=U.+Gether&title=Relationship+between+Conformational+Changes+in+the+Dopamine+Transporter+and+Cocaine-Like+Subjective+Effects+of+Uptake+Inhibitors&doi=10.1124%2Fmol.107.039800"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Relationship between conformational changes in the dopamine transporter and cocaine-like subjective effects of uptake inhibitors</span></div><div class="casAuthors">Loland, Claus J.; Desai, Rajeev I.; Zou, Mu-Fa; Cao, Jianjing; Grundt, Peter; Gerstbrein, Klaus; Sitte, Harald H.; Newman, Amy Hauck; Katz, Jonathan L.; Gether, Ulrik</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">813-823</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Cocaine exerts its stimulatory effect by inhibiting the dopamine transporter (DAT).  However, novel benztropine- and rimcazole-based inhibitors show reduced stimulant effects compared with cocaine, despite higher affinity and selectivity for DAT.  To investigate possible mechanisms, we compared the subjective effects of different inhibitors with their mol. mode of interaction at the DAT.  We detd. how different inhibitors affected accessibility of the sulfhydryl-reactive reagent [2-(trimethylammonium)ethyl]-methanethiosulfonate to an inserted cysteine (I159C), which is accessible when the extracellular transporter gate is open but inaccessible when it is closed.  The data indicated that cocaine analogs bind an open conformation, whereas benztropine and rimcazole analogs bind a closed conformation.  Next, we investigated the changes in inhibition potency of [3H]dopamine uptake of the compds. at a mutant DAT (Y335A) characterized by a global change in the conformational equil.  We obsd. a close relationship between the decrease in potencies of inhibitors at this mutant and cocaine-like responding in rats trained to discriminate cocaine from saline injections.  Our data suggest that chem. different DAT inhibitors stabilize distinct transporter conformations and that this in turn affects the cocaine-like subjective effects of these compds. in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryV1skqbjuE7Vg90H21EOLACvtfcHk0lh77rR8tR3K-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjt1egs7Y%253D&md5=3371614fa985881d76d801d8d07442cf</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1124%2Fmol.107.039800&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.107.039800%26sid%3Dliteratum%253Aachs%26aulast%3DLoland%26aufirst%3DC.%2BJ.%26aulast%3DDesai%26aufirst%3DR.%2BI.%26aulast%3DZou%26aufirst%3DM.-F.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DGrundt%26aufirst%3DP.%26aulast%3DGerstbrein%26aufirst%3DK.%26aulast%3DSitte%26aufirst%3DH.%2BH.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26aulast%3DGether%26aufirst%3DU.%26atitle%3DRelationship%2520between%2520Conformational%2520Changes%2520in%2520the%2520Dopamine%2520Transporter%2520and%2520Cocaine-Like%2520Subjective%2520Effects%2520of%2520Uptake%2520Inhibitors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2008%26volume%3D73%26spage%3D813%26epage%3D823%26doi%3D10.1124%2Fmol.107.039800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Beuming, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kniazeff, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergmann, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gracia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raniszewska, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javitch, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gether, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loland, C. J.</span><span> </span><span class="NLM_article-title">The Binding Sites for Cocaine and Dopamine in the Dopamine Transporter Overlap</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">780</span><span class="NLM_x">–</span> <span class="NLM_lpage">789</span><span class="refDoi"> DOI: 10.1038/nn.2146</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1038%2Fnn.2146" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=18568020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BD1cXns1Omsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2008&pages=780-789&author=T.+Beumingauthor=J.+Kniazeffauthor=M.+L.+Bergmannauthor=L.+Shiauthor=L.+Graciaauthor=K.+Raniszewskaauthor=A.+H.+Newmanauthor=J.+A.+Javitchauthor=H.+Weinsteinauthor=U.+Getherauthor=C.+J.+Loland&title=The+Binding+Sites+for+Cocaine+and+Dopamine+in+the+Dopamine+Transporter+Overlap&doi=10.1038%2Fnn.2146"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">The binding sites for cocaine and dopamine in the dopamine transporter overlap</span></div><div class="casAuthors">Beuming, Thijs; Kniazeff, Julie; Bergmann, Marianne L.; Shi, Lei; Gracia, Luis; Raniszewska, Klaudia; Newman, Amy Hauck; Javitch, Jonathan A.; Weinstein, Harel; Gether, Ulrik; Loland, Claus J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">780-789</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Beuming and colleagues detd. that the binding site for cocaine overlaps with that of dopamine on the dopamine transporter.  Detailed modeling and mutagenesis expts. revealed that this site is deeply buried amongst several transmembrane domains.  Cocaine is a widely abused substance with psychostimulant effects that are attributed to inhibition of the dopamine transporter (DAT).  We present mol. models for DAT binding of cocaine and cocaine analogs constructed from the high-resoln. structure of the bacterial transporter homolog LeuT.  Our models suggest that the binding site for cocaine and cocaine analogs is deeply buried between transmembrane segments 1, 3, 6 and 8, and overlaps with the binding sites for the substrates dopamine and amphetamine, as well as for benztropine-like DAT inhibitors.  We validated our models by detailed mutagenesis and by trapping the radiolabeled cocaine analog [3H]CFT in the transporter, either by crosslinking engineered cysteines or with an engineered Zn2+-binding site that was situated extracellularly to the predicted common binding pocket.  Our data demonstrate the mol. basis for the competitive inhibition of dopamine transport by cocaine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogCWenpzRZ47Vg90H21EOLACvtfcHk0lg1rv-Ruq46ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXns1Omsrw%253D&md5=7f96344e92478939540d84a37eaf3a70</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1038%2Fnn.2146&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.2146%26sid%3Dliteratum%253Aachs%26aulast%3DBeuming%26aufirst%3DT.%26aulast%3DKniazeff%26aufirst%3DJ.%26aulast%3DBergmann%26aufirst%3DM.%2BL.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DGracia%26aufirst%3DL.%26aulast%3DRaniszewska%26aufirst%3DK.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DWeinstein%26aufirst%3DH.%26aulast%3DGether%26aufirst%3DU.%26aulast%3DLoland%26aufirst%3DC.%2BJ.%26atitle%3DThe%2520Binding%2520Sites%2520for%2520Cocaine%2520and%2520Dopamine%2520in%2520the%2520Dopamine%2520Transporter%2520Overlap%26jtitle%3DNat.%2520Neurosci.%26date%3D2008%26volume%3D11%26spage%3D780%26epage%3D789%26doi%3D10.1038%2Fnn.2146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Wang, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penmatsa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouaux, E.</span><span> </span><span class="NLM_article-title">Neurotransmitter and psychostimulant Recognition by the Dopamine Transporter</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">521</span><span class="NLM_x">, </span> <span class="NLM_fpage">322</span><span class="NLM_x">–</span> <span class="NLM_lpage">327</span><span class="refDoi"> DOI: 10.1038/nature14431</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1038%2Fnature14431" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=25970245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1WltbbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=521&publication_year=2015&pages=322-327&author=K.+H.+Wangauthor=A.+Penmatsaauthor=E.+Gouaux&title=Neurotransmitter+and+psychostimulant+Recognition+by+the+Dopamine+Transporter&doi=10.1038%2Fnature14431"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Neurotransmitter and psychostimulant recognition by the dopamine transporter</span></div><div class="casAuthors">Wang, Kevin H.; Penmatsa, Aravind; Gouaux, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">521</span>
        (<span class="NLM_cas:issue">7552</span>),
    <span class="NLM_cas:pages">322-327</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Na+/Cl--coupled biogenic amine transporters are the primary targets of therapeutic and abused drugs, ranging from antidepressants to the psychostimulants cocaine and amphetamines, and to their cognate substrates.  Here we det. X-ray crystal structures of the Drosophila melanogaster dopamine transporter (dDAT) bound to its substrate dopamine, a substrate analog 3,4-dichlorophenethylamine, the psychostimulants D-amphetamine and methamphetamine, or to cocaine and cocaine analogs.  All ligands bind to the central binding site, located approx. halfway across the membrane bilayer, in close proximity to bound sodium and chloride ions.  The central binding site recognizes three chem. distinct classes of ligands via conformational changes that accommodate varying sizes and shapes, thus illustrating mol. principles that distinguish substrates from inhibitors in biogenic amine transporters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWbqTaT0RDD7Vg90H21EOLACvtfcHk0lg1rv-Ruq46ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1WltbbK&md5=1784d5fd0e7e1ddbe8346c96aaf98a00</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1038%2Fnature14431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14431%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DK.%2BH.%26aulast%3DPenmatsa%26aufirst%3DA.%26aulast%3DGouaux%26aufirst%3DE.%26atitle%3DNeurotransmitter%2520and%2520psychostimulant%2520Recognition%2520by%2520the%2520Dopamine%2520Transporter%26jtitle%3DNature%26date%3D2015%26volume%3D521%26spage%3D322%26epage%3D327%26doi%3D10.1038%2Fnature14431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Bisgaard, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsen, M. A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beuming, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loland, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gether, U.</span><span> </span><span class="NLM_article-title">The Binding Sites for Benztropines and Dopamine in the Dopamine Transporter Overlap</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">182</span><span class="NLM_x">–</span> <span class="NLM_lpage">190</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2010.08.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1016%2Fj.neuropharm.2010.08.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=20816875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVaitLzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2011&pages=182-190&author=H.+Bisgaardauthor=M.+A.+B.+Larsenauthor=S.+Mazierauthor=T.+Beumingauthor=A.+H.+Newmanauthor=H.+Weinsteinauthor=L.+Shiauthor=C.+J.+Lolandauthor=U.+Gether&title=The+Binding+Sites+for+Benztropines+and+Dopamine+in+the+Dopamine+Transporter+Overlap&doi=10.1016%2Fj.neuropharm.2010.08.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The binding sites for benztropines and dopamine in the dopamine transporter overlap</span></div><div class="casAuthors">Bisgaard, Heidi; Larsen, M. Andreas B.; Mazier, Sonia; Beuming, Thijs; Newman, Amy Hauck; Weinstein, Harel; Shi, Lei; Loland, Claus J.; Gether, Ulrik</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">182-190</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Analogs of benztropines (BZTs) are potent inhibitors of the dopamine transporter (DAT) but are less effective than cocaine as behavioral stimulants.  As a result, there have been efforts to evaluate these compds. as leads for potential medication for cocaine addiction.  Here we use computational modeling together with site-directed mutagenesis to characterize the binding site for BZTs in DAT.  Docking into mol. models based on the structure of the bacterial homolog LeuT supported a BZT binding site that overlaps with the substrate-binding pocket.  In agreement, mutations of residues within the pocket, including Val1523.46 to Ala or Ile, Ser4228.60 to Ala and Asn1573.51 to Cys or Ala, resulted in decreased affinity for BZT and the analog JHW007, as assessed in [3H]dopamine uptake inhibition assays and/or [3H]CFT competition binding assay.  A putative polar interaction of one of the Ph ring fluorine substituents in JHW007 with Asn1573.51 was used as a criterion for detg. likely binding poses and establish a structural context for the mutagenesis findings.  The anal. positioned the other fluorine-substituted Ph ring of JHW007 in close proximity to Ala47910.51/Ala48010.52 in transmembrane segment (TM) 10.  The lack of such an interaction for BZT led to a more tilted orientation, as compared to JHW007, bringing one of the Ph rings even closer to Ala47910.51/Ala48010.52.  Mutation of Ala47910.51 and Ala48010.52 to valines supported these predictions with a larger decrease in the affinity for BZT than for JHW007.  Summarized, our data suggest that BZTs display a classical competitive binding mode with binding sites overlapping those of cocaine and dopamine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR-5LmnkQ4_7Vg90H21EOLACvtfcHk0lg1rv-Ruq46ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVaitLzM&md5=b601a5fa6abe86a35f84193ee45970a7</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2010.08.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2010.08.021%26sid%3Dliteratum%253Aachs%26aulast%3DBisgaard%26aufirst%3DH.%26aulast%3DLarsen%26aufirst%3DM.%2BA.%2BB.%26aulast%3DMazier%26aufirst%3DS.%26aulast%3DBeuming%26aufirst%3DT.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DWeinstein%26aufirst%3DH.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DLoland%26aufirst%3DC.%2BJ.%26aulast%3DGether%26aufirst%3DU.%26atitle%3DThe%2520Binding%2520Sites%2520for%2520Benztropines%2520and%2520Dopamine%2520in%2520the%2520Dopamine%2520Transporter%2520Overlap%26jtitle%3DNeuropharmacology%26date%3D2011%26volume%3D60%26spage%3D182%26epage%3D190%26doi%3D10.1016%2Fj.neuropharm.2010.08.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Rais, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wozniak, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaaro-Peled, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strick, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engle, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandon, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rojas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slusher, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukamoto, T.</span><span> </span><span class="NLM_article-title">Pharmacokinetics of Oral D-Serine in D-Amino Acid Oxidase Knockout Mice</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">2067</span><span class="NLM_x">–</span> <span class="NLM_lpage">2073</span><span class="refDoi"> DOI: 10.1124/dmd.112.046482</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1124%2Fdmd.112.046482" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=22837388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFKkt73I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=2067-2073&author=R.+Raisauthor=A.+G.+Thomasauthor=K.+Wozniakauthor=Y.+Wuauthor=H.+Jaaro-Peledauthor=A.+Sawaauthor=C.+A.+Strickauthor=S.+J.+Engleauthor=N.+J.+Brandonauthor=C.+Rojasauthor=B.+S.+Slusherauthor=T.+Tsukamoto&title=Pharmacokinetics+of+Oral+D-Serine+in+D-Amino+Acid+Oxidase+Knockout+Mice&doi=10.1124%2Fdmd.112.046482"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics of oral D-serine in D-amino acid oxidase knockout mice</span></div><div class="casAuthors">Rais, Rana; Thomas, Ajit G.; Wozniak, Krystyna; Wu, Ying; Jaaro-Peled, Hanna; Sawa, Akira; Strick, Christine A.; Engle, Sandra J.; Brandon, Nicholas J.; Rojas, Camilo; Slusher, Barbara S.; Tsukamoto, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2067-2073</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">D-Amino acid oxidase (DAAO) catalyzes the oxidative deamination of D-amino acids including D-serine, a full agonist at the glycine modulatory site of the N-methyl-D-aspartate (NMDA) receptor.  To evaluate the significance of DAAO-mediated metab. in the pharmacokinetics of oral D-serine, plasma D-serine levels were measured in both wild-type mice and transgenic mice lacking DAAO.  Although D-serine levels were rapidly diminished in wild-type mice (t1/2 = 1.2 h), sustained drug levels over the course of 4 h (t1/2 > 10 h) were obsd. in mice lacking DAAO.  Coadministration of D-serine with 6-chlorobenzo[d]isoxazol-3-ol (CBIO), a small-mol. DAAO inhibitor, in wild-type mice resulted in the enhancement of plasma D-serine levels, although CBIO seems to have only temporary effects on the plasma D-serine levels due to glucuronidation of the key hydroxyl group.  These findings highlight the predominant role of DAAO in the clearance of D-serine from the systemic circulation.  Thus, a potent DAAO inhibitor with a longer half-life should be capable of maintaining high plasma D-serine levels over a sustained period of time and might have therapeutic implications for the treatment of schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOnvR-tnwQ-rVg90H21EOLACvtfcHk0ljqWmIH3onCRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFKkt73I&md5=c80a66d06d07cff75117790e0a927f84</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1124%2Fdmd.112.046482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.112.046482%26sid%3Dliteratum%253Aachs%26aulast%3DRais%26aufirst%3DR.%26aulast%3DThomas%26aufirst%3DA.%2BG.%26aulast%3DWozniak%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DJaaro-Peled%26aufirst%3DH.%26aulast%3DSawa%26aufirst%3DA.%26aulast%3DStrick%26aufirst%3DC.%2BA.%26aulast%3DEngle%26aufirst%3DS.%2BJ.%26aulast%3DBrandon%26aufirst%3DN.%2BJ.%26aulast%3DRojas%26aufirst%3DC.%26aulast%3DSlusher%26aufirst%3DB.%2BS.%26aulast%3DTsukamoto%26aufirst%3DT.%26atitle%3DPharmacokinetics%2520of%2520Oral%2520D-Serine%2520in%2520D-Amino%2520Acid%2520Oxidase%2520Knockout%2520Mice%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26spage%3D2067%26epage%3D2073%26doi%3D10.1124%2Fdmd.112.046482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Zolkowska, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Partilla, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setola, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prisinzano, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, M. H.</span><span> </span><span class="NLM_article-title">Evidence for the Involvement of Dopamine Transporters in Behavioral Stimulant Effects of Modafinil</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">329</span><span class="NLM_x">, </span> <span class="NLM_fpage">738</span><span class="NLM_x">–</span> <span class="NLM_lpage">746</span><span class="refDoi"> DOI: 10.1124/jpet.108.146142</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1124%2Fjpet.108.146142" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=19197004" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlt1OlsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=2009&pages=738-746&author=D.+Zolkowskaauthor=R.+Jainauthor=R.+B.+Rothmanauthor=J.+S.+Partillaauthor=B.+L.+Rothauthor=V.+Setolaauthor=T.+E.+Prisinzanoauthor=M.+H.+Baumann&title=Evidence+for+the+Involvement+of+Dopamine+Transporters+in+Behavioral+Stimulant+Effects+of+Modafinil&doi=10.1124%2Fjpet.108.146142"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil</span></div><div class="casAuthors">Zolkowska, Dorota; Jain, Raka; Rothman, Richard B.; Partilla, John S.; Roth, Bryan L.; Setola, Vincent; Prisinzano, Thomas E.; Baumann, Michael H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">329</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">738-746</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Modafinil is prescribed for numerous medical conditions, but the drug's mechanism of action is unclear.  Here, we examd. the interaction of modafinil with receptors and transporters in vitro and compared pharmacol. effects of the drug with those produced by indirect dopamine (DA) agonists 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR12909) and (+)-methamphetamine (METH).  Modafinil was screened at various receptors and transporters using binding assays.  Transporter-mediated uptake and release were examd. in rat brain synaptosomes.  Effects of modafinil on motor activity and neurochem. were detd. in rats undergoing in vivo microdialysis in nucleus accumbens.  Of the receptors and transporters assayed, modafinil displayed measurable potency only at DA transporters (DAT), inhibiting [3H]DA uptake, with an IC50 value of 4.0 μM.  Accordingly, modafinil pretreatment (10 μM) antagonized METH-induced release of the DAT substrate [3H]1-methyl-4-phenylpyridinium.  I.v. modafinil (20 and 60 mg/kg) produced dose-dependent increases in motor activity and extracellular DA, without affecting serotonin (5-HT).  Analogous results were obsd. for GBR12909 (1 and 3 mg/kg), whereas METH (0.3 and 1 mg/kg) increased DA and 5-HT.  Locomotor effects of all drugs were pos. correlated with dialyzate DA (P < 0.001).  Interestingly, modafinil pretreatment reduced METH-induced ambulation and DA release.  Our data show that modafinil interacts with DAT sites in rat brain, a property shared with agonist medications under investigation for treating cocaine dependence.  Nondopaminergic mechanisms may also contribute to the pharmacol. of modafinil.  Finally, the results suggest that modafinil should be tested as an adjunct for treating METH addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhab522ik-NrVg90H21EOLACvtfcHk0ljqWmIH3onCRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlt1OlsL4%253D&md5=0c5af6285ed23382c46a0d35bafbaa3b</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.146142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.146142%26sid%3Dliteratum%253Aachs%26aulast%3DZolkowska%26aufirst%3DD.%26aulast%3DJain%26aufirst%3DR.%26aulast%3DRothman%26aufirst%3DR.%2BB.%26aulast%3DPartilla%26aufirst%3DJ.%2BS.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DSetola%26aufirst%3DV.%26aulast%3DPrisinzano%26aufirst%3DT.%2BE.%26aulast%3DBaumann%26aufirst%3DM.%2BH.%26atitle%3DEvidence%2520for%2520the%2520Involvement%2520of%2520Dopamine%2520Transporters%2520in%2520Behavioral%2520Stimulant%2520Effects%2520of%2520Modafinil%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D329%26spage%3D738%26epage%3D746%26doi%3D10.1124%2Fjpet.108.146142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izenwasser, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, J. L.</span><span> </span><span class="NLM_article-title">Novel 3-α-(Diphenylmethoxy)tropane Analogs: Potent Dopamine Uptake Inhibitors without Cocaine-like Behavioral Profiles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">2258</span><span class="NLM_x">–</span> <span class="NLM_lpage">2261</span><span class="refDoi"> DOI: 10.1021/jm00041a002</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00041a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=2258-2261&author=A.+H.+Newmanauthor=A.+C.+Allenauthor=S.+Izenwasserauthor=J.+L.+Katz&title=Novel+3-%CE%B1-%28Diphenylmethoxy%29tropane+Analogs%3A+Potent+Dopamine+Uptake+Inhibitors+without+Cocaine-like+Behavioral+Profiles&doi=10.1021%2Fjm00041a002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm00041a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00041a002%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DAllen%26aufirst%3DA.%2BC.%26aulast%3DIzenwasser%26aufirst%3DS.%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26atitle%3DNovel%25203-%25CE%25B1-%2528Diphenylmethoxy%2529tropane%2520Analogs%253A%2520Potent%2520Dopamine%2520Uptake%2520Inhibitors%2520without%2520Cocaine-like%2520Behavioral%2520Profiles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D2258%26epage%3D2261%26doi%3D10.1021%2Fjm00041a002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Katz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izenwasser, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kline, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span> </span><span class="NLM_article-title">Novel 3α-Diphenylmethoxytropane Analogs: Selective Dopamine Uptake Inhibitors with Behavioral Effects Distinct from Those of Cocaine</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">288</span><span class="NLM_x">, </span> <span class="NLM_fpage">302</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=9862785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADyaK1MXisVyqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=1999&pages=302-315&author=J.+L.+Katzauthor=S.+Izenwasserauthor=R.+H.+Klineauthor=A.+C.+Allenauthor=A.+H.+Newman&title=Novel+3%CE%B1-Diphenylmethoxytropane+Analogs%3A+Selective+Dopamine+Uptake+Inhibitors+with+Behavioral+Effects+Distinct+from+Those+of+Cocaine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Novel 3α-diphenylmethoxytropane analogs: selective dopamine uptake inhibitors with behavioral effects distinct from those of cocaine</span></div><div class="casAuthors">Katz, Jonathan L.; Izenwasser, Sari; Kline, Richard H.; Allen, Andrew C.; Newman, Amy Hauck</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">288</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">302-315</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The pharmacol. effects were assessed for a series of 3α-diphenylmethoxy-1αH,5αH-tropane analogs which have structural similarities to cocaine.  Like cocaine, these compds. displaced [3H]WIN 35,428 binding from rat caudate and had affinities ranging from approx. 10-fold greater than cocaine (Ki=11.8 nM) to relatively low affinity (Ki=2000 nM).  The compds. also inhibited dopamine uptake with potencies corresponding to their affinities for WIN 35,428 binding sites.  Like the parent compd., benztropine, the 3α-(diphenylmethoxy)tropane analogs displaced [3H]pirenzepine from muscarinic M1 receptors with affinities ranging from 2 to 120 nM.  Cocaine produced dose-related increases in locomotor activity (horizontal ambulation) in Swiss Webster mice, whereas the 3α-(diphenylmethoxy)tropane analogs generally had lower efficacy than cocaine.  Compds. with fluoro-substituents in the Ph rings generally were among those with efficacy approaching that of cocaine; those with chloro- and bromo-substituents were markedly less efficacious, despite having binding affinities comparable to those of the corresponding fluoro-substituted compds.  The 3α-(diphenylmethoxy)tropane analogs were also examd. in rats trained to discriminate saline from cocaine (10 mg/kg, i.p.).  Cocaine produced a dose-related increase in responding on the cocaine-appropriate lever, reaching 100% at 10 mg/kg.  Only the 4',4''-difluoro-substituted analog produced effects similar to those of cocaine; the other compds. showed markedly reduced efficacy compared to cocaine.  Drug interaction studies showed that the antimuscarinics, atropine and scopolamine, potentiated rather than attenuated the locomotor stimulant and cocaine-like discriminative-stimulus effects of cocaine, indicating that the antimuscarinic effects of the 3α-diphenylmethoxytropane analogs did not contribute to their diminished cocaine-like activity.  Studies of the time course of selected compds. indicated that their reduced cocaine-like efficacy was likely not due to behavioral observations being conducted at an inopportune time period.  Because none of the 3α-diphenylmethoxytropane analogs studied showed evidence that they were binding to more than one site, and because the structure activity relationships among these drugs are distinctly different from those obtained with cocaine, these data suggest that the 3α-diphenylmethoxytropane analogs are accessing a different binding domain than that accessed by cocaine.  Binding to this domain may produce a behavioral profile that is distinct from that of the cocaine-like dopamine uptake inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVv6SJkGAJDrVg90H21EOLACvtfcHk0lg5bQI7OADK5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXisVyqug%253D%253D&md5=f2a3046324b849beee51eb2bd8bdac05</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26aulast%3DIzenwasser%26aufirst%3DS.%26aulast%3DKline%26aufirst%3DR.%2BH.%26aulast%3DAllen%26aufirst%3DA.%2BC.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DNovel%25203%25CE%25B1-Diphenylmethoxytropane%2520Analogs%253A%2520Selective%2520Dopamine%2520Uptake%2520Inhibitors%2520with%2520Behavioral%2520Effects%2520Distinct%2520from%2520Those%2520of%2520Cocaine%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1999%26volume%3D288%26spage%3D302%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Desai, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopajtic, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">French, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, J. L.</span><span> </span><span class="NLM_article-title">Relationship between In Vivo Occupancy at the Dopamine Transporter and Behavioral Effects of Cocaine, GBR 12909 [1-{2-[Bis-(4-fluorophenyl)methoxy]ethyl}-4-(3-phenylpropyl)piperazine], and Benztropine Analogs</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">315</span><span class="NLM_x">, </span> <span class="NLM_fpage">397</span><span class="NLM_x">–</span> <span class="NLM_lpage">404</span><span class="refDoi"> DOI: 10.1124/jpet.105.091231</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1124%2Fjpet.105.091231" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=16014753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVOks7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=315&publication_year=2005&pages=397-404&author=R.+I.+Desaiauthor=T.+A.+Kopajticauthor=D.+Frenchauthor=A.+H.+Newmanauthor=J.+L.+Katz&title=Relationship+between+In+Vivo+Occupancy+at+the+Dopamine+Transporter+and+Behavioral+Effects+of+Cocaine%2C+GBR+12909+%5B1-%7B2-%5BBis-%284-fluorophenyl%29methoxy%5Dethyl%7D-4-%283-phenylpropyl%29piperazine%5D%2C+and+Benztropine+Analogs&doi=10.1124%2Fjpet.105.091231"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Relationship between in Vivo occupancy at the dopamine transporter and behavioral effects of cocaine, GBR 12909 [1-{2-[bis-(4-fluorophenyl)methoxy]ethyl}-4-(3-phenylpropyl)piperazine],and benztropine analogs</span></div><div class="casAuthors">Desai, Rajeev I.; Kopajtic, Theresa A.; French, Dawn; Newman, Amy H.; Katz, Jonathan L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">315</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">397-404</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Analogs of benztropine (BZT) bind to the dopamine (DA) transporter and inhibit DA uptake but often have behavioral effects that differ from those of cocaine and other DA-uptake inhibitors.  To better understand these differences, we examd. the relationship between locomotor-stimulant effects of cocaine, 1-{2-[bis-(4-fluorophenyl)methoxy]ethyl}-4-(3-phenylpropyl)-piperazine (GBR 12909), and BZT analogs [(3α-[bis(4'-fluorophenyl)methoxy]-tropane) (AHN 1-055) and (N-allyl-3α-[bis(4'-fluorophenyl)methoxy]-tropane) (AHN 2-005)] and their in vivo displacement of the DA transporter ligand [125I]3β-(4-iodophenyl)-tropan-2β-carboxylic acid iso-Pr ester hydrochloride (RTI-121) in striatum.  Cocaine, GBR 12909, and BZT analogs each displaced [125I]RTI-121 and stimulated locomotor activity in a dose- and time-dependent manner.  The time course revealed a slower onset of both effects for AHN 1-055 and AHN 2-005 compared with cocaine and GBR 12909.  The BZT analogs were less effective than cocaine and GBR 12909 in stimulating locomotor activity.  Locomotor stimulant effects of cocaine were generally greater than predicted by the regression of displacement of [125I]RTI-121 and effect at short times after injection and less than predicted at longer times after injection.  This result suggests that the apparent rate of occupancy of the DA transporter, in addn. to percentage of sites occupied, contributes to the behavioral effects of cocaine.  The present results suggest that among drugs that act at the DA transporter, the slower apparent rates of occupancy with the DA transporter by the BZT analogs may contribute in an important way to differences in their effectiveness.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjPuttHGNvq7Vg90H21EOLACvtfcHk0lg5bQI7OADK5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVOks7nI&md5=aa3d51cc833c446f5895f06bf1c28b99</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.091231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.091231%26sid%3Dliteratum%253Aachs%26aulast%3DDesai%26aufirst%3DR.%2BI.%26aulast%3DKopajtic%26aufirst%3DT.%2BA.%26aulast%3DFrench%26aufirst%3DD.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26atitle%3DRelationship%2520between%2520In%2520Vivo%2520Occupancy%2520at%2520the%2520Dopamine%2520Transporter%2520and%2520Behavioral%2520Effects%2520of%2520Cocaine%252C%2520GBR%252012909%2520%255B1-%257B2-%255BBis-%25284-fluorophenyl%2529methoxy%255Dethyl%257D-4-%25283-phenylpropyl%2529piperazine%255D%252C%2520and%2520Benztropine%2520Analogs%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D315%26spage%3D397%26epage%3D404%26doi%3D10.1124%2Fjpet.105.091231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Hiranita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, M.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopajtic, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lupica, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, J. L.</span><span> </span><span class="NLM_article-title">2-Isoxazol-3-phenyltropane Derivatives of Cocaine: Molecular and Atypical System Effects at the Dopamine Transporter</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">349</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">309</span><span class="refDoi"> DOI: 10.1124/jpet.113.212738</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1124%2Fjpet.113.212738" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=24518035" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovVCmt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=349&publication_year=2014&pages=297-309&author=T.+Hiranitaauthor=D.+S.+Wilkinsonauthor=W.+C.+Hongauthor=M.-F.+Zouauthor=T.+A.+Kopajticauthor=P.+L.+Sotoauthor=C.+R.+Lupicaauthor=A.+H.+Newmanauthor=J.+L.+Katz&title=2-Isoxazol-3-phenyltropane+Derivatives+of+Cocaine%3A+Molecular+and+Atypical+System+Effects+at+the+Dopamine+Transporter&doi=10.1124%2Fjpet.113.212738"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">2-isoxazol-3-phenyltropane derivatives of cocaine: molecular and atypical system effects at the dopamine transporter</span></div><div class="casAuthors">Hiranita, Takato; Wilkinson, Derek S.; Hong, Weimin C.; Zou, Mu-Fa; Kopajtic, Theresa A.; Soto, Paul L.; Lupica, Carl R.; Newman, Amy H.; Katz, Jonathan L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">349</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">297-309, 13 pp.</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The present study examd. RTI-371 [3β-(4-methylphenyl)-2β-[3-(4-chlorophenyl)-isoxazol-5-yl]tropane], a phenyltropane cocaine analog with effects distinct from cocaine, and assessed potential mechanisms for those effects by comparison with its constitutional isomer, RTI-336 [3β-(4-chlorophenyl)-2β-[3-(4-methylphenyl)-isoxazol-5-yl]tropane].  In mice, RTI-371 was less effective than cocaine and RTI-336 in stimulating locomotion, and incompletely substituted (∼60% max. at 5 min or 1 h after injection) in a cocaine (10 mg/kg i.p.)/saline discrimination procedure; RTI-336 completely substituted.  In contrast to RTI-336, RTI-371 was not self-administered, and its pretreatment (1.0-10 mg/kg i.p.) dose-dependently decreased maximal cocaine self-administration more potently than food-maintained responding.  RTI-336 pretreatment dose-dependently left-shifted the cocaine self-administration dose-effect curve.  Both RTI-336 and RTI-371 displaced [3H]WIN35,428 [[3H](-)-3β-(4-fluorophenyl)-tropan-2β-carboxylic acid Me ester tartrate] binding to striatal dopamine transporters (DATs) with Ki values of 10.8 and 7.81 nM, resp., and had lower affinities at serotonin or norepinephrine transporters, or muscarinic and σ receptors.  The relative low affinity at these sites suggests the DAT as the primary target of RTI-371 with minimal contributions from these other targets.  In biochem. assays probing the outward-facing DAT conformation, both RTI-371 and RTI-336 had effects similar to cocaine, suggesting little contribution of DAT conformation to the unique pharmacol. of RTI-371.  The locomotor-stimulant effects of RTI-371 (3.0-30 mg/kg i.p.) were comparable in wild-type and knockout cannabinoid CB1 receptor (CB1R) mice, indicating that previously reported CB1 allosteric effects do not decrease cocaine-like effects of RTI-371.  DAT occupancy in vivo was most rapid with cocaine and least with RTI-371.  The slow apparent assocn. rate may allow compensatory actions that in turn dampen cocaine-like stimulation, and give RTI-371 its unique pharmacol. profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDwwGziyXAgbVg90H21EOLACvtfcHk0lg5bQI7OADK5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovVCmt7Y%253D&md5=0c4e7470799ae071011ab59b882e7165</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1124%2Fjpet.113.212738&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.113.212738%26sid%3Dliteratum%253Aachs%26aulast%3DHiranita%26aufirst%3DT.%26aulast%3DWilkinson%26aufirst%3DD.%2BS.%26aulast%3DHong%26aufirst%3DW.%2BC.%26aulast%3DZou%26aufirst%3DM.-F.%26aulast%3DKopajtic%26aufirst%3DT.%2BA.%26aulast%3DSoto%26aufirst%3DP.%2BL.%26aulast%3DLupica%26aufirst%3DC.%2BR.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26atitle%3D2-Isoxazol-3-phenyltropane%2520Derivatives%2520of%2520Cocaine%253A%2520Molecular%2520and%2520Atypical%2520System%2520Effects%2520at%2520the%2520Dopamine%2520Transporter%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2014%26volume%3D349%26spage%3D297%26epage%3D309%26doi%3D10.1124%2Fjpet.113.212738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Hong, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopajtic, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lomenzo, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jean, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madura, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surratt, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trudell, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, J. L.</span><span> </span><span class="NLM_article-title">2-Substituted 3β-Aryltropane Cocaine Analogs Produce Atypical Effects without Inducing Inward-Facing Dopamine Transporter Conformations</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">356</span><span class="NLM_x">, </span> <span class="NLM_fpage">624</span><span class="NLM_x">–</span> <span class="NLM_lpage">634</span><span class="refDoi"> DOI: 10.1124/jpet.115.230722</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1124%2Fjpet.115.230722" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=26769919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A280%3ADC%252BC28ngt1CitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=356&publication_year=2016&pages=624-634&author=W.+C.+Hongauthor=T.+A.+Kopajticauthor=L.+Xuauthor=S.+A.+Lomenzoauthor=B.+Jeanauthor=J.+D.+Maduraauthor=C.+K.+Surrattauthor=M.+L.+Trudellauthor=J.+L.+Katz&title=2-Substituted+3%CE%B2-Aryltropane+Cocaine+Analogs+Produce+Atypical+Effects+without+Inducing+Inward-Facing+Dopamine+Transporter+Conformations&doi=10.1124%2Fjpet.115.230722"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">2-Substituted 3β-Aryltropane Cocaine Analogs Produce Atypical Effects without Inducing Inward-Facing Dopamine Transporter Conformations</span></div><div class="casAuthors">Hong Weimin C; Kopajtic Theresa A; Xu Lifen; Lomenzo Stacey A; Jean Bernandie; Madura Jeffry D; Surratt Christopher K; Trudell Mark L; Katz Jonathan L</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of pharmacology and experimental therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">356</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">624-34</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Previous structure-activity relationship studies indicate that a series of cocaine analogs, 3β-aryltropanes with 2β-diarylmethoxy substituents, selectively bind to the dopamine transporter (DAT) with nanomolar affinities that are 10-fold greater than the affinities of their corresponding 2α-enantiomers.  The present study compared these compounds to cocaine with respect to locomotor effects in mice, and assessed their ability to substitute for cocaine (10 mg/kg, i.p.) in rats trained to discriminate cocaine from saline.  Despite nanomolar DAT affinity, only the 2β-Ph2COCH2-3β-4-Cl-Ph analog fully substituted for cocaine-like discriminative effects.  Whereas all of the 2β compounds increased locomotion, only the 2β-(4-ClPh)PhCOCH2-3β-4-Cl-Ph analog had cocaine-like efficacy.  None of the 2α-substituted compounds produced either of these cocaine-like effects.  To explore the molecular mechanisms of these drugs, their effects on DAT conformation were probed using a cysteine-accessibility assay.  Previous reports indicate that cocaine binds with substantially higher affinity to the DAT in its outward (extracellular)- compared with inward-facing conformation, whereas atypical DAT inhibitors, such as benztropine, have greater similarity in affinity to these conformations, and this is postulated to explain their divergent behavioral effects.  All of the 2β- and 2α-substituted compounds tested altered cysteine accessibility of DAT in a manner similar to cocaine.  Furthermore, molecular dynamics of in silico inhibitor-DAT complexes suggested that the 2-substituted compounds reach equilibrium in the binding pocket in a cocaine-like fashion.  These behavioral, biochemical, and computational results show that aryltropane analogs can bind to the DAT and stabilize outward-facing DAT conformations like cocaine, yet produce effects that differ from those of cocaine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSHUIt0a7sLpmx8TEN9K18QfW6udTcc2eZeRPh72vySc7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28ngt1CitA%253D%253D&md5=a21420fab70030162709440ede486173</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1124%2Fjpet.115.230722&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.115.230722%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DW.%2BC.%26aulast%3DKopajtic%26aufirst%3DT.%2BA.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DLomenzo%26aufirst%3DS.%2BA.%26aulast%3DJean%26aufirst%3DB.%26aulast%3DMadura%26aufirst%3DJ.%2BD.%26aulast%3DSurratt%26aufirst%3DC.%2BK.%26aulast%3DTrudell%26aufirst%3DM.%2BL.%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26atitle%3D2-Substituted%25203%25CE%25B2-Aryltropane%2520Cocaine%2520Analogs%2520Produce%2520Atypical%2520Effects%2520without%2520Inducing%2520Inward-Facing%2520Dopamine%2520Transporter%2520Conformations%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2016%26volume%3D356%26spage%3D624%26epage%3D634%26doi%3D10.1124%2Fjpet.115.230722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Scheffel, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boja, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhar, M. J.</span><span> </span><span class="NLM_article-title">Cocaine receptors: in vivo labeling with 3H-(−)cocaine, 3H-WIN 35,065–2, and 3H-WIN 35,428</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">390</span><span class="NLM_x">–</span> <span class="NLM_lpage">392</span><span class="refDoi"> DOI: 10.1002/syn.890040415</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1002%2Fsyn.890040415" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=2603151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADyaK3cXptFKhtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1989&pages=390-392&author=U.+Scheffelauthor=J.+W.+Bojaauthor=M.+J.+Kuhar&title=Cocaine+receptors%3A+in+vivo+labeling+with+3H-%28%E2%88%92%29cocaine%2C+3H-WIN+35%2C065%E2%80%932%2C+and+3H-WIN+35%2C428&doi=10.1002%2Fsyn.890040415"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Cocaine receptors: in vivo labeling with 3H-(-)cocaine, 3H-WIN 35065-2, and 3H-WIN 35428</span></div><div class="casAuthors">Scheffel, Ursula; Boja, John W.; Kuhar, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Synapse (New York, NY, United States)</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">390-2</span>CODEN:
                <span class="NLM_cas:coden">SYNAET</span>;
        ISSN:<span class="NLM_cas:issn">0887-4476</span>.
    </div><div class="casAbstract">The binding of tritiated (-)-cocaine and its 2 title analogs to the brain striatum and cerebellum was studied in mice.  The analogs WIN-35065-2 and WIN-35428 showed a stronger binding than cocaine to cocaine-binding sites in the striatum presumably assocd. with dopamine transports.  Both analogs are less prone to metab. than cocaine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2UAERaB5xILVg90H21EOLACvtfcHk0ljldAdAq_UNpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXptFKhtA%253D%253D&md5=eed1a9ec1ddf6a054b5fc81045289b37</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1002%2Fsyn.890040415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fsyn.890040415%26sid%3Dliteratum%253Aachs%26aulast%3DScheffel%26aufirst%3DU.%26aulast%3DBoja%26aufirst%3DJ.%2BW.%26aulast%3DKuhar%26aufirst%3DM.%2BJ.%26atitle%3DCocaine%2520receptors%253A%2520in%2520vivo%2520labeling%2520with%25203H-%2528%25E2%2588%2592%2529cocaine%252C%25203H-WIN%252035%252C065%25E2%2580%25932%252C%2520and%25203H-WIN%252035%252C428%26jtitle%3DSynapse%26date%3D1989%26volume%3D4%26spage%3D390%26epage%3D392%26doi%3D10.1002%2Fsyn.890040415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Cheng, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusoff, W. H.</span><span> </span><span class="NLM_article-title">Relationship between the Inhibition Constant (Ki) and the Concentration of Inhibitor which causes 50% Inhibition (I50) of an Enzymatic Reaction</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3099</span><span class="NLM_x">–</span> <span class="NLM_lpage">3108</span><span class="refDoi"> DOI: 10.1016/0006-2952(73)90196-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1016%2F0006-2952%2873%2990196-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=4202581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1973&pages=3099-3108&author=Y.-C.+Chengauthor=W.+H.+Prusoff&title=Relationship+between+the+Inhibition+Constant+%28Ki%29+and+the+Concentration+of+Inhibitor+which+causes+50%25+Inhibition+%28I50%29+of+an+Enzymatic+Reaction&doi=10.1016%2F0006-2952%2873%2990196-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Relation between the inhibition constant K1) and the concentration of inhibitor which causes fifty per cent inhibition (I50) of an enzymic reaction</span></div><div class="casAuthors">Cheng, Yung-Chi; Prusoff, William H.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3099-108</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">The Ki and I50 values are equal where the kinetics are non- or uncompetitive, but not where they are competitive.  The relation between the 2 values was analyzed for non- and uncompetitive bi- and monosubstrate reactions and for competitive bisubstrate reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqodFY_8msz57Vg90H21EOLACvtfcHk0ljldAdAq_UNpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D&md5=fe7175ca300d8f4085df87af37f8656c</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2873%2990196-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252873%252990196-2%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.-C.%26aulast%3DPrusoff%26aufirst%3DW.%2BH.%26atitle%3DRelationship%2520between%2520the%2520Inhibition%2520Constant%2520%2528Ki%2529%2520and%2520the%2520Concentration%2520of%2520Inhibitor%2520which%2520causes%252050%2525%2520Inhibition%2520%2528I50%2529%2520of%2520an%2520Enzymatic%2520Reaction%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1973%26volume%3D22%26spage%3D3099%26epage%3D3108%26doi%3D10.1016%2F0006-2952%2873%2990196-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Hiranita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanda, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopajtic, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, J. L.</span><span> </span><span class="NLM_article-title">Stimulants as Specific Inducers of Dopamine-Independent σ Agonist Self-Administration in Rats</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">347</span><span class="NLM_x">, </span> <span class="NLM_fpage">20</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span><span class="refDoi"> DOI: 10.1124/jpet.113.207522</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1124%2Fjpet.113.207522" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsF2ks7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2013&pages=20-29&author=T.+Hiranitaauthor=P.+L.+Sotoauthor=G.+Tandaauthor=T.+A.+Kopajticauthor=J.+L.+Katz&title=Stimulants+as+Specific+Inducers+of+Dopamine-Independent+%CF%83+Agonist+Self-Administration+in+Rats&doi=10.1124%2Fjpet.113.207522"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Stimulants as specific inducers of dopamine-independent σ agonist self-administration in rats</span></div><div class="casAuthors">Hiranita, Takato; Soto, Paul L.; Tanda, Gianluigi; Kopajtic, Theresa A.; Katz, Jonathan L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">20-29</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A previous study showed that cocaine self-administration induced dopamine-independent reinforcing effects of σ agonists mediated by their selective actions at σ1 receptors (σ1Rs), which are intracellularly mobile chaperone proteins implicated in abuse-related effects of stimulants.  The present study assessed whether the induction was specific to self-administration of cocaine.  Rats were trained to self-administer the dopamine releaser, d-methamphetamine (0.01-0.32 mg/kg per injection), the μ-opioid receptor agonist, heroin (0.001-0.032 mg/kg per injection), and the noncompetitive N-methyl-D-aspartate receptor/channel antagonist ketamine (0.032-1.0 mg/kg per injection).  As with cocaine, self-administration of d-methamphetamine induced reinforcing effects of the selective σ1R agonists PRE-084 [2-(4-morpholinethyl)1-phenylcyclohexanecarboxylate hydrochloride] and (+)-pentazocine (0.032-1.0 mg/kg per injection, each).  In contrast, neither self-administration of heroin nor ketamine induced PRE-084 or (+)-pentazocine (0.032-10 mg/kg per injection, each) self-administration.  Although the σ1R agonists did not maintain responding in subjects with histories of heroin or ketamine self-administration, substitution for those drugs was obtained with appropriate agonists (e.g., remifentanil, 0.1-3.2 μg/kg per injection, for heroin and (5S,10R)-(+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine ((+)-MK 801; dizocilpine), 0.32-10.0 μg/kg per injection, for ketamine).  The σR antagonist N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1-pyrrolidinyl)ethylamine dihydrobromide (BD 1008; 1.0-10 mg/kg) dose-dependently blocked PRE-084 self-administration but was inactive against d-methamphetamine, heroin, and ketamine.  In contrast, PRE-084 self-administration was affected neither by the dopamine receptor antagonist (+)-butaclamol (10-100 μg/kg) nor by the opioid antagonist (-)-naltrexone (1.0-10 mg/kg), whereas these antagonists were active against d-methamphetamine and heroin self-administration, resp.  The results indicate that experience specifically with indirect-acting dopamine agonists induces reinforcing effects of previously inactive σ1R agonists.  It is further suggested that induced σ1R reinforcing mechanisms may play an essential role in treatment-resistant stimulant abuse, suggesting new approaches for the development of effective medications for its treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKYX262DkAL7Vg90H21EOLACvtfcHk0lhdUQzfWJODoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsF2ks7zI&md5=3a6c50fc2758e9892cbe0c683b56b7d4</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1124%2Fjpet.113.207522&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.113.207522%26sid%3Dliteratum%253Aachs%26aulast%3DHiranita%26aufirst%3DT.%26aulast%3DSoto%26aufirst%3DP.%2BL.%26aulast%3DTanda%26aufirst%3DG.%26aulast%3DKopajtic%26aufirst%3DT.%2BA.%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26atitle%3DStimulants%2520as%2520Specific%2520Inducers%2520of%2520Dopamine-Independent%2520%25CF%2583%2520Agonist%2520Self-Administration%2520in%2520Rats%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2013%26volume%3D347%26spage%3D20%26epage%3D29%26doi%3D10.1124%2Fjpet.113.207522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levant, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keck, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Tranylcypromine Substituted <i>cis</i>-Hydroxycyclobutylnaphthamides as Potent and Selective Dopamine D3 Receptor Antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">4962</span><span class="NLM_x">–</span> <span class="NLM_lpage">4968</span><span class="refDoi"> DOI: 10.1021/jm401798r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401798r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BC2cXosVOnurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4962-4968&author=J.+Chenauthor=B.+Levantauthor=C.+Jiangauthor=T.+M.+Keckauthor=A.+H.+Newmanauthor=S.+Wang&title=Tranylcypromine+Substituted+cis-Hydroxycyclobutylnaphthamides+as+Potent+and+Selective+Dopamine+D3+Receptor+Antagonists&doi=10.1021%2Fjm401798r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Tranylcypromine Substituted cis-Hydroxycyclobutylnaphthamides as Potent and Selective Dopamine D3 Receptor Antagonists</span></div><div class="casAuthors">Chen, Jianyong; Levant, Beth; Jiang, Cheng; Keck, Thomas M.; Newman, Amy Hauck; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4962-4968</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report a class of potent and selective dopamine D3 receptor antagonists based upon tranylcypromine.  Although tranylcypromine has a low affinity for the rat D3 receptor (Ki = 12.8 μM), our efforts have yielded (1R,2S)-11 (CJ-1882), which has Ki values of 2.7 and 2.8 nM at the rat and human dopamine D3 receptors, resp., and displays resp. selectivities of >10000-fold and 223-fold over the rat and human D2 receptors.  Evaluation in a β-arrestin functional assay showed that (1R,2S)-11 is a potent and competitive antagonist at the human D3 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowWudWdAfWgLVg90H21EOLACvtfcHk0lhdUQzfWJODoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXosVOnurg%253D&md5=e2ddf0711d00103be281cb043b19ec3a</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fjm401798r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401798r%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DLevant%26aufirst%3DB.%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DKeck%26aufirst%3DT.%2BM.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DTranylcypromine%2520Substituted%2520cis-Hydroxycyclobutylnaphthamides%2520as%2520Potent%2520and%2520Selective%2520Dopamine%2520D3%2520Receptor%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4962%26epage%3D4968%26doi%3D10.1021%2Fjm401798r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Urizar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yano, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolster, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galés, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javitch, J. A.</span><span> </span><span class="NLM_article-title">CODA-RET Reveals Functional Selectivity as a Result of GPCR Heteromerization</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">624</span><span class="NLM_x">–</span> <span class="NLM_lpage">630</span><span class="refDoi"> DOI: 10.1038/nchembio.623</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1038%2Fnchembio.623" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=21785426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptlaktLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=624-630&author=E.+Urizarauthor=H.+Yanoauthor=R.+Kolsterauthor=C.+Gal%C3%A9sauthor=N.+Lambertauthor=J.+A.+Javitch&title=CODA-RET+Reveals+Functional+Selectivity+as+a+Result+of+GPCR+Heteromerization&doi=10.1038%2Fnchembio.623"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">CODA-RET reveals functional selectivity as a result of GPCR heteromerization</span></div><div class="casAuthors">Urizar, Eneko; Yano, Hideaki; Kolster, Rachel; Gales, Celine; Lambert, Nevin; Javitch, Jonathan A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">624-630</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Here the authors present a new method that combines protein complementation with resonance energy transfer to study conformational changes in response to activation of a defined G protein-coupled receptor heteromer, and the authors apply the approach to the putative dopamine D1-D2 receptor heteromer.  Remarkably, the potency of the D2 dopamine receptor (D2R) agonist R-(-)-10,11-dihydroxy-N-n-propylnoraporphine (NPA) to change the Gαi conformation via the D2R promoter in the D1-D2 heteromer was enhanced ten-fold relative to its potency in the D2R homomer.  In contrast, the potencies of the D2R agonists dopamine and quinpirole were the same in the homomer and heteromer.  Thus, the authors have uncovered a mol. mechanism for functional selectivity in which a drug acts differently at a G protein-coupled receptor (GPCR) promoter depending on the identity of the second promoter participating in the formation of the signaling unit-opening the door to enhancing pharmacol. specificity by targeting differences between homomeric and heteromeric signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCa-gFk2Y_C7Vg90H21EOLACvtfcHk0lhdUQzfWJODoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptlaktLk%253D&md5=65c3f8f3a8b5ed1bfdf99fc7d2712a9e</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.623%26sid%3Dliteratum%253Aachs%26aulast%3DUrizar%26aufirst%3DE.%26aulast%3DYano%26aufirst%3DH.%26aulast%3DKolster%26aufirst%3DR.%26aulast%3DGal%25C3%25A9s%26aufirst%3DC.%26aulast%3DLambert%26aufirst%3DN.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26atitle%3DCODA-RET%2520Reveals%2520Functional%2520Selectivity%2520as%2520a%2520Result%2520of%2520GPCR%2520Heteromerization%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D7%26spage%3D624%26epage%3D630%26doi%3D10.1038%2Fnchembio.623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Pedersen, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreassen, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loland, C. J.</span><span> </span><span class="NLM_article-title">A Conserved Salt Bridge between Transmembrane Segments 1 and 10 Constitutes an Extracellular Gate in the Dopamine Transporter</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">35003</span><span class="NLM_x">–</span> <span class="NLM_lpage">35014</span><span class="refDoi"> DOI: 10.1074/jbc.M114.586982</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1074%2Fjbc.M114.586982" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=25339174" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlvVSgug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=35003-35014&author=A.+V.+Pedersenauthor=T.+F.+Andreassenauthor=C.+J.+Loland&title=A+Conserved+Salt+Bridge+between+Transmembrane+Segments+1+and+10+Constitutes+an+Extracellular+Gate+in+the+Dopamine+Transporter&doi=10.1074%2Fjbc.M114.586982"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">A conserved salt bridge between transmembrane segments 1 and 10 constitutes an extracellular gate in the dopamine transporter</span></div><div class="casAuthors">Pedersen, Anders V.; Andreassen, Thorvald F.; Loland, Claus J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">35003-35014, 13 pp.</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Neurotransmitter transporters play an important role in termination of synaptic transmission by mediating reuptake of neurotransmitter, but the mol. processes behind translocation are still unclear.  The crystal structures of the bacterial homolog, LeuT, provided valuable insight into the structural and dynamic requirements for substrate transport.  These structures support the existence of gating domains controlling access to a central binding site.  On the extracellular side, access is controlled by the "thin gate" formed by an interaction between Arg-30 and Asp-404.  In the human dopamine transporter (DAT), the corresponding residues are Arg-85 and Asp-476.  Here, we present results supporting the existence of a similar interaction in DAT.  The DAT R85D mutant has a complete loss of function, but the addnl. insertion of an arginine in opposite position (R85D/D476R), causing a charge reversal, results in a rescue of binding sites for the cocaine analog [3H]CFT.  Also, the coordination of Zn2+ between introduced histidines (R85H/D476H) caused a ∼2.5-fold increase in [3H]CFT binding (Bmax).  Importantly, Zn2+ also inhibited [3H]dopamine transport in R85H/D476H, suggesting that a dynamic interaction is required for the transport process.  Furthermore, cysteine-reactive chem. shows that mutation of the gating residues causes a higher proportion of transporters to reside in the outward facing conformation.  Finally, we show that charge reversal of the corresponding residues (R104E/E493R) in the serotonin transporter (SERT) also rescues [3H](S)-citalopram binding, suggesting a conserved feature.  Taken together, these data suggest that the extracellular thin gate is present in monoamine transporters and that a dynamic interaction is required for substrate transport.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGob2g8cE5ScPrVg90H21EOLACvtfcHk0ljvhkg2KbKF4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlvVSgug%253D%253D&md5=8036920794dfc9fbf25a1f09f356cfaa</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M114.586982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M114.586982%26sid%3Dliteratum%253Aachs%26aulast%3DPedersen%26aufirst%3DA.%2BV.%26aulast%3DAndreassen%26aufirst%3DT.%2BF.%26aulast%3DLoland%26aufirst%3DC.%2BJ.%26atitle%3DA%2520Conserved%2520Salt%2520Bridge%2520between%2520Transmembrane%2520Segments%25201%2520and%252010%2520Constitutes%2520an%2520Extracellular%2520Gate%2520in%2520the%2520Dopamine%2520Transporter%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D35003%26epage%3D35014%26doi%3D10.1074%2Fjbc.M114.586982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 32 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Liang Tan, Qingtong Zhou, Wenzhong Yan, Jian Sun, Alan P. Kozikowski, Suwen Zhao, Xi-Ping Huang, <span class="NLM_string-name hlFld-ContribAuthor">Jianjun Cheng</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Bitopic 2-Phenylcyclopropylmethylamine (PCPMA) Derivatives as Selective Dopamine D3 Receptor Ligands. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (9)
                                     , 4579-4602. <a href="https://doi.org/10.1021/acs.jmedchem.9b01835" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01835</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01835&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01835%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BBitopic%252B2-Phenylcyclopropylmethylamine%252B%252528PCPMA%252529%252BDerivatives%252Bas%252BSelective%252BDopamine%252BD3%252BReceptor%252BLigands%26aulast%3DTan%26aufirst%3DLiang%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D18112019%26date%3D23042020%26date%3D13042020%26volume%3D63%26issue%3D9%26spage%3D4579%26epage%3D4602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Wesley Wei Wang, Leandro Gallo, Appaso Jadhav, Richard Hawkins, <span class="NLM_string-name hlFld-ContribAuthor">Christopher G. Parker</span>. </span><span class="cited-content_cbyCitation_article-title">The Druggability of Solute Carriers. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (8)
                                     , 3834-3867. <a href="https://doi.org/10.1021/acs.jmedchem.9b01237" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01237</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01237%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BDruggability%252Bof%252BSolute%252BCarriers%26aulast%3DWang%26aufirst%3DWesley%2BWei%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D30072019%26date%3D19122019%26date%3D27112019%26volume%3D63%26issue%3D8%26spage%3D3834%26epage%3D3867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Rachel D. Slack, Therese C. Ku, Jianjing Cao, JoLynn B. Giancola, Alessandro Bonifazi, Claus J. Loland, Alexandra Gadiano, Jenny Lam, Rana Rais, Barbara S. Slusher, Mark Coggiano, Gianluigi Tanda, <span class="NLM_string-name hlFld-ContribAuthor">Amy Hauck Newman</span>. </span><span class="cited-content_cbyCitation_article-title">Structure–Activity Relationships for a Series of (Bis(4-fluorophenyl)methyl)sulfinyl Alkyl Alicyclic Amines at the Dopamine Transporter: Functionalizing the Terminal Nitrogen Affects Affinity, Selectivity, and Metabolic Stability. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (5)
                                     , 2343-2357. <a href="https://doi.org/10.1021/acs.jmedchem.9b01188" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01188</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01188%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure%2525E2%252580%252593Activity%252BRelationships%252Bfor%252Ba%252BSeries%252Bof%252B%252528Bis%2525284-fluorophenyl%252529methyl%252529sulfinyl%252BAlkyl%252BAlicyclic%252BAmines%252Bat%252Bthe%252BDopamine%252BTransporter%25253A%252BFunctionalizing%252Bthe%252BTerminal%252BNitrogen%252BAffects%252BAffinity%25252C%252BSelectivity%25252C%252Band%252BMetabolic%252BStability%26aulast%3DSlack%26aufirst%3DRachel%2BD.%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D23072019%26date%3D14112019%26date%3D29102019%26volume%3D63%26issue%3D5%26spage%3D2343%26epage%3D2357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Amy Hauck Newman</span>. </span><span class="cited-content_cbyCitation_article-title">A Medicinal Chemist’s Journey at the National Institutes of Health One Molecule at a Time. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (3)
                                     , 221-224. <a href="https://doi.org/10.1021/acsmedchemlett.9b00478" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00478</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00478&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00478%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DA%252BMedicinal%252BChemist%2525E2%252580%252599s%252BJourney%252Bat%252Bthe%252BNational%252BInstitutes%252Bof%252BHealth%252BOne%252BMolecule%252Bat%252Ba%252BTime%26aulast%3DNewman%26aufirst%3DAmy%2BHauck%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D3%26spage%3D221%26epage%3D224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Predrag Kalaba, Marija Ilić, Nilima Y. Aher, Vladimir Dragačević, Marcus Wieder, Martin Zehl, Judith Wackerlig, Stanislav Beyl, Simone B. Sartori, Karl Ebner, Alexander Roller, Natalie Lukic, Tetyana Beryozkina, Eduardo Rene Perez Gonzalez, Philip Neill, Jawad Akbar Khan, Vasiliy Bakulev, Johann Jakob Leban, Steffen Hering, Christian Pifl, Nicolas Singewald, Jana Lubec, Ernst Urban, Harald H. Sitte, Thierry Langer, <span class="NLM_string-name hlFld-ContribAuthor">Gert Lubec</span>. </span><span class="cited-content_cbyCitation_article-title">Structure–Activity Relationships of Novel Thiazole-Based Modafinil Analogues Acting at Monoamine Transporters. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (1)
                                     , 391-417. <a href="https://doi.org/10.1021/acs.jmedchem.9b01938" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01938</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01938%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure%2525E2%252580%252593Activity%252BRelationships%252Bof%252BNovel%252BThiazole-Based%252BModafinil%252BAnalogues%252BActing%252Bat%252BMonoamine%252BTransporters%26aulast%3DKalaba%26aufirst%3DPredrag%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D23112019%26date%3D30122019%26date%3D16122019%26volume%3D63%26issue%3D1%26spage%3D391%26epage%3D417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jacqueline
D. Keighron, Juliana C. Quarterman, Jianjing Cao, Emily M. DeMarco, Mark A. Coggiano, Apre Gleaves, Rachel D. Slack, Claudio Zanettini, Amy Hauck Newman, <span class="NLM_string-name hlFld-ContribAuthor">Gianluigi Tanda</span>. </span><span class="cited-content_cbyCitation_article-title">Effects of (R)-Modafinil and Modafinil Analogues on Dopamine Dynamics Assessed by Voltammetry and Microdialysis in the Mouse Nucleus Accumbens Shell. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (4)
                                     , 2012-2021. <a href="https://doi.org/10.1021/acschemneuro.8b00340" title="DOI URL">https://doi.org/10.1021/acschemneuro.8b00340</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.8b00340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.8b00340%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DEffects%252Bof%252B%252528R%252529-Modafinil%252Band%252BModafinil%252BAnalogues%252Bon%252BDopamine%252BDynamics%252BAssessed%252Bby%252BVoltammetry%252Band%252BMicrodialysis%252Bin%252Bthe%252BMouse%252BNucleus%252BAccumbens%252BShell%26aulast%3DKeighron%26aufirst%3DJacqueline%2BD.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D10072018%26date%3D15012019%26date%3D31012019%26date%3D15012019%26volume%3D10%26issue%3D4%26spage%3D2012%26epage%3D2021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Fabio Del Bello, Alessandro Bonifazi, Gianfabio Giorgioni, Carlo Cifani, Maria Vittoria Micioni Di Bonaventura, Riccardo Petrelli, Alessandro Piergentili, Stefano Fontana, Valerio Mammoli, Hideaki Yano, Rosanna Matucci, Giulio Vistoli, <span class="NLM_string-name hlFld-ContribAuthor">Wilma Quaglia</span>. </span><span class="cited-content_cbyCitation_article-title">1-[3-(4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1) as a Model for the Rational Design of a Novel Class of Brain Penetrant Ligands with High Affinity and Selectivity for Dopamine D4 Receptor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (8)
                                     , 3712-3725. <a href="https://doi.org/10.1021/acs.jmedchem.8b00265" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00265</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00265%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D1-%25255B3-%2525284-Butylpiperidin-1-yl%252529propyl%25255D-1%25252C2%25252C3%25252C4-tetrahydroquinolin-2-one%252B%25252877-LH-28-1%252529%252Bas%252Ba%252BModel%252Bfor%252Bthe%252BRational%252BDesign%252Bof%252Ba%252BNovel%252BClass%252Bof%252BBrain%252BPenetrant%252BLigands%252Bwith%252BHigh%252BAffinity%252Band%252BSelectivity%252Bfor%252BDopamine%252BD4%252BReceptor%26aulast%3DDel%2BBello%26aufirst%3DFabio%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D16022018%26date%3D06042018%26date%3D28032018%26volume%3D61%26issue%3D8%26spage%3D3712%26epage%3D3725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mu-Fa  Zou</span>, <span class="hlFld-ContribAuthor ">Jianjing  Cao</span>, <span class="hlFld-ContribAuthor ">Ara M.  Abramyan</span>, <span class="hlFld-ContribAuthor ">Theresa  Kopajtic</span>, <span class="hlFld-ContribAuthor ">Claudio  Zanettini</span>, <span class="hlFld-ContribAuthor ">Daryl A.  Guthrie</span>, <span class="hlFld-ContribAuthor ">Rana  Rais</span>, <span class="hlFld-ContribAuthor ">Barbara S.  Slusher</span>, <span class="hlFld-ContribAuthor ">Lei  Shi</span>, <span class="hlFld-ContribAuthor ">Claus J.  Loland</span>, and <span class="hlFld-ContribAuthor ">Amy Hauck  Newman</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure–Activity Relationship Studies on a Series of 3α-[Bis(4-fluorophenyl)methoxy]tropanes and 3α-[Bis(4-fluorophenyl)methylamino]tropanes As Novel Atypical Dopamine Transporter (DAT) Inhibitors for the Treatment of Cocaine Use Disorders. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (24)
                                     , 10172-10187. <a href="https://doi.org/10.1021/acs.jmedchem.7b01454" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01454</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01454%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure%2525E2%252580%252593Activity%252BRelationship%252BStudies%252Bon%252Ba%252BSeries%252Bof%252B3%2525CE%2525B1-%25255BBis%2525284-fluorophenyl%252529methoxy%25255Dtropanes%252Band%252B3%2525CE%2525B1-%25255BBis%2525284-fluorophenyl%252529methylamino%25255Dtropanes%252BAs%252BNovel%252BAtypical%252BDopamine%252BTransporter%252B%252528DAT%252529%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BCocaine%252BUse%252BDisorders%26aulast%3DZou%26aufirst%3DMu-Fa%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D29092017%26date%3D11122017%26date%3D28122017%26volume%3D60%26issue%3D24%26spage%3D10172%26epage%3D10187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Predrag  Kalaba</span>, <span class="hlFld-ContribAuthor ">Nilima Y.  Aher</span>, <span class="hlFld-ContribAuthor ">Marija  Ilić</span>, <span class="hlFld-ContribAuthor ">Vladimir  Dragačević</span>, <span class="hlFld-ContribAuthor ">Marcus  Wieder</span>, <span class="hlFld-ContribAuthor ">Andras G.  Miklosi</span>, <span class="hlFld-ContribAuthor ">Martin  Zehl</span>, <span class="hlFld-ContribAuthor ">Judith  Wackerlig</span>, <span class="hlFld-ContribAuthor ">Alexander  Roller</span>, <span class="hlFld-ContribAuthor ">Tetyana  Beryozkina</span>, <span class="hlFld-ContribAuthor ">Bojana  Radoman</span>, <span class="hlFld-ContribAuthor ">Sivaprakasam R.  Saroja</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Lindner</span>, <span class="hlFld-ContribAuthor ">Eduardo Perez  Gonzalez</span>, <span class="hlFld-ContribAuthor ">Vasiliy  Bakulev</span>, <span class="hlFld-ContribAuthor ">Johann Jakob  Leban</span>, <span class="hlFld-ContribAuthor ">Harald H.  Sitte</span>, <span class="hlFld-ContribAuthor ">Ernst  Urban</span>, <span class="hlFld-ContribAuthor ">Thierry  Langer</span>, and <span class="hlFld-ContribAuthor ">Gert  Lubec</span>  . </span><span class="cited-content_cbyCitation_article-title">Heterocyclic Analogues of Modafinil as Novel, Atypical Dopamine Transporter Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (22)
                                     , 9330-9348. <a href="https://doi.org/10.1021/acs.jmedchem.7b01313" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01313</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01313%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHeterocyclic%252BAnalogues%252Bof%252BModafinil%252Bas%252BNovel%25252C%252BAtypical%252BDopamine%252BTransporter%252BInhibitors%26aulast%3DKalaba%26aufirst%3DPredrag%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D06092017%26date%3D09112017%26date%3D22112017%26date%3D01112017%26volume%3D60%26issue%3D22%26spage%3D9330%26epage%3D9348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ara M.  Abramyan</span>, <span class="hlFld-ContribAuthor ">Sebastian  Stolzenberg</span>, <span class="hlFld-ContribAuthor ">Zheng  Li</span>, <span class="hlFld-ContribAuthor ">Claus J.  Loland</span>, <span class="hlFld-ContribAuthor ">Frank  Noé</span>, and <span class="hlFld-ContribAuthor ">Lei  Shi</span>  . </span><span class="cited-content_cbyCitation_article-title">The Isomeric Preference of an Atypical Dopamine Transporter Inhibitor Contributes to Its Selection of the Transporter Conformation. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2017,</strong> <em>8 </em>
                                    (8)
                                     , 1735-1746. <a href="https://doi.org/10.1021/acschemneuro.7b00094" title="DOI URL">https://doi.org/10.1021/acschemneuro.7b00094</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.7b00094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.7b00094%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DThe%252BIsomeric%252BPreference%252Bof%252Ban%252BAtypical%252BDopamine%252BTransporter%252BInhibitor%252BContributes%252Bto%252BIts%252BSelection%252Bof%252Bthe%252BTransporter%252BConformation%26aulast%3DAbramyan%26aufirst%3DAra%2BM.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D10032017%26date%3D25042017%26date%3D04052017%26date%3D16082017%26date%3D25042017%26volume%3D8%26issue%3D8%26spage%3D1735%26epage%3D1746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David J  Heal</span>, <span class="hlFld-ContribAuthor ">Sharon L  Smith</span>. </span><span class="cited-content_cbyCitation_article-title">Prospects for new drugs to treat binge-eating disorder: Insights from psychopathology and neuropharmacology. </span><span class="cited-content_cbyCitation_journal-name">Journal of Psychopharmacology</span><span> <strong>2021,</strong> <em>85 </em>, 026988112110324. <a href="https://doi.org/10.1177/02698811211032475" title="DOI URL">https://doi.org/10.1177/02698811211032475</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/02698811211032475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F02698811211032475%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Psychopharmacology%26atitle%3DProspects%252Bfor%252Bnew%252Bdrugs%252Bto%252Btreat%252Bbinge-eating%252Bdisorder%25253A%252BInsights%252Bfrom%252Bpsychopathology%252Band%252Bneuropharmacology%26aulast%3DHeal%26aufirst%3DDavid%2BJ%26date%3D2021%26date%3D2021%26volume%3D85%26spage%3D026988112110324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Melinda  Hersey</span>, <span class="hlFld-ContribAuthor ">Amanda K.  Bacon</span>, <span class="hlFld-ContribAuthor ">Lydia G.  Bailey</span>, <span class="hlFld-ContribAuthor ">Mark A.  Coggiano</span>, <span class="hlFld-ContribAuthor ">Amy H.  Newman</span>, <span class="hlFld-ContribAuthor ">Lorenzo  Leggio</span>, <span class="hlFld-ContribAuthor ">Gianluigi  Tanda</span>. </span><span class="cited-content_cbyCitation_article-title">Psychostimulant Use Disorder, an Unmet Therapeutic Goal: Can Modafinil Narrow the Gap?. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Neuroscience</span><span> <strong>2021,</strong> <em>15 </em><a href="https://doi.org/10.3389/fnins.2021.656475" title="DOI URL">https://doi.org/10.3389/fnins.2021.656475</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnins.2021.656475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnins.2021.656475%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Neuroscience%26atitle%3DPsychostimulant%252BUse%252BDisorder%25252C%252Ban%252BUnmet%252BTherapeutic%252BGoal%25253A%252BCan%252BModafinil%252BNarrow%252Bthe%252BGap%25253F%26aulast%3DHersey%26aufirst%3DMelinda%26date%3D2021%26date%3D2021%26volume%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gianluigi  Tanda</span>, <span class="hlFld-ContribAuthor ">Melinda  Hersey</span>, <span class="hlFld-ContribAuthor ">Briana  Hempel</span>, <span class="hlFld-ContribAuthor ">Zheng-Xiong  Xi</span>, <span class="hlFld-ContribAuthor ">Amy Hauck  Newman</span>. </span><span class="cited-content_cbyCitation_article-title">Modafinil and its structural analogs as atypical dopamine uptake inhibitors and potential medications for psychostimulant use disorder. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Pharmacology</span><span> <strong>2021,</strong> <em>56 </em>, 13-21. <a href="https://doi.org/10.1016/j.coph.2020.07.007" title="DOI URL">https://doi.org/10.1016/j.coph.2020.07.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.coph.2020.07.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.coph.2020.07.007%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Pharmacology%26atitle%3DModafinil%252Band%252Bits%252Bstructural%252Banalogs%252Bas%252Batypical%252Bdopamine%252Buptake%252Binhibitors%252Band%252Bpotential%252Bmedications%252Bfor%252Bpsychostimulant%252Buse%252Bdisorder%26aulast%3DTanda%26aufirst%3DGianluigi%26date%3D2021%26volume%3D56%26spage%3D13%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amy Hauck  Newman</span>, <span class="hlFld-ContribAuthor ">Therese  Ku</span>, <span class="hlFld-ContribAuthor ">Chloe J.  Jordan</span>, <span class="hlFld-ContribAuthor ">Alessandro  Bonifazi</span>, <span class="hlFld-ContribAuthor ">Zheng-Xiong  Xi</span>. </span><span class="cited-content_cbyCitation_article-title">New Drugs, Old Targets: Tweaking the Dopamine System to Treat Psychostimulant Use Disorders. </span><span class="cited-content_cbyCitation_journal-name">Annual Review of Pharmacology and Toxicology</span><span> <strong>2021,</strong> <em>61 </em>
                                    (1)
                                     , 609-628. <a href="https://doi.org/10.1146/annurev-pharmtox-030220-124205" title="DOI URL">https://doi.org/10.1146/annurev-pharmtox-030220-124205</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1146/annurev-pharmtox-030220-124205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1146%2Fannurev-pharmtox-030220-124205%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnual%2520Review%2520of%2520Pharmacology%2520and%2520Toxicology%26atitle%3DNew%252BDrugs%25252C%252BOld%252BTargets%25253A%252BTweaking%252Bthe%252BDopamine%252BSystem%252Bto%252BTreat%252BPsychostimulant%252BUse%252BDisorders%26aulast%3DNewman%26aufirst%3DAmy%2BHauck%26date%3D2021%26volume%3D61%26issue%3D1%26spage%3D609%26epage%3D628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">JoLynn B.  Giancola</span>, <span class="hlFld-ContribAuthor ">Alessandro  Bonifazi</span>, <span class="hlFld-ContribAuthor ">Jianjing  Cao</span>, <span class="hlFld-ContribAuthor ">Therese  Ku</span>, <span class="hlFld-ContribAuthor ">Alexandra J.  Haraczy</span>, <span class="hlFld-ContribAuthor ">Jenny  Lam</span>, <span class="hlFld-ContribAuthor ">Rana  Rais</span>, <span class="hlFld-ContribAuthor ">Mark A.  Coggiano</span>, <span class="hlFld-ContribAuthor ">Gianluigi  Tanda</span>, <span class="hlFld-ContribAuthor ">Amy Hauck  Newman</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-activity relationships for a series of (Bis(4-fluorophenyl)methyl)sulfinylethyl-aminopiperidines and -piperidine amines at the dopamine transporter: Bioisosteric replacement of the piperazine improves metabolic stability. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>208 </em>, 112674. <a href="https://doi.org/10.1016/j.ejmech.2020.112674" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112674</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112674%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-activity%252Brelationships%252Bfor%252Ba%252Bseries%252Bof%252B%252528Bis%2525284-fluorophenyl%252529methyl%252529sulfinylethyl-aminopiperidines%252Band%252B-piperidine%252Bamines%252Bat%252Bthe%252Bdopamine%252Btransporter%25253A%252BBioisosteric%252Breplacement%252Bof%252Bthe%252Bpiperazine%252Bimproves%252Bmetabolic%252Bstability%26aulast%3DGiancola%26aufirst%3DJoLynn%2BB.%26date%3D2020%26volume%3D208%26spage%3D112674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Renee A.  Rotolo</span>, <span class="hlFld-ContribAuthor ">Predrag  Kalaba</span>, <span class="hlFld-ContribAuthor ">Vladimir  Dragacevic</span>, <span class="hlFld-ContribAuthor ">Rose E.  Presby</span>, <span class="hlFld-ContribAuthor ">Julia  Neri</span>, <span class="hlFld-ContribAuthor ">Emily  Robertson</span>, <span class="hlFld-ContribAuthor ">Jen-Hau  Yang</span>, <span class="hlFld-ContribAuthor ">Merce  Correa</span>, <span class="hlFld-ContribAuthor ">Vasiliy  Bakulev</span>, <span class="hlFld-ContribAuthor ">Natalia N.  Volkova</span>, <span class="hlFld-ContribAuthor ">Christian  Pifl</span>, <span class="hlFld-ContribAuthor ">Gert  Lubec</span>, <span class="hlFld-ContribAuthor ">John D.  Salamone</span>. </span><span class="cited-content_cbyCitation_article-title">Behavioral and dopamine transporter binding properties of the modafinil analog (S, S)-CE-158: reversal of the motivational effects of tetrabenazine and enhancement of progressive ratio responding. </span><span class="cited-content_cbyCitation_journal-name">Psychopharmacology</span><span> <strong>2020,</strong> <em>237 </em>
                                    (11)
                                     , 3459-3470. <a href="https://doi.org/10.1007/s00213-020-05625-6" title="DOI URL">https://doi.org/10.1007/s00213-020-05625-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00213-020-05625-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00213-020-05625-6%26sid%3Dliteratum%253Aachs%26jtitle%3DPsychopharmacology%26atitle%3DBehavioral%252Band%252Bdopamine%252Btransporter%252Bbinding%252Bproperties%252Bof%252Bthe%252Bmodafinil%252Banalog%252B%252528S%25252C%252BS%252529-CE-158%25253A%252Breversal%252Bof%252Bthe%252Bmotivational%252Beffects%252Bof%252Btetrabenazine%252Band%252Benhancement%252Bof%252Bprogressive%252Bratio%252Bresponding%26aulast%3DRotolo%26aufirst%3DRenee%2BA.%26date%3D2020%26date%3D2020%26volume%3D237%26issue%3D11%26spage%3D3459%26epage%3D3470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carl A  Roberts</span>, <span class="hlFld-ContribAuthor ">Andrew  Jones</span>, <span class="hlFld-ContribAuthor ">Harry  Sumnall</span>, <span class="hlFld-ContribAuthor ">Suzanne H  Gage</span>, <span class="hlFld-ContribAuthor ">Catharine  Montgomery</span>. </span><span class="cited-content_cbyCitation_article-title">How effective are pharmaceuticals for cognitive enhancement in healthy adults? A series of meta-analyses of cognitive performance during acute administration of modafinil, methylphenidate and D-amphetamine. </span><span class="cited-content_cbyCitation_journal-name">European Neuropsychopharmacology</span><span> <strong>2020,</strong> <em>38 </em>, 40-62. <a href="https://doi.org/10.1016/j.euroneuro.2020.07.002" title="DOI URL">https://doi.org/10.1016/j.euroneuro.2020.07.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.euroneuro.2020.07.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.euroneuro.2020.07.002%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Neuropsychopharmacology%26atitle%3DHow%252Beffective%252Bare%252Bpharmaceuticals%252Bfor%252Bcognitive%252Benhancement%252Bin%252Bhealthy%252Badults%25253F%252BA%252Bseries%252Bof%252Bmeta-analyses%252Bof%252Bcognitive%252Bperformance%252Bduring%252Bacute%252Badministration%252Bof%252Bmodafinil%25252C%252Bmethylphenidate%252Band%252BD-amphetamine%26aulast%3DRoberts%26aufirst%3DCarl%2BA%26date%3D2020%26volume%3D38%26spage%3D40%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ana  Sousa</span>, <span class="hlFld-ContribAuthor ">Ricardo Jorge  Dinis-Oliveira</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacokinetic and pharmacodynamic of the cognitive enhancer modafinil: Relevant clinical and forensic aspects. </span><span class="cited-content_cbyCitation_journal-name">Substance Abuse</span><span> <strong>2020,</strong> <em>41 </em>
                                    (2)
                                     , 155-173. <a href="https://doi.org/10.1080/08897077.2019.1700584" title="DOI URL">https://doi.org/10.1080/08897077.2019.1700584</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/08897077.2019.1700584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F08897077.2019.1700584%26sid%3Dliteratum%253Aachs%26jtitle%3DSubstance%2520Abuse%26atitle%3DPharmacokinetic%252Band%252Bpharmacodynamic%252Bof%252Bthe%252Bcognitive%252Benhancer%252Bmodafinil%25253A%252BRelevant%252Bclinical%252Band%252Bforensic%252Baspects%26aulast%3DSousa%26aufirst%3DAna%26date%3D2020%26date%3D2020%26volume%3D41%26issue%3D2%26spage%3D155%26epage%3D173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Danielle B.  Cross</span>, <span class="hlFld-ContribAuthor ">Jonathan  Tiu</span>, <span class="hlFld-ContribAuthor ">Chaitanya  Medicherla</span>, <span class="hlFld-ContribAuthor ">Koto  Ishida</span>, <span class="hlFld-ContribAuthor ">Aaron  Lord</span>, <span class="hlFld-ContribAuthor ">Barry  Czeisler</span>, <span class="hlFld-ContribAuthor ">Christopher  Wu</span>, <span class="hlFld-ContribAuthor ">Danielle  Golub</span>, <span class="hlFld-ContribAuthor ">Amabel  Karoub</span>, <span class="hlFld-ContribAuthor ">Christopher  Hernandez</span>, <span class="hlFld-ContribAuthor ">Shadi  Yaghi</span>, <span class="hlFld-ContribAuthor ">Jose  Torres</span>. </span><span class="cited-content_cbyCitation_article-title">Modafinil in Recovery after Stroke (MIRAS): A Retrospective Study. </span><span class="cited-content_cbyCitation_journal-name">Journal of Stroke and Cerebrovascular Diseases</span><span> <strong>2020,</strong> <em>29 </em>
                                    (4)
                                     , 104645. <a href="https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.104645" title="DOI URL">https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.104645</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jstrokecerebrovasdis.2020.104645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jstrokecerebrovasdis.2020.104645%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Stroke%2520and%2520Cerebrovascular%2520Diseases%26atitle%3DModafinil%252Bin%252BRecovery%252Bafter%252BStroke%252B%252528MIRAS%252529%25253A%252BA%252BRetrospective%252BStudy%26aulast%3DCross%26aufirst%3DDanielle%2BB.%26date%3D2020%26volume%3D29%26issue%3D4%26spage%3D104645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mariama  Jaiteh</span>, <span class="hlFld-ContribAuthor ">Ismael  Rodríguez-Espigares</span>, <span class="hlFld-ContribAuthor ">Jana  Selent</span>, <span class="hlFld-ContribAuthor ">Jens  Carlsson</span>, . </span><span class="cited-content_cbyCitation_article-title">Performance of virtual screening against GPCR homology models: Impact of template selection and treatment of binding site plasticity. </span><span class="cited-content_cbyCitation_journal-name">PLOS Computational Biology</span><span> <strong>2020,</strong> <em>16 </em>
                                    (3)
                                     , e1007680. <a href="https://doi.org/10.1371/journal.pcbi.1007680" title="DOI URL">https://doi.org/10.1371/journal.pcbi.1007680</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pcbi.1007680&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pcbi.1007680%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520Computational%2520Biology%26atitle%3DPerformance%252Bof%252Bvirtual%252Bscreening%252Bagainst%252BGPCR%252Bhomology%252Bmodels%25253A%252BImpact%252Bof%252Btemplate%252Bselection%252Band%252Btreatment%252Bof%252Bbinding%252Bsite%252Bplasticity%26aulast%3DJaiteh%26aufirst%3DMariama%26date%3D2020%26date%3D2020%26volume%3D16%26issue%3D3%26spage%3De1007680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahmet Sureyya  Rifaioglu</span>, <span class="hlFld-ContribAuthor ">Esra  Nalbat</span>, <span class="hlFld-ContribAuthor ">Volkan  Atalay</span>, <span class="hlFld-ContribAuthor ">Maria Jesus  Martin</span>, <span class="hlFld-ContribAuthor ">Rengul  Cetin-Atalay</span>, <span class="hlFld-ContribAuthor ">Tunca  Doğan</span>. </span><span class="cited-content_cbyCitation_article-title">DEEPScreen: high performance drug–target interaction prediction with convolutional neural networks using 2-D structural compound representations. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2020,</strong> <em>11 </em>
                                    (9)
                                     , 2531-2557. <a href="https://doi.org/10.1039/C9SC03414E" title="DOI URL">https://doi.org/10.1039/C9SC03414E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9SC03414E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9SC03414E%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DDEEPScreen%25253A%252Bhigh%252Bperformance%252Bdrug%2525E2%252580%252593target%252Binteraction%252Bprediction%252Bwith%252Bconvolutional%252Bneural%252Bnetworks%252Busing%252B2-D%252Bstructural%252Bcompound%252Brepresentations%26aulast%3DRifaioglu%26aufirst%3DAhmet%2BSureyya%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D9%26spage%3D2531%26epage%3D2557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chloe J.  Jordan</span>, <span class="hlFld-ContribAuthor ">Jianjing  Cao</span>, <span class="hlFld-ContribAuthor ">Amy Hauck  Newman</span>, <span class="hlFld-ContribAuthor ">Zheng-Xiong  Xi</span>. </span><span class="cited-content_cbyCitation_article-title">Progress in agonist therapy for substance use disorders: Lessons learned from methadone and buprenorphine. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2019,</strong> <em>158 </em>, 107609. <a href="https://doi.org/10.1016/j.neuropharm.2019.04.015" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2019.04.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2019.04.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2019.04.015%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DProgress%252Bin%252Bagonist%252Btherapy%252Bfor%252Bsubstance%252Buse%252Bdisorders%25253A%252BLessons%252Blearned%252Bfrom%252Bmethadone%252Band%252Bbuprenorphine%26aulast%3DJordan%26aufirst%3DChloe%2BJ.%26date%3D2019%26volume%3D158%26spage%3D107609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jacqueline D.  Keighron</span>, <span class="hlFld-ContribAuthor ">JoLynn B.  Giancola</span>, <span class="hlFld-ContribAuthor ">Rachel J.  Shaffer</span>, <span class="hlFld-ContribAuthor ">Emily M.  DeMarco</span>, <span class="hlFld-ContribAuthor ">Mark A.  Coggiano</span>, <span class="hlFld-ContribAuthor ">Rachel D.  Slack</span>, <span class="hlFld-ContribAuthor ">Amy Hauck  Newman</span>, <span class="hlFld-ContribAuthor ">Gianluigi  Tanda</span>. </span><span class="cited-content_cbyCitation_article-title">Distinct effects of (
              R
              )‐modafinil and its (
              R
              )‐ and (
              S
              )‐fluoro‐analogs on mesolimbic extracellular dopamine assessed by voltammetry and microdialysis in rats. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Neuroscience</span><span> <strong>2019,</strong> <em>50 </em>
                                    (3)
                                     , 2045-2053. <a href="https://doi.org/10.1111/ejn.14256" title="DOI URL">https://doi.org/10.1111/ejn.14256</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/ejn.14256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fejn.14256%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Neuroscience%26atitle%3DDistinct%252Beffects%252Bof%252B%252528%252BR%252B%252529%2525E2%252580%252590modafinil%252Band%252Bits%252B%252528%252BR%252B%252529%2525E2%252580%252590%252Band%252B%252528%252BS%252B%252529%2525E2%252580%252590fluoro%2525E2%252580%252590analogs%252Bon%252Bmesolimbic%252Bextracellular%252Bdopamine%252Bassessed%252Bby%252Bvoltammetry%252Band%252Bmicrodialysis%252Bin%252Brats%26aulast%3DKeighron%26aufirst%3DJacqueline%2BD.%26date%3D2019%26date%3D2018%26volume%3D50%26issue%3D3%26spage%3D2045%26epage%3D2053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amy Hauck  Newman</span>, <span class="hlFld-ContribAuthor ">Jianjing  Cao</span>, <span class="hlFld-ContribAuthor ">Jacqueline D.  Keighron</span>, <span class="hlFld-ContribAuthor ">Chloe J.  Jordan</span>, <span class="hlFld-ContribAuthor ">Guo-Hua  Bi</span>, <span class="hlFld-ContribAuthor ">Ying  Liang</span>, <span class="hlFld-ContribAuthor ">Ara M.  Abramyan</span>, <span class="hlFld-ContribAuthor ">Alicia J.  Avelar</span>, <span class="hlFld-ContribAuthor ">Christopher W.  Tschumi</span>, <span class="hlFld-ContribAuthor ">Michael J.  Beckstead</span>, <span class="hlFld-ContribAuthor ">Lei  Shi</span>, <span class="hlFld-ContribAuthor ">Gianluigi  Tanda</span>, <span class="hlFld-ContribAuthor ">Zheng-Xiong  Xi</span>. </span><span class="cited-content_cbyCitation_article-title">Translating the atypical dopamine uptake inhibitor hypothesis toward therapeutics for treatment of psychostimulant use disorders. </span><span class="cited-content_cbyCitation_journal-name">Neuropsychopharmacology</span><span> <strong>2019,</strong> <em>44 </em>
                                    (8)
                                     , 1435-1444. <a href="https://doi.org/10.1038/s41386-019-0366-z" title="DOI URL">https://doi.org/10.1038/s41386-019-0366-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41386-019-0366-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41386-019-0366-z%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropsychopharmacology%26atitle%3DTranslating%252Bthe%252Batypical%252Bdopamine%252Buptake%252Binhibitor%252Bhypothesis%252Btoward%252Btherapeutics%252Bfor%252Btreatment%252Bof%252Bpsychostimulant%252Buse%252Bdisorders%26aulast%3DNewman%26aufirst%3DAmy%2BHauck%26date%3D2019%26date%3D2019%26volume%3D44%26issue%3D8%26spage%3D1435%26epage%3D1444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shreyas  Bhat</span>, <span class="hlFld-ContribAuthor ">Amy Hauck  Newman</span>, <span class="hlFld-ContribAuthor ">Michael  Freissmuth</span>. </span><span class="cited-content_cbyCitation_article-title">How to rescue misfolded SERT, DAT and NET: targeting conformational intermediates with atypical inhibitors and partial releasers. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Society Transactions</span><span> <strong>2019,</strong> <em>47 </em>
                                    (3)
                                     , 861-874. <a href="https://doi.org/10.1042/BST20180512" title="DOI URL">https://doi.org/10.1042/BST20180512</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/BST20180512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FBST20180512%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Society%2520Transactions%26atitle%3DHow%252Bto%252Brescue%252Bmisfolded%252BSERT%25252C%252BDAT%252Band%252BNET%25253A%252Btargeting%252Bconformational%252Bintermediates%252Bwith%252Batypical%252Binhibitors%252Band%252Bpartial%252Breleasers%26aulast%3DBhat%26aufirst%3DShreyas%26date%3D2019%26date%3D2019%26volume%3D47%26issue%3D3%26spage%3D861%26epage%3D874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Renee A.  Rotolo</span>, <span class="hlFld-ContribAuthor ">Vladimir  Dragacevic</span>, <span class="hlFld-ContribAuthor ">Predrag  Kalaba</span>, <span class="hlFld-ContribAuthor ">Ernst  Urban</span>, <span class="hlFld-ContribAuthor ">Martin  Zehl</span>, <span class="hlFld-ContribAuthor ">Alexander  Roller</span>, <span class="hlFld-ContribAuthor ">Judith  Wackerlig</span>, <span class="hlFld-ContribAuthor ">Thierry  Langer</span>, <span class="hlFld-ContribAuthor ">Marco  Pistis</span>, <span class="hlFld-ContribAuthor ">Maria Antonietta  De Luca</span>, <span class="hlFld-ContribAuthor ">Francesca  Caria</span>, <span class="hlFld-ContribAuthor ">Rebecca  Schwartz</span>, <span class="hlFld-ContribAuthor ">Rose E.  Presby</span>, <span class="hlFld-ContribAuthor ">Jen-Hau  Yang</span>, <span class="hlFld-ContribAuthor ">Shanna  Samels</span>, <span class="hlFld-ContribAuthor ">Merce  Correa</span>, <span class="hlFld-ContribAuthor ">Gert  Lubec</span>, <span class="hlFld-ContribAuthor ">John D.  Salamone</span>. </span><span class="cited-content_cbyCitation_article-title">The Novel Atypical Dopamine Uptake Inhibitor (S)-CE-123 Partially Reverses the Effort-Related Effects of the Dopamine Depleting Agent Tetrabenazine and Increases Progressive Ratio Responding. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2019,</strong> <em>10 </em><a href="https://doi.org/10.3389/fphar.2019.00682" title="DOI URL">https://doi.org/10.3389/fphar.2019.00682</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2019.00682&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2019.00682%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DThe%252BNovel%252BAtypical%252BDopamine%252BUptake%252BInhibitor%252B%252528S%252529-CE-123%252BPartially%252BReverses%252Bthe%252BEffort-Related%252BEffects%252Bof%252Bthe%252BDopamine%252BDepleting%252BAgent%252BTetrabenazine%252Band%252BIncreases%252BProgressive%252BRatio%252BResponding%26aulast%3DRotolo%26aufirst%3DRenee%2BA.%26date%3D2019%26date%3D2019%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael J.  Tomlinson</span>, <span class="hlFld-ContribAuthor ">Danielle  Krout</span>, <span class="hlFld-ContribAuthor ">Akula Bala  Pramod</span>, <span class="hlFld-ContribAuthor ">John R.  Lever</span>, <span class="hlFld-ContribAuthor ">Amy Hauck  Newman</span>, <span class="hlFld-ContribAuthor ">L. Keith  Henry</span>, <span class="hlFld-ContribAuthor ">Roxanne A.  Vaughan</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of the benztropine analog [125I]GA II 34 binding site on the human dopamine transporter. </span><span class="cited-content_cbyCitation_journal-name">Neurochemistry International</span><span> <strong>2019,</strong> <em>123 </em>, 34-45. <a href="https://doi.org/10.1016/j.neuint.2018.08.008" title="DOI URL">https://doi.org/10.1016/j.neuint.2018.08.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuint.2018.08.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuint.2018.08.008%26sid%3Dliteratum%253Aachs%26jtitle%3DNeurochemistry%2520International%26atitle%3DIdentification%252Bof%252Bthe%252Bbenztropine%252Banalog%252B%25255B125I%25255DGA%252BII%252B34%252Bbinding%252Bsite%252Bon%252Bthe%252Bhuman%252Bdopamine%252Btransporter%26aulast%3DTomlinson%26aufirst%3DMichael%2BJ.%26date%3D2019%26volume%3D123%26spage%3D34%26epage%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brendan J.  Tunstall</span>, <span class="hlFld-ContribAuthor ">Chelsea P.  Ho</span>, <span class="hlFld-ContribAuthor ">Jianjing  Cao</span>, <span class="hlFld-ContribAuthor ">Janaína C.M.  Vendruscolo</span>, <span class="hlFld-ContribAuthor ">Brooke E.  Schmeichel</span>, <span class="hlFld-ContribAuthor ">Rachel D.  Slack</span>, <span class="hlFld-ContribAuthor ">Gianluigi  Tanda</span>, <span class="hlFld-ContribAuthor ">Alexandra J.  Gadiano</span>, <span class="hlFld-ContribAuthor ">Rana  Rais</span>, <span class="hlFld-ContribAuthor ">Barbara S.  Slusher</span>, <span class="hlFld-ContribAuthor ">George F.  Koob</span>, <span class="hlFld-ContribAuthor ">Amy H.  Newman</span>, <span class="hlFld-ContribAuthor ">Leandro F.  Vendruscolo</span>. </span><span class="cited-content_cbyCitation_article-title">Atypical dopamine transporter inhibitors attenuate compulsive-like methamphetamine self-administration in rats. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2018,</strong> <em>131 </em>, 96-103. <a href="https://doi.org/10.1016/j.neuropharm.2017.12.006" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2017.12.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2017.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2017.12.006%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DAtypical%252Bdopamine%252Btransporter%252Binhibitors%252Battenuate%252Bcompulsive-like%252Bmethamphetamine%252Bself-administration%252Bin%252Brats%26aulast%3DTunstall%26aufirst%3DBrendan%2BJ.%26date%3D2018%26volume%3D131%26spage%3D96%26epage%3D103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rohit B.  Kamble</span>, <span class="hlFld-ContribAuthor ">Dattatraya  Devalankar</span>, <span class="hlFld-ContribAuthor ">Gurunath  Suryavanshi</span>. </span><span class="cited-content_cbyCitation_article-title">Two stereocentered HKR of
              anti
              -β,β′-diphenylpropanoxirane and
              anti
              -3-phenylethyloxiranes catalysed by Co(
              iii
              )(salen)-OAc complex: enantioselective synthesis of (+)-sertraline and (+)-naproxen. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2018,</strong> <em>42 </em>
                                    (12)
                                     , 10414-10420. <a href="https://doi.org/10.1039/C8NJ01616J" title="DOI URL">https://doi.org/10.1039/C8NJ01616J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8NJ01616J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8NJ01616J%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DTwo%252Bstereocentered%252BHKR%252Bof%252Banti%252B-%2525CE%2525B2%25252C%2525CE%2525B2%2525E2%252580%2525B2-diphenylpropanoxirane%252Band%252Banti%252B-3-phenylethyloxiranes%252Bcatalysed%252Bby%252BCo%252528%252Biii%252B%252529%252528salen%252529-OAc%252Bcomplex%25253A%252Benantioselective%252Bsynthesis%252Bof%252B%252528%25252B%252529-sertraline%252Band%252B%252528%25252B%252529-naproxen%26aulast%3DKamble%26aufirst%3DRohit%2BB.%26date%3D2018%26date%3D2018%26volume%3D42%26issue%3D12%26spage%3D10414%26epage%3D10420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alicia J.  Avelar</span>, <span class="hlFld-ContribAuthor ">Jianjing  Cao</span>, <span class="hlFld-ContribAuthor ">Amy Hauck  Newman</span>, <span class="hlFld-ContribAuthor ">Michael J.  Beckstead</span>. </span><span class="cited-content_cbyCitation_article-title">Atypical dopamine transporter inhibitors R-modafinil and JHW 007 differentially affect D2 autoreceptor neurotransmission and the firing rate of midbrain dopamine neurons. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2017,</strong> <em>123 </em>, 410-419. <a href="https://doi.org/10.1016/j.neuropharm.2017.06.016" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2017.06.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2017.06.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2017.06.016%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DAtypical%252Bdopamine%252Btransporter%252Binhibitors%252BR-modafinil%252Band%252BJHW%252B007%252Bdifferentially%252Baffect%252BD2%252Bautoreceptor%252Bneurotransmission%252Band%252Bthe%252Bfiring%252Brate%252Bof%252Bmidbrain%252Bdopamine%252Bneurons%26aulast%3DAvelar%26aufirst%3DAlicia%2BJ.%26date%3D2017%26volume%3D123%26spage%3D410%26epage%3D419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hai-Ying  Zhang</span>, <span class="hlFld-ContribAuthor ">Guo-Hua  Bi</span>, <span class="hlFld-ContribAuthor ">Hong-Ju  Yang</span>, <span class="hlFld-ContribAuthor ">Yi  He</span>, <span class="hlFld-ContribAuthor ">Gilbert  Xue</span>, <span class="hlFld-ContribAuthor ">Jiajing  Cao</span>, <span class="hlFld-ContribAuthor ">Gianluigi  Tanda</span>, <span class="hlFld-ContribAuthor ">Eliot L  Gardner</span>, <span class="hlFld-ContribAuthor ">Amy Hauck  Newman</span>, <span class="hlFld-ContribAuthor ">Zheng-Xiong  Xi</span>. </span><span class="cited-content_cbyCitation_article-title">The Novel Modafinil Analog, JJC8-016, as a Potential Cocaine Abuse Pharmacotherapeutic. </span><span class="cited-content_cbyCitation_journal-name">Neuropsychopharmacology</span><span> <strong>2017,</strong> <em>42 </em>
                                    (9)
                                     , 1871-1883. <a href="https://doi.org/10.1038/npp.2017.41" title="DOI URL">https://doi.org/10.1038/npp.2017.41</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/npp.2017.41&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnpp.2017.41%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropsychopharmacology%26atitle%3DThe%252BNovel%252BModafinil%252BAnalog%25252C%252BJJC8-016%25252C%252Bas%252Ba%252BPotential%252BCocaine%252BAbuse%252BPharmacotherapeutic%26aulast%3DZhang%26aufirst%3DHai-Ying%26date%3D2017%26date%3D2017%26volume%3D42%26issue%3D9%26spage%3D1871%26epage%3D1883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kirsten C.  Morley</span>, <span class="hlFld-ContribAuthor ">Jennifer L.  Cornish</span>, <span class="hlFld-ContribAuthor ">Alon  Faingold</span>, <span class="hlFld-ContribAuthor ">Katie  Wood</span>, <span class="hlFld-ContribAuthor ">Paul S.  Haber</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacotherapeutic agents in the treatment of methamphetamine dependence. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2017,</strong> <em>26 </em>
                                    (5)
                                     , 563-578. <a href="https://doi.org/10.1080/13543784.2017.1313229" title="DOI URL">https://doi.org/10.1080/13543784.2017.1313229</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543784.2017.1313229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543784.2017.1313229%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DPharmacotherapeutic%252Bagents%252Bin%252Bthe%252Btreatment%252Bof%252Bmethamphetamine%252Bdependence%26aulast%3DMorley%26aufirst%3DKirsten%2BC.%26date%3D2017%26date%3D2017%26volume%3D26%26issue%3D5%26spage%3D563%26epage%3D578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/medium/jm-2016-01373u_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/large/jm-2016-01373u_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01373&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/medium/jm-2016-01373u_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/large/jm-2016-01373u_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of known DAT inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/large/jm-2016-01373u_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01373&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/medium/jm-2016-01373u_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/large/jm-2016-01373u_0007.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>8a</b>–<b>8k</b> and <b>9a</b>–<b>9i</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/large/jm-2016-01373u_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01373&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) TFA, CH<sub>2</sub>Cl<sub>2</sub>, r.t. overnight; (ii) K<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O/acetone, overnight; (b) PPh<sub>3</sub>, CBr<sub>4</sub>, CH<sub>3</sub>CN, r.t. overnight; (c) appropriate piperazine, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux, overnight; (d) H<sub>2</sub>O<sub>2</sub>, AcOH/MeOH, 40 °C, overnight.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/medium/jm-2016-01373u_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/large/jm-2016-01373u_0008.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>10a</b>,<b>b</b> and <b>11a</b>,<b>b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/large/jm-2016-01373u_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01373&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2-benzyloxirane, isopropanol, reflux, overnight; (b) H<sub>2</sub>O<sub>2</sub>, AcOH/MeOH, 40 °C, overnight.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/medium/jm-2016-01373u_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/large/jm-2016-01373u_0009.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compounds <b>13a</b>–<b>g</b> and <b>14 a</b>–<b>g</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/large/jm-2016-01373u_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01373&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) THF, CDI, r.t. 2 h; (ii) substituted piperazine analogue, THF, r.t. overnight; (b) (i) SOCl<sub>2</sub>, reflux, 2 h; (ii) appropriate piperazine; (c) H<sub>2</sub>O<sub>2</sub>, AcOH/MeOH, 40 °C, overnight.</p></p></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/medium/jm-2016-01373u_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/large/jm-2016-01373u_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Inhibition potency of [<sup>3</sup>H]DA uptake by modafinil analogues and cocaine. COS7 cells transiently expressing DAT wild type were incubated with [<sup>3</sup>H]DA at the indicated concentrations of <b>4</b> (green), <b>8d</b> (brown), <b>9d</b> (magenta), <b>11b</b> (black), and cocaine (cyan). The inhibition potency of <b>2</b> as assessed previously<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> is inserted for comparison (dotted line). Data are the means ± SEM of 3–10 experiments performed in triplicate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/large/jm-2016-01373u_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01373&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/medium/jm-2016-01373u_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/large/jm-2016-01373u_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Assessment of DAT binding profiles by modafinil analogues. As demonstrated previously,<a onclick="showRef(event, 'ref13 ref43'); return false;" href="javascript:void(0);" class="ref ref13 ref43">(13, 43)</a> a characteristic feature for atypical DAT inhibitors is that, in contrast to cocaine, their binding depends on the presence of the OH-group on Tyr156. Inhibition of [<sup>3</sup>H]WIN35,428 binding to DAT WT (black) or the Y156F (green) mutant by (A) cocaine, (B) <b>2</b>, (C) <b>4</b>, and (D) <b>11b</b>. The fold change in IC<sub>50</sub> values between WT and Y156F is 1.4, 10, 2.8, and 14.9 for cocaine, <b>2</b>, <b>4</b>, and <b>11b</b>, respectively. Binding assays are performed as triplicates on COS7 cells transiently expressing DAT WT or Y156F (<i>n</i> = 3–6). Data are shown as the means ± SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/large/jm-2016-01373u_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01373&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/medium/jm-2016-01373u_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/large/jm-2016-01373u_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Phase I metabolic stability of selected analogues in mouse liver microsomes. Compounds <b>8d</b>, <b>9d</b>, and <b>11b</b> were tested in mouse liver microsomes fortified with NADPH. Compounds <b>8d</b> and <b>9d</b> both showed slow metabolism with a half-life of approximately 60 min suggesting the compounds to be stable. Compound <b>11b</b>, on the contrary, had a much shorter half-life of 13 min suggesting rapid metabolism. Note: control experiments without cofactors were conducted in parallel, and in all cases, >95% compound remained at 60 min suggesting that the compounds were undergoing Cyp dependent metabolism. Testosterone was used as a positive control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/large/jm-2016-01373u_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01373&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/medium/jm-2016-01373u_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/large/jm-2016-01373u_0006.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Locomotor effects of (<i>R</i>)-modafinil [<b>(</b><i><b>R</b></i><b>)-2</b>] and its analogues <b>4</b> and <b>11b</b> compared to cocaine in mice. Systemic administration of cocaine (3, 10 mg/kg, i.p.) produced a robust dose-dependent increase in locomotion (A). However, <b>(</b><i><b>R</b></i><b>)-2</b> and its analogues <b>4</b> and <b>11b</b>, at the same dose of 10 mg/kg, did not (C,D) or produced a very mild increase (B) in locomotion. When the dose was increased to 30 mg/kg, <b>(</b><i><b>R</b></i><b>)-2</b> and <b>11b</b> produced a significant dose-dependent increase in locomotion, while its analogue <b>4</b> did not. *<i>p</i> < 0.05, **<i>p</i> < 0.01, and ***<i>p</i> < 0.001, compared to the vehicle control group at each time point marked.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01373/20161202/images/large/jm-2016-01373u_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01373&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i81">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16372" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16372" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 59 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Keck, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">John, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czoty, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nader, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span> </span><span class="NLM_article-title">Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">5361</span><span class="NLM_x">–</span> <span class="NLM_lpage">5380</span><span class="refDoi"> DOI: 10.1021/jm501512b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501512b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsFGgu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=5361-5380&author=T.+M.+Keckauthor=W.+S.+Johnauthor=P.+W.+Czotyauthor=M.+A.+Naderauthor=A.+H.+Newman&title=Identifying+Medication+Targets+for+Psychostimulant+Addiction%3A+Unraveling+the+Dopamine+D3+Receptor+Hypothesis&doi=10.1021%2Fjm501512b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis</span></div><div class="casAuthors">Keck, Thomas M.; John, William S.; Czoty, Paul W.; Nader, Michael A.; Newman, Amy Hauck</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5361-5380</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The dopamine D3 receptor (D3R) is a target for developing medications to treat substance use disorders.  D3R-selective compds. with high affinity and varying efficacies have been discovered, providing crit. research tools for cell-based studies that have been translated to in vivo models of drug abuse.  D3R antagonists and partial agonists have shown esp. promising results in rodent models of relapse-like behavior, including stress-, drug-, and cue-induced reinstatement of drug seeking.  However, to date, translation to human studies has been limited.  Herein, we present an overview and illustrate some of the pitfalls and challenges of developing novel D3R-selective compds. toward clin. utility, esp. for treatment of cocaine abuse.  Future research and development of D3R-selective antagonists and partial agonists for substance abuse remains critically important but will also require further evaluation and development of translational animal models to det. the best time in the addiction cycle to target D3Rs for optimal therapeutic efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKVPGvcTvN87Vg90H21EOLACvtfcHk0liWCpnK9pP3lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsFGgu74%253D&md5=99f531d840ad7f94d0eeadeb6fd48100</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Fjm501512b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501512b%26sid%3Dliteratum%253Aachs%26aulast%3DKeck%26aufirst%3DT.%2BM.%26aulast%3DJohn%26aufirst%3DW.%2BS.%26aulast%3DCzoty%26aufirst%3DP.%2BW.%26aulast%3DNader%26aufirst%3DM.%2BA.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DIdentifying%2520Medication%2520Targets%2520for%2520Psychostimulant%2520Addiction%253A%2520Unraveling%2520the%2520Dopamine%2520D3%2520Receptor%2520Hypothesis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D5361%26epage%3D5380%26doi%3D10.1021%2Fjm501512b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Czoty, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoops, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rush, C. R.</span><span> </span><span class="NLM_article-title">Evaluation of the “Pipeline” for Development of Medications for Cocaine Use Disorder: A Review of Translational Preclinical, Human Laboratory, and Clinical Trial Research</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">533</span><span class="NLM_x">–</span> <span class="NLM_lpage">562</span><span class="refDoi"> DOI: 10.1124/pr.115.011668</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1124%2Fpr.115.011668" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2016&pages=533-562&author=P.+W.+Czotyauthor=W.+W.+Stoopsauthor=C.+R.+Rush&title=Evaluation+of+the+%E2%80%9CPipeline%E2%80%9D+for+Development+of+Medications+for+Cocaine+Use+Disorder%3A+A+Review+of+Translational+Preclinical%2C+Human+Laboratory%2C+and+Clinical+Trial+Research&doi=10.1124%2Fpr.115.011668"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1124%2Fpr.115.011668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.115.011668%26sid%3Dliteratum%253Aachs%26aulast%3DCzoty%26aufirst%3DP.%2BW.%26aulast%3DStoops%26aufirst%3DW.%2BW.%26aulast%3DRush%26aufirst%3DC.%2BR.%26atitle%3DEvaluation%2520of%2520the%2520%25E2%2580%259CPipeline%25E2%2580%259D%2520for%2520Development%2520of%2520Medications%2520for%2520Cocaine%2520Use%2520Disorder%253A%2520A%2520Review%2520of%2520Translational%2520Preclinical%252C%2520Human%2520Laboratory%252C%2520and%2520Clinical%2520Trial%2520Research%26jtitle%3DPharmacol.%2520Rev.%26date%3D2016%26volume%3D68%26spage%3D533%26epage%3D562%26doi%3D10.1124%2Fpr.115.011668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Schuster, C. R.; Kuhar, M. J.; Balster, R. L.</span>, Eds.  <span class="citation_source-book">Pharmacological Aspects of Drug Dependence: Toward an Integrated Neurobehavioral Approach</span>; <span> </span><span class="NLM_article-title">Handbook of Experimental Pharmacology</span>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1996</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">118</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1007%2F978-3-642-60963-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1996&author=C.+R.+Schuster&author=M.+J.+Kuhar&author=R.+L.+Balster&title=Pharmacological+Aspects+of+Drug+Dependence%3A+Toward+an+Integrated+Neurobehavioral+Approach"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-60963-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-642-60963-3%26sid%3Dliteratum%253Aachs%26aulast%3DSchuster%26aufirst%3DC.%2BR.%26btitle%3DPharmacological%2520Aspects%2520of%2520Drug%2520Dependence%253A%2520Toward%2520an%2520Integrated%2520Neurobehavioral%2520Approach%26atitle%3DHandbook%2520of%2520Experimental%2520Pharmacology%26pub%3DSpringer%26date%3D1996%26volume%3D118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Schmitt, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E. A.</span><span> </span><span class="NLM_article-title">Regulation of the Dopamine Transporter</span> <span class="citation_source-journal">Ann. N. Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1187</span><span class="NLM_x">, </span> <span class="NLM_fpage">316</span><span class="NLM_x">–</span> <span class="NLM_lpage">340</span><span class="refDoi"> DOI: 10.1111/j.1749-6632.2009.05148.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1111%2Fj.1749-6632.2009.05148.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1187&publication_year=2010&pages=316-340&author=K.+C.+Schmittauthor=M.+E.+A.+Reith&title=Regulation+of+the+Dopamine+Transporter&doi=10.1111%2Fj.1749-6632.2009.05148.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Fj.1749-6632.2009.05148.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1749-6632.2009.05148.x%26sid%3Dliteratum%253Aachs%26aulast%3DSchmitt%26aufirst%3DK.%2BC.%26aulast%3DReith%26aufirst%3DM.%2BE.%2BA.%26atitle%3DRegulation%2520of%2520the%2520Dopamine%2520Transporter%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2010%26volume%3D1187%26spage%3D316%26epage%3D340%26doi%3D10.1111%2Fj.1749-6632.2009.05148.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Fleckenstein, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volz, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddle, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibb, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, G. R.</span><span> </span><span class="NLM_article-title">New Insights into the Mechanism of Action of Amphetamines</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">681</span><span class="NLM_x">–</span> <span class="NLM_lpage">698</span><span class="refDoi"> DOI: 10.1146/annurev.pharmtox.47.120505.105140</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1146%2Fannurev.pharmtox.47.120505.105140" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=17209801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BD2sXit1alurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2007&pages=681-698&author=A.+E.+Fleckensteinauthor=T.+J.+Volzauthor=E.+L.+Riddleauthor=J.+W.+Gibbauthor=G.+R.+Hanson&title=New+Insights+into+the+Mechanism+of+Action+of+Amphetamines&doi=10.1146%2Fannurev.pharmtox.47.120505.105140"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">New insights into the mechanism of action of amphetamines</span></div><div class="casAuthors">Fleckenstein, Annette E.; Volz, Trent J.; Riddle, Evan L.; Gibb, James W.; Hanson, Glen R.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">681-698</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Amphetamine is a psychostimulant commonly used to treat several disorders, including attention deficit, narcolepsy, and obesity.  Plasmalemmal and vesicular monoamine transporters, such as the neuronal dopamine transporter and the vesicular monoamine transporter-2, are two of its principal targets.  This review focuses on new insights, obtained from both in vivo and in vitro studies, into the mol. mechanisms whereby amphetamine, and the closely related compds. methamphetamine and methylenedioxymethamphetamine, cause monoamine, and particularly dopamine, release.  These mechanisms include amphetamine-induced exchange diffusion, reverse transport, and channel-like transport phenomena as well as the weak base properties of amphetamine.  Addnl., amphetamine analogs may affect monoamine transporters through phosphorylation, transporter trafficking, and the prodn. of reactive oxygen and nitrogen species.  All of these mechanisms have potential implications for both amphetamine- and methamphetamine-induced neurotoxicity, as well as dopaminergic neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraPle7JPAeKrVg90H21EOLACvtfcHk0liCtl_1NuSAGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXit1alurs%253D&md5=ead84eb20c530d952c181a79122a1971</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pharmtox.47.120505.105140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pharmtox.47.120505.105140%26sid%3Dliteratum%253Aachs%26aulast%3DFleckenstein%26aufirst%3DA.%2BE.%26aulast%3DVolz%26aufirst%3DT.%2BJ.%26aulast%3DRiddle%26aufirst%3DE.%2BL.%26aulast%3DGibb%26aufirst%3DJ.%2BW.%26aulast%3DHanson%26aufirst%3DG.%2BR.%26atitle%3DNew%2520Insights%2520into%2520the%2520Mechanism%2520of%2520Action%2520of%2520Amphetamines%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2007%26volume%3D47%26spage%3D681%26epage%3D698%26doi%3D10.1146%2Fannurev.pharmtox.47.120505.105140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Wood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sage, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anagnostaras, S. G.</span><span> </span><span class="NLM_article-title">Psychostimulants and Cognition: A Continuum of Behavioral and Cognitive Activation</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">221</span><span class="refDoi"> DOI: 10.1124/pr.112.007054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1124%2Fpr.112.007054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=24344115" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVGnu73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2014&pages=193-221&author=S.+Woodauthor=J.+R.+Sageauthor=T.+Shumanauthor=S.+G.+Anagnostaras&title=Psychostimulants+and+Cognition%3A+A+Continuum+of+Behavioral+and+Cognitive+Activation&doi=10.1124%2Fpr.112.007054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Psychostimulants and cognition: a continuum of behavioral and cognitive activation</span></div><div class="casAuthors">Wood, Suzanne; Sage, Jennifer R.; Shuman, Tristan; Anagnostaras, Stephan G.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">193-221, 29 pp.</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">1521-0081</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Psychostimulants such as cocaine have been used as performance enhancers throughout recorded history.  Although psychostimulants are commonly prescribed to improve attention and cognition, a great deal of literature has described their ability to induce cognitive deficits, as well as addiction.  How can a single drug class be known to produce both cognitive enhancement and impairment.  Properties of the particular stimulant drug itself and individual differences between users have both been suggested to dictate the outcome of stimulant use.  A more parsimonious alternative, which we endorse, is that dose is the crit. detg. factor in cognitive effects of stimulant drugs.  Herein, we review several popular stimulants (cocaine, amphetamine, methylphenidate, modafinil, and caffeine), outlining their history of use, mechanism of action, and use and abuse today.  One common graphic depiction of the cognitive effects of psychostimulants is an inverted U-shaped dose-effect curve.  Moderate arousal is beneficial to cognition, whereas too much activation leads to cognitive impairment.  In parallel to this schematic, we propose a continuum of psychostimulant activation that covers the transition from one drug effect to another as stimulant intake is increased.  Low doses of stimulants effect increased arousal, attention, and cognitive enhancement; moderate doses can lead to feelings of euphoria and power, as well as addiction and cognitive impairment; and very high doses lead to psychosis and circulatory collapse.  This continuum helps account for the seemingly disparate effects of stimulant drugs, with the same drug being assocd. with cognitive enhancement and impairment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKUCx_-Q7V6rVg90H21EOLACvtfcHk0liCtl_1NuSAGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVGnu73E&md5=ec43a4e0babb213d36455c2a070ba16e</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1124%2Fpr.112.007054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.112.007054%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DS.%26aulast%3DSage%26aufirst%3DJ.%2BR.%26aulast%3DShuman%26aufirst%3DT.%26aulast%3DAnagnostaras%26aufirst%3DS.%2BG.%26atitle%3DPsychostimulants%2520and%2520Cognition%253A%2520A%2520Continuum%2520of%2520Behavioral%2520and%2520Cognitive%2520Activation%26jtitle%3DPharmacol.%2520Rev.%26date%3D2014%26volume%3D66%26spage%3D193%26epage%3D221%26doi%3D10.1124%2Fpr.112.007054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Trifilieff, P.; Martinez, D.</span><span> </span><span class="NLM_article-title">Chapter Five. Cocaine: Mechanism and Effects in the Human Brain</span>. In  <span class="citation_source-book">The Effects of Drug Abuse on the Human Nervous System</span>; <span class="NLM_contrib-group">Madras, B.; Kuhar, K.</span>, Eds.; <span class="NLM_publisher-name">Elsevier Inc.</span>: <span class="NLM_publisher-loc">Oxford, United Kingdom</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">133</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1016%2FB978-0-12-418679-8.00005-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&pages=103-133&author=P.+Trifilieff&author=D.+Martinezauthor=B.+Madras&author=K.+Kuhar&title=The+Effects+of+Drug+Abuse+on+the+Human+Nervous+System"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-418679-8.00005-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-418679-8.00005-8%26sid%3Dliteratum%253Aachs%26aulast%3DTrifilieff%26aufirst%3DP.%26atitle%3DChapter%2520Five.%2520Cocaine%253A%2520Mechanism%2520and%2520Effects%2520in%2520the%2520Human%2520Brain%26btitle%3DThe%2520Effects%2520of%2520Drug%2520Abuse%2520on%2520the%2520Human%2520Nervous%2520System%26aulast%3DMadras%26aufirst%3DB.%26pub%3DElsevier%2520Inc%26date%3D2014%26spage%3D103%26epage%3D133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Stoops, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rush, C. R.</span><span> </span><span class="NLM_article-title">Agonist Replacement for Stimulant Dependence: A Review of Clinical Research</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">7026</span><span class="NLM_x">–</span> <span class="NLM_lpage">7035</span><span class="refDoi"> DOI: 10.2174/138161281940131209142843</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.2174%2F138161281940131209142843" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFelu7vK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=7026-7035&author=W.+W.+Stoopsauthor=C.+R.+Rush&title=Agonist+Replacement+for+Stimulant+Dependence%3A+A+Review+of+Clinical+Research&doi=10.2174%2F138161281940131209142843"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Agonist Replacement for Stimulant Dependence: A Review of Clinical Research</span></div><div class="casAuthors">Stoops, William W.; Rush, Craig R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">7026-7035</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Stimulant use disorders are an unrelenting public health concern worldwide.  Agonist replacement therapy is among the most effective strategies for managing substance use disorders including nicotine and opioid dependence.  The present paper reviewed clin. data from human lab. self-administration studies and clin. trials to det. whether agonist replacement therapy is a viable strategy for managing cocaine and/or amphetamine use disorders.  The extant literature suggests that agonist replacement therapy may be effective for managing stimulant use disorders, however, the clin. selection of an agonist replacement medication likely needs to be based on the pharmacol. mechanism of the medication and the stimulant abused by patients.  Specifically, dopamine releasers appear most effective for reducing cocaine use whereas dopamine reuptake inhibitors appear most effective for reducing amphetamine use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRmnvr2wpDebVg90H21EOLACvtfcHk0lgEXUs85q3Dzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFelu7vK&md5=358bce5530e1cb2e8698172565b366a8</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2174%2F138161281940131209142843&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161281940131209142843%26sid%3Dliteratum%253Aachs%26aulast%3DStoops%26aufirst%3DW.%2BW.%26aulast%3DRush%26aufirst%3DC.%2BR.%26atitle%3DAgonist%2520Replacement%2520for%2520Stimulant%2520Dependence%253A%2520A%2520Review%2520of%2520Clinical%2520Research%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2013%26volume%3D19%26spage%3D7026%26epage%3D7035%26doi%3D10.2174%2F138161281940131209142843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Preti, A.</span><span> </span><span class="NLM_article-title">Review: New Developments in the Pharmacotherapy of Cocaine Abuse</span> <span class="citation_source-journal">Addict. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span><span class="refDoi"> DOI: 10.1111/j.1369-1600.2007.00061.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1111%2Fj.1369-1600.2007.00061.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=17508985" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVOqur3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=133-151&author=A.+Preti&title=Review%3A+New+Developments+in+the+Pharmacotherapy+of+Cocaine+Abuse&doi=10.1111%2Fj.1369-1600.2007.00061.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">New developments in the pharmacotherapy of cocaine abuse</span></div><div class="casAuthors">Preti, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Addiction Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">133-151</span>CODEN:
                <span class="NLM_cas:coden">ADBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1355-6215</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Despite huge advances in the neuroscience of substance abuse and dependence in the past 20 years, no approved pharmacol. treatment exists for cocaine abuse.  The available drugs for the treatment of cocaine abuse are poorly effective, hence the need for new compds. to be screened and tested for efficacy: targeting symptoms might improve the effectiveness of the treatment of cocaine abuse and dependence.  On the basis of the known neurochem. of cocaine, some target compds. have been studied: among others.  BP-897, a D3 partial agonist: vanoxerine, a highly selective inhibitor of dopamine uptake: aripiprazole, a partial mixed-action agonist approved for the treatment of schizophrenia.  Recently modafinil, approved for the treatment of narcolepsy, proved effective in favoring cocaine abstinence in cocaine-abusing people.  Some placebo-controlled studies also reported the effectiveness of topiramate, a licensed antiepileptic drug, and of tiagabine, a gamma-aminobutyric acid (GABA) re-uptake inhibitor also approved as an anticonvulsant: both compds. increased cocaine abstinence with no serious adverse events.  Promising results came from two more compds. acting on the GABA circuits, baclofen and valproic acid.  Finally disulfiram, prescribed with active psychosocial therapy, was found to favor higher retention rates and longer abstinence periods from both alc. and cocaine in polydrug-abusing patients.  An alternative approach rests on the use of vaccines, to date in the exptl. stage still.  Psychosocial treatments are a useful companion in the pharmacotherapy of cocaine abuse, with group therapy and contingency management therapies improving motivation and social functioning, particularly in patients abusing alc. as well.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBg9wU-hybkLVg90H21EOLACvtfcHk0lgEXUs85q3Dzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVOqur3N&md5=93b4725efc304ddaee04534fa1ecfa8c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1111%2Fj.1369-1600.2007.00061.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1369-1600.2007.00061.x%26sid%3Dliteratum%253Aachs%26aulast%3DPreti%26aufirst%3DA.%26atitle%3DReview%253A%2520New%2520Developments%2520in%2520the%2520Pharmacotherapy%2520of%2520Cocaine%2520Abuse%26jtitle%3DAddict.%2520Biol.%26date%3D2007%26volume%3D12%26spage%3D133%26epage%3D151%26doi%3D10.1111%2Fj.1369-1600.2007.00061.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Gowrishankar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blakely, R. D.</span><span> </span><span class="NLM_article-title">Good Riddance to Dopamine: Roles for the Dopamine Transporter in Synaptic Function and Dopamine-Associated Brain Disorders</span> <span class="citation_source-journal">Neurochem. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">42</span><span class="NLM_x">–</span> <span class="NLM_lpage">48</span><span class="refDoi"> DOI: 10.1016/j.neuint.2013.10.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1016%2Fj.neuint.2013.10.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpvVSgsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2014&pages=42-48&author=R.+Gowrishankarauthor=M.+K.+Hahnauthor=R.+D.+Blakely&title=Good+Riddance+to+Dopamine%3A+Roles+for+the+Dopamine+Transporter+in+Synaptic+Function+and+Dopamine-Associated+Brain+Disorders&doi=10.1016%2Fj.neuint.2013.10.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Good riddance to dopamine: Roles for the dopamine transporter in synaptic function and dopamine-associated brain disorders</span></div><div class="casAuthors">Gowrishankar, Raajaram; Hahn, Maureen K.; Blakely, Randy D.</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">42-48</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The neurotransmitter dopamine (DA) plays a crit. role in CNS circuits that provide for attention, executive function, reward responses, motivation and movement.  DA is inactivated by the cocaine- and amphetamine-sensitive DA transporter (DAT), a protein that also provides a pathway for non-vesicular DA release.  After a brief review of DAT function and psychostimulant actions, we consider the importance DAT in relation to the distinct firing patterns of DA neurons that permit awareness of novelty and reward.  Finally, we review recent efforts to gather direct support for DAT-linked disorders, with a specific focus on DAT mutations recently identified in subjects with ADHD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3ijhHU6X1e7Vg90H21EOLACvtfcHk0ljGeJURcT5tKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpvVSgsbg%253D&md5=328ac7c14194158f305afabd63f0637a</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2013.10.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2013.10.016%26sid%3Dliteratum%253Aachs%26aulast%3DGowrishankar%26aufirst%3DR.%26aulast%3DHahn%26aufirst%3DM.%2BK.%26aulast%3DBlakely%26aufirst%3DR.%2BD.%26atitle%3DGood%2520Riddance%2520to%2520Dopamine%253A%2520Roles%2520for%2520the%2520Dopamine%2520Transporter%2520in%2520Synaptic%2520Function%2520and%2520Dopamine-Associated%2520Brain%2520Disorders%26jtitle%3DNeurochem.%2520Int.%26date%3D2014%26volume%3D73%26spage%3D42%26epage%3D48%26doi%3D10.1016%2Fj.neuint.2013.10.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Heal, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheetham, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. L.</span><span> </span><span class="NLM_article-title">The Neuropharmacology of ADHD Drugs In Vivo: Insights on Efficacy and Safety</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">608</span><span class="NLM_x">–</span> <span class="NLM_lpage">618</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2009.08.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1016%2Fj.neuropharm.2009.08.020" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2009&pages=608-618&author=D.+J.+Healauthor=S.+C.+Cheethamauthor=S.+L.+Smith&title=The+Neuropharmacology+of+ADHD+Drugs+In+Vivo%3A+Insights+on+Efficacy+and+Safety&doi=10.1016%2Fj.neuropharm.2009.08.020"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2009.08.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2009.08.020%26sid%3Dliteratum%253Aachs%26aulast%3DHeal%26aufirst%3DD.%2BJ.%26aulast%3DCheetham%26aufirst%3DS.%2BC.%26aulast%3DSmith%26aufirst%3DS.%2BL.%26atitle%3DThe%2520Neuropharmacology%2520of%2520ADHD%2520Drugs%2520In%2520Vivo%253A%2520Insights%2520on%2520Efficacy%2520and%2520Safety%26jtitle%3DNeuropharmacology%26date%3D2009%26volume%3D57%26spage%3D608%26epage%3D618%26doi%3D10.1016%2Fj.neuropharm.2009.08.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Mereu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanda, G.</span><span> </span><span class="NLM_article-title">The Neurobiology of Modafinil as an Enhancer of Cognitive Performance and a Potential Treatment for Substance Use Disorders</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">229</span><span class="NLM_x">, </span> <span class="NLM_fpage">415</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span><span class="refDoi"> DOI: 10.1007/s00213-013-3232-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1007%2Fs00213-013-3232-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=23934211" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1CrsLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=229&publication_year=2013&pages=415-434&author=M.+Mereuauthor=A.+Bonciauthor=A.+H.+Newmanauthor=G.+Tanda&title=The+Neurobiology+of+Modafinil+as+an+Enhancer+of+Cognitive+Performance+and+a+Potential+Treatment+for+Substance+Use+Disorders&doi=10.1007%2Fs00213-013-3232-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders</span></div><div class="casAuthors">Mereu, Maddalena; Bonci, Antonello; Newman, Amy Hauck; Tanda, Gianluigi</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">229</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">415-434</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Rationale and objectives: Modafinil (MOD) and its R-enantiomer (R-MOD) are approved medications for narcolepsy and other sleep disorders.  They have also been used, off-label, as cognitive enhancers in populations of patients with mental disorders, including substance abusers that demonstrate impaired cognitive function.  A debated nonmedical use of MOD in healthy individuals to improve intellectual performance is raising questions about its potential abuse liability in this population.  Results and conclusions: MOD has low micromolar affinity for the dopamine transporter (DAT).  Inhibition of dopamine (DA) reuptake via the DAT explains the enhancement of DA levels in several brain areas, an effect shared with psychostimulants like cocaine, methylphenidate, and the amphetamines.  However, its neurochem. effects and anatomical pattern of brain area activation differ from typical psychostimulants and are consistent with its beneficial effects on cognitive performance processes such as attention, learning, and memory.  At variance with typical psychostimulants, MOD shows very low, if any, abuse liability, in spite of its use as a cognitive enhancer by otherwise healthy individuals.  Finally, recent clin. studies have focused on the potential use of MOD as a medication for treatment of drug abuse, but have not shown consistent outcomes.  However, pos. trends in several result measures suggest that medications that improve cognitive function, like MOD or R-MOD, may be beneficial for the treatment of substance use disorders in certain patient populations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpk7rhhVPs1w7Vg90H21EOLACvtfcHk0lgdQQuojxdLdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1CrsLvN&md5=65a22f87cf0588b5050f1a8993392990</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1007%2Fs00213-013-3232-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-013-3232-4%26sid%3Dliteratum%253Aachs%26aulast%3DMereu%26aufirst%3DM.%26aulast%3DBonci%26aufirst%3DA.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DTanda%26aufirst%3DG.%26atitle%3DThe%2520Neurobiology%2520of%2520Modafinil%2520as%2520an%2520Enhancer%2520of%2520Cognitive%2520Performance%2520and%2520a%2520Potential%2520Treatment%2520for%2520Substance%2520Use%2520Disorders%26jtitle%3DPsychopharmacology%26date%3D2013%26volume%3D229%26spage%3D415%26epage%3D434%26doi%3D10.1007%2Fs00213-013-3232-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Loland, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mereu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okunola, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prisinzano, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopajtic, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanda, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span> </span><span class="NLM_article-title">R-Modafinil (Armodafinil): A Unique Dopamine Uptake Inhibitor and Potential Medication for Psychostimulant Abuse</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">405</span><span class="NLM_x">–</span> <span class="NLM_lpage">413</span><span class="refDoi"> DOI: 10.1016/j.biopsych.2012.03.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1016%2Fj.biopsych.2012.03.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=22537794" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtFelt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=405-413&author=C.+J.+Lolandauthor=M.+Mereuauthor=O.+M.+Okunolaauthor=J.+Caoauthor=T.+E.+Prisinzanoauthor=S.+Mazierauthor=T.+Kopajticauthor=L.+Shiauthor=J.+L.+Katzauthor=G.+Tandaauthor=A.+H.+Newman&title=R-Modafinil+%28Armodafinil%29%3A+A+Unique+Dopamine+Uptake+Inhibitor+and+Potential+Medication+for+Psychostimulant+Abuse&doi=10.1016%2Fj.biopsych.2012.03.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">R-Modafinil (Armodafinil): A Unique Dopamine Uptake Inhibitor and Potential Medication for Psychostimulant Abuse</span></div><div class="casAuthors">Loland, Claus J.; Mereu, Maddalena; Okunola, Oluyomi M.; Cao, Jianjing; Prisinzano, Thomas E.; Mazier, Sonia; Kopajtic, Theresa; Shi, Lei; Katz, Jonathan L.; Tanda, Gianluigi; Newman, Amy Hauck</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">405-413</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">(±)-Modafinil has piqued interest as a treatment for attention-deficit/hyperactivity disorder and stimulant dependence.  The R-enantiomer of modafinil might have unique pharmacol. properties that should be further investigated.  (±)-Modafinil and its R-(-)- and S-(+)-enantiomers were synthesized and tested for inhibition of [3H] dopamine (DA) uptake and [3H]WIN 35428 binding in human dopamine transporter (DAT) wild-type and mutants with altered conformational equil.  Data were compared with cocaine and the atypical DA uptake inhibitor, JHW 007.  R- and S-modafinil were also evaluated in microdialysis studies in the mouse nucleus accumbens shell and in a cocaine discrimination procedure.  (±)-, R-, and S-modafinil bind to the DAT and inhibit DA uptake less potently than cocaine, with R-modafinil having approx. threefold higher affinity than its S-enantiomer.  Mol. docking studies revealed subtle differences in binding modes for the enantiomers.  R-modafinil was significantly less potent in the DAT Y156F mutant compared with wild-type DAT, whereas S-modafinil was affected less.  Studies with the Y335A DAT mutant showed that the R- and S-enantiomers tolerated the inward-facing conformation better than cocaine, which was further supported by [2-(trimethylammonium)ethyl]-methanethiosulfonate reactivity on the DAT E2C I159C.  Microdialysis studies demonstrated that both R- and S-modafinil produced increases in extracellular DA concns. in the nucleus accumbens shell less efficaciously than cocaine and with a longer duration of action.  Both enantiomers fully substituted in mice trained to discriminate cocaine from saline.R-modafinil displays an in vitro profile different from cocaine.  Future trials with R-modafinil as a substitute therapy with the potential benefit of cognitive enhancement for psychostimulant addiction are warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjL4KiRs4PUbVg90H21EOLACvtfcHk0lgdQQuojxdLdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtFelt74%253D&md5=78808210fc68d2fbcdd97190f03b63d0</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2012.03.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2012.03.022%26sid%3Dliteratum%253Aachs%26aulast%3DLoland%26aufirst%3DC.%2BJ.%26aulast%3DMereu%26aufirst%3DM.%26aulast%3DOkunola%26aufirst%3DO.%2BM.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DPrisinzano%26aufirst%3DT.%2BE.%26aulast%3DMazier%26aufirst%3DS.%26aulast%3DKopajtic%26aufirst%3DT.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26aulast%3DTanda%26aufirst%3DG.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DR-Modafinil%2520%2528Armodafinil%2529%253A%2520A%2520Unique%2520Dopamine%2520Uptake%2520Inhibitor%2520and%2520Potential%2520Medication%2520for%2520Psychostimulant%2520Abuse%26jtitle%3DBiol.%2520Psychiatry%26date%3D2012%26volume%3D72%26spage%3D405%26epage%3D413%26doi%3D10.1016%2Fj.biopsych.2012.03.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Dackis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samaha, F. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kampman, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornish, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poole, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, C. P.</span><span> </span><span class="NLM_article-title">Modafinil and Cocaine: A Double-Blind, Placebo-Controlled Drug Interaction Study</span> <span class="citation_source-journal">Drug Alcohol Depend.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">37</span><span class="refDoi"> DOI: 10.1016/S0376-8716(02)00335-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1016%2FS0376-8716%2802%2900335-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BD3sXis12rtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2003&pages=29-37&author=C.+A.+Dackisauthor=K.+G.+Lynchauthor=E.+Yuauthor=F.+F.+Samahaauthor=K.+M.+Kampmanauthor=J.+W.+Cornishauthor=A.+Rowanauthor=S.+Pooleauthor=L.+Whiteauthor=C.+P.+O%E2%80%99Brien&title=Modafinil+and+Cocaine%3A+A+Double-Blind%2C+Placebo-Controlled+Drug+Interaction+Study&doi=10.1016%2FS0376-8716%2802%2900335-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study</span></div><div class="casAuthors">Dackis, Charles A.; Lynch, Kevin G.; Yu, Elmer; Samaha, Frederick F.; Kampman, Kyle M.; Cornish, James W.; Rowan, Amy; Poole, Sabrina; White, Lenae; O'Brien, Charles P.</div><div class="citationInfo"><span class="NLM_cas:title">Drug and Alcohol Dependence</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-37</span>CODEN:
                <span class="NLM_cas:coden">DADEDV</span>;
        ISSN:<span class="NLM_cas:issn">0376-8716</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">Modafinil is a novel compd. that is approved for the treatment of narcolepsy.  It is now being studied as a potential treatment for cocaine dependence.  Cocaine withdrawal symptoms are assocd. with poor clin. outcome and are likely to be reversed by modafinil.  In addn., the neurotransmitter actions of modafinil are opposite to cocaine-induced neuroadaptations affecting dopamine and glutamate reward circuits.  Since cocaine-dependent subjects might use cocaine during a clin. trial with modafinil, this study tested the safety of i.v. cocaine (30 mg) in combination with modafinil.  Each of seven subjects received a baseline (open-label) cocaine infusion.  Three subsequent cocaine infusions were administered after subjects received 4 days of low dose modafinil (200 mg/day), high dose modafinil (400 mg/day), or placebo in randomized double-blind sequences.  One subject received placebo prior to all infusions.  Our results indicate that co-administering modafinil and a single dose of i.v. cocaine is not assocd. with medical risk in terms of blood pressure, pulse, temp., or ECG measures.  Furthermore, pretreatment with modafinil did not intensify cocaine euphoria or cocaine-induced craving.  In fact, cocaine euphoria was significantly blunted in one of our subjective measures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3OAw9c_66srVg90H21EOLACvtfcHk0lg0oF8WJsOT2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXis12rtrY%253D&md5=603e451bce498d1622e63999509fbb8e</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2FS0376-8716%2802%2900335-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0376-8716%252802%252900335-6%26sid%3Dliteratum%253Aachs%26aulast%3DDackis%26aufirst%3DC.%2BA.%26aulast%3DLynch%26aufirst%3DK.%2BG.%26aulast%3DYu%26aufirst%3DE.%26aulast%3DSamaha%26aufirst%3DF.%2BF.%26aulast%3DKampman%26aufirst%3DK.%2BM.%26aulast%3DCornish%26aufirst%3DJ.%2BW.%26aulast%3DRowan%26aufirst%3DA.%26aulast%3DPoole%26aufirst%3DS.%26aulast%3DWhite%26aufirst%3DL.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DC.%2BP.%26atitle%3DModafinil%2520and%2520Cocaine%253A%2520A%2520Double-Blind%252C%2520Placebo-Controlled%2520Drug%2520Interaction%2520Study%26jtitle%3DDrug%2520Alcohol%2520Depend.%26date%3D2003%26volume%3D70%26spage%3D29%26epage%3D37%26doi%3D10.1016%2FS0376-8716%2802%2900335-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Malcolm, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swayngim, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donovan, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeVane, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elkashef, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mojsiak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myrick, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedden, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cochran, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolson, R. F.</span><span> </span><span class="NLM_article-title">Modafinil and Cocaine Interactions</span> <span class="citation_source-journal">Am. J. Drug Alcohol Abuse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">577</span><span class="NLM_x">–</span> <span class="NLM_lpage">587</span><span class="refDoi"> DOI: 10.1080/00952990600920425</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1080%2F00952990600920425" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A280%3ADC%252BD28noslanuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2006&pages=577-587&author=R.+Malcolmauthor=K.+Swayngimauthor=J.+L.+Donovanauthor=C.+L.+DeVaneauthor=A.+Elkashefauthor=N.+Chiangauthor=R.+Khanauthor=J.+Mojsiakauthor=D.+L.+Myrickauthor=S.+Heddenauthor=K.+Cochranauthor=R.+F.+Woolson&title=Modafinil+and+Cocaine+Interactions&doi=10.1080%2F00952990600920425"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Modafinil and cocaine interactions</span></div><div class="casAuthors">Malcolm Robert; Swayngim Karla; Donovan Jennifer L; DeVane C Lindsay; Elkashef Ahmed; Chiang Nora; Khan Roberta; Mojsiak Jurij; Myrick Donald L; Hedden Sarra; Cochran Kristi; Woolson Robert F</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of drug and alcohol abuse</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">577-87</span>
        ISSN:<span class="NLM_cas:issn">0095-2990</span>.
    </div><div class="casAbstract">This Phase I trial evaluated the interaction between modafinil steady-state and cocaine.  Twelve non-treatment seeking, cocaine dependent volunteers received four sets of randomized blinded infusions of saline, 20 mg IV cocaine, and 40 mg IV cocaine.  Modafinil was given open label at 0 mg, 400 mg, or 800 mg.  Modafinil combined with IV cocaine did not result in any significant hemodynamic interactions.  Modafinil significantly dampened scores on Visual Analog Scale measures as compared to baseline cocaine conditions.  No significant alterations in labs occurred.  Further outpatient trials of modafinil appear to be warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSP_heaDwdoPJ6KlWarZTAzfW6udTcc2ebpqsgaj-47grntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28noslanuw%253D%253D&md5=6da6cf5481414f3693e6078f20f23178</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1080%2F00952990600920425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00952990600920425%26sid%3Dliteratum%253Aachs%26aulast%3DMalcolm%26aufirst%3DR.%26aulast%3DSwayngim%26aufirst%3DK.%26aulast%3DDonovan%26aufirst%3DJ.%2BL.%26aulast%3DDeVane%26aufirst%3DC.%2BL.%26aulast%3DElkashef%26aufirst%3DA.%26aulast%3DChiang%26aufirst%3DN.%26aulast%3DKhan%26aufirst%3DR.%26aulast%3DMojsiak%26aufirst%3DJ.%26aulast%3DMyrick%26aufirst%3DD.%2BL.%26aulast%3DHedden%26aufirst%3DS.%26aulast%3DCochran%26aufirst%3DK.%26aulast%3DWoolson%26aufirst%3DR.%2BF.%26atitle%3DModafinil%2520and%2520Cocaine%2520Interactions%26jtitle%3DAm.%2520J.%2520Drug%2520Alcohol%2520Abuse%26date%3D2006%26volume%3D32%26spage%3D577%26epage%3D587%26doi%3D10.1080%2F00952990600920425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Hart, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haney, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vosburg, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foltin, R. W.</span><span> </span><span class="NLM_article-title">Smoked Cocaine Self-Administration is Decreased by Modafinil</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">761</span><span class="NLM_x">–</span> <span class="NLM_lpage">768</span><span class="refDoi"> DOI: 10.1038/sj.npp.1301472</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1038%2Fsj.npp.1301472" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=17568397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhvVykt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2008&pages=761-768&author=C.+L.+Hartauthor=M.+Haneyauthor=S.+K.+Vosburgauthor=E.+Rubinauthor=R.+W.+Foltin&title=Smoked+Cocaine+Self-Administration+is+Decreased+by+Modafinil&doi=10.1038%2Fsj.npp.1301472"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Smoked cocaine self-administration is decreased by modafinil</span></div><div class="casAuthors">Hart, Carl L.; Haney, Margaret; Vosburg, Suzanne K.; Rubin, Eric; Foltin, Richard W.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">761-768</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Modafinil has been reported to reduce cocaine use in a clin. sample of infrequent users (2 days/wk), but the effects of modafinil on cocaine self-administration in the lab. have not been studied.  The present study investigated the effects of modafinil maintenance on cocaine self-administration by frequent users (4 days/wk) under controlled lab. conditions.  During this 48-day double-blind, crossover design study, the effects of modafinil maintenance (0, 200, and 400 mg/day) on response to smoked cocaine (0, 12, 25, and 50 mg) were examd. in nontreatment-seeking cocaine-dependent individuals (n = 8).  Cocaine significantly increased self-administration, subjective-effect ratings, and cardiovascular measures; modafinil at both doses (200 and 400 mg/day) markedly attenuated these effects.  These findings agree with data from previous human lab. and clin. investigations of modafinil as a potential cocaine abuse treatment medication.  Thus, our data support the potential of modafinil as a pharmacotherapy for cocaine dependence.  Neuropsychopharmacol. (2008) 33, 761-768; doi:10.1038/sj.npp.1301472; published online 13 June 2007.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrL8E5sCPheKLVg90H21EOLACvtfcHk0lhwOQWfOv-IeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhvVykt7o%253D&md5=e399fbba32fc9718ac7a8a642bff717a</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fsj.npp.1301472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.npp.1301472%26sid%3Dliteratum%253Aachs%26aulast%3DHart%26aufirst%3DC.%2BL.%26aulast%3DHaney%26aufirst%3DM.%26aulast%3DVosburg%26aufirst%3DS.%2BK.%26aulast%3DRubin%26aufirst%3DE.%26aulast%3DFoltin%26aufirst%3DR.%2BW.%26atitle%3DSmoked%2520Cocaine%2520Self-Administration%2520is%2520Decreased%2520by%2520Modafinil%26jtitle%3DNeuropsychopharmacology%26date%3D2008%26volume%3D33%26spage%3D761%26epage%3D768%26doi%3D10.1038%2Fsj.npp.1301472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Newman, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Negus, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prisinzano, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mello, N. K.</span><span> </span><span class="NLM_article-title">Behavioral Evaluation of Modafinil and the Abuse-Related Effects of Cocaine in Rhesus Monkeys</span> <span class="citation_source-journal">Exp. Clin. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">395</span><span class="NLM_x">–</span> <span class="NLM_lpage">408</span><span class="refDoi"> DOI: 10.1037/a0021042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1037%2Fa0021042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVagsb3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=395-408&author=J.+L.+Newmanauthor=S.+S.+Negusauthor=A.+Lozamaauthor=T.+E.+Prisinzanoauthor=N.+K.+Mello&title=Behavioral+Evaluation+of+Modafinil+and+the+Abuse-Related+Effects+of+Cocaine+in+Rhesus+Monkeys&doi=10.1037%2Fa0021042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Behavioral evaluation of modafinil and the abuse-related effects of cocaine in rhesus monkeys</span></div><div class="casAuthors">Newman, Jennifer L.; Lozama, Anthony; Prisinzano, Thomas E.; Negus, S. Stevens; Mello, Nancy K.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental and Clinical Psychopharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">395-408</span>CODEN:
                <span class="NLM_cas:coden">ECLPES</span>;
        ISSN:<span class="NLM_cas:issn">1064-1297</span>.
    
            (<span class="NLM_cas:orgname">American Psychological Association</span>)
        </div><div class="casAbstract">Modafinil is a central nervous system stimulant used to promote wakefulness, and it is being evaluated clin. as an agonist medication for treating stimulant abuse.  This is the first report of the effects of modafinil on the abuse-related effects of cocaine in nonhuman primates.  The behavioral effects of modafinil were examd. in three studies.  First, the discriminative stimulus effects of modafinil (3.2-32 mg/kg) were evaluated in rhesus monkeys (Macaca mulatta) trained to discriminate either low (0.18 mg/kg, IM) or high (0.4 mg/kg, IM) doses of cocaine from saline.  Modafinil dose-dependently substituted for cocaine in 6 of 7 monkeys.  In the second study, the effects of chronically administered modafinil (32-56 mg/kg/day, IV) on food- and cocaine-maintained (0.001-0.1 mg/kg/inj) operant responding were examd.  Modafinil was administered 3 times/h for 23 h/day to ensure stable drug levels.  Chronic treatment with 32 mg/kg/day modafinil selectively reduced responding maintained by intermediate and peak reinforcing doses of cocaine, but responding maintained by higher doses of cocaine was unaffected.  Food-maintained behavior did not change during chronic modafinil treatment.  In a third study, modafinil (32 and 56 mg/kg/day, IV) was examd. in a reinstatement model.  Modafinil transiently increased responding during extinction.  These findings indicate that modafinil shares discriminative stimulus effects with cocaine and selectively reduces responding maintained by reinforcing doses of cocaine.  In addn., modafinil reinstated cocaine-seeking behavior, which may reflect its cocaine-like discriminative stimulus effects.  These data support clin. findings and indicate that these preclin. models may be useful for predicting the effectiveness of agonist medications for drug abuse treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrO36RqqltDtrVg90H21EOLACvtfcHk0lhwOQWfOv-IeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVagsb3J&md5=a8c26d78f40e16a6fafa722d001e91d5</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1037%2Fa0021042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1037%252Fa0021042%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DJ.%2BL.%26aulast%3DNegus%26aufirst%3DS.%2BS.%26aulast%3DLozama%26aufirst%3DA.%26aulast%3DPrisinzano%26aufirst%3DT.%2BE.%26aulast%3DMello%26aufirst%3DN.%2BK.%26atitle%3DBehavioral%2520Evaluation%2520of%2520Modafinil%2520and%2520the%2520Abuse-Related%2520Effects%2520of%2520Cocaine%2520in%2520Rhesus%2520Monkeys%26jtitle%3DExp.%2520Clin.%2520Psychopharmacol.%26date%3D2010%26volume%3D18%26spage%3D395%26epage%3D408%26doi%3D10.1037%2Fa0021042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Irwin, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjurstrom, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olmstead, R.</span><span> </span><span class="NLM_article-title">Polysomnographic Measures of Sleep in Cocaine Dependence and Alcohol Dependence: Implications for Age-Related Loss of Slow Wave, Stage 3 Sleep</span> <span class="citation_source-journal">Addiction</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">1084</span><span class="NLM_x">–</span> <span class="NLM_lpage">1092</span><span class="refDoi"> DOI: 10.1111/add.13300</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1111%2Fadd.13300" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2016&pages=1084-1092&author=M.+R.+Irwinauthor=M.+F.+Bjurstromauthor=R.+Olmstead&title=Polysomnographic+Measures+of+Sleep+in+Cocaine+Dependence+and+Alcohol+Dependence%3A+Implications+for+Age-Related+Loss+of+Slow+Wave%2C+Stage+3+Sleep&doi=10.1111%2Fadd.13300"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1111%2Fadd.13300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fadd.13300%26sid%3Dliteratum%253Aachs%26aulast%3DIrwin%26aufirst%3DM.%2BR.%26aulast%3DBjurstrom%26aufirst%3DM.%2BF.%26aulast%3DOlmstead%26aufirst%3DR.%26atitle%3DPolysomnographic%2520Measures%2520of%2520Sleep%2520in%2520Cocaine%2520Dependence%2520and%2520Alcohol%2520Dependence%253A%2520Implications%2520for%2520Age-Related%2520Loss%2520of%2520Slow%2520Wave%252C%2520Stage%25203%2520Sleep%26jtitle%3DAddiction%26date%3D2016%26volume%3D111%26spage%3D1084%26epage%3D1092%26doi%3D10.1111%2Fadd.13300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Irwin, M. R.; Opp, M. R.</span><span> </span><span class="NLM_article-title">Sleep-Health: Reciprocal Regulation of Sleep and Innate Immunity</span>.  <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span>[Online Early Access] DOI: <span class="refDoi"> DOI: 10.1038/npp.2016.148</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1038%2Fnpp.2016.148" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=M.+R.+Irwin&author=M.+R.+Opp&title=Sleep-Health%3A+Reciprocal+Regulation+of+Sleep+and+Innate+Immunity&doi=10.1038%2Fnpp.2016.148"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2016.148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2016.148%26sid%3Dliteratum%253Aachs%26aulast%3DIrwin%26aufirst%3DM.%2BR.%26atitle%3DSleep-Health%253A%2520Reciprocal%2520Regulation%2520of%2520Sleep%2520and%2520Innate%2520Immunity%26jtitle%3DNeuropsychopharmacology%26date%3D2016%26doi%3D10.1038%2Fnpp.2016.148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Martinez-Raga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cepeda, C.</span><span> </span><span class="NLM_article-title">K. and S. Modafinil: A Useful Medication for Cocaine Addiction? Review of the Evidence from Neuropharmacological, Experimental and Clinical Studies</span> <span class="citation_source-journal">Curr. Drug Abuse Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">221</span><span class="refDoi"> DOI: 10.2174/1874473710801020213</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.2174%2F1874473710801020213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=19630720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BD1cXntFCrsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2008&pages=213-221&author=J.+Martinez-Ragaauthor=C.+Cepeda&title=K.+and+S.+Modafinil%3A+A+Useful+Medication+for+Cocaine+Addiction%3F+Review+of+the+Evidence+from+Neuropharmacological%2C+Experimental+and+Clinical+Studies&doi=10.2174%2F1874473710801020213"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Modafinil: a useful medication for cocaine addiction? review of the evidence from neuropharmacological, experimental and clinical studies</span></div><div class="casAuthors">Martinez-Raga, Jose; Knecht, Carlos; Cepeda, Sonsoles</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Abuse Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-221</span>CODEN:
                <span class="NLM_cas:coden">CDARDV</span>;
        ISSN:<span class="NLM_cas:issn">1874-4737</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Cocaine addiction is a chronic relapsing disorder assocd. with severe medical and psychosocial complications.  However, there are no approved medications for cocaine dependent individuals.  Modafinil, a medication that differs chem. and pharmacol. from other central nervous system stimulants, has been suggested to be potentially useful for this complex disorder.  The present paper aims to critically review the published evidence from lab. and clin. studies on modafinil for cocaine addiction, including discussion of its pharmacol. characteristics and how it may relate with cocaine neurobiol.  While its exact mechanism of action remains to be elucidated, different neurotransmitter systems have been implicated, including modulation on dopamine, glutamate/GABA, noradrenaline and the hypocretin/orexin system, but it is possible that modafinil acts by a synergistic combination of mechanisms.  With a favorable pharmacokinetic profile, it appears to have a low abuse potential.  Lab. and clin. studies provide consistent, albeit preliminary, evidence of the potential usefulness of modafinil for cocaine dependent patients.  Not only there is no evidence of pharmacokinetic interactions between modafinil and cocaine, but in addn. cocaine induced euphoria and cardiovascular effects appear to be attenuated by modafinil.  Furthermore, modafinil has been shown to decrease cocaine self-administration.  In addn., modafinil treated patient are more likely to achieve protracted abstinence than placebo treated patients.  However, further research is needed to confirm these findings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphUk-JjG420rVg90H21EOLACvtfcHk0lh5HuaKDRnk3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXntFCrsLw%253D&md5=231bfe95f2ba7bcfada19c0b3e731732</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.2174%2F1874473710801020213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1874473710801020213%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez-Raga%26aufirst%3DJ.%26aulast%3DCepeda%26aufirst%3DC.%26atitle%3DK.%2520and%2520S.%2520Modafinil%253A%2520A%2520Useful%2520Medication%2520for%2520Cocaine%2520Addiction%253F%2520Review%2520of%2520the%2520Evidence%2520from%2520Neuropharmacological%252C%2520Experimental%2520and%2520Clinical%2520Studies%26jtitle%3DCurr.%2520Drug%2520Abuse%2520Rev.%26date%3D2008%26volume%3D1%26spage%3D213%26epage%3D221%26doi%3D10.2174%2F1874473710801020213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Anderson, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shemanski, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vocci, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciraulo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dackis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roache, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salloum, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somoza, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urschel, H. C.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elkashef, A. M.</span><span> </span><span class="NLM_article-title">Modafinil for the Treatment of Cocaine Dependence</span> <span class="citation_source-journal">Drug Alcohol Depend.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="NLM_x">–</span> <span class="NLM_lpage">139</span><span class="refDoi"> DOI: 10.1016/j.drugalcdep.2009.04.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1016%2Fj.drugalcdep.2009.04.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=19560290" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosleiu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2009&pages=133-139&author=A.+L.+Andersonauthor=M.+S.+Reidauthor=S.-H.+Liauthor=T.+Holmesauthor=L.+Shemanskiauthor=A.+Sleeauthor=E.+V.+Smithauthor=R.+Kahnauthor=N.+Chiangauthor=F.+Vocciauthor=D.+Cirauloauthor=C.+Dackisauthor=J.+D.+Roacheauthor=I.+M.+Salloumauthor=E.+Somozaauthor=H.+C.+Urschelauthor=A.+M.+Elkashef&title=Modafinil+for+the+Treatment+of+Cocaine+Dependence&doi=10.1016%2Fj.drugalcdep.2009.04.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Modafinil for the treatment of cocaine dependence</span></div><div class="casAuthors">Anderson, Ann L.; Reid, Malcolm S.; Li, Shou-Hua; Holmes, Tyson; Shemanski, Lynn; Slee, April; Smith, Edwina V.; Kahn, Roberta; Chiang, Nora; Vocci, Frank; Ciraulo, Domenic; Dackis, Charles; Roache, John D.; Salloum, Ihsan M.; Somoza, Eugene; Urschel, Harold C., III; Elkashef, Ahmed M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug and Alcohol Dependence</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">133-139</span>CODEN:
                <span class="NLM_cas:coden">DADEDV</span>;
        ISSN:<span class="NLM_cas:issn">0376-8716</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Modafinil was tested for efficacy in facilitating abstinence in cocaine-dependent patients, compared to placebo.  This was a double-blind placebo-controlled study, with 12 wk of treatment and a 4-wk follow-up.  Six outpatient substance abuse treatment clinics participated in the study.  There were 210 treatment-seekers randomized, having a diagnosis of cocaine dependence; 72 participants were randomized to placebo, 69 to modafinil 200 mg, and 69 to modafinil 400 mg, taken once daily on awakening.  Participants came to the clinic three times per wk for assessments and urine drug screens, and had one hour of individual psychotherapy weekly.  The primary outcome measure was the weekly percentage of cocaine non-use days.  The GEE regression anal. showed that for the total sample, there was no significant difference between either modafinil group and placebo in the change in av. weekly percent of cocaine non-use days over the 12-wk treatment period (p > 0.79).  However, two secondary outcomes showed significant effects by modafinil 200 mg: the max. no. of consecutive non-use days for cocaine (p = 0.02), and a redn. in craving (p = 0.04).  Also, a post hoc anal. showed a significant effect of modafinil that increased the weekly percentage of non-use days in the subgroup of those cocaine patients who did not have a history of alc. dependence (p < 0.02).  These data suggest that modafinil, in combination with individual behavioral therapy, was effective for increasing cocaine non-use days in participants without co-morbid alc. dependence, and in reducing cocaine craving.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9pQ-oRIN93bVg90H21EOLACvtfcHk0lhpgRHmNS-xRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosleiu7g%253D&md5=ff0d575a8b8e77162121c855de376554</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.drugalcdep.2009.04.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drugalcdep.2009.04.015%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DA.%2BL.%26aulast%3DReid%26aufirst%3DM.%2BS.%26aulast%3DLi%26aufirst%3DS.-H.%26aulast%3DHolmes%26aufirst%3DT.%26aulast%3DShemanski%26aufirst%3DL.%26aulast%3DSlee%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DE.%2BV.%26aulast%3DKahn%26aufirst%3DR.%26aulast%3DChiang%26aufirst%3DN.%26aulast%3DVocci%26aufirst%3DF.%26aulast%3DCiraulo%26aufirst%3DD.%26aulast%3DDackis%26aufirst%3DC.%26aulast%3DRoache%26aufirst%3DJ.%2BD.%26aulast%3DSalloum%26aufirst%3DI.%2BM.%26aulast%3DSomoza%26aufirst%3DE.%26aulast%3DUrschel%26aufirst%3DH.%2BC.%26aulast%3DElkashef%26aufirst%3DA.%2BM.%26atitle%3DModafinil%2520for%2520the%2520Treatment%2520of%2520Cocaine%2520Dependence%26jtitle%3DDrug%2520Alcohol%2520Depend.%26date%3D2009%26volume%3D104%26spage%3D133%26epage%3D139%26doi%3D10.1016%2Fj.drugalcdep.2009.04.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Kampman, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettinati, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spratt, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wierzbicki, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dackis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, C. P.</span><span> </span><span class="NLM_article-title">A Double Blind, Placebo Controlled Trial of Modafinil for the Treatment of Cocaine Dependence without Co-Morbid Alcohol Dependence</span> <span class="citation_source-journal">Drug Alcohol Depend.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">155</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span><span class="refDoi"> DOI: 10.1016/j.drugalcdep.2015.08.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1016%2Fj.drugalcdep.2015.08.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlGku7vM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=2015&pages=105-110&author=K.+M.+Kampmanauthor=K.+G.+Lynchauthor=H.+M.+Pettinatiauthor=K.+Sprattauthor=M.+R.+Wierzbickiauthor=C.+Dackisauthor=C.+P.+O%E2%80%99Brien&title=A+Double+Blind%2C+Placebo+Controlled+Trial+of+Modafinil+for+the+Treatment+of+Cocaine+Dependence+without+Co-Morbid+Alcohol+Dependence&doi=10.1016%2Fj.drugalcdep.2015.08.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">A double blind, placebo controlled trial of modafinil for the treatment of cocaine dependence without co-morbid alcohol dependence</span></div><div class="casAuthors">Kampman, Kyle M.; Lynch, Kevin G.; Pettinati, Helen M.; Spratt, Kelly; Wierzbicki, Michael R.; Dackis, Charles; O'Brien, Charles P.</div><div class="citationInfo"><span class="NLM_cas:title">Drug and Alcohol Dependence</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">155</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">105-110</span>CODEN:
                <span class="NLM_cas:coden">DADEDV</span>;
        ISSN:<span class="NLM_cas:issn">0376-8716</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Modafinil is a medication approved for narcolepsy and shift work sleep disorder.  It has both dopaminergic and glutamatergic activity that could be useful for the treatment of cocaine dependence.  Modafinil has reduced cocaine subjective effects and cocaine self-administration in human lab. trials and has reduced cocaine use in cocaine dependent patients in some clin. trials.  This was an 8-wk, double blind, placebo controlled clin. trial involving 94 cocaine dependent subjects.  Subjects received 300 mg of modafinil or identical placebo daily along with weekly individual therapy.  The primary outcome measure was cocaine use measured by self-report, and confirmed by twice weekly urine benzoylecgonine tests (UBT).  Addnl. outcome measures included cocaine craving measured by the Brief Substance Craving Scale and global improvement measured by the Clin. Global Impression Scale (CGI).  The odds ratio (OR) in favor of abstinence for modafinil vs. placebo was 2.54 (p = . 03) and modafinil-treated subjects were significantly more likely than placebo-treated subjects to be abstinent from cocaine during the last 3 wk of the trial, 23% vs. 9%, χ2 = 3.9, p < .05.  Modafinil treated subjects were more likely to report very low levels of cocaine craving intensity and duration on the Brief Substance Craving Scale (OR = 2.04, p = .03 and OR 1.06, p = .03 resp.).  Modafinil-treated subjects were also more likely than placebo-treated subjects to rate themselves as "very much improved" on the CGI (OR = 2.69, p = .03).  Modafinil may be an efficacious treatment for cocaine dependence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKlp1r4LCr97Vg90H21EOLACvtfcHk0lhpgRHmNS-xRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlGku7vM&md5=284894c7d171d8d9e8bde18538d90bef</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.drugalcdep.2015.08.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drugalcdep.2015.08.005%26sid%3Dliteratum%253Aachs%26aulast%3DKampman%26aufirst%3DK.%2BM.%26aulast%3DLynch%26aufirst%3DK.%2BG.%26aulast%3DPettinati%26aufirst%3DH.%2BM.%26aulast%3DSpratt%26aufirst%3DK.%26aulast%3DWierzbicki%26aufirst%3DM.%2BR.%26aulast%3DDackis%26aufirst%3DC.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DC.%2BP.%26atitle%3DA%2520Double%2520Blind%252C%2520Placebo%2520Controlled%2520Trial%2520of%2520Modafinil%2520for%2520the%2520Treatment%2520of%2520Cocaine%2520Dependence%2520without%2520Co-Morbid%2520Alcohol%2520Dependence%26jtitle%3DDrug%2520Alcohol%2520Depend.%26date%3D2015%26volume%3D155%26spage%3D105%26epage%3D110%26doi%3D10.1016%2Fj.drugalcdep.2015.08.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Agoston, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izenwasser, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kline, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span> </span><span class="NLM_article-title">Novel <i>N</i>-Substituted 3α-[Bis(4′-fluorophenyl)methoxy]tropane Analogues: Selective Ligands for the Dopamine Transporter</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">4329</span><span class="NLM_x">–</span> <span class="NLM_lpage">4339</span><span class="refDoi"> DOI: 10.1021/jm970525a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm970525a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=4329-4339&author=G.+E.+Agostonauthor=J.+H.+Wuauthor=S.+Izenwasserauthor=C.+Georgeauthor=J.+Katzauthor=R.+H.+Klineauthor=A.+H.+Newman&title=Novel+N-Substituted+3%CE%B1-%5BBis%284%E2%80%B2-fluorophenyl%29methoxy%5Dtropane+Analogues%3A+Selective+Ligands+for+the+Dopamine+Transporter&doi=10.1021%2Fjm970525a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm970525a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970525a%26sid%3Dliteratum%253Aachs%26aulast%3DAgoston%26aufirst%3DG.%2BE.%26aulast%3DWu%26aufirst%3DJ.%2BH.%26aulast%3DIzenwasser%26aufirst%3DS.%26aulast%3DGeorge%26aufirst%3DC.%26aulast%3DKatz%26aufirst%3DJ.%26aulast%3DKline%26aufirst%3DR.%2BH.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DNovel%2520N-Substituted%25203%25CE%25B1-%255BBis%25284%25E2%2580%25B2-fluorophenyl%2529methoxy%255Dtropane%2520Analogues%253A%2520Selective%2520Ligands%2520for%2520the%2520Dopamine%2520Transporter%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D4329%26epage%3D4339%26doi%3D10.1021%2Fjm970525a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Schmitt, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, M. E. A.</span><span> </span><span class="NLM_article-title">The Atypical Stimulant and Nootropic Modafinil Interacts with the Dopamine Transporter in a Different Manner than Classical Cocaine-Like Inhibitors</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e25790</span><span class="refDoi"> DOI: 10.1371/journal.pone.0025790</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1371%2Fjournal.pone.0025790" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=22043293" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVCku73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e25790&author=K.+C.+Schmittauthor=M.+E.+A.+Reith&title=The+Atypical+Stimulant+and+Nootropic+Modafinil+Interacts+with+the+Dopamine+Transporter+in+a+Different+Manner+than+Classical+Cocaine-Like+Inhibitors&doi=10.1371%2Fjournal.pone.0025790"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The atypical stimulant and nootropic modafinil interacts with the dopamine transporter in a different manner than classical cocaine-like inhibitors</span></div><div class="casAuthors">Schmitt, Kyle C.; Reith, Maarten E. A.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e25790</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Modafinil is a mild psychostimulant with pro-cognitive and antidepressant effects.  Unlike many conventional stimulants, modafinil has little appreciable potential for abuse, making it a promising therapeutic agent for cocaine addiction.  The chief mol. target of modafinil is the dopamine transporter (DAT); however, the mechanistic details underlying modafinil's unique effects remain unknown.  Recent studies suggest that the conformational effects of a given DAT ligand influence the magnitude of the ligand's reinforcing properties.  For example, the atypical DAT inhibitors benztropine and GBR12909 do not share cocaine's notorious addictive liability, despite having greater binding affinity.  Here, we show that the binding mechanism of modafinil is different than cocaine and similar to other atypical inhibitors.  We previously established two mutations (W84L and D313N) that increase the likelihood that the DAT will adopt an outward-facing conformational state - these mutations increase the affinity of cocaine-like inhibitors considerably, but have little or opposite effect on atypical inhibitor binding.  Thus, a compd.'s WT/mutant affinity ratio can indicate whether the compd. preferentially interacts with a more outward- or inward-facing conformational state.  Modafinil displayed affinity ratios similar to those of benztropine, GBR12909 and bupropion (which lack cocaine-like effects in humans), but far different than those of cocaine, β-CFT or methylphenidate.  Whereas treatment with zinc (known to stabilize an outward-facing transporter state) increased the affinity of cocaine and methylphenidate two-fold, it had little or no effect on the binding of modafinil, benztropine, bupropion or GBR12909.  Addnl., computational modeling of inhibitor binding indicated that while β-CFT and methylphenidate stabilize an "open-to-out" conformation, binding of either modafinil or bupropion gives rise to a more closed conformation.  Our findings highlight a mechanistic difference between modafinil and cocaine-like stimulants and further demonstrate that the conformational effects of a given DAT inhibitor influence its phenomenol. effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk_0tcjHjbqbVg90H21EOLACvtfcHk0ljF1Msr_NKG8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVCku73L&md5=6599e43f3f518b78bf834fb6c6d72010</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0025790&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0025790%26sid%3Dliteratum%253Aachs%26aulast%3DSchmitt%26aufirst%3DK.%2BC.%26aulast%3DReith%26aufirst%3DM.%2BE.%2BA.%26atitle%3DThe%2520Atypical%2520Stimulant%2520and%2520Nootropic%2520Modafinil%2520Interacts%2520with%2520the%2520Dopamine%2520Transporter%2520in%2520a%2520Different%2520Manner%2520than%2520Classical%2520Cocaine-Like%2520Inhibitors%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De25790%26doi%3D10.1371%2Fjournal.pone.0025790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Wang, X.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bi, G.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, J.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okunola-Bakare, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slack, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xi, Z.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span> </span><span class="NLM_article-title">R-Modafinil Attenuates Nicotine-Taking and Nicotine-Seeking Behavior in Alcohol-Preferring Rats</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">1762</span><span class="NLM_x">–</span> <span class="NLM_lpage">1771</span><span class="refDoi"> DOI: 10.1038/npp.2015.24</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1038%2Fnpp.2015.24" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2015&pages=1762-1771&author=X.-F.+Wangauthor=G.-H.+Biauthor=Y.+Heauthor=H.-J.+Yangauthor=J.-T.+Gaoauthor=O.+M.+Okunola-Bakareauthor=R.+D.+Slackauthor=E.+L.+Gardnerauthor=Z.-X.+Xiauthor=A.+H.+Newman&title=R-Modafinil+Attenuates+Nicotine-Taking+and+Nicotine-Seeking+Behavior+in+Alcohol-Preferring+Rats&doi=10.1038%2Fnpp.2015.24"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2015.24&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2015.24%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.-F.%26aulast%3DBi%26aufirst%3DG.-H.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DH.-J.%26aulast%3DGao%26aufirst%3DJ.-T.%26aulast%3DOkunola-Bakare%26aufirst%3DO.%2BM.%26aulast%3DSlack%26aufirst%3DR.%2BD.%26aulast%3DGardner%26aufirst%3DE.%2BL.%26aulast%3DXi%26aufirst%3DZ.-X.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DR-Modafinil%2520Attenuates%2520Nicotine-Taking%2520and%2520Nicotine-Seeking%2520Behavior%2520in%2520Alcohol-Preferring%2520Rats%26jtitle%3DNeuropsychopharmacology%26date%3D2015%26volume%3D40%26spage%3D1762%26epage%3D1771%26doi%3D10.1038%2Fnpp.2015.24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prisinzano, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okunola, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopajtic, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shook, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span> </span><span class="NLM_article-title">SARs at the Monoamine Transporters for a Novel Series of Modafinil Analogues</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">48</span><span class="NLM_x">–</span> <span class="NLM_lpage">52</span><span class="refDoi"> DOI: 10.1021/ml1002025</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml1002025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht12lt7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=48-52&author=J.+Caoauthor=T.+E.+Prisinzanoauthor=O.+M.+Okunolaauthor=T.+Kopajticauthor=M.+Shookauthor=J.+L.+Katzauthor=A.+H.+Newman&title=SARs+at+the+Monoamine+Transporters+for+a+Novel+Series+of+Modafinil+Analogues&doi=10.1021%2Fml1002025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">SARs at the Monoamine Transporters for a Novel Series of Modafinil Analogues</span></div><div class="casAuthors">Cao, Jianjing; Prisinzano, Thomas E.; Okunola, Oluyomi M.; Kopajtic, Theresa; Shook, Matthew; Katz, Jonathan L.; Hauck Newman, Amy</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">48-52</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of modafinil (1) analogs were synthesized wherein (1) para-halo-substitutents were added to the aryl rings, (2) the sulfoxide function was removed, and (3) the primary amide group was replaced with secondary and tertiary amides and amines to investigate the effects of these chem. modifications on dopamine transporter, serotonin transporter, and norepinephrine transporter binding.  In addn., the locomotor-stimulant effects in mice of (±)-modafinil (1) (I), its R- and S-enantiomers, and its para-chloro sulfinylacetamide analog (5c) (II) were compared to those of cocaine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDr9ac-J7nqbVg90H21EOLACvtfcHk0ljF1Msr_NKG8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht12lt7bN&md5=660e546e8524b2e5e8b448ee5bf0e567</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fml1002025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml1002025%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DPrisinzano%26aufirst%3DT.%2BE.%26aulast%3DOkunola%26aufirst%3DO.%2BM.%26aulast%3DKopajtic%26aufirst%3DT.%26aulast%3DShook%26aufirst%3DM.%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DSARs%2520at%2520the%2520Monoamine%2520Transporters%2520for%2520a%2520Novel%2520Series%2520of%2520Modafinil%2520Analogues%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D48%26epage%3D52%26doi%3D10.1021%2Fml1002025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Okunola-Bakare, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopajtic, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loland, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span> </span><span class="NLM_article-title">Elucidation of Structural Elements for Selectivity across Monoamine Transporters: Novel 2-[(Diphenylmethyl)sulfinyl]acetamide (Modafinil) Analogues</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">1000</span><span class="NLM_x">–</span> <span class="NLM_lpage">1013</span><span class="refDoi"> DOI: 10.1021/jm401754x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401754x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslyhtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1000-1013&author=O.+M.+Okunola-Bakareauthor=J.+Caoauthor=T.+Kopajticauthor=J.+L.+Katzauthor=C.+J.+Lolandauthor=L.+Shiauthor=A.+H.+Newman&title=Elucidation+of+Structural+Elements+for+Selectivity+across+Monoamine+Transporters%3A+Novel+2-%5B%28Diphenylmethyl%29sulfinyl%5Dacetamide+%28Modafinil%29+Analogues&doi=10.1021%2Fjm401754x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Elucidation of Structural Elements for Selectivity across Monoamine Transporters: Novel 2-[(Diphenylmethyl)sulfinyl]acetamide (Modafinil) Analogues</span></div><div class="casAuthors">Okunola-Bakare, Oluyomi M.; Cao, Jianjing; Kopajtic, Theresa; Katz, Jonathan L.; Loland, Claus J.; Shi, Lei; Newman, Amy Hauck</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1000-1013</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">2-[(Diphenylmethyl)sulfinyl]acetamide (modafinil, (±)-1) is a unique dopamine uptake inhibitor that binds the dopamine transporter (DAT) differently than cocaine and may have potential for the treatment of psychostimulant abuse.  To further investigate structural requirements for this divergent binding mode, novel thio- and sulfinylacetamide and ethanamine analogs of (±)-1 were synthesized wherein (1) the di-Ph rings were substituted with Me, trifluoromethyl, and halogen substituents and (2) substituents were added to the terminal amide/amine nitrogen.  Halogen substitution of the di-Ph rings of (±)-1 gave several amide analogs with improved binding affinity for DAT and robust selectivity over the serotonin transporter (SERT), whereas affinity improved at SERT over DAT for the p-halo-substituted amine analogs.  Mol. docking studies, using a subset of analogs with DAT and SERT homol. models, and functional data obtained with DAT (A480T) and SERT (T497A) mutants defined a role for TM10 in the substrate/inhibitor S1 binding sites of DAT and SERT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjxRhiOBM-ErVg90H21EOLACvtfcHk0liFogfbjkg_rA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslyhtrY%253D&md5=8c9679d83c0101e335bd59867b0c2863</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm401754x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401754x%26sid%3Dliteratum%253Aachs%26aulast%3DOkunola-Bakare%26aufirst%3DO.%2BM.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DKopajtic%26aufirst%3DT.%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26aulast%3DLoland%26aufirst%3DC.%2BJ.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DElucidation%2520of%2520Structural%2520Elements%2520for%2520Selectivity%2520across%2520Monoamine%2520Transporters%253A%2520Novel%25202-%255B%2528Diphenylmethyl%2529sulfinyl%255Dacetamide%2520%2528Modafinil%2529%2520Analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D1000%26epage%3D1013%26doi%3D10.1021%2Fjm401754x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Lewis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prisinzano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dersch, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, K. C.</span><span> </span><span class="NLM_article-title">Further Exploration of 1-{2-[Bis-(4-fluorophenyl)methoxy]ethyl}piperazine (GBR 12909): role of <i>N</i>-Aromatic, <i>N</i>-Heteroaromatic, and 3-Oxygenated <i>N</i>-Phenylpropyl Substituents on Affinity for the Dopamine and Serotonin Transporter</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1385</span><span class="NLM_x">–</span> <span class="NLM_lpage">1389</span><span class="refDoi"> DOI: 10.1016/S0960-894X(03)00108-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1016%2FS0960-894X%2803%2900108-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1385-1389&author=D.+Lewisauthor=Y.+Zhangauthor=T.+Prisinzanoauthor=C.+M.+Derschauthor=R.+B.+Rothmanauthor=A.+E.+Jacobsonauthor=K.+C.+Rice&title=Further+Exploration+of+1-%7B2-%5BBis-%284-fluorophenyl%29methoxy%5Dethyl%7Dpiperazine+%28GBR+12909%29%3A+role+of+N-Aromatic%2C+N-Heteroaromatic%2C+and+3-Oxygenated+N-Phenylpropyl+Substituents+on+Affinity+for+the+Dopamine+and+Serotonin+Transporter&doi=10.1016%2FS0960-894X%2803%2900108-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2803%2900108-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252803%252900108-2%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DPrisinzano%26aufirst%3DT.%26aulast%3DDersch%26aufirst%3DC.%2BM.%26aulast%3DRothman%26aufirst%3DR.%2BB.%26aulast%3DJacobson%26aufirst%3DA.%2BE.%26aulast%3DRice%26aufirst%3DK.%2BC.%26atitle%3DFurther%2520Exploration%2520of%25201-%257B2-%255BBis-%25284-fluorophenyl%2529methoxy%255Dethyl%257Dpiperazine%2520%2528GBR%252012909%2529%253A%2520role%2520of%2520N-Aromatic%252C%2520N-Heteroaromatic%252C%2520and%25203-Oxygenated%2520N-Phenylpropyl%2520Substituents%2520on%2520Affinity%2520for%2520the%2520Dopamine%2520and%2520Serotonin%2520Transporter%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D1385%26epage%3D1389%26doi%3D10.1016%2FS0960-894X%2803%2900108-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Hsin, L.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dersch, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stafford, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glowa, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, K. C.</span><span> </span><span class="NLM_article-title">Development of Long-Acting Dopamine Transporter Ligands as Potential Cocaine-Abuse Therapeutic Agents: Chiral Hydroxyl-Containing Derivatives of 1-[2-[Bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine and 1-[2-(Diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1321</span><span class="NLM_x">–</span> <span class="NLM_lpage">1329</span><span class="refDoi"> DOI: 10.1021/jm010430f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm010430f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtVWlu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=1321-1329&author=L.-W.+Hsinauthor=C.+M.+Derschauthor=M.+H.+Baumannauthor=D.+Staffordauthor=J.+R.+Glowaauthor=R.+B.+Rothmanauthor=A.+E.+Jacobsonauthor=K.+C.+Rice&title=Development+of+Long-Acting+Dopamine+Transporter+Ligands+as+Potential+Cocaine-Abuse+Therapeutic+Agents%3A+Chiral+Hydroxyl-Containing+Derivatives+of+1-%5B2-%5BBis%284-fluorophenyl%29methoxy%5Dethyl%5D-4-%283-phenylpropyl%29piperazine+and+1-%5B2-%28Diphenylmethoxy%29ethyl%5D-4-%283-phenylpropyl%29piperazine&doi=10.1021%2Fjm010430f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Long-Acting Dopamine Transporter Ligands as Potential Cocaine-Abuse Therapeutic Agents: Chiral Hydroxyl-Containing Derivatives of 1-[2-[Bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine and 1-[2-(Diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine</span></div><div class="casAuthors">Hsin, Ling-Wei; Dersch, Christina M.; Baumann, Michael H.; Stafford, David; Glowa, John R.; Rothman, Richard B.; Jacobson, Arthur E.; Rice, Kenner C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1321-1329</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In the search for long-acting agents for the treatment of cocaine abuse, a series of optically pure hydroxylated derivs. of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR 12909) and 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine (GBR 12935) were synthesized and evaluated in vitro and in vivo.  The enantiomers of the 2-hydroxylated analogs displayed substantial enantioselectivity.  The S enantiomers displayed higher dopamine transporter (DAT) affinity and the R enantiomers were found to interact at the serotonin transporter (SERT) with higher affinity.  The two-carbon spacer between the hydroxyl group and the piperazine ring was essential for enantioselectivity, and the length of the alkyl chain between the Ph group and the piperazine ring influenced binding affinity and selectivity for the DAT and SERT.  Phenylethyl analogs had a higher binding affinity for the SERT and a weaker affinity and selectivity for the DAT than the corresponding phenylpropyl analogs.  Thus, (S)-(+)-1-[4-[2-[bis(4-fluorophenyl)methoxy]ethyl]piperazinyl]-3-phenylpropan-2-ol (I) displayed the highest affinity to the DAT, and (S)-(+)-1-[4-[2-(diphenylmethoxy)ethyl]piperazinyl]-3-phenylpropan-2-ol (II) had the highest selectivity.  II is one of the most DAT selective ligands known.  In accord with the in vitro data, I showed greater potency than its (R)-isomer in elevating extracellular dopamine levels in a microdialysis assay and in inhibiting cocaine-maintained responding in rhesus monkeys.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_q2bi-qjXXrVg90H21EOLACvtfcHk0liFogfbjkg_rA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtVWlu7Y%253D&md5=6e1a7400e69f4183bd83ef377c5d2944</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm010430f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010430f%26sid%3Dliteratum%253Aachs%26aulast%3DHsin%26aufirst%3DL.-W.%26aulast%3DDersch%26aufirst%3DC.%2BM.%26aulast%3DBaumann%26aufirst%3DM.%2BH.%26aulast%3DStafford%26aufirst%3DD.%26aulast%3DGlowa%26aufirst%3DJ.%2BR.%26aulast%3DRothman%26aufirst%3DR.%2BB.%26aulast%3DJacobson%26aufirst%3DA.%2BE.%26aulast%3DRice%26aufirst%3DK.%2BC.%26atitle%3DDevelopment%2520of%2520Long-Acting%2520Dopamine%2520Transporter%2520Ligands%2520as%2520Potential%2520Cocaine-Abuse%2520Therapeutic%2520Agents%253A%2520Chiral%2520Hydroxyl-Containing%2520Derivatives%2520of%25201-%255B2-%255BBis%25284-fluorophenyl%2529methoxy%255Dethyl%255D-4-%25283-phenylpropyl%2529piperazine%2520and%25201-%255B2-%2528Diphenylmethoxy%2529ethyl%255D-4-%25283-phenylpropyl%2529piperazine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D1321%26epage%3D1329%26doi%3D10.1021%2Fjm010430f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Matecka, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dersch, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wojnicki, F. H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glowa, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeVries, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pert, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, K. C.</span><span> </span><span class="NLM_article-title">Heteroaromatic Analogs of 1-[2-(Diphenylmethoxy)ethyl]- and 1-[2-[Bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909) as High-Affinity Dopamine Reuptake Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">705</span><span class="NLM_x">–</span> <span class="NLM_lpage">716</span><span class="refDoi"> DOI: 10.1021/jm9606599</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9606599" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=705-716&author=D.+Mateckaauthor=D.+Lewisauthor=R.+B.+Rothmanauthor=C.+M.+Derschauthor=F.+H.+E.+Wojnickiauthor=J.+R.+Glowaauthor=A.+C.+DeVriesauthor=A.+Pertauthor=K.+C.+Rice&title=Heteroaromatic+Analogs+of+1-%5B2-%28Diphenylmethoxy%29ethyl%5D-+and+1-%5B2-%5BBis%284-fluorophenyl%29methoxy%5Dethyl%5D-4-%283-phenylpropyl%29piperazines+%28GBR+12935+and+GBR+12909%29+as+High-Affinity+Dopamine+Reuptake+Inhibitors&doi=10.1021%2Fjm9606599"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm9606599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9606599%26sid%3Dliteratum%253Aachs%26aulast%3DMatecka%26aufirst%3DD.%26aulast%3DLewis%26aufirst%3DD.%26aulast%3DRothman%26aufirst%3DR.%2BB.%26aulast%3DDersch%26aufirst%3DC.%2BM.%26aulast%3DWojnicki%26aufirst%3DF.%2BH.%2BE.%26aulast%3DGlowa%26aufirst%3DJ.%2BR.%26aulast%3DDeVries%26aufirst%3DA.%2BC.%26aulast%3DPert%26aufirst%3DA.%26aulast%3DRice%26aufirst%3DK.%2BC.%26atitle%3DHeteroaromatic%2520Analogs%2520of%25201-%255B2-%2528Diphenylmethoxy%2529ethyl%255D-%2520and%25201-%255B2-%255BBis%25284-fluorophenyl%2529methoxy%255Dethyl%255D-4-%25283-phenylpropyl%2529piperazines%2520%2528GBR%252012935%2520and%2520GBR%252012909%2529%2520as%2520High-Affinity%2520Dopamine%2520Reuptake%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D705%26epage%3D716%26doi%3D10.1021%2Fjm9606599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Matecka, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radesca, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Costa, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dersch, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Partilla, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pert, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glowa, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wojnicki, F. H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, K. C.</span><span> </span><span class="NLM_article-title">Development of Novel, Potent, and Selective Dopamine Reuptake Inhibitors through Alteration of the Piperazine Ring of 1-[2-(Diphenylmethoxy)ethyl]- and 1-[2-[Bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">4704</span><span class="NLM_x">–</span> <span class="NLM_lpage">4716</span><span class="refDoi"> DOI: 10.1021/jm960305h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm960305h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=4704-4716&author=D.+Mateckaauthor=R.+B.+Rothmanauthor=L.+Radescaauthor=B.+R.+de+Costaauthor=C.+M.+Derschauthor=J.+S.+Partillaauthor=A.+Pertauthor=J.+R.+Glowaauthor=F.+H.+E.+Wojnickiauthor=K.+C.+Rice&title=Development+of+Novel%2C+Potent%2C+and+Selective+Dopamine+Reuptake+Inhibitors+through+Alteration+of+the+Piperazine+Ring+of+1-%5B2-%28Diphenylmethoxy%29ethyl%5D-+and+1-%5B2-%5BBis%284-fluorophenyl%29methoxy%5Dethyl%5D-4-%283-phenylpropyl%29piperazines+%28GBR+12935+and+GBR+12909%29&doi=10.1021%2Fjm960305h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm960305h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm960305h%26sid%3Dliteratum%253Aachs%26aulast%3DMatecka%26aufirst%3DD.%26aulast%3DRothman%26aufirst%3DR.%2BB.%26aulast%3DRadesca%26aufirst%3DL.%26aulast%3Dde%2BCosta%26aufirst%3DB.%2BR.%26aulast%3DDersch%26aufirst%3DC.%2BM.%26aulast%3DPartilla%26aufirst%3DJ.%2BS.%26aulast%3DPert%26aufirst%3DA.%26aulast%3DGlowa%26aufirst%3DJ.%2BR.%26aulast%3DWojnicki%26aufirst%3DF.%2BH.%2BE.%26aulast%3DRice%26aufirst%3DK.%2BC.%26atitle%3DDevelopment%2520of%2520Novel%252C%2520Potent%252C%2520and%2520Selective%2520Dopamine%2520Reuptake%2520Inhibitors%2520through%2520Alteration%2520of%2520the%2520Piperazine%2520Ring%2520of%25201-%255B2-%2528Diphenylmethoxy%2529ethyl%255D-%2520and%25201-%255B2-%255BBis%25284-fluorophenyl%2529methoxy%255Dethyl%255D-4-%25283-phenylpropyl%2529piperazines%2520%2528GBR%252012935%2520and%2520GBR%252012909%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D4704%26epage%3D4716%26doi%3D10.1021%2Fjm960305h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Lewis, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matecka, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span> </span><span class="NLM_article-title">Oxygenated Analogues of 1-[2-(Diphenylmethoxy)ethyl]- and 1-[2-[Bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909) as Potential Extended-Action Cocaine-Abuse Therapeutic Agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">5029</span><span class="NLM_x">–</span> <span class="NLM_lpage">5042</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm990291q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=5029-5042&author=D.+B.+Lewisauthor=D.+Mateckaauthor=Y.+Zhang&title=Oxygenated+Analogues+of+1-%5B2-%28Diphenylmethoxy%29ethyl%5D-+and+1-%5B2-%5BBis%284-fluorophenyl%29methoxy%5Dethyl%5D-4-%283-phenylpropyl%29piperazines+%28GBR+12935+and+GBR+12909%29+as+Potential+Extended-Action+Cocaine-Abuse+Therapeutic+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm990291q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990291q%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DD.%2BB.%26aulast%3DMatecka%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DOxygenated%2520Analogues%2520of%25201-%255B2-%2528Diphenylmethoxy%2529ethyl%255D-%2520and%25201-%255B2-%255BBis%25284-fluorophenyl%2529methoxy%255Dethyl%255D-4-%25283-phenylpropyl%2529piperazines%2520%2528GBR%252012935%2520and%2520GBR%252012909%2529%2520as%2520Potential%2520Extended-Action%2520Cocaine-Abuse%2520Therapeutic%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D5029%26epage%3D5042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Lewis, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matecka, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsin, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dersch, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stafford, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glowa, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, K. C.</span><span> </span><span class="NLM_article-title">Oxygenated Analogues of 1-[2-(Diphenylmethoxy)ethyl]- and 1-[2-[Bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909) as Potential Extended-Action Cocaine-Abuse Therapeutic Agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">5029</span><span class="NLM_x">–</span> <span class="NLM_lpage">5042</span><span class="refDoi"> DOI: 10.1021/jm990291q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990291q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=5029-5042&author=D.+B.+Lewisauthor=D.+Mateckaauthor=Y.+Zhangauthor=L.+W.+Hsinauthor=C.+M.+Derschauthor=D.+Staffordauthor=J.+R.+Glowaauthor=R.+B.+Rothmanauthor=K.+C.+Rice&title=Oxygenated+Analogues+of+1-%5B2-%28Diphenylmethoxy%29ethyl%5D-+and+1-%5B2-%5BBis%284-fluorophenyl%29methoxy%5Dethyl%5D-4-%283-phenylpropyl%29piperazines+%28GBR+12935+and+GBR+12909%29+as+Potential+Extended-Action+Cocaine-Abuse+Therapeutic+Agents&doi=10.1021%2Fjm990291q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm990291q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990291q%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DD.%2BB.%26aulast%3DMatecka%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DHsin%26aufirst%3DL.%2BW.%26aulast%3DDersch%26aufirst%3DC.%2BM.%26aulast%3DStafford%26aufirst%3DD.%26aulast%3DGlowa%26aufirst%3DJ.%2BR.%26aulast%3DRothman%26aufirst%3DR.%2BB.%26aulast%3DRice%26aufirst%3DK.%2BC.%26atitle%3DOxygenated%2520Analogues%2520of%25201-%255B2-%2528Diphenylmethoxy%2529ethyl%255D-%2520and%25201-%255B2-%255BBis%25284-fluorophenyl%2529methoxy%255Dethyl%255D-4-%25283-phenylpropyl%2529piperazines%2520%2528GBR%252012935%2520and%2520GBR%252012909%2529%2520as%2520Potential%2520Extended-Action%2520Cocaine-Abuse%2520Therapeutic%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D5029%26epage%3D5042%26doi%3D10.1021%2Fjm990291q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Rothman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mele, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akunne, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greig, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thurkauf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Costa, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pert, A.</span><span> </span><span class="NLM_article-title">GBR12909 Antagonizes the Ability of Cocaine to Elevate Extracellular Levels of Dopamine</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">397</span><span class="refDoi"> DOI: 10.1016/0091-3057(91)90570-R</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1016%2F0091-3057%2891%2990570-R" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1839568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADyaK38XhsFOgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1991&pages=387-397&author=R.+B.+Rothmanauthor=A.+Meleauthor=A.+A.+Reidauthor=H.+C.+Akunneauthor=N.+Greigauthor=A.+Thurkaufauthor=B.+R.+de+Costaauthor=K.+C.+Riceauthor=A.+Pert&title=GBR12909+Antagonizes+the+Ability+of+Cocaine+to+Elevate+Extracellular+Levels+of+Dopamine&doi=10.1016%2F0091-3057%2891%2990570-R"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">GBR12909 antagonizes the ability of cocaine to elevate extracellular levels of dopamine</span></div><div class="casAuthors">Rothman, Richard B.; Mele, Andrea; Reid, Audrey A.; Akunne, Hyacinth C.; Greig, Nigel; Thurkauf, Andrew; De Costa, Brian R.; Rice, Kenner C.; Pert, Agu</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology, Biochemistry and Behavior</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">387-97</span>CODEN:
                <span class="NLM_cas:coden">PBBHAU</span>;
        ISSN:<span class="NLM_cas:issn">0091-3057</span>.
    </div><div class="casAbstract">Rats were administered various i.p. doses of the high-affinity dopamine (DA) reuptake inhibitor GBR12909.  The brain caudate nuclei were removed 60 min after drug administration and striatal membranes were prepd.  GBR12909 produced a dose-dependent decrease in the binding of [3H]GBR12935 to the DA transporter (ED50∼ 10 mg/kg).  Satn. binding studies with [3H]GBR12935 showed that this was due to increased residual drug, and decreased Bmax.  At 25 mg/kg i.p., GBR12909 produced a 50% decrease in Bmax and a 3.4-fold increase in Kd.  In microdialysis studies, GBR12909 (25 mg/kg i.p.) produced a modest, long-lasting, and stable elevation of extracellular DA.  Administration of cocaine through the microdialysis probe to rats pretreated with saline or GBR12909 (25 mg/kg i.p.) produced a dose-dependent increase in extracellular DA in both groups.  GBR12909 inhibited the cocaine-induced increases in extracellular DA by ∼ 50% at all doses.  At a dose sufficient to decrease by 50% the Bmax of [3H]GBR12935 binding sites, GBR12909 antagonizes the ability of cocaine to elevate extracellular DA by 50%.  GBR12909 may have a use in the medical treatment of cocaine addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdR8WIxCGwGbVg90H21EOLACvtfcHk0liQ74ksNebIDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XhsFOgtQ%253D%253D&md5=d79867ab017e0a9837f8f074318636e7</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2F0091-3057%2891%2990570-R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0091-3057%252891%252990570-R%26sid%3Dliteratum%253Aachs%26aulast%3DRothman%26aufirst%3DR.%2BB.%26aulast%3DMele%26aufirst%3DA.%26aulast%3DReid%26aufirst%3DA.%2BA.%26aulast%3DAkunne%26aufirst%3DH.%2BC.%26aulast%3DGreig%26aufirst%3DN.%26aulast%3DThurkauf%26aufirst%3DA.%26aulast%3Dde%2BCosta%26aufirst%3DB.%2BR.%26aulast%3DRice%26aufirst%3DK.%2BC.%26aulast%3DPert%26aufirst%3DA.%26atitle%3DGBR12909%2520Antagonizes%2520the%2520Ability%2520of%2520Cocaine%2520to%2520Elevate%2520Extracellular%2520Levels%2520of%2520Dopamine%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1991%26volume%3D40%26spage%3D387%26epage%3D397%26doi%3D10.1016%2F0091-3057%2891%2990570-R" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopajtic, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span> </span><span class="NLM_article-title">Dual DAT/σ1 Receptor Ligands Based on 3-(4-(3-(Bis(4-fluorophenyl)amino)propyl)piperazin-1-yl)-1-phenylpropan-1-ol</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5238</span><span class="NLM_x">–</span> <span class="NLM_lpage">5241</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2008.08.065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1016%2Fj.bmcl.2008.08.065" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5238-5241&author=J.+Caoauthor=T.+Kopajticauthor=J.+L.+Katzauthor=A.+H.+Newman&title=Dual+DAT%2F%CF%831+Receptor+Ligands+Based+on+3-%284-%283-%28Bis%284-fluorophenyl%29amino%29propyl%29piperazin-1-yl%29-1-phenylpropan-1-ol&doi=10.1016%2Fj.bmcl.2008.08.065"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.08.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.08.065%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DKopajtic%26aufirst%3DT.%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DDual%2520DAT%252F%25CF%25831%2520Receptor%2520Ligands%2520Based%2520on%25203-%25284-%25283-%2528Bis%25284-fluorophenyl%2529amino%2529propyl%2529piperazin-1-yl%2529-1-phenylpropan-1-ol%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5238%26epage%3D5241%26doi%3D10.1016%2Fj.bmcl.2008.08.065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulkarni, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Husbands, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowen, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopajtic, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span> </span><span class="NLM_article-title">Dual Probes for the Dopamine Transporter and σ1 Receptors: Novel Piperazinyl Alkyl-bis(4′-fluorophenyl)amine Analogues as Potential Cocaine-Abuse Therapeutic Agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2589</span><span class="NLM_x">–</span> <span class="NLM_lpage">2598</span><span class="refDoi"> DOI: 10.1021/jm030008u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030008u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=2589-2598&author=J.+Caoauthor=S.+S.+Kulkarniauthor=S.+M.+Husbandsauthor=W.+D.+Bowenauthor=W.+Williamsauthor=T.+Kopajticauthor=J.+L.+Katzauthor=C.+Georgeauthor=A.+H.+Newman&title=Dual+Probes+for+the+Dopamine+Transporter+and+%CF%831+Receptors%3A+Novel+Piperazinyl+Alkyl-bis%284%E2%80%B2-fluorophenyl%29amine+Analogues+as+Potential+Cocaine-Abuse+Therapeutic+Agents&doi=10.1021%2Fjm030008u"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm030008u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030008u%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DKulkarni%26aufirst%3DS.%2BS.%26aulast%3DHusbands%26aufirst%3DS.%2BM.%26aulast%3DBowen%26aufirst%3DW.%2BD.%26aulast%3DWilliams%26aufirst%3DW.%26aulast%3DKopajtic%26aufirst%3DT.%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26aulast%3DGeorge%26aufirst%3DC.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DDual%2520Probes%2520for%2520the%2520Dopamine%2520Transporter%2520and%2520%25CF%25831%2520Receptors%253A%2520Novel%2520Piperazinyl%2520Alkyl-bis%25284%25E2%2580%25B2-fluorophenyl%2529amine%2520Analogues%2520as%2520Potential%2520Cocaine-Abuse%2520Therapeutic%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D2589%26epage%3D2598%26doi%3D10.1021%2Fjm030008u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Husbands, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izenwasser, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopajtic, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowen, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilner, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span> </span><span class="NLM_article-title">Structure–Activity Relationships at the Monoamine Transporters and σ Receptors for a Novel Series of 9-[3-(<i>cis</i>-3,5-Dimethyl-1-piperazinyl)-propyl]carbazole (Rimcazole) Analogues</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">4446</span><span class="NLM_x">–</span> <span class="NLM_lpage">4455</span><span class="refDoi"> DOI: 10.1021/jm9902943</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9902943" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=4446-4455&author=S.+M.+Husbandsauthor=S.+Izenwasserauthor=T.+Kopajticauthor=W.+D.+Bowenauthor=B.+J.+Vilnerauthor=J.+L.+Katzauthor=A.+H.+Newman&title=Structure%E2%80%93Activity+Relationships+at+the+Monoamine+Transporters+and+%CF%83+Receptors+for+a+Novel+Series+of+9-%5B3-%28cis-3%2C5-Dimethyl-1-piperazinyl%29-propyl%5Dcarbazole+%28Rimcazole%29+Analogues&doi=10.1021%2Fjm9902943"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm9902943&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9902943%26sid%3Dliteratum%253Aachs%26aulast%3DHusbands%26aufirst%3DS.%2BM.%26aulast%3DIzenwasser%26aufirst%3DS.%26aulast%3DKopajtic%26aufirst%3DT.%26aulast%3DBowen%26aufirst%3DW.%2BD.%26aulast%3DVilner%26aufirst%3DB.%2BJ.%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DStructure%25E2%2580%2593Activity%2520Relationships%2520at%2520the%2520Monoamine%2520Transporters%2520and%2520%25CF%2583%2520Receptors%2520for%2520a%2520Novel%2520Series%2520of%25209-%255B3-%2528cis-3%252C5-Dimethyl-1-piperazinyl%2529-propyl%255Dcarbazole%2520%2528Rimcazole%2529%2520Analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D4446%26epage%3D4455%26doi%3D10.1021%2Fjm9902943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Husbands, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izenwasser, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loeloff, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowen, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilner, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span> </span><span class="NLM_article-title">Isothiocyanate Derivatives of 9-[3-(<i>cis</i>-3,5-Dimethyl-1-piperazinyl)propyl]-carbazole (Rimcazole): Irreversible Ligands for the Dopamine Transporter</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">4340</span><span class="NLM_x">–</span> <span class="NLM_lpage">4346</span><span class="refDoi"> DOI: 10.1021/jm9705519</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9705519" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADyaK1cXjtFKlug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=4340-4346&author=S.+M.+Husbandsauthor=S.+Izenwasserauthor=R.+J.+Loeloffauthor=J.+L.+Katzauthor=W.+D.+Bowenauthor=B.+J.+Vilnerauthor=A.+H.+Newman&title=Isothiocyanate+Derivatives+of+9-%5B3-%28cis-3%2C5-Dimethyl-1-piperazinyl%29propyl%5D-carbazole+%28Rimcazole%29%3A+Irreversible+Ligands+for+the+Dopamine+Transporter&doi=10.1021%2Fjm9705519"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Isothiocyanate derivatives of 9-[3-(cis-3,5-dimethyl-1-piperazinyl)propyl]carbazole (Rimcazole): irreversible ligands for the dopamine transporter</span></div><div class="casAuthors">Husbands, Stephen M.; Izenwasser, Sari; Loeloff, Richard J.; Katz, Jonathan L.; Bowen, Wayne D.; Vilner, Bertold J.; Newman, Amy Hauck</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">4340-4346</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cocaine has been reported to bind to the dopamine transporter in a biphasic fashion, and the low-affinity component may play a modulatory role in cocaine's psychomotor stimulant effects.  To study this further, the authors have prepd. a series of irreversible ligands based on rimcazole [I; 9-[3-(cis-3,5-dimethyl-1-piperazinyl)propyl]carbazole], a compd. that has been postulated to bind only to the low-affinity site.  The alkylating moiety, isothiocyanate, is attached to the distal nitrogen of the piperazine ring via alkyl chains of varying lengths or directly attached to one of the arom. groups.  It was found that substitution on the piperazine nitrogen caused an initial decrease in affinity that was recovered as the alkyl chain length increased.  Isothiocyanate deriv. II of rimcazole, with the highest affinity for the dopamine transporter (DAT), binds in a monophasic and irreversible manner, as evidenced by the greatly diminished binding of [3H]WIN 35,428 in tissue that had been preincubated with the ligand and then thoroughly washed using centrifugation.  The dose-dependent redn. in Bmax was accompanied by a concn.-related decrease in KD values.  This shift in KD to a lower value suggests that the preincubation with isothiocyanate II produced a preferential irreversible binding to the low-affinity [3H]WIN 35,428 site on the dopamine transporter.  These ligands may prove to be important tools with which to study the significance of the low-affinity site on the DAT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJm0uovk7Z7LVg90H21EOLACvtfcHk0liQ74ksNebIDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjtFKlug%253D%253D&md5=b3d7f07a10569ea9be26b9bd324c4b31</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm9705519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9705519%26sid%3Dliteratum%253Aachs%26aulast%3DHusbands%26aufirst%3DS.%2BM.%26aulast%3DIzenwasser%26aufirst%3DS.%26aulast%3DLoeloff%26aufirst%3DR.%2BJ.%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26aulast%3DBowen%26aufirst%3DW.%2BD.%26aulast%3DVilner%26aufirst%3DB.%2BJ.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DIsothiocyanate%2520Derivatives%2520of%25209-%255B3-%2528cis-3%252C5-Dimethyl-1-piperazinyl%2529propyl%255D-carbazole%2520%2528Rimcazole%2529%253A%2520Irreversible%2520Ligands%2520for%2520the%2520Dopamine%2520Transporter%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D4340%26epage%3D4346%26doi%3D10.1021%2Fjm9705519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Hiranita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohut, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopajtic, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanda, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, J. L.</span><span> </span><span class="NLM_article-title">Decreases in Cocaine Self-Administration with Dual Inhibition of the Dopamine Transporter and σ Receptors</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">339</span><span class="NLM_x">, </span> <span class="NLM_fpage">662</span><span class="NLM_x">–</span> <span class="NLM_lpage">677</span><span class="refDoi"> DOI: 10.1124/jpet.111.185025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1124%2Fjpet.111.185025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFehtbvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=2011&pages=662-677&author=T.+Hiranitaauthor=P.+L.+Sotoauthor=S.+J.+Kohutauthor=T.+Kopajticauthor=J.+Caoauthor=A.+H.+Newmanauthor=G.+Tandaauthor=J.+L.+Katz&title=Decreases+in+Cocaine+Self-Administration+with+Dual+Inhibition+of+the+Dopamine+Transporter+and+%CF%83+Receptors&doi=10.1124%2Fjpet.111.185025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Decreases in cocaine self-administration with dual inhibition of the dopamine transporter and σ receptors</span></div><div class="casAuthors">Hiranita, Takato; Soto, Paul L.; Kohut, Stephen J.; Kopajtic, Theresa; Cao, Jianjing; Newman, Amy H.; Tanda, Gianluigi; Katz, Jonathan L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">339</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">662-677</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Sigma receptor (σR) antagonists attenuate many behavioral effects of cocaine but typically not its reinforcing effects in self-administration procedures.  However, the σR antagonist rimcazole and its N-propylphenyl analogs, [3-(cis-3,5-dimethyl-4-[3-phenylpropyl]-1-piperazinyl)-propyl]diphenylamine hydrochloride (SH 3-24) and 9-[3-(cis-3,5-dimethyl-4-[3-phenylpropyl]-1-piperazinyl)-propyl]carbazole hydrobromide (SH 3-28), dose-dependently decreased the maximal rates of cocaine self-administration without affecting comparable responding maintained by food reinforcement.  In contrast, a variety of σR antagonists [N-phenethylpiperidine oxalate (AC927), N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1-pyrrolidinyl)ethylamine dihydrobromide (BD 1008), N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(dimethylamino) ethylamine dihydrobromide (BD 1047), N-[2-(3,4-dichlorophenyl) ethyl]-4-methylpiperazine dihydrochloride (BD 1063), and N,N-dipropyl-2-[4-methoxy-3-(2-phenylethoxy)phenyl]-ethylamine monohydrochloride (NE-100)] had no effect on cocaine self-administration across the range of doses that decreased rates of food-maintained responding.  Rimcazole analogs differed from selective σR antagonists in their dual affinities for σRs and the dopamine transporter (DAT) assessed with radioligand binding.  Selective DAT inhibitors and σR antagonists were studied alone and in combination on cocaine self-administration to det. whether actions at both σRs and the DAT were sufficient to reproduce the effects of rimcazole analogs.  Typical DAT inhibitors [2β-carbomethoxy-3β-(4-fluorophenyl)tropane (WIN 35,428), methylphenidate, and nomifensine] dose-dependently shifted the cocaine dose-effect curve leftward.  Combinations of DAT inhibitor and σR antagonist doses that were behaviorally inactive alone decreased cocaine self-administration without effects on food-maintained responding.  In addn., whereas the DAT inhibitors were self-administered at rates similar to those of cocaine, neither rimcazole analogs nor typical σR antagonists (NE-100 and AC927) maintained responding above control levels across a wide range of doses.  These findings suggest that the unique effects of rimcazole analogs are due to dual actions at the DAT and σRs and that a combined target approach may have utility in development of medical treatments for cocaine abuse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs0gcxwJwV_LVg90H21EOLACvtfcHk0lhI1dZKXkKasQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFehtbvJ&md5=7be9d75e9be58be204e9f89e672f4a5a</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1124%2Fjpet.111.185025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.111.185025%26sid%3Dliteratum%253Aachs%26aulast%3DHiranita%26aufirst%3DT.%26aulast%3DSoto%26aufirst%3DP.%2BL.%26aulast%3DKohut%26aufirst%3DS.%2BJ.%26aulast%3DKopajtic%26aufirst%3DT.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DTanda%26aufirst%3DG.%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26atitle%3DDecreases%2520in%2520Cocaine%2520Self-Administration%2520with%2520Dual%2520Inhibition%2520of%2520the%2520Dopamine%2520Transporter%2520and%2520%25CF%2583%2520Receptors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D339%26spage%3D662%26epage%3D677%26doi%3D10.1124%2Fjpet.111.185025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Katz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiranita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopajtic, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesangeau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayanan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdelazeem, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCurdy, C. R.</span><span> </span><span class="NLM_article-title">Blockade of Cocaine or σ Receptor Agonist Self Administration by Subtype-Selective σ Receptor Antagonists</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">358</span><span class="NLM_x">, </span> <span class="NLM_fpage">109</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span><span class="refDoi"> DOI: 10.1124/jpet.116.232728</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1124%2Fjpet.116.232728" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=27189970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFOhsLnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=2016&pages=109-124&author=J.+L.+Katzauthor=T.+Hiranitaauthor=T.+A.+Kopajticauthor=K.+C.+Riceauthor=C.+Mesangeauauthor=S.+Narayananauthor=A.+H.+Abdelazeemauthor=C.+R.+McCurdy&title=Blockade+of+Cocaine+or+%CF%83+Receptor+Agonist+Self+Administration+by+Subtype-Selective+%CF%83+Receptor+Antagonists&doi=10.1124%2Fjpet.116.232728"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Blockade of cocaine or σ receptor agonist self administration by subtype-selective σ receptor antagonists</span></div><div class="casAuthors">Katz, Jonathan L.; Hiranita, Takato; Kopajtic, Theresa A.; Rice, Kenner C.; Mesangeau, Christophe; Narayanan, Sanju; Abdelazeem, Ahmed H.; McCurdy, Christopher R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">358</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">109-124</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The identification of sigma receptor (σR) subtypes has been based on radioligand binding and, despite progress with σ1R cellular function, less is known about σR subtype functions in vivo.  Recent findings that cocaine self administration experience will trigger σR agonist self administration was used in this study to assess the in vivo receptor subtype specificity of the agonists (1)-pentazocine, PRE-084 [2-(4-morpholinethyl) 1-phenylcyclohexanecarboxylate hydrochloride], and 1,3-di-o-tolylguanidine (DTG) and several novel putative σR antagonists.  Radioligand binding studies detd. in vitro σR selectivity of the novel compds., which were subsequently studied for self administration and antagonism of cocaine, (1)-pentazocine, PRE-084, or DTG self administration.  Across the dose ranges studied, none of the novel compds. were self administered, nor did they alter cocaine self administration.  All compds. blocked DTG self administration, with a subset also blocking (1)-pentazocine and PRE-084 self administration.  The most selective of the compds. in binding σ1Rs blocked cocaine self administration when combined with a dopamine transport inhibitor, either methylphenidate or nomifensine.  These drug combinations did not decrease rates of responding maintained by food reinforcement.  In contrast, the most selective of the compds. in binding σ2Rs had no effect on cocaine self administration in combination with either dopamine transport inhibitor.  Thus, these results identify subtype-specific in vivo antagonists, and the utility of σR agonist substitution for cocaine self administration as an assay capable of distinguishing σR subtype selectivity in vivo.  These results further suggest that effectiveness of dual σR antagonism and dopamine transport inhibition in blocking cocaine self administration is specific for σ1Rs and further support this dual targeting approach to development of cocaine antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqz4jCUfp7CsLVg90H21EOLACvtfcHk0lhI1dZKXkKasQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFOhsLnK&md5=721dfe4db5a272382b8c6a50b1dda748</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1124%2Fjpet.116.232728&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.116.232728%26sid%3Dliteratum%253Aachs%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26aulast%3DHiranita%26aufirst%3DT.%26aulast%3DKopajtic%26aufirst%3DT.%2BA.%26aulast%3DRice%26aufirst%3DK.%2BC.%26aulast%3DMesangeau%26aufirst%3DC.%26aulast%3DNarayanan%26aufirst%3DS.%26aulast%3DAbdelazeem%26aufirst%3DA.%2BH.%26aulast%3DMcCurdy%26aufirst%3DC.%2BR.%26atitle%3DBlockade%2520of%2520Cocaine%2520or%2520%25CF%2583%2520Receptor%2520Agonist%2520Self%2520Administration%2520by%2520Subtype-Selective%2520%25CF%2583%2520Receptor%2520Antagonists%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2016%26volume%3D358%26spage%3D109%26epage%3D124%26doi%3D10.1124%2Fjpet.116.232728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Katz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiranita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, T.-P.</span><span> </span><span class="NLM_article-title">A Role for Sigma Receptors in Stimulant Self-Administration and Addiction</span> <span class="citation_source-journal">Behav. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">100</span><span class="NLM_x">–</span> <span class="NLM_lpage">115</span><span class="refDoi"> DOI: 10.1097/FBP.0000000000000209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1097%2FFBP.0000000000000209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=26650253" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BC28XktVOht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2016&pages=100-115&author=J.+L.+Katzauthor=W.+C.+Hongauthor=T.+Hiranitaauthor=T.-P.+Su&title=A+Role+for+Sigma+Receptors+in+Stimulant+Self-Administration+and+Addiction&doi=10.1097%2FFBP.0000000000000209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">A role for sigma receptors in stimulant self-administration and addiction</span></div><div class="casAuthors">Katz, Jonathan L.; Hong, Weimin C.; Hiranita, Takato; Su, Tsung-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Behavioural Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2 and 3</span>),
    <span class="NLM_cas:pages">100-115</span>CODEN:
                <span class="NLM_cas:coden">BPHAEL</span>;
        ISSN:<span class="NLM_cas:issn">0955-8810</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  Sigma-1 receptors (σ1Rs) are structurally unique intracellular proteins that function as chaperones. σ1Rs translocate from the mitochondria-assocd. membrane to other subcellular compartments, and can influence a host of targets, including ion channels, G-protein-coupled receptors, lipids, and other signaling proteins.  Drugs binding to σRs can induce or block the actions of σRs.  Studies indicate that stimulant self-administration induces the reinforcing effects of σR agonists, because of dopamine transporter actions.  Once established, the reinforcing effects of σR agonists are independent of dopaminergic mechanisms traditionally thought to be crit. to the reinforcing effects of stimulants.  Self-administered doses of σR agonists do not increase dopamine concns. in the nucleus accumbens shell, a transmitter and brain region considered important for the reinforcing effects of abused drugs.  However, self-administration of σR agonists is blocked by σR antagonists.  Several effects of stimulants have been blocked by σR antagonists, including the reinforcing effects, assessed by a place-conditioning procedure.  However, the self-administration of stimulants is largely unaffected by σR antagonists, indicating fundamental differences in the mechanisms underlying these two procedures used to assess the reinforcing effects.  When σR antagonists are administered in combination with dopamine uptake inhibitors, an effective and specific blockade of stimulant self-administration is obtained.  Actions of stimulant drugs related to their abuse induce unique changes in σR activity and the changes induced potentially create redundant and, once established, independent reinforcement pathways.  Concomitant targeting of both dopaminergic pathways and σR proteins produces a selective antagonism of stimulant self-administration, suggesting new avenues for combination chemotherapies to specifically combat stimulant abuse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozieYVfrbwdLVg90H21EOLACvtfcHk0lhwgkYdWH7jnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktVOht7o%253D&md5=262279d7e148fade608c21d7c6f87704</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1097%2FFBP.0000000000000209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FFBP.0000000000000209%26sid%3Dliteratum%253Aachs%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26aulast%3DHong%26aufirst%3DW.%2BC.%26aulast%3DHiranita%26aufirst%3DT.%26aulast%3DSu%26aufirst%3DT.-P.%26atitle%3DA%2520Role%2520for%2520Sigma%2520Receptors%2520in%2520Stimulant%2520Self-Administration%2520and%2520Addiction%26jtitle%3DBehav.%2520Pharmacol.%26date%3D2016%26volume%3D27%26spage%3D100%26epage%3D115%26doi%3D10.1097%2FFBP.0000000000000209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Rothman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prisinzano, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span> </span><span class="NLM_article-title">Dopamine Transport Inhibitors Based on GBR12909 and Benztropine as Potential Medications to Treat Cocaine Addiction</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span><span class="refDoi"> DOI: 10.1016/j.bcp.2007.08.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1016%2Fj.bcp.2007.08.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=17897630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVCksLjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2008&pages=2-16&author=R.+B.+Rothmanauthor=M.+H.+Baumannauthor=T.+E.+Prisinzanoauthor=A.+H.+Newman&title=Dopamine+Transport+Inhibitors+Based+on+GBR12909+and+Benztropine+as+Potential+Medications+to+Treat+Cocaine+Addiction&doi=10.1016%2Fj.bcp.2007.08.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine transport inhibitors based on GBR12909 and benztropine as potential medications to treat cocaine addiction</span></div><div class="casAuthors">Rothman, Richard B.; Baumann, Michael H.; Prisinzano, Thomas E.; Newman, Amy Hauck</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2-16</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The discovery and development of medications to treat addiction and notably, cocaine addiction, have been frustrated by both the complexity of the disorder and the lack of target validation in human subjects.  The dopamine transporter has historically been a primary target for cocaine abuse medication development, but addictive liability and other confounds of such inhibitors of dopamine uptake have limited clin. evaluation and validation.  Herein we describe efforts to develop analogs of the dopamine uptake inhibitors GBR 12909 and benztropine that show promising profiles in animal models of cocaine abuse that contrast to that of cocaine.  Their unique pharmacol. profiles have provided important insights into the reinforcing actions of cocaine and we propose that clin. investigation of novel dopamine uptake inhibitors will facilitate the discovery of cocaine-abuse medications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyk01dVAiBsLVg90H21EOLACvtfcHk0lhwgkYdWH7jnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVCksLjK&md5=98fbd67bb986dc0557788d219a760a80</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2007.08.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2007.08.007%26sid%3Dliteratum%253Aachs%26aulast%3DRothman%26aufirst%3DR.%2BB.%26aulast%3DBaumann%26aufirst%3DM.%2BH.%26aulast%3DPrisinzano%26aufirst%3DT.%2BE.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DDopamine%2520Transport%2520Inhibitors%2520Based%2520on%2520GBR12909%2520and%2520Benztropine%2520as%2520Potential%2520Medications%2520to%2520Treat%2520Cocaine%2520Addiction%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2008%26volume%3D75%26spage%3D2%26epage%3D16%26doi%3D10.1016%2Fj.bcp.2007.08.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Loland, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, M.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerstbrein, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sitte, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gether, U.</span><span> </span><span class="NLM_article-title">Relationship between Conformational Changes in the Dopamine Transporter and Cocaine-Like Subjective Effects of Uptake Inhibitors</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">813</span><span class="NLM_x">–</span> <span class="NLM_lpage">823</span><span class="refDoi"> DOI: 10.1124/mol.107.039800</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1124%2Fmol.107.039800" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=17978168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjt1egs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=813-823&author=C.+J.+Lolandauthor=R.+I.+Desaiauthor=M.-F.+Zouauthor=J.+Caoauthor=P.+Grundtauthor=K.+Gerstbreinauthor=H.+H.+Sitteauthor=A.+H.+Newmanauthor=J.+L.+Katzauthor=U.+Gether&title=Relationship+between+Conformational+Changes+in+the+Dopamine+Transporter+and+Cocaine-Like+Subjective+Effects+of+Uptake+Inhibitors&doi=10.1124%2Fmol.107.039800"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Relationship between conformational changes in the dopamine transporter and cocaine-like subjective effects of uptake inhibitors</span></div><div class="casAuthors">Loland, Claus J.; Desai, Rajeev I.; Zou, Mu-Fa; Cao, Jianjing; Grundt, Peter; Gerstbrein, Klaus; Sitte, Harald H.; Newman, Amy Hauck; Katz, Jonathan L.; Gether, Ulrik</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">813-823</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Cocaine exerts its stimulatory effect by inhibiting the dopamine transporter (DAT).  However, novel benztropine- and rimcazole-based inhibitors show reduced stimulant effects compared with cocaine, despite higher affinity and selectivity for DAT.  To investigate possible mechanisms, we compared the subjective effects of different inhibitors with their mol. mode of interaction at the DAT.  We detd. how different inhibitors affected accessibility of the sulfhydryl-reactive reagent [2-(trimethylammonium)ethyl]-methanethiosulfonate to an inserted cysteine (I159C), which is accessible when the extracellular transporter gate is open but inaccessible when it is closed.  The data indicated that cocaine analogs bind an open conformation, whereas benztropine and rimcazole analogs bind a closed conformation.  Next, we investigated the changes in inhibition potency of [3H]dopamine uptake of the compds. at a mutant DAT (Y335A) characterized by a global change in the conformational equil.  We obsd. a close relationship between the decrease in potencies of inhibitors at this mutant and cocaine-like responding in rats trained to discriminate cocaine from saline injections.  Our data suggest that chem. different DAT inhibitors stabilize distinct transporter conformations and that this in turn affects the cocaine-like subjective effects of these compds. in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryV1skqbjuE7Vg90H21EOLACvtfcHk0lhwgkYdWH7jnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjt1egs7Y%253D&md5=3371614fa985881d76d801d8d07442cf</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1124%2Fmol.107.039800&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.107.039800%26sid%3Dliteratum%253Aachs%26aulast%3DLoland%26aufirst%3DC.%2BJ.%26aulast%3DDesai%26aufirst%3DR.%2BI.%26aulast%3DZou%26aufirst%3DM.-F.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DGrundt%26aufirst%3DP.%26aulast%3DGerstbrein%26aufirst%3DK.%26aulast%3DSitte%26aufirst%3DH.%2BH.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26aulast%3DGether%26aufirst%3DU.%26atitle%3DRelationship%2520between%2520Conformational%2520Changes%2520in%2520the%2520Dopamine%2520Transporter%2520and%2520Cocaine-Like%2520Subjective%2520Effects%2520of%2520Uptake%2520Inhibitors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2008%26volume%3D73%26spage%3D813%26epage%3D823%26doi%3D10.1124%2Fmol.107.039800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Beuming, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kniazeff, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergmann, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gracia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raniszewska, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javitch, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gether, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loland, C. J.</span><span> </span><span class="NLM_article-title">The Binding Sites for Cocaine and Dopamine in the Dopamine Transporter Overlap</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">780</span><span class="NLM_x">–</span> <span class="NLM_lpage">789</span><span class="refDoi"> DOI: 10.1038/nn.2146</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1038%2Fnn.2146" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=18568020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BD1cXns1Omsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2008&pages=780-789&author=T.+Beumingauthor=J.+Kniazeffauthor=M.+L.+Bergmannauthor=L.+Shiauthor=L.+Graciaauthor=K.+Raniszewskaauthor=A.+H.+Newmanauthor=J.+A.+Javitchauthor=H.+Weinsteinauthor=U.+Getherauthor=C.+J.+Loland&title=The+Binding+Sites+for+Cocaine+and+Dopamine+in+the+Dopamine+Transporter+Overlap&doi=10.1038%2Fnn.2146"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">The binding sites for cocaine and dopamine in the dopamine transporter overlap</span></div><div class="casAuthors">Beuming, Thijs; Kniazeff, Julie; Bergmann, Marianne L.; Shi, Lei; Gracia, Luis; Raniszewska, Klaudia; Newman, Amy Hauck; Javitch, Jonathan A.; Weinstein, Harel; Gether, Ulrik; Loland, Claus J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">780-789</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Beuming and colleagues detd. that the binding site for cocaine overlaps with that of dopamine on the dopamine transporter.  Detailed modeling and mutagenesis expts. revealed that this site is deeply buried amongst several transmembrane domains.  Cocaine is a widely abused substance with psychostimulant effects that are attributed to inhibition of the dopamine transporter (DAT).  We present mol. models for DAT binding of cocaine and cocaine analogs constructed from the high-resoln. structure of the bacterial transporter homolog LeuT.  Our models suggest that the binding site for cocaine and cocaine analogs is deeply buried between transmembrane segments 1, 3, 6 and 8, and overlaps with the binding sites for the substrates dopamine and amphetamine, as well as for benztropine-like DAT inhibitors.  We validated our models by detailed mutagenesis and by trapping the radiolabeled cocaine analog [3H]CFT in the transporter, either by crosslinking engineered cysteines or with an engineered Zn2+-binding site that was situated extracellularly to the predicted common binding pocket.  Our data demonstrate the mol. basis for the competitive inhibition of dopamine transport by cocaine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogCWenpzRZ47Vg90H21EOLACvtfcHk0ljxbbuRUMjX2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXns1Omsrw%253D&md5=7f96344e92478939540d84a37eaf3a70</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1038%2Fnn.2146&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.2146%26sid%3Dliteratum%253Aachs%26aulast%3DBeuming%26aufirst%3DT.%26aulast%3DKniazeff%26aufirst%3DJ.%26aulast%3DBergmann%26aufirst%3DM.%2BL.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DGracia%26aufirst%3DL.%26aulast%3DRaniszewska%26aufirst%3DK.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DWeinstein%26aufirst%3DH.%26aulast%3DGether%26aufirst%3DU.%26aulast%3DLoland%26aufirst%3DC.%2BJ.%26atitle%3DThe%2520Binding%2520Sites%2520for%2520Cocaine%2520and%2520Dopamine%2520in%2520the%2520Dopamine%2520Transporter%2520Overlap%26jtitle%3DNat.%2520Neurosci.%26date%3D2008%26volume%3D11%26spage%3D780%26epage%3D789%26doi%3D10.1038%2Fnn.2146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Wang, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penmatsa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouaux, E.</span><span> </span><span class="NLM_article-title">Neurotransmitter and psychostimulant Recognition by the Dopamine Transporter</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">521</span><span class="NLM_x">, </span> <span class="NLM_fpage">322</span><span class="NLM_x">–</span> <span class="NLM_lpage">327</span><span class="refDoi"> DOI: 10.1038/nature14431</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1038%2Fnature14431" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=25970245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1WltbbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=521&publication_year=2015&pages=322-327&author=K.+H.+Wangauthor=A.+Penmatsaauthor=E.+Gouaux&title=Neurotransmitter+and+psychostimulant+Recognition+by+the+Dopamine+Transporter&doi=10.1038%2Fnature14431"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Neurotransmitter and psychostimulant recognition by the dopamine transporter</span></div><div class="casAuthors">Wang, Kevin H.; Penmatsa, Aravind; Gouaux, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">521</span>
        (<span class="NLM_cas:issue">7552</span>),
    <span class="NLM_cas:pages">322-327</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Na+/Cl--coupled biogenic amine transporters are the primary targets of therapeutic and abused drugs, ranging from antidepressants to the psychostimulants cocaine and amphetamines, and to their cognate substrates.  Here we det. X-ray crystal structures of the Drosophila melanogaster dopamine transporter (dDAT) bound to its substrate dopamine, a substrate analog 3,4-dichlorophenethylamine, the psychostimulants D-amphetamine and methamphetamine, or to cocaine and cocaine analogs.  All ligands bind to the central binding site, located approx. halfway across the membrane bilayer, in close proximity to bound sodium and chloride ions.  The central binding site recognizes three chem. distinct classes of ligands via conformational changes that accommodate varying sizes and shapes, thus illustrating mol. principles that distinguish substrates from inhibitors in biogenic amine transporters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWbqTaT0RDD7Vg90H21EOLACvtfcHk0ljxbbuRUMjX2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1WltbbK&md5=1784d5fd0e7e1ddbe8346c96aaf98a00</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1038%2Fnature14431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14431%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DK.%2BH.%26aulast%3DPenmatsa%26aufirst%3DA.%26aulast%3DGouaux%26aufirst%3DE.%26atitle%3DNeurotransmitter%2520and%2520psychostimulant%2520Recognition%2520by%2520the%2520Dopamine%2520Transporter%26jtitle%3DNature%26date%3D2015%26volume%3D521%26spage%3D322%26epage%3D327%26doi%3D10.1038%2Fnature14431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Bisgaard, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsen, M. A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beuming, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loland, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gether, U.</span><span> </span><span class="NLM_article-title">The Binding Sites for Benztropines and Dopamine in the Dopamine Transporter Overlap</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">182</span><span class="NLM_x">–</span> <span class="NLM_lpage">190</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2010.08.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1016%2Fj.neuropharm.2010.08.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=20816875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVaitLzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2011&pages=182-190&author=H.+Bisgaardauthor=M.+A.+B.+Larsenauthor=S.+Mazierauthor=T.+Beumingauthor=A.+H.+Newmanauthor=H.+Weinsteinauthor=L.+Shiauthor=C.+J.+Lolandauthor=U.+Gether&title=The+Binding+Sites+for+Benztropines+and+Dopamine+in+the+Dopamine+Transporter+Overlap&doi=10.1016%2Fj.neuropharm.2010.08.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The binding sites for benztropines and dopamine in the dopamine transporter overlap</span></div><div class="casAuthors">Bisgaard, Heidi; Larsen, M. Andreas B.; Mazier, Sonia; Beuming, Thijs; Newman, Amy Hauck; Weinstein, Harel; Shi, Lei; Loland, Claus J.; Gether, Ulrik</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">182-190</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Analogs of benztropines (BZTs) are potent inhibitors of the dopamine transporter (DAT) but are less effective than cocaine as behavioral stimulants.  As a result, there have been efforts to evaluate these compds. as leads for potential medication for cocaine addiction.  Here we use computational modeling together with site-directed mutagenesis to characterize the binding site for BZTs in DAT.  Docking into mol. models based on the structure of the bacterial homolog LeuT supported a BZT binding site that overlaps with the substrate-binding pocket.  In agreement, mutations of residues within the pocket, including Val1523.46 to Ala or Ile, Ser4228.60 to Ala and Asn1573.51 to Cys or Ala, resulted in decreased affinity for BZT and the analog JHW007, as assessed in [3H]dopamine uptake inhibition assays and/or [3H]CFT competition binding assay.  A putative polar interaction of one of the Ph ring fluorine substituents in JHW007 with Asn1573.51 was used as a criterion for detg. likely binding poses and establish a structural context for the mutagenesis findings.  The anal. positioned the other fluorine-substituted Ph ring of JHW007 in close proximity to Ala47910.51/Ala48010.52 in transmembrane segment (TM) 10.  The lack of such an interaction for BZT led to a more tilted orientation, as compared to JHW007, bringing one of the Ph rings even closer to Ala47910.51/Ala48010.52.  Mutation of Ala47910.51 and Ala48010.52 to valines supported these predictions with a larger decrease in the affinity for BZT than for JHW007.  Summarized, our data suggest that BZTs display a classical competitive binding mode with binding sites overlapping those of cocaine and dopamine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR-5LmnkQ4_7Vg90H21EOLACvtfcHk0ljxbbuRUMjX2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVaitLzM&md5=b601a5fa6abe86a35f84193ee45970a7</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2010.08.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2010.08.021%26sid%3Dliteratum%253Aachs%26aulast%3DBisgaard%26aufirst%3DH.%26aulast%3DLarsen%26aufirst%3DM.%2BA.%2BB.%26aulast%3DMazier%26aufirst%3DS.%26aulast%3DBeuming%26aufirst%3DT.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DWeinstein%26aufirst%3DH.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DLoland%26aufirst%3DC.%2BJ.%26aulast%3DGether%26aufirst%3DU.%26atitle%3DThe%2520Binding%2520Sites%2520for%2520Benztropines%2520and%2520Dopamine%2520in%2520the%2520Dopamine%2520Transporter%2520Overlap%26jtitle%3DNeuropharmacology%26date%3D2011%26volume%3D60%26spage%3D182%26epage%3D190%26doi%3D10.1016%2Fj.neuropharm.2010.08.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Rais, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wozniak, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaaro-Peled, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strick, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engle, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandon, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rojas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slusher, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukamoto, T.</span><span> </span><span class="NLM_article-title">Pharmacokinetics of Oral D-Serine in D-Amino Acid Oxidase Knockout Mice</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">2067</span><span class="NLM_x">–</span> <span class="NLM_lpage">2073</span><span class="refDoi"> DOI: 10.1124/dmd.112.046482</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1124%2Fdmd.112.046482" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=22837388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFKkt73I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=2067-2073&author=R.+Raisauthor=A.+G.+Thomasauthor=K.+Wozniakauthor=Y.+Wuauthor=H.+Jaaro-Peledauthor=A.+Sawaauthor=C.+A.+Strickauthor=S.+J.+Engleauthor=N.+J.+Brandonauthor=C.+Rojasauthor=B.+S.+Slusherauthor=T.+Tsukamoto&title=Pharmacokinetics+of+Oral+D-Serine+in+D-Amino+Acid+Oxidase+Knockout+Mice&doi=10.1124%2Fdmd.112.046482"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics of oral D-serine in D-amino acid oxidase knockout mice</span></div><div class="casAuthors">Rais, Rana; Thomas, Ajit G.; Wozniak, Krystyna; Wu, Ying; Jaaro-Peled, Hanna; Sawa, Akira; Strick, Christine A.; Engle, Sandra J.; Brandon, Nicholas J.; Rojas, Camilo; Slusher, Barbara S.; Tsukamoto, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2067-2073</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">D-Amino acid oxidase (DAAO) catalyzes the oxidative deamination of D-amino acids including D-serine, a full agonist at the glycine modulatory site of the N-methyl-D-aspartate (NMDA) receptor.  To evaluate the significance of DAAO-mediated metab. in the pharmacokinetics of oral D-serine, plasma D-serine levels were measured in both wild-type mice and transgenic mice lacking DAAO.  Although D-serine levels were rapidly diminished in wild-type mice (t1/2 = 1.2 h), sustained drug levels over the course of 4 h (t1/2 > 10 h) were obsd. in mice lacking DAAO.  Coadministration of D-serine with 6-chlorobenzo[d]isoxazol-3-ol (CBIO), a small-mol. DAAO inhibitor, in wild-type mice resulted in the enhancement of plasma D-serine levels, although CBIO seems to have only temporary effects on the plasma D-serine levels due to glucuronidation of the key hydroxyl group.  These findings highlight the predominant role of DAAO in the clearance of D-serine from the systemic circulation.  Thus, a potent DAAO inhibitor with a longer half-life should be capable of maintaining high plasma D-serine levels over a sustained period of time and might have therapeutic implications for the treatment of schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOnvR-tnwQ-rVg90H21EOLACvtfcHk0liGkUZQmjqs8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFKkt73I&md5=c80a66d06d07cff75117790e0a927f84</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1124%2Fdmd.112.046482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.112.046482%26sid%3Dliteratum%253Aachs%26aulast%3DRais%26aufirst%3DR.%26aulast%3DThomas%26aufirst%3DA.%2BG.%26aulast%3DWozniak%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DJaaro-Peled%26aufirst%3DH.%26aulast%3DSawa%26aufirst%3DA.%26aulast%3DStrick%26aufirst%3DC.%2BA.%26aulast%3DEngle%26aufirst%3DS.%2BJ.%26aulast%3DBrandon%26aufirst%3DN.%2BJ.%26aulast%3DRojas%26aufirst%3DC.%26aulast%3DSlusher%26aufirst%3DB.%2BS.%26aulast%3DTsukamoto%26aufirst%3DT.%26atitle%3DPharmacokinetics%2520of%2520Oral%2520D-Serine%2520in%2520D-Amino%2520Acid%2520Oxidase%2520Knockout%2520Mice%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26spage%3D2067%26epage%3D2073%26doi%3D10.1124%2Fdmd.112.046482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Zolkowska, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Partilla, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setola, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prisinzano, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, M. H.</span><span> </span><span class="NLM_article-title">Evidence for the Involvement of Dopamine Transporters in Behavioral Stimulant Effects of Modafinil</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">329</span><span class="NLM_x">, </span> <span class="NLM_fpage">738</span><span class="NLM_x">–</span> <span class="NLM_lpage">746</span><span class="refDoi"> DOI: 10.1124/jpet.108.146142</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1124%2Fjpet.108.146142" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=19197004" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlt1OlsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=2009&pages=738-746&author=D.+Zolkowskaauthor=R.+Jainauthor=R.+B.+Rothmanauthor=J.+S.+Partillaauthor=B.+L.+Rothauthor=V.+Setolaauthor=T.+E.+Prisinzanoauthor=M.+H.+Baumann&title=Evidence+for+the+Involvement+of+Dopamine+Transporters+in+Behavioral+Stimulant+Effects+of+Modafinil&doi=10.1124%2Fjpet.108.146142"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil</span></div><div class="casAuthors">Zolkowska, Dorota; Jain, Raka; Rothman, Richard B.; Partilla, John S.; Roth, Bryan L.; Setola, Vincent; Prisinzano, Thomas E.; Baumann, Michael H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">329</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">738-746</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Modafinil is prescribed for numerous medical conditions, but the drug's mechanism of action is unclear.  Here, we examd. the interaction of modafinil with receptors and transporters in vitro and compared pharmacol. effects of the drug with those produced by indirect dopamine (DA) agonists 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR12909) and (+)-methamphetamine (METH).  Modafinil was screened at various receptors and transporters using binding assays.  Transporter-mediated uptake and release were examd. in rat brain synaptosomes.  Effects of modafinil on motor activity and neurochem. were detd. in rats undergoing in vivo microdialysis in nucleus accumbens.  Of the receptors and transporters assayed, modafinil displayed measurable potency only at DA transporters (DAT), inhibiting [3H]DA uptake, with an IC50 value of 4.0 μM.  Accordingly, modafinil pretreatment (10 μM) antagonized METH-induced release of the DAT substrate [3H]1-methyl-4-phenylpyridinium.  I.v. modafinil (20 and 60 mg/kg) produced dose-dependent increases in motor activity and extracellular DA, without affecting serotonin (5-HT).  Analogous results were obsd. for GBR12909 (1 and 3 mg/kg), whereas METH (0.3 and 1 mg/kg) increased DA and 5-HT.  Locomotor effects of all drugs were pos. correlated with dialyzate DA (P < 0.001).  Interestingly, modafinil pretreatment reduced METH-induced ambulation and DA release.  Our data show that modafinil interacts with DAT sites in rat brain, a property shared with agonist medications under investigation for treating cocaine dependence.  Nondopaminergic mechanisms may also contribute to the pharmacol. of modafinil.  Finally, the results suggest that modafinil should be tested as an adjunct for treating METH addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhab522ik-NrVg90H21EOLACvtfcHk0liGkUZQmjqs8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlt1OlsL4%253D&md5=0c5af6285ed23382c46a0d35bafbaa3b</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.146142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.146142%26sid%3Dliteratum%253Aachs%26aulast%3DZolkowska%26aufirst%3DD.%26aulast%3DJain%26aufirst%3DR.%26aulast%3DRothman%26aufirst%3DR.%2BB.%26aulast%3DPartilla%26aufirst%3DJ.%2BS.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DSetola%26aufirst%3DV.%26aulast%3DPrisinzano%26aufirst%3DT.%2BE.%26aulast%3DBaumann%26aufirst%3DM.%2BH.%26atitle%3DEvidence%2520for%2520the%2520Involvement%2520of%2520Dopamine%2520Transporters%2520in%2520Behavioral%2520Stimulant%2520Effects%2520of%2520Modafinil%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D329%26spage%3D738%26epage%3D746%26doi%3D10.1124%2Fjpet.108.146142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izenwasser, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, J. L.</span><span> </span><span class="NLM_article-title">Novel 3-α-(Diphenylmethoxy)tropane Analogs: Potent Dopamine Uptake Inhibitors without Cocaine-like Behavioral Profiles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">2258</span><span class="NLM_x">–</span> <span class="NLM_lpage">2261</span><span class="refDoi"> DOI: 10.1021/jm00041a002</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00041a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=2258-2261&author=A.+H.+Newmanauthor=A.+C.+Allenauthor=S.+Izenwasserauthor=J.+L.+Katz&title=Novel+3-%CE%B1-%28Diphenylmethoxy%29tropane+Analogs%3A+Potent+Dopamine+Uptake+Inhibitors+without+Cocaine-like+Behavioral+Profiles&doi=10.1021%2Fjm00041a002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm00041a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00041a002%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DAllen%26aufirst%3DA.%2BC.%26aulast%3DIzenwasser%26aufirst%3DS.%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26atitle%3DNovel%25203-%25CE%25B1-%2528Diphenylmethoxy%2529tropane%2520Analogs%253A%2520Potent%2520Dopamine%2520Uptake%2520Inhibitors%2520without%2520Cocaine-like%2520Behavioral%2520Profiles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D2258%26epage%3D2261%26doi%3D10.1021%2Fjm00041a002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Katz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izenwasser, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kline, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span> </span><span class="NLM_article-title">Novel 3α-Diphenylmethoxytropane Analogs: Selective Dopamine Uptake Inhibitors with Behavioral Effects Distinct from Those of Cocaine</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">288</span><span class="NLM_x">, </span> <span class="NLM_fpage">302</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=9862785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADyaK1MXisVyqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=1999&pages=302-315&author=J.+L.+Katzauthor=S.+Izenwasserauthor=R.+H.+Klineauthor=A.+C.+Allenauthor=A.+H.+Newman&title=Novel+3%CE%B1-Diphenylmethoxytropane+Analogs%3A+Selective+Dopamine+Uptake+Inhibitors+with+Behavioral+Effects+Distinct+from+Those+of+Cocaine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Novel 3α-diphenylmethoxytropane analogs: selective dopamine uptake inhibitors with behavioral effects distinct from those of cocaine</span></div><div class="casAuthors">Katz, Jonathan L.; Izenwasser, Sari; Kline, Richard H.; Allen, Andrew C.; Newman, Amy Hauck</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">288</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">302-315</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The pharmacol. effects were assessed for a series of 3α-diphenylmethoxy-1αH,5αH-tropane analogs which have structural similarities to cocaine.  Like cocaine, these compds. displaced [3H]WIN 35,428 binding from rat caudate and had affinities ranging from approx. 10-fold greater than cocaine (Ki=11.8 nM) to relatively low affinity (Ki=2000 nM).  The compds. also inhibited dopamine uptake with potencies corresponding to their affinities for WIN 35,428 binding sites.  Like the parent compd., benztropine, the 3α-(diphenylmethoxy)tropane analogs displaced [3H]pirenzepine from muscarinic M1 receptors with affinities ranging from 2 to 120 nM.  Cocaine produced dose-related increases in locomotor activity (horizontal ambulation) in Swiss Webster mice, whereas the 3α-(diphenylmethoxy)tropane analogs generally had lower efficacy than cocaine.  Compds. with fluoro-substituents in the Ph rings generally were among those with efficacy approaching that of cocaine; those with chloro- and bromo-substituents were markedly less efficacious, despite having binding affinities comparable to those of the corresponding fluoro-substituted compds.  The 3α-(diphenylmethoxy)tropane analogs were also examd. in rats trained to discriminate saline from cocaine (10 mg/kg, i.p.).  Cocaine produced a dose-related increase in responding on the cocaine-appropriate lever, reaching 100% at 10 mg/kg.  Only the 4',4''-difluoro-substituted analog produced effects similar to those of cocaine; the other compds. showed markedly reduced efficacy compared to cocaine.  Drug interaction studies showed that the antimuscarinics, atropine and scopolamine, potentiated rather than attenuated the locomotor stimulant and cocaine-like discriminative-stimulus effects of cocaine, indicating that the antimuscarinic effects of the 3α-diphenylmethoxytropane analogs did not contribute to their diminished cocaine-like activity.  Studies of the time course of selected compds. indicated that their reduced cocaine-like efficacy was likely not due to behavioral observations being conducted at an inopportune time period.  Because none of the 3α-diphenylmethoxytropane analogs studied showed evidence that they were binding to more than one site, and because the structure activity relationships among these drugs are distinctly different from those obtained with cocaine, these data suggest that the 3α-diphenylmethoxytropane analogs are accessing a different binding domain than that accessed by cocaine.  Binding to this domain may produce a behavioral profile that is distinct from that of the cocaine-like dopamine uptake inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVv6SJkGAJDrVg90H21EOLACvtfcHk0liGkUZQmjqs8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXisVyqug%253D%253D&md5=f2a3046324b849beee51eb2bd8bdac05</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26aulast%3DIzenwasser%26aufirst%3DS.%26aulast%3DKline%26aufirst%3DR.%2BH.%26aulast%3DAllen%26aufirst%3DA.%2BC.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26atitle%3DNovel%25203%25CE%25B1-Diphenylmethoxytropane%2520Analogs%253A%2520Selective%2520Dopamine%2520Uptake%2520Inhibitors%2520with%2520Behavioral%2520Effects%2520Distinct%2520from%2520Those%2520of%2520Cocaine%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1999%26volume%3D288%26spage%3D302%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Desai, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopajtic, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">French, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, J. L.</span><span> </span><span class="NLM_article-title">Relationship between In Vivo Occupancy at the Dopamine Transporter and Behavioral Effects of Cocaine, GBR 12909 [1-{2-[Bis-(4-fluorophenyl)methoxy]ethyl}-4-(3-phenylpropyl)piperazine], and Benztropine Analogs</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">315</span><span class="NLM_x">, </span> <span class="NLM_fpage">397</span><span class="NLM_x">–</span> <span class="NLM_lpage">404</span><span class="refDoi"> DOI: 10.1124/jpet.105.091231</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1124%2Fjpet.105.091231" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=16014753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVOks7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=315&publication_year=2005&pages=397-404&author=R.+I.+Desaiauthor=T.+A.+Kopajticauthor=D.+Frenchauthor=A.+H.+Newmanauthor=J.+L.+Katz&title=Relationship+between+In+Vivo+Occupancy+at+the+Dopamine+Transporter+and+Behavioral+Effects+of+Cocaine%2C+GBR+12909+%5B1-%7B2-%5BBis-%284-fluorophenyl%29methoxy%5Dethyl%7D-4-%283-phenylpropyl%29piperazine%5D%2C+and+Benztropine+Analogs&doi=10.1124%2Fjpet.105.091231"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Relationship between in Vivo occupancy at the dopamine transporter and behavioral effects of cocaine, GBR 12909 [1-{2-[bis-(4-fluorophenyl)methoxy]ethyl}-4-(3-phenylpropyl)piperazine],and benztropine analogs</span></div><div class="casAuthors">Desai, Rajeev I.; Kopajtic, Theresa A.; French, Dawn; Newman, Amy H.; Katz, Jonathan L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">315</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">397-404</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Analogs of benztropine (BZT) bind to the dopamine (DA) transporter and inhibit DA uptake but often have behavioral effects that differ from those of cocaine and other DA-uptake inhibitors.  To better understand these differences, we examd. the relationship between locomotor-stimulant effects of cocaine, 1-{2-[bis-(4-fluorophenyl)methoxy]ethyl}-4-(3-phenylpropyl)-piperazine (GBR 12909), and BZT analogs [(3α-[bis(4'-fluorophenyl)methoxy]-tropane) (AHN 1-055) and (N-allyl-3α-[bis(4'-fluorophenyl)methoxy]-tropane) (AHN 2-005)] and their in vivo displacement of the DA transporter ligand [125I]3β-(4-iodophenyl)-tropan-2β-carboxylic acid iso-Pr ester hydrochloride (RTI-121) in striatum.  Cocaine, GBR 12909, and BZT analogs each displaced [125I]RTI-121 and stimulated locomotor activity in a dose- and time-dependent manner.  The time course revealed a slower onset of both effects for AHN 1-055 and AHN 2-005 compared with cocaine and GBR 12909.  The BZT analogs were less effective than cocaine and GBR 12909 in stimulating locomotor activity.  Locomotor stimulant effects of cocaine were generally greater than predicted by the regression of displacement of [125I]RTI-121 and effect at short times after injection and less than predicted at longer times after injection.  This result suggests that the apparent rate of occupancy of the DA transporter, in addn. to percentage of sites occupied, contributes to the behavioral effects of cocaine.  The present results suggest that among drugs that act at the DA transporter, the slower apparent rates of occupancy with the DA transporter by the BZT analogs may contribute in an important way to differences in their effectiveness.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjPuttHGNvq7Vg90H21EOLACvtfcHk0linNfvYZjxxXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVOks7nI&md5=aa3d51cc833c446f5895f06bf1c28b99</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.091231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.091231%26sid%3Dliteratum%253Aachs%26aulast%3DDesai%26aufirst%3DR.%2BI.%26aulast%3DKopajtic%26aufirst%3DT.%2BA.%26aulast%3DFrench%26aufirst%3DD.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26atitle%3DRelationship%2520between%2520In%2520Vivo%2520Occupancy%2520at%2520the%2520Dopamine%2520Transporter%2520and%2520Behavioral%2520Effects%2520of%2520Cocaine%252C%2520GBR%252012909%2520%255B1-%257B2-%255BBis-%25284-fluorophenyl%2529methoxy%255Dethyl%257D-4-%25283-phenylpropyl%2529piperazine%255D%252C%2520and%2520Benztropine%2520Analogs%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D315%26spage%3D397%26epage%3D404%26doi%3D10.1124%2Fjpet.105.091231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Hiranita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, M.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopajtic, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lupica, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, J. L.</span><span> </span><span class="NLM_article-title">2-Isoxazol-3-phenyltropane Derivatives of Cocaine: Molecular and Atypical System Effects at the Dopamine Transporter</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">349</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">309</span><span class="refDoi"> DOI: 10.1124/jpet.113.212738</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1124%2Fjpet.113.212738" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=24518035" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovVCmt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=349&publication_year=2014&pages=297-309&author=T.+Hiranitaauthor=D.+S.+Wilkinsonauthor=W.+C.+Hongauthor=M.-F.+Zouauthor=T.+A.+Kopajticauthor=P.+L.+Sotoauthor=C.+R.+Lupicaauthor=A.+H.+Newmanauthor=J.+L.+Katz&title=2-Isoxazol-3-phenyltropane+Derivatives+of+Cocaine%3A+Molecular+and+Atypical+System+Effects+at+the+Dopamine+Transporter&doi=10.1124%2Fjpet.113.212738"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">2-isoxazol-3-phenyltropane derivatives of cocaine: molecular and atypical system effects at the dopamine transporter</span></div><div class="casAuthors">Hiranita, Takato; Wilkinson, Derek S.; Hong, Weimin C.; Zou, Mu-Fa; Kopajtic, Theresa A.; Soto, Paul L.; Lupica, Carl R.; Newman, Amy H.; Katz, Jonathan L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">349</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">297-309, 13 pp.</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The present study examd. RTI-371 [3β-(4-methylphenyl)-2β-[3-(4-chlorophenyl)-isoxazol-5-yl]tropane], a phenyltropane cocaine analog with effects distinct from cocaine, and assessed potential mechanisms for those effects by comparison with its constitutional isomer, RTI-336 [3β-(4-chlorophenyl)-2β-[3-(4-methylphenyl)-isoxazol-5-yl]tropane].  In mice, RTI-371 was less effective than cocaine and RTI-336 in stimulating locomotion, and incompletely substituted (∼60% max. at 5 min or 1 h after injection) in a cocaine (10 mg/kg i.p.)/saline discrimination procedure; RTI-336 completely substituted.  In contrast to RTI-336, RTI-371 was not self-administered, and its pretreatment (1.0-10 mg/kg i.p.) dose-dependently decreased maximal cocaine self-administration more potently than food-maintained responding.  RTI-336 pretreatment dose-dependently left-shifted the cocaine self-administration dose-effect curve.  Both RTI-336 and RTI-371 displaced [3H]WIN35,428 [[3H](-)-3β-(4-fluorophenyl)-tropan-2β-carboxylic acid Me ester tartrate] binding to striatal dopamine transporters (DATs) with Ki values of 10.8 and 7.81 nM, resp., and had lower affinities at serotonin or norepinephrine transporters, or muscarinic and σ receptors.  The relative low affinity at these sites suggests the DAT as the primary target of RTI-371 with minimal contributions from these other targets.  In biochem. assays probing the outward-facing DAT conformation, both RTI-371 and RTI-336 had effects similar to cocaine, suggesting little contribution of DAT conformation to the unique pharmacol. of RTI-371.  The locomotor-stimulant effects of RTI-371 (3.0-30 mg/kg i.p.) were comparable in wild-type and knockout cannabinoid CB1 receptor (CB1R) mice, indicating that previously reported CB1 allosteric effects do not decrease cocaine-like effects of RTI-371.  DAT occupancy in vivo was most rapid with cocaine and least with RTI-371.  The slow apparent assocn. rate may allow compensatory actions that in turn dampen cocaine-like stimulation, and give RTI-371 its unique pharmacol. profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDwwGziyXAgbVg90H21EOLACvtfcHk0linNfvYZjxxXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovVCmt7Y%253D&md5=0c4e7470799ae071011ab59b882e7165</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1124%2Fjpet.113.212738&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.113.212738%26sid%3Dliteratum%253Aachs%26aulast%3DHiranita%26aufirst%3DT.%26aulast%3DWilkinson%26aufirst%3DD.%2BS.%26aulast%3DHong%26aufirst%3DW.%2BC.%26aulast%3DZou%26aufirst%3DM.-F.%26aulast%3DKopajtic%26aufirst%3DT.%2BA.%26aulast%3DSoto%26aufirst%3DP.%2BL.%26aulast%3DLupica%26aufirst%3DC.%2BR.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26atitle%3D2-Isoxazol-3-phenyltropane%2520Derivatives%2520of%2520Cocaine%253A%2520Molecular%2520and%2520Atypical%2520System%2520Effects%2520at%2520the%2520Dopamine%2520Transporter%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2014%26volume%3D349%26spage%3D297%26epage%3D309%26doi%3D10.1124%2Fjpet.113.212738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Hong, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopajtic, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lomenzo, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jean, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madura, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surratt, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trudell, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, J. L.</span><span> </span><span class="NLM_article-title">2-Substituted 3β-Aryltropane Cocaine Analogs Produce Atypical Effects without Inducing Inward-Facing Dopamine Transporter Conformations</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">356</span><span class="NLM_x">, </span> <span class="NLM_fpage">624</span><span class="NLM_x">–</span> <span class="NLM_lpage">634</span><span class="refDoi"> DOI: 10.1124/jpet.115.230722</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1124%2Fjpet.115.230722" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=26769919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A280%3ADC%252BC28ngt1CitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=356&publication_year=2016&pages=624-634&author=W.+C.+Hongauthor=T.+A.+Kopajticauthor=L.+Xuauthor=S.+A.+Lomenzoauthor=B.+Jeanauthor=J.+D.+Maduraauthor=C.+K.+Surrattauthor=M.+L.+Trudellauthor=J.+L.+Katz&title=2-Substituted+3%CE%B2-Aryltropane+Cocaine+Analogs+Produce+Atypical+Effects+without+Inducing+Inward-Facing+Dopamine+Transporter+Conformations&doi=10.1124%2Fjpet.115.230722"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">2-Substituted 3β-Aryltropane Cocaine Analogs Produce Atypical Effects without Inducing Inward-Facing Dopamine Transporter Conformations</span></div><div class="casAuthors">Hong Weimin C; Kopajtic Theresa A; Xu Lifen; Lomenzo Stacey A; Jean Bernandie; Madura Jeffry D; Surratt Christopher K; Trudell Mark L; Katz Jonathan L</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of pharmacology and experimental therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">356</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">624-34</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Previous structure-activity relationship studies indicate that a series of cocaine analogs, 3β-aryltropanes with 2β-diarylmethoxy substituents, selectively bind to the dopamine transporter (DAT) with nanomolar affinities that are 10-fold greater than the affinities of their corresponding 2α-enantiomers.  The present study compared these compounds to cocaine with respect to locomotor effects in mice, and assessed their ability to substitute for cocaine (10 mg/kg, i.p.) in rats trained to discriminate cocaine from saline.  Despite nanomolar DAT affinity, only the 2β-Ph2COCH2-3β-4-Cl-Ph analog fully substituted for cocaine-like discriminative effects.  Whereas all of the 2β compounds increased locomotion, only the 2β-(4-ClPh)PhCOCH2-3β-4-Cl-Ph analog had cocaine-like efficacy.  None of the 2α-substituted compounds produced either of these cocaine-like effects.  To explore the molecular mechanisms of these drugs, their effects on DAT conformation were probed using a cysteine-accessibility assay.  Previous reports indicate that cocaine binds with substantially higher affinity to the DAT in its outward (extracellular)- compared with inward-facing conformation, whereas atypical DAT inhibitors, such as benztropine, have greater similarity in affinity to these conformations, and this is postulated to explain their divergent behavioral effects.  All of the 2β- and 2α-substituted compounds tested altered cysteine accessibility of DAT in a manner similar to cocaine.  Furthermore, molecular dynamics of in silico inhibitor-DAT complexes suggested that the 2-substituted compounds reach equilibrium in the binding pocket in a cocaine-like fashion.  These behavioral, biochemical, and computational results show that aryltropane analogs can bind to the DAT and stabilize outward-facing DAT conformations like cocaine, yet produce effects that differ from those of cocaine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSHUIt0a7sLpmx8TEN9K18QfW6udTcc2ebIp8_RpwPIyLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28ngt1CitA%253D%253D&md5=a21420fab70030162709440ede486173</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1124%2Fjpet.115.230722&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.115.230722%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DW.%2BC.%26aulast%3DKopajtic%26aufirst%3DT.%2BA.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DLomenzo%26aufirst%3DS.%2BA.%26aulast%3DJean%26aufirst%3DB.%26aulast%3DMadura%26aufirst%3DJ.%2BD.%26aulast%3DSurratt%26aufirst%3DC.%2BK.%26aulast%3DTrudell%26aufirst%3DM.%2BL.%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26atitle%3D2-Substituted%25203%25CE%25B2-Aryltropane%2520Cocaine%2520Analogs%2520Produce%2520Atypical%2520Effects%2520without%2520Inducing%2520Inward-Facing%2520Dopamine%2520Transporter%2520Conformations%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2016%26volume%3D356%26spage%3D624%26epage%3D634%26doi%3D10.1124%2Fjpet.115.230722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Scheffel, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boja, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhar, M. J.</span><span> </span><span class="NLM_article-title">Cocaine receptors: in vivo labeling with 3H-(−)cocaine, 3H-WIN 35,065–2, and 3H-WIN 35,428</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">390</span><span class="NLM_x">–</span> <span class="NLM_lpage">392</span><span class="refDoi"> DOI: 10.1002/syn.890040415</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1002%2Fsyn.890040415" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=2603151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADyaK3cXptFKhtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1989&pages=390-392&author=U.+Scheffelauthor=J.+W.+Bojaauthor=M.+J.+Kuhar&title=Cocaine+receptors%3A+in+vivo+labeling+with+3H-%28%E2%88%92%29cocaine%2C+3H-WIN+35%2C065%E2%80%932%2C+and+3H-WIN+35%2C428&doi=10.1002%2Fsyn.890040415"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Cocaine receptors: in vivo labeling with 3H-(-)cocaine, 3H-WIN 35065-2, and 3H-WIN 35428</span></div><div class="casAuthors">Scheffel, Ursula; Boja, John W.; Kuhar, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Synapse (New York, NY, United States)</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">390-2</span>CODEN:
                <span class="NLM_cas:coden">SYNAET</span>;
        ISSN:<span class="NLM_cas:issn">0887-4476</span>.
    </div><div class="casAbstract">The binding of tritiated (-)-cocaine and its 2 title analogs to the brain striatum and cerebellum was studied in mice.  The analogs WIN-35065-2 and WIN-35428 showed a stronger binding than cocaine to cocaine-binding sites in the striatum presumably assocd. with dopamine transports.  Both analogs are less prone to metab. than cocaine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2UAERaB5xILVg90H21EOLACvtfcHk0lj6Rp-8Umd8XA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXptFKhtA%253D%253D&md5=eed1a9ec1ddf6a054b5fc81045289b37</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1002%2Fsyn.890040415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fsyn.890040415%26sid%3Dliteratum%253Aachs%26aulast%3DScheffel%26aufirst%3DU.%26aulast%3DBoja%26aufirst%3DJ.%2BW.%26aulast%3DKuhar%26aufirst%3DM.%2BJ.%26atitle%3DCocaine%2520receptors%253A%2520in%2520vivo%2520labeling%2520with%25203H-%2528%25E2%2588%2592%2529cocaine%252C%25203H-WIN%252035%252C065%25E2%2580%25932%252C%2520and%25203H-WIN%252035%252C428%26jtitle%3DSynapse%26date%3D1989%26volume%3D4%26spage%3D390%26epage%3D392%26doi%3D10.1002%2Fsyn.890040415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Cheng, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusoff, W. H.</span><span> </span><span class="NLM_article-title">Relationship between the Inhibition Constant (Ki) and the Concentration of Inhibitor which causes 50% Inhibition (I50) of an Enzymatic Reaction</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3099</span><span class="NLM_x">–</span> <span class="NLM_lpage">3108</span><span class="refDoi"> DOI: 10.1016/0006-2952(73)90196-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1016%2F0006-2952%2873%2990196-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=4202581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1973&pages=3099-3108&author=Y.-C.+Chengauthor=W.+H.+Prusoff&title=Relationship+between+the+Inhibition+Constant+%28Ki%29+and+the+Concentration+of+Inhibitor+which+causes+50%25+Inhibition+%28I50%29+of+an+Enzymatic+Reaction&doi=10.1016%2F0006-2952%2873%2990196-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Relation between the inhibition constant K1) and the concentration of inhibitor which causes fifty per cent inhibition (I50) of an enzymic reaction</span></div><div class="casAuthors">Cheng, Yung-Chi; Prusoff, William H.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3099-108</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">The Ki and I50 values are equal where the kinetics are non- or uncompetitive, but not where they are competitive.  The relation between the 2 values was analyzed for non- and uncompetitive bi- and monosubstrate reactions and for competitive bisubstrate reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqodFY_8msz57Vg90H21EOLACvtfcHk0lj6Rp-8Umd8XA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXhtVGgs7c%253D&md5=fe7175ca300d8f4085df87af37f8656c</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2873%2990196-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252873%252990196-2%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.-C.%26aulast%3DPrusoff%26aufirst%3DW.%2BH.%26atitle%3DRelationship%2520between%2520the%2520Inhibition%2520Constant%2520%2528Ki%2529%2520and%2520the%2520Concentration%2520of%2520Inhibitor%2520which%2520causes%252050%2525%2520Inhibition%2520%2528I50%2529%2520of%2520an%2520Enzymatic%2520Reaction%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1973%26volume%3D22%26spage%3D3099%26epage%3D3108%26doi%3D10.1016%2F0006-2952%2873%2990196-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Hiranita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanda, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopajtic, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, J. L.</span><span> </span><span class="NLM_article-title">Stimulants as Specific Inducers of Dopamine-Independent σ Agonist Self-Administration in Rats</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">347</span><span class="NLM_x">, </span> <span class="NLM_fpage">20</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span><span class="refDoi"> DOI: 10.1124/jpet.113.207522</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1124%2Fjpet.113.207522" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsF2ks7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2013&pages=20-29&author=T.+Hiranitaauthor=P.+L.+Sotoauthor=G.+Tandaauthor=T.+A.+Kopajticauthor=J.+L.+Katz&title=Stimulants+as+Specific+Inducers+of+Dopamine-Independent+%CF%83+Agonist+Self-Administration+in+Rats&doi=10.1124%2Fjpet.113.207522"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Stimulants as specific inducers of dopamine-independent σ agonist self-administration in rats</span></div><div class="casAuthors">Hiranita, Takato; Soto, Paul L.; Tanda, Gianluigi; Kopajtic, Theresa A.; Katz, Jonathan L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">20-29</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A previous study showed that cocaine self-administration induced dopamine-independent reinforcing effects of σ agonists mediated by their selective actions at σ1 receptors (σ1Rs), which are intracellularly mobile chaperone proteins implicated in abuse-related effects of stimulants.  The present study assessed whether the induction was specific to self-administration of cocaine.  Rats were trained to self-administer the dopamine releaser, d-methamphetamine (0.01-0.32 mg/kg per injection), the μ-opioid receptor agonist, heroin (0.001-0.032 mg/kg per injection), and the noncompetitive N-methyl-D-aspartate receptor/channel antagonist ketamine (0.032-1.0 mg/kg per injection).  As with cocaine, self-administration of d-methamphetamine induced reinforcing effects of the selective σ1R agonists PRE-084 [2-(4-morpholinethyl)1-phenylcyclohexanecarboxylate hydrochloride] and (+)-pentazocine (0.032-1.0 mg/kg per injection, each).  In contrast, neither self-administration of heroin nor ketamine induced PRE-084 or (+)-pentazocine (0.032-10 mg/kg per injection, each) self-administration.  Although the σ1R agonists did not maintain responding in subjects with histories of heroin or ketamine self-administration, substitution for those drugs was obtained with appropriate agonists (e.g., remifentanil, 0.1-3.2 μg/kg per injection, for heroin and (5S,10R)-(+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine ((+)-MK 801; dizocilpine), 0.32-10.0 μg/kg per injection, for ketamine).  The σR antagonist N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1-pyrrolidinyl)ethylamine dihydrobromide (BD 1008; 1.0-10 mg/kg) dose-dependently blocked PRE-084 self-administration but was inactive against d-methamphetamine, heroin, and ketamine.  In contrast, PRE-084 self-administration was affected neither by the dopamine receptor antagonist (+)-butaclamol (10-100 μg/kg) nor by the opioid antagonist (-)-naltrexone (1.0-10 mg/kg), whereas these antagonists were active against d-methamphetamine and heroin self-administration, resp.  The results indicate that experience specifically with indirect-acting dopamine agonists induces reinforcing effects of previously inactive σ1R agonists.  It is further suggested that induced σ1R reinforcing mechanisms may play an essential role in treatment-resistant stimulant abuse, suggesting new approaches for the development of effective medications for its treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKYX262DkAL7Vg90H21EOLACvtfcHk0lj6Rp-8Umd8XA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsF2ks7zI&md5=3a6c50fc2758e9892cbe0c683b56b7d4</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1124%2Fjpet.113.207522&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.113.207522%26sid%3Dliteratum%253Aachs%26aulast%3DHiranita%26aufirst%3DT.%26aulast%3DSoto%26aufirst%3DP.%2BL.%26aulast%3DTanda%26aufirst%3DG.%26aulast%3DKopajtic%26aufirst%3DT.%2BA.%26aulast%3DKatz%26aufirst%3DJ.%2BL.%26atitle%3DStimulants%2520as%2520Specific%2520Inducers%2520of%2520Dopamine-Independent%2520%25CF%2583%2520Agonist%2520Self-Administration%2520in%2520Rats%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2013%26volume%3D347%26spage%3D20%26epage%3D29%26doi%3D10.1124%2Fjpet.113.207522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levant, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keck, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Tranylcypromine Substituted <i>cis</i>-Hydroxycyclobutylnaphthamides as Potent and Selective Dopamine D3 Receptor Antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">4962</span><span class="NLM_x">–</span> <span class="NLM_lpage">4968</span><span class="refDoi"> DOI: 10.1021/jm401798r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401798r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BC2cXosVOnurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4962-4968&author=J.+Chenauthor=B.+Levantauthor=C.+Jiangauthor=T.+M.+Keckauthor=A.+H.+Newmanauthor=S.+Wang&title=Tranylcypromine+Substituted+cis-Hydroxycyclobutylnaphthamides+as+Potent+and+Selective+Dopamine+D3+Receptor+Antagonists&doi=10.1021%2Fjm401798r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Tranylcypromine Substituted cis-Hydroxycyclobutylnaphthamides as Potent and Selective Dopamine D3 Receptor Antagonists</span></div><div class="casAuthors">Chen, Jianyong; Levant, Beth; Jiang, Cheng; Keck, Thomas M.; Newman, Amy Hauck; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4962-4968</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report a class of potent and selective dopamine D3 receptor antagonists based upon tranylcypromine.  Although tranylcypromine has a low affinity for the rat D3 receptor (Ki = 12.8 μM), our efforts have yielded (1R,2S)-11 (CJ-1882), which has Ki values of 2.7 and 2.8 nM at the rat and human dopamine D3 receptors, resp., and displays resp. selectivities of >10000-fold and 223-fold over the rat and human D2 receptors.  Evaluation in a β-arrestin functional assay showed that (1R,2S)-11 is a potent and competitive antagonist at the human D3 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowWudWdAfWgLVg90H21EOLACvtfcHk0lh_49ZGcnc7KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXosVOnurg%253D&md5=e2ddf0711d00103be281cb043b19ec3a</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fjm401798r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401798r%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DLevant%26aufirst%3DB.%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DKeck%26aufirst%3DT.%2BM.%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DTranylcypromine%2520Substituted%2520cis-Hydroxycyclobutylnaphthamides%2520as%2520Potent%2520and%2520Selective%2520Dopamine%2520D3%2520Receptor%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4962%26epage%3D4968%26doi%3D10.1021%2Fjm401798r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Urizar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yano, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolster, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galés, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javitch, J. A.</span><span> </span><span class="NLM_article-title">CODA-RET Reveals Functional Selectivity as a Result of GPCR Heteromerization</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">624</span><span class="NLM_x">–</span> <span class="NLM_lpage">630</span><span class="refDoi"> DOI: 10.1038/nchembio.623</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1038%2Fnchembio.623" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=21785426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptlaktLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=624-630&author=E.+Urizarauthor=H.+Yanoauthor=R.+Kolsterauthor=C.+Gal%C3%A9sauthor=N.+Lambertauthor=J.+A.+Javitch&title=CODA-RET+Reveals+Functional+Selectivity+as+a+Result+of+GPCR+Heteromerization&doi=10.1038%2Fnchembio.623"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">CODA-RET reveals functional selectivity as a result of GPCR heteromerization</span></div><div class="casAuthors">Urizar, Eneko; Yano, Hideaki; Kolster, Rachel; Gales, Celine; Lambert, Nevin; Javitch, Jonathan A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">624-630</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Here the authors present a new method that combines protein complementation with resonance energy transfer to study conformational changes in response to activation of a defined G protein-coupled receptor heteromer, and the authors apply the approach to the putative dopamine D1-D2 receptor heteromer.  Remarkably, the potency of the D2 dopamine receptor (D2R) agonist R-(-)-10,11-dihydroxy-N-n-propylnoraporphine (NPA) to change the Gαi conformation via the D2R promoter in the D1-D2 heteromer was enhanced ten-fold relative to its potency in the D2R homomer.  In contrast, the potencies of the D2R agonists dopamine and quinpirole were the same in the homomer and heteromer.  Thus, the authors have uncovered a mol. mechanism for functional selectivity in which a drug acts differently at a G protein-coupled receptor (GPCR) promoter depending on the identity of the second promoter participating in the formation of the signaling unit-opening the door to enhancing pharmacol. specificity by targeting differences between homomeric and heteromeric signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCa-gFk2Y_C7Vg90H21EOLACvtfcHk0lh_49ZGcnc7KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptlaktLk%253D&md5=65c3f8f3a8b5ed1bfdf99fc7d2712a9e</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.623%26sid%3Dliteratum%253Aachs%26aulast%3DUrizar%26aufirst%3DE.%26aulast%3DYano%26aufirst%3DH.%26aulast%3DKolster%26aufirst%3DR.%26aulast%3DGal%25C3%25A9s%26aufirst%3DC.%26aulast%3DLambert%26aufirst%3DN.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26atitle%3DCODA-RET%2520Reveals%2520Functional%2520Selectivity%2520as%2520a%2520Result%2520of%2520GPCR%2520Heteromerization%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D7%26spage%3D624%26epage%3D630%26doi%3D10.1038%2Fnchembio.623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Pedersen, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreassen, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loland, C. J.</span><span> </span><span class="NLM_article-title">A Conserved Salt Bridge between Transmembrane Segments 1 and 10 Constitutes an Extracellular Gate in the Dopamine Transporter</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">35003</span><span class="NLM_x">–</span> <span class="NLM_lpage">35014</span><span class="refDoi"> DOI: 10.1074/jbc.M114.586982</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=10.1074%2Fjbc.M114.586982" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=25339174" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlvVSgug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=35003-35014&author=A.+V.+Pedersenauthor=T.+F.+Andreassenauthor=C.+J.+Loland&title=A+Conserved+Salt+Bridge+between+Transmembrane+Segments+1+and+10+Constitutes+an+Extracellular+Gate+in+the+Dopamine+Transporter&doi=10.1074%2Fjbc.M114.586982"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">A conserved salt bridge between transmembrane segments 1 and 10 constitutes an extracellular gate in the dopamine transporter</span></div><div class="casAuthors">Pedersen, Anders V.; Andreassen, Thorvald F.; Loland, Claus J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">35003-35014, 13 pp.</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Neurotransmitter transporters play an important role in termination of synaptic transmission by mediating reuptake of neurotransmitter, but the mol. processes behind translocation are still unclear.  The crystal structures of the bacterial homolog, LeuT, provided valuable insight into the structural and dynamic requirements for substrate transport.  These structures support the existence of gating domains controlling access to a central binding site.  On the extracellular side, access is controlled by the "thin gate" formed by an interaction between Arg-30 and Asp-404.  In the human dopamine transporter (DAT), the corresponding residues are Arg-85 and Asp-476.  Here, we present results supporting the existence of a similar interaction in DAT.  The DAT R85D mutant has a complete loss of function, but the addnl. insertion of an arginine in opposite position (R85D/D476R), causing a charge reversal, results in a rescue of binding sites for the cocaine analog [3H]CFT.  Also, the coordination of Zn2+ between introduced histidines (R85H/D476H) caused a ∼2.5-fold increase in [3H]CFT binding (Bmax).  Importantly, Zn2+ also inhibited [3H]dopamine transport in R85H/D476H, suggesting that a dynamic interaction is required for the transport process.  Furthermore, cysteine-reactive chem. shows that mutation of the gating residues causes a higher proportion of transporters to reside in the outward facing conformation.  Finally, we show that charge reversal of the corresponding residues (R104E/E493R) in the serotonin transporter (SERT) also rescues [3H](S)-citalopram binding, suggesting a conserved feature.  Taken together, these data suggest that the extracellular thin gate is present in monoamine transporters and that a dynamic interaction is required for substrate transport.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGob2g8cE5ScPrVg90H21EOLACvtfcHk0lh_49ZGcnc7KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlvVSgug%253D%253D&md5=8036920794dfc9fbf25a1f09f356cfaa</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M114.586982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M114.586982%26sid%3Dliteratum%253Aachs%26aulast%3DPedersen%26aufirst%3DA.%2BV.%26aulast%3DAndreassen%26aufirst%3DT.%2BF.%26aulast%3DLoland%26aufirst%3DC.%2BJ.%26atitle%3DA%2520Conserved%2520Salt%2520Bridge%2520between%2520Transmembrane%2520Segments%25201%2520and%252010%2520Constitutes%2520an%2520Extracellular%2520Gate%2520in%2520the%2520Dopamine%2520Transporter%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D35003%26epage%3D35014%26doi%3D10.1074%2Fjbc.M114.586982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i77"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01373">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_80308"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b01373">10.1021/acs.jmedchem.6b01373</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Elemental analysis results (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01373/suppl_file/jm6b01373_si_001.pdf">PDF</a>)</p></li><li><p class="inline">SMILES data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01373/suppl_file/jm6b01373_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01373/suppl_file/jm6b01373_si_001.pdf">jm6b01373_si_001.pdf (131.67 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01373/suppl_file/jm6b01373_si_002.csv">jm6b01373_si_002.csv (3.55 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b01373&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-23%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b01373" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b01373" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799141cdd0422f0","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
